SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13E-3
RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION
13(E)
OF THE SECURITIES ACT OF 1934
PowerSchool
Holdings, Inc.
(Name of the Issuer)
PowerSchool
Holdings, Inc.
Vista Equity Partners Fund VI, L.P.
Vista Equity Partners Fund VI-A, L.P.
VEPF VI FAF, L.P.
Severin Topco, LLC
VEP
Group, LLC
Robert F. Smith
Pinnacle Holdings I L.P.
Onex Partners IV Select LP
Onex US Principals LP
Onex Partners IV LP
Onex
Partners IV GP LP
Onex Partners IV PV LP
Onex Powerschool LP
OPH
B LP
Onex Partners Canadian GP Inc.
Onex American Holdings GP LLC
Onex Private Equity Holdings LLC
Onex Partners IV GP Ltd.
Onex Partners IV GP LLC
Onex Corporation
Gerald
W. Schwartz
(Names of Persons Filing Statement)
Class A Common Stock, par value $0.0001 per share
(Title of Class of Securities)
73939C106
(CUSIP Number
of Class of Securities)
|
|
|
|
|
PowerSchool Holdings, Inc.
Hardeep Gulati Chief
Executive Officer 150 Parkshore Drive
Folsom, CA 95630 (877) 873-1550 |
|
Vista Equity Partners Fund VI, L.P.
Vista Equity Partners Fund VI-A, L.P.
VEPF VI FAF, L.P. Severin
Topco, LLC VEP Group, LLC
c/o Vista Equity Partners
4 Embarcadero Center, 20th Floor
San Francisco, CA 94111
(415) 765-6500
Robert F. Smith c/o Vista
Equity Partners 401 Congress Drive, Suite 3100
Austin, TX 78701 (512)
730-2400 |
|
Pinnacle Holdings I L.P.
Onex Partners IV Select LP
Onex US Principals LP
Onex Partners IV LP Onex
Partners IV GP LP Onex Partners IV PV LP
Onex Powerschool LP OPH B
LP Onex American Holdings GP LLC
Onex Private Equity Holdings LLC
Onex Partners IV GP LLC
712 Fifth Avenue, 40th Floor
New York, NY 10019 (212) 582-2211 Onex
Partners IV GP Ltd. Onex Partners Canadian GP Inc.
Onex Corporation Gerald
W. Schwartz 161 Bay Street, 49th Floor
Toronto, Ontario, Canada M5J 2S1
(416) 362-7711 |
(Name, Address, and Telephone Numbers of Person Authorized to Receive Notices and Communications on Behalf of
the Persons Filing Statement)
With copies to
|
|
|
Damien R. Zoubek
Sanjay Murti Freshfields
Bruckhaus Deringer US LLP 175 Greenwich Street
New York, NY 10007 (212) 277-4000 |
|
Daniel Wolf, P.C.
David M. Klein, P.C.
Kirkland & Ellis LLP
601 Lexington Avenue New
York, NY 10022 (212) 446-4800 |
This statement is filed in connection with (check the appropriate box):
|
|
|
|
|
a. |
|
☒ |
|
The filing of solicitation materials or an information statement subject to Regulation 14A, Regulation 14C or Rule 13e-3(c) under the Securities Exchange Act of 1934. |
|
|
|
b. |
|
☐ |
|
The filing of a registration statement under the Securities Act of 1933. |
|
|
|
c. |
|
☐ |
|
A tender offer. |
|
|
|
d. |
|
☐ |
|
None of the above. |
Check the following box if the soliciting materials or information statement referred to in checking box
(a) are preliminary copies: ☒
Check the following box if the filing is a final amendment reporting the results of the
transaction: ☐
Neither the Securities and Exchange Commission nor any state securities commission has approved or
disapproved of this transaction, passed upon the merits or fairness of this transaction, or passed upon the adequacy or accuracy of the disclosure in this transaction statement on Schedule 13E-3. Any
representation to the contrary is a criminal offense.
INTRODUCTION
This Transaction Statement on Schedule 13E-3 (the Transaction Statement) is being
filed with the U.S. Securities and Exchange Commission (the SEC) pursuant to Section 13(e) of the Securities Exchange Act of 1934, as amended (the Exchange Act), jointly by the following persons (each, a Filing
Person, and collectively, the Filing Persons): (1) PowerSchool Holdings, Inc., a Delaware corporation (PowerSchool or the Company) and the issuer of the Class A common stock, par value $0.0001 per
share (the Class A Common Stock) that is the subject of the Rule 13e-3 transaction; (2) Vista Equity Partners Fund VI, L.P., a Cayman Islands exempted limited partnership (VEPF
VI); (3) Vista Equity Partners Fund VI-A, L.P., a Cayman Islands exempted limited partnership (VEPF VI-A); (4) VEPF VI FAF, L.P., a Cayman
Islands exempted limited partnership (VEPF FAF); (5) Severin Topco, LLC, a Delaware limited liability company (Severin Topco); (6) VEP Group, LLC, a Delaware limited liability company; (7) Robert F. Smith;
(8) Pinnacle Holdings I L.P., a Delaware limited partnership (Pinnacle Holdings); (9) Onex Partners IV Select LP, a Cayman Islands exempted limited partnership (Onex Partners IV Select); (10) Onex US Principals LP,
a Delaware limited partnership (Onex US Principals); (11) Onex Partners IV LP, a Cayman Islands exempted limited partnership (Onex Partners IV); (12) Onex Partners IV GP LP, a Cayman Islands exempted limited partnership
(Onex Partners IV GP); (13) Onex Partners IV PV LP, a Delaware limited partnership (Onex Partners IV PV); (14) Onex Powerschool LP, a Delaware limited partnership (Onex Powerschool); (15) OPH B LP; (16) Onex
Partners Canadian GP Inc., a corporation organized under the laws of the Province of Ontario; (17) Onex American Holdings GP LLC, a Delaware limited liability company; (18) Onex Private Equity Holdings LLC, a Delaware limited liability
company; (19) Onex Partners IV GP Ltd., a Cayman Islands exempted limited partnership; (20) Onex Partners IV GP LLC, a Delaware limited liability company; (21) Onex Corporation, a corporation organized under the laws of the Province
of Ontario; and (22) Gerald W. Schwartz.
This Transaction Statement relates to the Agreement and Plan of Merger, dated June 6,
2024 (including all exhibits and documents attached thereto, and as it may be amended from time to time, the Merger Agreement), by and among BCPE Polymath Buyer, Inc., a Delaware corporation (Parent), BCPE Polymath Merger
Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (Merger Sub), and PowerSchool. The Merger Agreement provides that, subject to the terms and conditions set forth in the Merger Agreement and the applicable
provisions of the General Corporation Law of the State of Delaware (the DGCL), Merger Sub will be merged with and into PowerSchool (the Merger), the separate corporate existence of Merger Sub will thereupon cease, and
PowerSchool will continue as the surviving corporation of the Merger and as a wholly owned subsidiary of Parent (the transactions contemplated by the Merger Agreement, including the Merger, collectively, the Transactions).
At the effective time of the Merger (the Effective Time), upon the terms and subject to the conditions set forth in the Merger
Agreement, by virtue of the Merger and without any action on the part of Parent, each issued and outstanding share of Class A Common Stock, other than (i) each share of common stock, par value $0.001 per share of Merger Sub that is issued
and outstanding as of immediately prior to the Effective Time will automatically be converted into one validly issued, fully paid and nonassessable share of common stock of the surviving corporation of the Merger; (ii) each share of
Class A Common Stock that is issued and outstanding as of immediately prior to the Effective Time (other than Owned Company Shares (including Rollover Shares) or Dissenting Company Shares) will be automatically cancelled, extinguished and
converted into the right to receive cash in an amount equal to $22.80, without interest thereon (the Per Share Price); (iii) any shares of Class A Common Stock held by PowerSchool as treasury stock or owned by Parent or any of its
affiliates or subsidiaries (including Merger Sub), in each case as of immediately prior to the Effective Time, which will automatically be cancelled and extinguished without conversion thereof or consideration paid in exchange (Owned Company
Shares); (iv) certain shares of Class A Common Stock (the Rollover Shares), which will be transferred together with certain limited liability company units of PowerSchool Holdings LLC (the Rollover Units) held by
the Principal Stockholders (as defined below) to BCPE Polymath Topco, LP, a Delaware limited partnership and affiliate of investment funds advised by Bain Capital Private Equity, LP (BCPE Topco), immediately prior to the Effective Time,
pursuant to support and rollover agreements entered into in connection with the Merger Agreement; and (v) shares of Class A Common Stock that are issued and outstanding immediately prior to the Effective Time (other than Owned Company
Shares) held by holders who have not consented to the adoption of the Merger Agreement in writing and who have properly exercised appraisal rights with respect to their shares in accordance with, and who have complied with, Section 262 of the
DGCL, will not be converted into the right to receive the Per Share Price (Dissenting Company Shares), and holders of such Dissenting Company Shares will be entitled to receive payment of the fair value of such Dissenting Company Shares
in accordance with the provisions of Section 262 of the DGCL unless and until any such holder fails to perfect or effectively withdraws or loses their rights to appraisal and payment under the DGCL. At the Effective time, each Owned Company
2
Share will automatically be cancelled and extinguished without any conversion thereof or consideration paid in exchange and any shares of Class B common stock, par value $0.0001 per share
(the Class B Common Stock and, together with the Class A Common Stock, the Company Common Stock), of PowerSchool issued and outstanding immediately prior to the Effective Time will automatically be cancelled and
shall cease to exist and no payment shall be made with respect thereto, and the holders thereof shall cease to have any rights with respect thereto. Upon consummation of the Merger, the Class A Common Stock will no longer be publicly traded,
and PowerSchools stockholders (other than holders of the Rollover Shares, indirectly) will cease to have any ownership interest in PowerSchool. The Rollover Shares will be exchanged by the Principal Stockholders immediately prior to the
Effective Time for common units of BCPE Topco, in accordance with the terms of the Support and Rollover Agreements, each dated as of June 6, 2024 (as may be amended, restated or otherwise modified from time to time), by and among investment
funds affiliated with Vista Equity Partners and Onex Partners Manager LP, PowerSchool and Parent. Vista and Onex have committed to a rollover so they will hold, in the aggregate, approximately 49% of the pro forma post-Closing capitalization table
of BCPE Topco.
In connection with entering into the Merger Agreement, on June 6, 2024, PowerSchool and the TRA Holders (as defined
in the Tax Receivable Agreement, dated as of July 27, 2021, by and among PowerSchool, PowerSchool Holdings, LLC and the other parties identified therein (the Tax Receivable Agreement)) party thereto, entered into an amendment to the
Tax Receivable Agreement (the TRA Amendment), pursuant to which the parties agreed, among other things, to (i) amend PowerSchools existing Tax Receivable Agreement, such that the Tax Receivable Agreement will automatically
terminate upon the Effective Time and (ii) the TRA Holders agreed to waive certain Tax Benefit Payments (as defined in the TRA Amendment) pursuant to the Tax Receivable Agreement, including all amounts that would have otherwise become payable
to the TRA Holders in connection with the consummation of the Merger. From and after the Effective Time, no Early Termination Payment or Tax Benefit Payment (each as defined in the TRA Amendment) will be made to any TRA Holder pursuant to the Tax
Receivable Agreement.
The board of directors of PowerSchool (the Board) formed a special committee of the Board (the
Special Committee), comprised solely of independent and disinterested members of the Board, to review, evaluate and provide input on a potential sale of PowerSchool and certain alternatives thereto (including remaining an independent
company), to determine whether such a potential sale is advisable and fair to and in the best interest of PowerSchool and its stockholders and to recommend to the Board what action, if any, should be taken with respect to the potential sale of
PowerSchool. In connection with the formation of the Special Committee, the Board resolved that it would not approve any potential sale of PowerSchool that would involve the Principal Stockholders participating in an equity rollover or receiving
payments under the Tax Receivable Agreement without a prior favorable recommendation from the Special Committee. The Special Committee, as more fully described in the Information Statement (as defined below), unanimously (i) determined that it
is fair to, and in the best interests of, PowerSchool and its stockholders, and declared it advisable, to enter into the Merger Agreement providing for the Merger, with PowerSchool being the surviving corporation in the Merger in accordance with the
DGCL upon the terms and subject to the conditions set forth therein; (ii) resolved to recommend that the Board approve and adopt the Merger Agreement; and (iii) resolved to recommend that the Board submit the Merger Agreement to
PowerSchools stockholders for their adoption and recommend that PowerSchools stockholders vote in favor of the Merger Agreement. Unaffiliated Stockholders means the Companys unaffiliated security holders as
defined under Rule 13e-3 of the Exchange Act.
The Board, acting on the unanimous
recommendation of the Special Committee, has (i) determined that it is fair to, and in the best interests of, PowerSchool and its stockholders, and declared it advisable, to enter into the Merger Agreement providing for the Merger in accordance
with the DGCL upon the terms and subject to the conditions set forth therein; (ii) approved the execution and delivery of the Merger Agreement by PowerSchool, the performance by PowerSchool of its covenants and other obligations thereunder, and
the consummation of the Merger and the other transactions contemplated by the Merger Agreement upon the terms and subject to the conditions set forth therein; (iii) directed that the adoption of the Merger Agreement be submitted for
consideration by PowerSchools stockholders in accordance with the Merger Agreement; and (iv) resolved to recommend that PowerSchools stockholders approve and adopt the Merger Agreement in accordance with the DGCL.
The adoption of the Merger Agreement by PowerSchools stockholders required the affirmative vote or written consent by holders of a
majority of the outstanding shares of Company Common Stock entitled to vote thereon. On June 7, 2024, Severin Topco, VEPF VI, VEPF VI-A, VEPF FAF, Onex Partners IV Select, Onex US Principals, Onex
Partners IV, Onex Partners IV GP, Onex Partners IV PV, Onex Powerschool and Pinnacle Holdings (collectively, the Principal Stockholders), which together on June 7, 2024 beneficially owned
3
105,321,745 shares of Class A Common Stock and 36,914,501 shares of Class B Common Stock, representing approximately 69.8% of the aggregate voting power of the issued and outstanding
shares of Company Common Stock, delivered a written consent approving and adopting in all respects the Merger Agreement and the Transactions, including the Merger. As a result, no further action by any stockholder of PowerSchool is required under
applicable law or the Merger Agreement (or otherwise) to adopt the Merger Agreement, and PowerSchool will not be soliciting your vote for or consent to the adoption of the Merger Agreement and the approval of the Transactions and will not call a
stockholders meeting for purposes of voting on the adoption of the Merger Agreement and the approval of the Transactions, including the Merger.
Concurrently with the filing of this Transaction Statement, PowerSchool is filing a notice of written consent and appraisal rights and
information statement (the Information Statement) under Regulation 14C of the Exchange Act with the SEC. The Information Statement is attached hereto as Exhibit (a)(1). A copy of the Merger Agreement is attached to the Information
Statement as Annex A. As of the date hereof, the Information Statement is in preliminary form, and is subject to completion or amendment. Terms used but not defined in this Transaction Statement have the meanings assigned to them in the Information
Statement.
Pursuant to General Instruction F to Schedule 13E-3, the information in the
Information Statement, including all annexes thereto, is expressly incorporated by reference herein in its entirety, and responses to each item herein are qualified in their entirety by the information contained in the Information Statement. The
cross-references below are being supplied pursuant to General Instruction G to Schedule 13E-3 and show the location in the Information Statement of the information required to be included in response to
the items of Schedule 13E-3.
The information concerning PowerSchool contained in, or
incorporated by reference into, this Transaction Statement and the Information Statement was supplied by PowerSchool. Similarly, all information concerning each other Filing Person contained in, or incorporated by reference into, this Transaction
Statement and the Information Statement was supplied by such Filing Person. No Filing Person, including PowerSchool, is responsible for the accuracy of any information supplied by any other Filing Person.
Item 1. Summary Term Sheet
The
information set forth in the Information Statement under the following captions is incorporated herein by reference:
Summary
Questions and Answers About the Merger
Item 2. Subject Company Information
(a) Name and address. The information set forth in the Information Statement under the following caption is incorporated herein
by reference:
The Parties to the Merger Agreement
(b) Securities. The information set forth in the Information Statement under the following captions is incorporated herein by
reference:
Summary
Questions and Answers About the Merger
Important Information Regarding PowerSchool
Important Information Regarding PowerSchoolSecurity Ownership of Certain Beneficial Owners and Management
(c) Trading market and price. The information set forth in the Information Statement under the following caption is incorporated
herein by reference:
Important Information Regarding PowerSchoolMarket Price of PowerSchool Class A Common Stock
(d) Dividends. The information set forth in the Information Statement under the following caption is incorporated herein by
reference:
4
Important Information Regarding PowerSchoolDividends
(e) Prior public offerings. The information set forth in the Information Statement under the following caption is incorporated
herein by reference:
Important Information Regarding PowerSchoolPrior Public Offerings
(f) Prior share purchases. The information set forth in the Information Statement under the following captions is incorporated
herein by reference:
Important Information Regarding PowerSchoolPrior Public Offerings
Important Information Regarding PowerSchoolTransactions in PowerSchool Class A Common Stock
Important Information Regarding PowerSchoolPast Contracts, Transactions, Negotiations and Agreements
Item 3. Identity and Background of Filing Person
(a) (c) Name and Address of Each Filing Person; Business and Background of Entities; Business and Background of
Natural Persons. The information set forth in the Information Statement under the following captions is incorporated herein by reference:
SummaryThe Parties to the Merger Agreement
The Parties to the Merger Agreement
Important Information Regarding PowerSchool
Important Information Regarding Vista and Onex
Item 4. Terms of the Transaction
(a) (1) Material terms. Tender offers. Not applicable
(a) (2) Mergers or Similar Transactions. The information set forth in the Information Statement under the
following captions is incorporated herein by reference:
Summary
Questions and Answers About the Merger
Special FactorsBackground of the Merger
Special FactorsRecommendation of the Special Committee and the Board; Reasons for the Merger
Special FactorsReasons of Vista and Onex for the Merger
Special FactorsPosition of Vista and Onex as to the Fairness of the Merger
Special FactorsPlans for PowerSchool After the Merger
Special FactorsCertain Effects of the Merger
Special FactorsCertain Effects on the Company if the Merger Is Not Completed
Special FactorsInterests of Our Directors and Executive Officers in the Merger
Special FactorsMaterial United States Federal Income Tax Consequences of the Merger
The Merger AgreementProcedures for Receiving Merger Consideration
The Merger AgreementConsideration to be Received in the Merger
The Merger AgreementConditions to Consummation of the Merger
Annex AAgreement and Plan of Merger
5
(c) Different terms. The information set forth in the Information Statement
under the following captions is incorporated herein by reference:
Summary
Questions and Answers About the Merger
Special FactorsCertain Effects of the Merger
Special FactorsFinancing
Special FactorsInterests of Our Directors and Executive Officers in the Merger
The Merger AgreementConsideration to be Received in the Merger
The Merger AgreementProcedure for Receiving Merger Consideration
The Merger AgreementSupport and Rollover Agreements
The Merger AgreementTRA Amendment
The Merger AgreementIndemnification and Insurance
Annex AAgreement and Plan of Merger
Annex DVista Support and Rollover Agreement
Annex EOnex Support and Rollover Agreement
Annex FTRA Amendment
(d)
Appraisal rights. The information set forth in the Information Statement under the following captions is incorporated herein by reference:
Questions and Answers About the Merger
Special FactorsCertain Effects of the Merger
Appraisal Rights
Annex GSection 262 of the General Corporation Law of the State of Delaware
(e) Provisions for unaffiliated security holders. The information set forth in the Information Statement under the following
captions is incorporated herein by reference:
Special FactorsRecommendation of the Special Committee and the Board; Reasons
for the Merger
Provisions for Unaffiliated Stockholders
(f) Eligibility for listing or trading. Not applicable.
Item 5. Past Contacts, Transactions, Negotiations and Agreements
(a)(1) (2) Transactions. The information set forth in the Information Statement under the following
captions is incorporated herein by reference:
Summary
Special FactorsBackground of the Merger
Special FactorsCertain Effects of the Merger
Special FactorsFinancing
Special FactorsInterests of Our Directors and Executive Officers in the Merger
The Merger Agreement
6
The Merger AgreementSupport and Rollover Agreements
The Merger AgreementTRA Amendment
Important Information Regarding PowerSchoolPrior Public Offerings
Important Information Regarding PowerSchoolTransactions in PowerSchool Class A Common Stock
Important Information Regarding PowerSchoolPast Contracts, Transactions, Negotiations and Agreements
Important Information Regarding Vista and Onex
Annex AAgreement and Plan of Merger
Annex DVista Support and Rollover Agreement
Annex EOnex Support and Rollover Agreement
Annex FTRA Amendment
(b) (c) Significant corporate events; Negotiations or contacts. The information set forth in the
Information Statement under the following captions is incorporated herein by reference:
Summary
Special FactorsBackground of the Merger
Special FactorsRecommendation of the Special Committee and the Board; Reasons for the Merger
Special FactorsReasons of Vista and Onex for the Merger
Special FactorsPosition of Vista and Onex as to the Fairness of the Merger
Special FactorsFinancing
Special FactorsInterests of Our Directors and Executive Officers in the Merger
The Merger Agreement
The Merger AgreementSupport and Rollover Agreements
The Merger AgreementTRA Amendment
Annex AAgreement and Plan of Merger
Annex DVista Support and Rollover Agreement
Annex EOnex Support and Rollover Agreement
Annex FTRA Amendment
(e)
Agreements involving the subject companys securities. The information set forth in the Information Statement under the following captions is incorporated herein by reference:
Summary
Questions and Answers About the Merger
Special FactorsBackground of the Merger
Special FactorsCertain Effects of the Merger
Special FactorsInterests of Our Directors and Executive Officers in the Merger
The Merger Agreement
The Merger AgreementSupport and Rollover Agreements
7
The Merger AgreementTRA Amendment
Important Information Regarding PowerSchoolTransactions in PowerSchool Class A Common Stock
Important Information Regarding PowerSchoolPast Contracts, Transactions, Negotiations and Agreements
Annex AAgreement and Plan of Merger
Annex DVista Support and Rollover Agreement
Annex EOnex Support and Rollover Agreement
Annex FTRA Amendment
Item 6.
Purposes of the Transaction and Plans or Proposals
(b) Use of securities acquired. The information set forth in the
Information Statement under the following captions is incorporated herein by reference:
Summary
Special FactorsPlans for PowerSchool After the Merger
Special FactorsCertain Effects of the Merger
Special FactorsCertain Effects on the Company if the Merger is Not Completed
Special FactorsFinancing
Special FactorsInterests of Our Directors and Executive Officers in the Merger
Special FactorsDelisting and Deregistration of Class A Common Stock
The Merger AgreementConsideration to be Received in the Merger
The Merger AgreementProcedures for Receiving Merger Consideration
Annex AAgreement and Plan of Merger
(c)(1) (8) Plans. The information set forth in the Information Statement under the following captions is
incorporated herein by reference:
Summary
Questions and Answers About the Merger
Special FactorsBackground of the Merger
Special FactorsRecommendation of the Special Committee and the Board; Reasons for the Merger
Special FactorsReasons of Vista and Onex for the Merger
Special FactorsPosition of Vista and Onex as to the Fairness of the Merger
Special FactorsPlans for PowerSchool After the Merger
Special FactorsCertain Effects of the Merger
Special FactorsCertain Effects on the Company if the Merger is Not Completed
Special FactorsFinancing
Special FactorsInterests of Our Directors and Executive Officers in the Merger
Special FactorsDelisting and Deregistration of Class A Common Stock
The Merger AgreementConsideration to be Received in the Merger
The Merger AgreementSupport and Rollover Agreements
8
The Merger AgreementTRA Amendment
Important Information Regarding PowerSchool
Annex AAgreement and Plan of Merger
Item 7. Purposes, Alternatives, Reasons and Effects
(a) Purposes. The information set forth in the Information Statement under the following captions is incorporated herein by
reference:
Summary
Questions and Answers About the Merger
Special FactorsBackground of the Merger
Special FactorsRecommendation of the Special Committee and the Board; Reasons for the Merger
Special FactorsReasons of Vista and Onex for the Merger
Special FactorsPosition of Vista and Onex as to the Fairness of the Merger
Special Factor Plans for PowerSchool After the Merger
Special FactorsCertain Effects of the Merger
(b) Alternatives. The information set forth in the Information Statement under the following captions is incorporated herein by
reference:
Summary
Special FactorsBackground of the Merger
Special FactorsRecommendation of the Special Committee and the Board; Reasons for the Merger
Special FactorsReasons of Vista and Onex for the Merger
Special FactorsPosition of Vista and Onex as to the Fairness of the Merger
Special FactorsCertain Effects on PowerSchool if the Merger is Not Completed
(c) Reasons. The information set forth in the Information Statement under the following captions is incorporated herein by
reference:
Summary
Special FactorsBackground of the Merger
Special FactorsRecommendation of the Special Committee and the Board; Reasons for the Merger
Special FactorsOpinion of Goldman Sachs & Co. LLC
Special FactorsOpinion of Centerview Partners LLC
Special FactorsReasons of Vista and Onex for the Merger
Special FactorsPosition of Vista and Onex as to the Fairness of the Merger
Special FactorsCertain Effects of the Merger
Special FactorsCertain Effects on the Company if the Merger is Not Completed
Special FactorsCertain Company Financial Forecasts
Annex BOpinion of Goldman Sachs & Co. LLC
Annex COpinion of Centerview Partners LLC
9
(d) Effects. The information set forth in the Information Statement under the
following captions is incorporated herein by reference:
Summary
Questions and Answers About the Merger
Special FactorsBackground of the Merger
Special FactorsRecommendation of the Special Committee and the Board; Reasons for the Merger
Special FactorsOpinion of Goldman Sachs & Co. LLC
Special FactorsOpinion of Centerview Partners LLC
Special FactorsReasons of Vista and Onex for the Merger
Special FactorsPosition of Vista and Onex as to the Fairness of the Merger
Special FactorsPlans for PowerSchool After the Merger
Special FactorsCertain Effects of the Merger
Special FactorsCertain Effects on the Company if the Merger is Not Completed
Special FactorsFinancing
Special FactorsInterests of Our Directors and Executive Officers in the Merger
Special FactorsFees and Expenses
Special FactorsDelisting and Deregistration of Class A Common Stock
Special FactorsMaterial United States Federal Income Tax Consequences of the Merger
The Merger AgreementConsideration to be Received in the Merger
The Merger AgreementIndemnification and Insurance
Appraisal Rights
Annex AAgreement and Plan of Merger
Annex BOpinion of Goldman Sachs & Co. LLC
Annex COpinion of Centerview Partners LLC
Item 8. Fairness of the Transaction
(a) (b) Fairness; Factors considered in determining fairness. The information set forth in the
Information Statement under the following captions is incorporated herein by reference:
Summary
Questions and Answers About the Merger
Special FactorsBackground of the Merger
Special FactorsRecommendation of the Special Committee and the Board; Reasons for the Merger
Special FactorsOpinion of Goldman Sachs & Co. LLC
Special FactorsOpinion of Centerview Partners LLC
Special FactorsReasons of Vista and Onex for the Merger
Special FactorsPosition of Vista and Onex as to the Fairness of the Merger
10
Special FactorsCertain Effects of the Merger
Special FactorsInterests of Our Directors and Executive Officers in the Merger
Annex BOpinion of Goldman Sachs & Co. LLC
Annex COpinion of Centerview Partners LLC
The discussion materials dated March 5, 2024, the Presentations to the Board dated April 17, 2024, April 24, 2024 and June 6, 2024, each
prepared by Goldman Sachs & Co. LLC, and the Tax Receivable Agreement Presentation dated April 9, 2024, prepared by Ernst & Young LLP, and reviewed by the Board, are filed as Exhibits (c)(iii) (c)(vi) and Exhibit (c)(xii) and are
incorporated herein by reference.
The discussion materials to the Special Committee dated May 1, 2024, May 3, 2024, May 6, 2024, June 5,
2024 and June 6, 2024, each prepared by Centerview Partners LLC and reviewed by the Special Committee, are filed as Exhibits (c)(vii) (c)(xi) and are incorporated herein by reference.
(c) Approval of security holders. The information set forth in the Information Statement under the following captions is
incorporated herein by reference:
Summary
Questions and Answers about the Merger
Special FactorsBackground of the Merger
Special FactorsRecommendation of the Special Committee and the Board; Reasons for the Merger
Special FactorsRequired Stockholder Approval for the Merger
The Merger AgreementCompany Stockholder Approval
Annex AAgreement and Plan of Merger
(d) Unaffiliated representative. The information set forth in the Information Statement under the following captions is
incorporated herein by reference:
Summary
Special FactorsBackground of the Merger
Special FactorsRecommendation of the Special Committee and the Board; Reasons for the Merger
Special FactorsReasons of Vista and Onex for the Merger
Special FactorsPosition of Vista and Onex as to the Fairness of the Merger
Provisions for Unaffiliated Stockholders
(e) Approval of directors. The information set forth in the Information Statement under the following captions is incorporated
herein by reference:
Summary
Questions and Answers About the Merger
Special FactorsBackground of the Merger
Special FactorsRecommendation of the Special Committee and the Board; Reasons for the Merger
Special FactorsReasons of Vista and Onex for the Merger
Special FactorsPosition of Vista and Onex as to the Fairness of the Merger
Special FactorsInterests of Our Directors and Executive Officers in the Merger
(f) Other offers. The information set forth in the Information Statement under the following captions is incorporated herein by
reference:
Special FactorsBackground of the Merger
Special FactorsRecommendation of the Special Committee and the Board; Reasons for the Merger
11
Item 9. Reports, Opinions, Appraisals and Negotiations
(a) (b) Report, opinion or appraisal; Preparer and summary of the report, opinion or appraisal. The
information set forth in the Information Statement under the following captions is incorporated herein by reference:
Summary
Questions and Answers About the Merger
Special FactorsBackground of the Merger
Special FactorsRecommendation of the Special Committee and the Board; Reasons for the Merger
Special FactorsOpinion of Goldman Sachs & Co. LLC
Special FactorsOpinion of Centerview Partners LLC
Special FactorsReasons of Vista and Onex for the Merger
Special FactorsPosition of Vista and Onex as to the Fairness of the Merger
Where You Can Find More Information
Annex BOpinion of Goldman Sachs & Co. LLC
Annex COpinion of Centerview Partners LLC
The discussion materials dated March 5, 2024, the Presentations to the Board dated April 17, 2024, April 24, 2024 and June 6, 2024, each
prepared by Goldman Sachs & Co. LLC, and the Tax Receivable Agreement Presentation dated April 9, 2024, prepared by Ernst & Young LLP, and reviewed by the Board, are filed as Exhibits (c)(iii) (c)(vi) and Exhibit (c)(xii) and are
incorporated herein by reference.
The discussion materials to the Special Committee dated May 1, 2024, May 3, 2024, May 6, 2024, June 5,
2024 and June 6, 2024, each prepared by Centerview Partners LLC and reviewed by the Special Committee, are filed as Exhibits (c)(vii) (c)(xi) and are incorporated herein by reference.
(c) Availability of documents. The reports, opinions or appraisals referenced in this Item 9 will be made available for
inspection and copying at the principal executive offices of the Company during its regular business hours by any interested equity holder of the Company or by a representative who has been so designated in writing.
Item 10. Source and Amounts of Funds or Other Consideration
(a) (b), (d) Source of funds; Conditions; Borrowed funds. The information set forth in the Information
Statement under the following captions is incorporated herein by reference:
Summary
Special FactorsFinancing
The Merger AgreementConduct of Business by PowerSchool Prior to Consummation of the Merger
The Merger AgreementConditions to Consummation of the Merger
Annex AAgreement and Plan of Merger
(c) Expenses. The information set forth in the Information Statement under the following captions is incorporated herein by
reference:
Summary
Questions and Answers About the Merger
Special FactorsCertain Effects on the Company if the Merger is Not Completed
Special FactorsFees and Expenses
The Merger AgreementTermination Fees and Expenses
Annex AAgreement and Plan of Merger
12
Item 11. Interest in Securities of the Subject Company
(a) Securities ownership. The information set forth in the Information Statement under the following captions is incorporated
herein by reference:
Summary
Special FactorsInterests of Our Directors and Executive Officers in the Merger
The Merger AgreementSupport and Rollover Agreements
Important Information Regarding PowerSchool
Important Information Regarding PowerSchoolSecurity Ownership of Certain Beneficial Owners and Management
Annex DVista Support and Rollover Agreement
Annex EOnex Support and Rollover Agreement
(b) Securities transactions. The information set forth in the Information Statement under the following captions is incorporated
herein by reference:
Special FactorsBackground of the Merger
The Merger Agreement
The Merger AgreementSupport and Rollover Agreements
Important Information Regarding PowerSchoolPrior Public Offerings
Important Information Regarding PowerSchoolTransactions in PowerSchool Class A Common Stock
Annex AAgreement and Plan of Merger
Annex DVista Support and Rollover Agreement
Annex EOnex Support and Rollover Agreement
Item 12. The Solicitation or Recommendation
(d) Intent to tender or vote in a going-private transaction. Not applicable.
(e) Recommendation of others. Not applicable.
Item 13. Financial Information
(a)
Financial statements. The audited consolidated financial statements set forth in Item 8 of the Companys Annual Report on Form 10-K for the fiscal year ended December 31, 2023 are
incorporated herein by reference.
The information set forth in the Information Statement under the following captions is incorporated
herein by reference:
Special FactorsCertain Effects of the Merger
Special FactorsCertain Company Financial Forecasts
Important Information Regarding PowerSchoolBook Value Per Share
Where You Can Find More Information
(b) Pro forma information. Not applicable.
Item 14. Persons/Assets, Retained, Employed, Compensated or Used
(a) (b) Solicitations or recommendations; Employees and corporate assets. The information set forth in
the Information Statement under the following captions is incorporated herein by reference:
13
Summary
Questions and Answers About the Merger
Special FactorsBackground of the Merger
Special FactorsRecommendation of the Special Committee and the Board; Reasons for the Merger
Special FactorsReasons of Vista and Onex for the Merger
Special FactorsPosition of Vista and Onex as to the Fairness of the Merger
Special FactorsInterests of Our Directors and Executive Officers in the Merger
Special FactorsFees and Expenses
Item 15. Additional Information
(b) Golden Parachute Compensation. The information set forth in the Information Statement under the following captions is
incorporated herein by reference:
Summary
Special FactorsCertain Effects of the Merger
Special FactorsInterests of Our Directors and Executive Officers in the Merger
The Merger AgreementConsideration to be Received in the Merger
Annex AAgreement and Plan of Merger
(c) Other material information. The information set forth in the Information Statement, including all annexes thereto, is
incorporated herein by reference.
Item 16. Exhibits
The following exhibits are filed herewith:
|
|
|
(a)(i) |
|
Preliminary Information Statement of PowerSchool Holdings, Inc. (included in the Schedule 14C filed on July 23, 2024 and incorporated herein by reference). |
|
|
(a)(ii) |
|
Notice of Written Consent and Appraisal Rights (included in the Information Statement and incorporated herein by reference). |
|
|
(b)(i) |
|
Equity Commitment Letter, dated as of June 6, 2024, by and among BCPE Polymath Buyer, Inc., Bain Capital Fund XIII, L.P. and Bain Capital Fund (Lux) XIII, SCSp. |
|
|
(b)(ii) |
|
Limited Guarantee, dated as of June 6, 2024, entered into by Bain Capital Fund XIII, L.P. and Bain Capital Fund (Lux) XIII, SCSp in favor of PowerSchool Holdings, Inc. |
|
|
(b)(iii) |
|
Commitment Letter, dated as of June, 2024, by and among BCPE Polymath Buyer, Inc., Ares Capital Management LLC, Blackstone Alternative Credit Advisors LP, Blue Owl Credit Advisors LLC, Golub Capital LLC, HPS Investment Partners LLC and Sixth Street Partners, LLC. |
|
|
(c)(i) |
|
Opinion of Goldman Sachs & Co. LLC, dated June 6, 2024 (included as Annex B to the Information Statement and incorporated herein by reference). |
|
|
(c)(ii) |
|
Opinion of Centerview Partners LLC, dated June 6, 2024 (included as Annex C to the Information Statement and incorporated herein by reference). |
|
|
(c)(iii) |
|
Discussion Materials prepared by Goldman Sachs & Co. LLC for the Board of Directors, dated March 5, 2024. |
|
|
(c)(iv) |
|
Tax Receivable Agreement Presentation by Ernst & Young LLP for the Board of Directors, dated April 9, 2024. |
|
|
(c)(v)* |
|
Presentation to the Board of Directors by Goldman Sachs & Co. LLC, dated April 17, 2024.
|
14
|
|
|
(c)(vi)* |
|
Presentation to the Board of Directors by Goldman Sachs & Co. LLC, dated April 24, 2024. |
|
|
(c)(vii) |
|
Discussion materials prepared by Centerview Partners LLC for the Special Committee of the Board of Directors, dated May 1, 2024 |
|
|
(c)(viii) |
|
Discussion materials prepared by Centerview Partners LLC for the Special Committee of the Board of Directors, dated May 3, 2024. |
|
|
(c)(ix) |
|
Discussion materials prepared by Centerview Partners LLC for the Special Committee of the Board of Directors, dated May 6, 2024. |
|
|
(c)(x) |
|
Discussion materials prepared by Centerview Partners LLC for the Special Committee of the Board of Directors, dated June 5, 2024. |
|
|
(c)(xi) |
|
Discussion materials prepared by Centerview Partners LLC for the Special Committee of the Board of Directors, dated June 6, 2024. |
|
|
(c)(xii)* |
|
Presentation to the Board of Directors by Goldman Sachs & Co. LLC, dated June 6, 2024. |
|
|
(d)(i) |
|
Agreement and Plan of Merger, dated as of June 6, 2024, by and among PowerSchool Holdings, Inc., BCPE Polymath Buyer, Inc. and BCPE Polymath Merger Sub, Inc. (included as Annex A to the Information Statement and incorporated herein by reference). |
|
|
(d)(ii) |
|
Support and Rollover Agreement, by and among PowerSchool Holdings, Inc., BCPE Polymath Buyer, Inc., and BCPE Polymath Merger Sub, Inc., Vista Consulting Group, LLC, the stockholder parties thereto and the other signatory parties thereto, dated June 6, 2024. (included as Annex D to the Information Statement and incorporated herein by reference). |
|
|
(d)(iii) |
|
Support and Rollover Agreement, by and among PowerSchool Holdings, Inc., BCPE Polymath Buyer, Inc., and BCPE Polymath Merger Sub, Inc., Onex Partners Manager LP., the stockholder parties thereto and the other signatory parties thereto, dated June 6, 2024. (included as Annex E to the Information Statement and incorporated herein by reference). |
|
|
(d)(iv) |
|
Amendment No. 1 to the Tax Receivable Agreement, by and among PowerSchool Holdings, Inc. and the TRA Holders parties thereto, dated June 6, 2024. (included as Annex F to the Information Statement and incorporated herein by reference). |
|
|
(f) |
|
Section 262 of the General Corporation Law of the State of Delaware (included as Annex G to the Information Statement and incorporated herein by reference). |
|
|
(g) |
|
None. |
|
|
107 |
|
Filing Fee Table. |
* |
Certain portions of this exhibits marked with [****] have been redacted and separately filed with
the Securities and Exchange Commission pursuant to a request for confidential treatment. |
15
SIGNATURES
After due inquiry and to the best of the undersigneds knowledge and belief, the undersigned certifies that the information set forth in
this statement is true, complete and correct.
|
|
|
POWERSCHOOL HOLDINGS, INC. |
|
|
By: |
|
/s/ Hardeep Gulati |
|
|
Name: Hardeep Gulati |
|
|
Title: Chief Executive Officer |
[Signature Page
to SC 13E-3]
16
After due inquiry and to the best of the undersigneds knowledge and belief, the
undersigned certifies that the information set forth in this statement is true, complete and correct.
|
|
|
VISTA EQUITY PARTNERS FUND VI, L.P. |
|
By: Vista Equity Partners Fund VI GP, L.P. |
Its: General Partner |
|
By: VEPF VI GP, Ltd. |
Its: General Partner |
|
|
By: |
|
/s/ Robert F. Smith |
|
|
Name: Robert F. Smith |
|
|
Title: Director |
|
VISTA EQUITY PARTNERS FUND VI-A, L.P. |
|
By: Vista Equity Partners Fund VI GP, L.P. |
Its: General Partner |
|
By: VEPF VI GP, Ltd. |
Its: General Partner |
|
|
By: |
|
/s/ Robert F. Smith |
|
|
Name: Robert F. Smith |
|
|
Title: Director |
|
VEPF VI FAF, L.P. |
|
By: Vista Equity Partners Fund VI GP, L.P. |
Its: General Partner |
|
By: VEPF VI GP, Ltd. |
Its: General Partner |
|
|
By: |
|
/s/ Robert F. Smith |
|
|
Name: Robert F. Smith |
|
|
Title: Director |
|
SEVERIN TOPCO, LLC |
|
|
By: |
|
/s/ Hardeep Gulati |
|
|
Name: Hardeep Gulati |
|
|
Title: Chief Executive Officer |
|
VEP GROUP, LLC |
|
|
By: |
|
/s/ Robert F. Smith |
|
|
Name: Robert F. Smith |
|
|
Title: Managing Member |
[Signature Page
to SC 13E-3]
17
|
|
|
By: |
|
/s/ Robert F. Smith |
|
|
Name: Robert F. Smith |
[Signature Page
to SC 13E-3]
18
After due inquiry and to the best of the undersigneds knowledge and belief, the
undersigned certifies that the information set forth in this statement is true, complete and correct.
|
|
|
PINNACLE HOLDINGS I L.P. |
|
By: Pinnacle Holdings I GP Inc. |
Its: General Partner |
|
|
By: |
|
/s/ Laurence Goldberg |
|
|
Name: Laurence Goldberg |
|
|
Title: Vice President |
|
ONEX PARTNERS IV SELECT LP |
|
By: Onex Partners IV GP LLC |
Its: General Partner |
|
|
By: |
|
/s/ Joshua Hausman |
|
|
Name: Joshua Hausman |
|
|
Title: Director |
|
ONEX US PRINCIPALS LP |
|
By: Onex American Holdings GP LLC |
Its: General Partner |
|
|
By: |
|
/s/ Joshua Hausman |
|
|
Name: Joshua Hausman |
|
|
Title: Director |
|
ONEX PARTNERS IV LP |
|
By: Onex Partners IV GP LP |
Its: General Partner |
|
By: Onex Partners IV GP Limited |
Its: General Partner |
|
|
By: |
|
/s/ Joshua Hausman |
|
|
Name: Joshua Hausman |
|
|
Title: Director |
|
ONEX PARTNERS IV GP LP |
|
By: Onex Partners IV GP Limited |
Its: General Partner |
|
|
By: |
|
/s/ Joshua Hausman |
|
|
Name: Joshua Hausman |
|
|
Title: Director |
[Signature Page
to SC 13E-3]
19
|
|
|
ONEX PARTNERS IV PV LP |
|
By: Onex Partners IV GP LP |
Its: General Partner |
|
By: Onex Partners IV GP Limited |
Its: General Partner |
|
|
By: |
|
/s/ Joshua Hausman |
|
|
Name: Joshua Hausman |
|
|
Title: Director |
|
ONEX POWERSCHOOL LP |
|
By: Onex American Holdings GP LLC |
Its: General Partner |
|
|
By: |
|
/s/ Joshua Hausman |
|
|
Name: Joshua Hausman |
|
|
Title: Director |
|
OPH B LP |
|
By: OPH B GP LLC |
Its: General Partner |
|
By: Onex Partners Holdings LLC |
Its: Managing Member |
|
|
By: |
|
/s/ Joshua Hausman |
|
|
Name: Joshua Hausman |
|
|
Title: Director |
|
ONEX PARTNERS CANADIAN GP INC. |
|
|
By: |
|
/s/ David Copeland |
|
|
Name: David Copeland |
|
|
Title: Vice President |
|
ONEX AMERICAN HOLDINGS GP LLC |
|
|
By: |
|
/s/ Joshua Hausman |
|
|
Name: Joshua Hausman |
|
|
Title: Director |
|
ONEX PRIVATE EQUITY HOLDINGS LLC |
|
|
By: |
|
/s/ Joshua Hausman |
|
|
Name: Joshua Hausman |
|
|
Title: Director |
[Signature Page
to SC 13E-3]
20
|
|
|
ONEX PARTNERS IV GP LTD. |
|
|
By: |
|
/s/ Joshua Hausman |
|
|
Name: Joshua Hausman |
|
|
Title: Director |
|
ONEX PARTNERS IV GP LLC |
|
|
By: |
|
/s/ Joshua Hausman |
|
|
Name: Joshua Hausman |
|
|
Title: Director |
|
ONEX CORPORATION |
|
|
By: |
|
/s/ David Copeland |
|
|
Name: David Copeland |
|
|
Title: Managing Director, Finance |
|
|
By: |
|
/s/ Gerald W. Schwartz |
|
|
Name: Gerald W. Schwartz |
[Signature Page
to SC 13E-3]
21
Exhibit (b)(i)
June 6, 2024
BCPE Polymath Buyer, Inc.
c/o Bain Capital Private Equity, LP
200 Clarendon Street
Boston, MA 02116
Ladies and Gentlemen:
This letter agreement (this Agreement) sets forth the commitment of each of Bain Capital Fund XIII, L.P., a Delaware
limited partnership, and Bain Capital Fund (Lux) XIII, SCSp, a special limited partnership organized and established under the laws of Grand Duchy of Luxembourg (each individually, a Fund and collectively, the
Funds), to purchase, directly or indirectly, on the terms and subject to the conditions contained herein, certain equity interests of BCPE Polymath Buyer, Inc., a newly formed Delaware corporation
(Parent), formed to acquire, hold and dispose of, directly or indirectly, equity interests of PowerSchool Holdings, Inc., a Delaware corporation (the Company), pursuant to the transactions
contemplated by that certain Agreement and Plan of Merger (as amended, amended and restated, supplemented or otherwise modified from time to time, the Merger Agreement), dated as of the date hereof, by and among Parent, the
Company and BCPE Polymath Merger Sub, Inc., a Delaware corporation (Merger Sub). Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to such terms in the Merger Agreement.
1. Commitments. Each Fund hereby commits, severally and not jointly or jointly and severally, on the terms and subject to
conditions set forth herein, at or prior to the Closing, to purchase, or shall cause the purchase of, directly or indirectly through one or more intermediate entities, equity securities of Parent for an aggregate purchase price not to exceed such
Funds Pro Rata Percentage (as defined below) of $1,748,566,902 (as to each Fund, the Individual Commitment Cap, and in the aggregate, the Commitment Amount) (such commitment, the
Commitment), the proceeds of which, together with the net proceeds of the Debt Financing, will be used, as needed, solely to (i) fund amounts required to be paid by Parent pursuant to the last sentence of
Section 2.7(d), Section 2.8(e) and Section 2.9(b) of the Merger Agreement and (ii) without duplication, pay related fees, costs and expenses required to be paid by Parent or
Merger Sub in connection with the Merger at the Closing pursuant to the Merger Agreement (collectively, clauses (i) and (ii), Closing Payments). Notwithstanding anything to the contrary in this Agreement, (a) this
Agreement may not be enforced against any Fund without giving effect to its Individual Commitment Cap, and no Fund shall be liable for any amounts hereunder in excess of its Individual Commitment Cap, and (b) each Fund may allocate all or a
portion of its Commitment to one or more affiliated investment funds, affiliated separately managed accounts or affiliated investment vehicles and such Funds portion of the Commitment Amount will be reduced by its Pro Rata Percentage of any
amounts actually contributed to Parent by such other Persons (and not returned) at or prior to the Closing, so long as such assignment would not reasonably be expected to (i) prevent, impair or delay the consummation of the transactions
contemplated by the Merger Agreement or (ii) require any additional regulatory filings, of which the failure to obtain would prevent, impair or delay the consummation of the transactions contemplated by the Merger
1
Agreement; provided, however, that any such assignment shall not relieve such Fund of any of its obligations under this letter (including its obligation to fund its Individual Commitment Cap of
the Commitment hereunder), except to the extent performed at Closing by such affiliated investment funds, affiliated separately managed accounts or affiliated investment vehicles. All payments hereunder shall be made in lawful money of the United
States, in immediately available funds.
2. Conditions. Each Funds obligation to fund its Pro Rata Percentage of the
Commitment Amount shall be subject to (i) the execution and delivery of the Merger Agreement by the Parties to the Merger Agreement, (ii) satisfaction or valid waiver of each of the conditions to Parent and Merger Subs obligations to
effect the Closing set forth in Section 7.1 and Section 7.2 of the Merger Agreement (in each case, other than any conditions that by their nature are to be satisfied at the Closing, but
subject to the prior or substantially concurrent satisfaction or valid waiver of such conditions), (iii) the substantially simultaneous consummation of the Closing in accordance with the terms of the Merger Agreement, (iv) the substantially
contemporaneous funding of the full amount of the Debt Financing in accordance with the terms of the Debt Commitment Letter and (v) the consummation of the Rollover immediately prior to or substantially concurrent with the consummation of the
Closing pursuant to the terms of the Merger Agreement and the Support and Rollover Agreement.
3. Limited Guarantee.
Concurrently with the execution and delivery of this Agreement, the Funds have executed and delivered to the Company a limited guarantee pursuant to which the Funds have agreed, on the terms and subject to the conditions therein, to guarantee
certain of Parents payment obligations under the Merger Agreement (the Limited Guarantee). Each Fund acknowledges and agrees that if the conditions described in Section 2 hereof are
satisfied, the Company may seek an order of specific performance to enforce each Funds obligation to fund its Pro Rata Percentage of the Commitment Amount hereunder, pursuant to (and on the terms and subject to the conditions of)
Section 9.9(b)(ii) of the Merger Agreement (the Specific Performance Rights). Other than the Specific Performance Rights and the other Retained Claims (as defined in the Limited Guarantee), the
Companys right to receive payment from Parent of the Guaranteed Obligations (as defined in the Limited Guarantee), subject to the Cap (as defined in the Limited Guarantee) and otherwise on the terms and subject to the conditions of the Limited
Guarantee, is and shall be the sole and exclusive direct or indirect remedy (whether at law or in equity) available to the Company, its Subsidiaries, any of their respective directors, officers, employees, and Affiliates, and each of the Rollover
Stockholders and any other security holder of the Company who has executed and delivered a Support and Rollover Agreement and any of their respective Affiliates (each such Person, a Company Related Party) (or available to
any Person claiming by, through, or on behalf or for the benefit of any of the Company Related Parties) against the Funds or any other Non-Recourse Party (as defined in the Limited Guarantee) with respect to
any claim (whether sounding in contract or tort, under statute or otherwise) arising under or related to the Merger Agreement, the Limited Guarantee, this Agreement or the transactions contemplated hereby or thereby or related negotiations,
including without limitation in connection with any breach or alleged breach by Parent or Merger Sub of any obligation under or related to the Merger Agreement, whether or not any such breach or alleged breach is caused by the Funds breach of
their obligations under this Agreement and any breach or alleged breach by the Funds of any obligation under or related to the Limited Guarantee or this Agreement. Each Fund agrees, solely in the context of Section 9.9(b)
of the Merger Agreement, not to oppose the granting of an injunction or specific performance on the basis that (i) the Company has an adequate remedy at law or (ii) an award of specific performance is not an appropriate remedy for any
reason at law or in equity.
2
4. Confidentiality. This Agreement shall be treated as confidential and is
being provided to Parent solely in connection with the transactions contemplated by the Merger Agreement. This Agreement may not be used, circulated, quoted or otherwise referred to in any document (other than the Limited Guarantee and the Merger
Agreement) by Parent, the Company or their respective Affiliates except with the prior written consent of Parent and the Funds in each instance; provided, that no such written consent is required for any disclosure of the existence of this
Agreement (i) to the extent required by applicable Law (provided, that to the extent permissible by applicable Law, the disclosing party shall use its commercially reasonable efforts to give the
non-disclosing parties prior notice of such disclosure and, upon any such other partys request, shall use commercially reasonable efforts to obtain confidential treatment for the existence and terms of
this letter) or in connection with any litigation related to the Merger Agreement or the transactions contemplated hereby or thereby, (ii) in connection with seeking the approval, consent, or waiver from, or in connection with the filing of any
notices or similar responses, in each case with any Governmental Authority as required by the Merger Agreement, or (iii) to representatives of Parent or the Company who reasonably need to know of the existence of this Agreement in connection
with the transactions contemplated hereby. Notwithstanding the foregoing, this Agreement may be provided to certain investment funds managed or controlled by Affiliates of Bain Capital Private Equity, LP, and the existence of this Agreement may be
disclosed by them to (x) their respective Affiliates and representatives who are subject to confidentiality obligations and (y) to the extent required by Law.
5. Representations and Warranties. Each Fund hereby represents and warrants to Parent that (a) it is duly organized, validly
existing and in good standing under the laws of the jurisdiction of its organization, (b) it has all requisite power and authority to execute, deliver and perform this Agreement, (c) the execution, delivery and performance of this
Agreement by it has been duly and validly authorized and approved by all necessary general partner, manager or other organizational action by such Fund, (d) this Agreement has been duly and validly executed and delivered by such Fund and
(assuming due execution and delivery of this Agreement, the Merger Agreement and the Limited Guarantee by all the other parties hereto and thereto) constitutes a legal, valid and binding obligation of such Fund, enforceable against such Fund in
accordance with its terms, subject to (i) the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other similar laws affecting creditors rights generally, and (ii) general equitable principles
(whether considered in a proceeding in equity or at law), (e) to the extent, if any, that such Funds governing documents or other agreements limit the amount such Fund may commit to any one investment, such Funds Pro Rata Percentage of
the Commitment Amount is less than the maximum amount that such Fund is permitted to invest in any one portfolio investment pursuant to the terms of such governing documents or other agreements, (f) such Fund has uncalled capital commitments or
otherwise has available funds in excess of the sum of such Funds Pro Rata Percentage of the Commitment Amount hereunder plus the aggregate amount of all other commitments and obligations it currently has outstanding and (g) the execution,
delivery and performance by such Fund of this Agreement does not (i) violate such Funds agreement of limited partnership or other organizational documents, (ii) violate any Law or judgment applicable to it, or (iii) result in
any violation of, or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation or acceleration of any obligation or to the loss of any benefit under, any Contract to which it is a party,
except where such violation or default would not prevent such Funds ability to perform its obligations hereunder.
3
6. Parties in Interest; Enforceability. This Agreement (a) is solely for
the benefit of, and shall only be binding upon, the parties hereto and their respective successors and permitted assigns and (b) is not intended to, and does not, confer upon any other Person any benefits, rights or remedies, except that
(i) the Company is an express third-party beneficiary hereof solely in respect of (x) the Specific Performance Rights described in Section 3 of this Agreement and (y) the rights expressly provided for in
Sections 7 and 12 of this Agreement and (ii) each Non-Recourse Party is an express third-party beneficiary hereof and may rely upon and enforce the provisions of Sections 3 and
13 hereof. Neither Parents creditors nor any Person claiming by, through, or on behalf or for the benefit of Parent, the Company or any of their respective Affiliates shall have any right to enforce this Agreement or to cause Parent to
enforce this Agreement.
7. Amendment. No amendment, modification or waiver of any provision of this Agreement will be
enforceable unless approved in writing by Parent, the Funds and the Company. No failure or delay by any such Person in exercising any right, power or privilege in connection with this Agreement shall operate as a waiver thereof nor shall any single
or partial exercise thereof, preclude any other or further exercise thereof or the exercise of any other right, power or privilege, and no waiver of any of the provisions of this Agreement shall be deemed or shall constitute, a waiver of any other
provisions, whether or not similar, nor shall any waiver constitute a continuing waiver.
8. Termination. This Agreement and
all obligations of each Fund to fund its Pro Rata Percentage of the Commitment Amount will terminate automatically and immediately upon the earliest to occur of (a) the consummation of the Closing (at which time such obligations shall be
discharged) and the funding in full of the Commitment hereunder, subject to any reduction in accordance with Section 1 (at which time all such obligations shall be discharged), (b) any valid termination of the Merger Agreement pursuant to
Article VIII thereof, (c) payment by the Parent or the Guarantors (as defined in the Limited Guarantee) of any Guaranteed Obligations, subject to the Cap (as defined in the Limited Guarantee), and (d) the commencement of a claim by any
Company Related Party (or any Person claiming by, through or on behalf or for the benefit of any of the foregoing) against any Fund or any Non-Recourse Party under this Agreement, the Limited Guarantee or the
Merger Agreement (other than the Company asserting any Retained Claim against the applicable Non-Recourse Party(ies) to the extent such Retained Claim may be asserted pursuant to
Section 8 of the Limited Guarantee).
9. Headings; Construction. The descriptive headings contained
in this Agreement are for convenience of reference only and are not intended to be part of or to affect the meaning or interpretation of this Agreement. Each party acknowledges that it and its respective counsel have reviewed this Agreement and that
any rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Agreement.
10. Governing Law; Jurisdiction; Venue; Waiver of Jury Trial.
(a) This Agreement and all actions, proceedings, causes of action, claims or counterclaims (whether based on contract,
tort, statute or otherwise) based upon, arising
4
out of or relating to this Agreement or in the negotiation, administration, performance and enforcement thereof (including any claim or cause of action based upon, arising out of or related to
any representation or warranty made in connection with this Agreement or as an inducement to enter into this Agreement), shall be governed by, and construed in accordance with the Laws of the State of Delaware, including its statutes of limitations,
without giving effect to any choice or conflict of laws provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws, including any statutes of limitations, of any jurisdiction other
than the State of Delaware.
(b) Each of the parties to this Agreement (a) irrevocably consents to the service
of the summons and complaint and any other process (whether inside or outside the territorial jurisdiction of the Chosen Courts) in any Legal Proceeding relating to the Merger or this Agreement, for and on behalf of itself or any of its properties
or assets, in accordance with Section 9.2 of the Merger Agreement or in such other manner as may be permitted by applicable Law, and nothing in this Section 10 will affect the right of any Party to
serve legal process in any other manner permitted by applicable Law; (b) irrevocably and unconditionally consents and submits itself and its properties and assets in any Legal Proceeding to the exclusive general jurisdiction of the Court of
Chancery of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, if the Court of Chancery of the State of Delaware declines to accept jurisdiction over a particular matter, any other state or federal court
within the State of Delaware) (the Chosen Courts) in the event that any dispute or controversy arises out of this Agreement or the transactions contemplated hereby; (c) agrees that it shall not attempt to deny or defeat such
personal jurisdiction by motion or other request for leave from any such court; (d) agrees that any Legal Proceeding arising in connection with this Agreement or the transactions contemplated hereby shall be brought, tried and determined only
in the Chosen Courts; (e) waives any objection that it may now or hereafter have to the venue of any such Legal Proceeding in the Chosen Courts or that such Legal Proceeding was brought in an inconvenient court and agrees not to plead or claim
the same; and (f) agrees that it shall not bring any Legal Proceeding relating to this Agreement or the transactions contemplated hereby in any court other than the Chosen Courts. Each of the parties to this Agreement agrees that a final
judgment in any Legal Proceeding in the Chosen Courts will be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law.
(c) EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE PURSUANT TO THIS AGREEMENT IS LIKELY TO
INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT THAT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL PROCEEDING (WHETHER FOR BREACH OF CONTRACT, TORTIOUS
CONDUCT OR OTHERWISE) DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT. EACH PARTY ACKNOWLEDGES AND AGREES THAT (i) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH
OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (ii) IT
5
UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER; (iii) IT MAKES THIS WAIVER VOLUNTARILY; AND (iv) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS,
THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 10.
11. Entire Agreement; Integration. This
Agreement, the Merger Agreement, the Limited Guarantee and the Confidentiality Agreement constitute the entire agreement of the parties with respect to the subject matter hereof, and supersedes all prior agreements, understandings and statements,
written or oral, between the Funds or any of their Affiliates, on the one hand, and Parent or any of its Affiliates, on the other, with respect to the transactions contemplated hereby.
12. No Assignment. This Agreement, and any of the rights, interests or obligations hereunder, may not be assigned, in whole or in
part, by Parent or any Fund without the prior written consent of the Funds and the Company; provided, that, each Fund may assign all or a portion of its respective obligations to fund the Commitment Amount to any Person that agrees to assume
such Funds obligations hereunder or otherwise pursuant to and in compliance with the terms set forth in Section 1 hereof. The granting of such consent in a given instance shall be solely in the discretion of the Funds
and the Company and, if granted, shall not constitute a waiver of the requirement to obtain the Funds or the Companys consent with respect to any subsequent assignment. Any purported assignment of this Agreement or the Commitment in
contravention of this Section 12 shall be void.
13. No Recourse against Affiliates, etc.
Notwithstanding anything that may be expressed or implied in this Agreement, by its acceptance hereof Parent covenants, acknowledges and agrees that (a) no Person other than each Fund (and their respective permitted assignees, if applicable)
shall have any obligation hereunder (whether of an equitable, contractual, tort, statutory or other nature), (b) notwithstanding that each Fund is a limited partnership, no recourse hereunder or under any documents or instruments delivered in
connection herewith may be sought or had against any Non-Recourse Party, whether by the enforcement of any judgment or assessment or by any legal or equitable proceeding or by virtue of any statute, regulation
or other applicable law, and (c) no liability whatsoever will attach to, be imposed on or otherwise be incurred by any Non-Recourse Party in connection with this Agreement for any obligation of each Fund
under this Agreement or in connection with the Commitment, or any claim based on, in respect of, or by reason of this Agreement or the Commitment; provided, however, that nothing in this Section 13 is intended
or shall be construed to limit the contractual obligations of each Fund under the Limited Guarantee or the contractual obligations of Parent under the Merger Agreement.
14. Counterparts. This Agreement may be executed in any number of counterparts (including by DocuSign or by .pdf delivered via
email), and each such counterpart when executed will be deemed an original instrument and all such counterparts shall together constitute one and the same agreement.
15. Pro Rata Percentage. Each party hereto acknowledges and agrees that (a) this Agreement is not intended to, and does not,
create any agency, partnership, fiduciary or joint venture relationship between or among any of the parties hereto and neither this Agreement nor any other document or agreement entered into by any party hereto relating to the subject matter hereof
shall be construed to suggest otherwise, (b) the obligations of each of the Funds under this
6
Agreement are solely contractual in nature and (c) the determination of each Fund was independent of each other. Notwithstanding anything to the contrary contained in this Agreement, the
liability of each Fund hereunder shall be several, not joint or joint and several, based upon its respective Pro Rata Percentage, and no Fund shall be obligated to contribute any amounts hereunder in excess of its Pro Rata Percentage of the
Commitment Amount. The Pro Rata Percentage of each Fund is as set forth below:
|
|
|
|
|
Bain Capital Fund XIII, L.P. |
|
|
87.069 |
% |
Bain Capital Fund (Lux) XIII, SCSp |
|
|
12.931 |
% |
16. Notices. All notices and other communications hereunder must be in writing and will be deemed
to have been duly delivered and received hereunder (i) four (4) Business Days after being sent by registered or certified mail, return receipt requested, postage prepaid; (ii) one Business Day after being sent for next Business Day
delivery, fees prepaid, via a reputable nationwide overnight courier service; or (iii) immediately upon delivery by electronic mail or by hand (with a written or electronic confirmation of delivery), in each case to the intended recipient as
set forth below:
If to the Funds:
Bain
Capital Fund XIII, L.P.
Bain Capital Fund (Lux) XIII, SCSp
c/o Bain Capital Private Equity, LP
200 Clarendon Street
Boston,
MA 02116
Attn.: David Humphrey; Max de Groen Bryan Curran
Email: **********; **********; **********
with a copy (which shall not constitute actual or constructive notice) to:
Ropes & Gray LLP
Prudential Tower
800 Boylston
Street
Boston, MA 02199
Attn: William Shields; Charles Boer; David Hutchins; Jessica Cooney; Thomas Holden; Thomas Fraser
Email: **********; **********; **********; **********; **********; **********
7
If to Parent:
c/o Bain Capital Private Equity, LP
200 Clarendon Street
Boston,
MA 02116
Attn: David Humphrey; Max de Groen; Bryan Curran
Email: **********; **********; **********
with a copy (which will not constitute notice) to:
Ropes & Gray LLP
Prudential Tower
800 Boylston
Street
Boston, MA 02199
Attn: William Shields; Charles Boer; David Hutchins; Jessica Cooney;
Thomas Holden; Thomas Fraser
Email: **********; **********; **********; **********;
**********; **********
Any notice received at
the addressees location on any Business Day after 5:00 p.m., addressees local time, or on any day that is not a Business Day will be deemed to have been received at 9:00 a.m., addressees local time, on the next Business Day. From
time to time, any party hereto may provide notice to the other parties of a change in its address or e-mail address through a notice given in accordance with this Section 16, except
that that notice of any change to the address or any of the other details specified in or pursuant to this Section 16 will not be deemed to have been received until, and will be deemed to have been received upon, the later
of the date (A) specified in such notice; or (B) that is five (5) Business Days after such notice would otherwise be deemed to have been received pursuant to this Section 16.
[Remainder of the page intentionally left blank signature page follows]
8
|
|
|
Sincerely, |
|
BAIN CAPITAL FUND XIII, L.P. |
|
By: Bain Capital XIII General Partner, LLC |
Its: General Partner |
|
By: Bain Capital Investors, LLC |
Its: Manager |
|
|
By: |
|
/s/ Max de Groen |
Name: |
|
Max de Groen |
Title: |
|
Authorized Signatory |
|
BAIN CAPITAL FUND (LUX) XIII, SCSP |
|
By: Bain Capital Fund XIII (Lux) General |
Partner, S.à.r.l. |
Its: General Partner |
|
|
By: |
|
/s/ Alexis Hennebaut |
Name: |
|
Alexis Hennebaut |
Title: |
|
Manager |
|
|
By: |
|
/s/ Sean Kelly |
Name: |
|
Sean Kelly |
Title: |
|
Manager |
[Signature Page to Equity Commitment Letter]
Agreed to and accepted:
|
|
|
BCPE POLYMATH BUYER, INC. |
|
|
By: |
|
/s/ Valentin Fernandez |
Name: |
|
Valentin Fernandez |
Title: |
|
Vice President & Treasurer |
[Signature Page to Equity Commitment Letter]
Exhibit (b)(ii)
LIMITED GUARANTEE
This
LIMITED GUARANTEE, dated as of June 6, 2024 (this Limited Guarantee), by each of Bain Capital Fund XIII, L.P., a Delaware limited partnership, and Bain Capital Fund (Lux) XIII, SCSp, a special limited partnership
organized and established under the laws of Grand Duchy of Luxembourg (each individually, a Guarantor, and collectively, the Guarantors), in favor of PowerSchool Holdings, Inc., a Delaware
corporation (the Guaranteed Party). Capitalized terms used and not otherwise defined herein shall have the meaning ascribed to such terms in the Merger Agreement (as defined below).
1. Guarantee. To induce the Guaranteed Party to enter into the Agreement and Plan of Merger, dated as of the date hereof,
by and among the Guaranteed Party, BCPE Polymath Buyer, Inc., a Delaware corporation (Parent), and BCPE Polymath Merger Sub, Inc., a Delaware corporation (Merger Sub) (as amended, amended and
restated, supplemented or otherwise modified from time to time, the Merger Agreement), the Guarantors, intending to be legally bound, each hereby expressly, absolutely, irrevocably and unconditionally guarantees (as a
primary obligor and not merely as surety) to the Guaranteed Party, severally (and not jointly and severally), on the terms and conditions set forth herein, subject to each Guarantors respective Cap (as defined below), the due and punctual
payment, observance, performance and discharge of its Pro Rata Percentage (as defined below) of (a) each of (i) the Parent Termination Fee if, as and when the Parent Termination Fee becomes payable by Parent to the Guaranteed Party under
Section 8.3(c) of the Merger Agreement and (ii) any Enforcement Expenses incurred by the Guaranteed Party in accordance with Section 8.3(f) of the Merger Agreement, and (b) any
Reimbursement Obligations owed to the Guaranteed Party pursuant to Section 6.6(f) or Section 6.6(g) of the Merger Agreement (provided that such Reimbursement Obligations shall not exceed
$2,000,000), in each case, if, as and when such obligations become payable under the Merger Agreement (the obligations set forth in the foregoing clauses (a) and (b), the Guaranteed Obligations); provided, that,
notwithstanding anything in this Limited Guarantee to the contrary, in no event shall each Guarantors aggregate liability for the Guaranteed Obligations exceed its Pro Rata Percentage of $273,800,000 (the Cap), and
this Limited Guarantee may not be enforced against any Guarantor without giving effect to the applicable Guarantors Pro Rata Percentage of the Cap (and to the provisions of Sections 7 and 8 hereof). This Limited Guarantee may be
enforced only for the payment of money by each Guarantor up to each applicable Guarantors Pro Rata Percentage of the Guaranteed Obligations (up to such Guarantors Pro Rata Percentage of the Cap), and the Guarantors shall not have any
obligation or liability to any Person relating to, arising out of or in connection with this Limited Guarantee, the Merger Agreement or the Equity Commitment Letter (as defined below), other than as expressly set forth herein or in the Equity
Commitment Letter. All payments hereunder shall be made in lawful money of the United States, in immediately available funds by wire transfer to an account or accounts designated in writing by the Guaranteed Party. Each Guarantor promises and
undertakes to make all payments hereunder (to the extent due in accordance with the terms hereof) free and clear of any deduction, offset, defense, claim or counterclaim of any kind (other than any such defense, claim or counterclaim that Parent or
Merger Sub may have pursuant to the terms of the Merger Agreement (excluding, any insolvency, bankruptcy, reorganization or other similar proceeding (or any consequences or effects thereof) affecting Parent or Merger Sub or any other Person
interested in the transactions contemplated by the Merger Agreement).
If Parent or Merger Sub fails to discharge any portion of the Guaranteed Obligations when
due (whether or not any bankruptcy or similar proceeding shall have stayed the accrual or collection of any of such payment obligations or operated as a discharge thereof), upon the Guaranteed Partys demand, each Guarantors liability to
the Guaranteed Party hereunder in respect of such Guarantors Pro Rata Percentage of the portion of such Guaranteed Obligations (up to such Guarantors Pro Rata Percentage of the Cap) shall become immediately due and payable, and the
Guaranteed Party may at any time and from time to time, at the Guaranteed Partys option, and so long as Parent or Merger Sub has failed to discharge such portion of the Guaranteed Obligations, take any and all actions available hereunder to
enforce each Guarantors obligation hereunder to collect the Guaranteed Obligations (subject to the Cap) from each Guarantor (subject to such Guarantors Pro Rata Percentage of the Cap).
In furtherance of the foregoing, each Guarantor acknowledges that the Guaranteed Party may, in its sole discretion, bring and prosecute a
separate action or actions against such Guarantor for such Guarantors Pro Rata Percentage of any unsatisfied Guaranteed Obligations (subject to such Guarantors Pro Rata Percentage of the Cap), regardless of whether any such action is
brought against Parent or Merger Sub or whether Parent or Merger Sub is joined in any such action or actions.
2. Nature of
Guarantee. Each Guarantors liability hereunder is absolute, unconditional, irrevocable and continuing irrespective of any modification, amendment or waiver of, or any consent to departure from, the Merger Agreement that may be agreed
to by Parent or Merger Sub in accordance with the terms of the Merger Agreement. Without limiting the foregoing, the Guaranteed Party shall not be obligated to file any claim relating to the Guaranteed Obligations in the event that Parent or Merger
Sub becomes subject to a bankruptcy, insolvency, reorganization or similar proceeding, and the failure of the Guaranteed Party to so file shall not affect any Guarantors obligations hereunder. This Limited Guarantee is a guarantee of payment
and performance and not of collection. In the event that any payment hereunder is rescinded or must otherwise be, and is, returned to the Guarantors for any reason whatsoever, each Guarantor shall remain liable hereunder (in accordance with the
terms hereof) as if such payment had not been made.
3. Changes in Obligations, Certain Waivers. Each Guarantor agrees
that the Guaranteed Party may, in its sole discretion, at any time and from time to time, without notice to or further consent of such Guarantor, extend the time of payment of any of the Guaranteed Obligations, and may also enter into any agreement
with Parent or Merger Sub for the extension, renewal, payment, compromise, discharge or release thereof, in whole or in part, without in any way impairing or affecting each Guarantors obligations under this Limited Guarantee or affecting the
validity or enforceability of this Limited Guarantee. Subject to termination of this Limited Guarantee as provided herein, each Guarantor agrees that the obligations of such Guarantor hereunder shall not be released or discharged, in whole or in
part, or otherwise affected by, and each Guarantor irrevocably waives any defense (except to the extent Parent or Merger Sub have such defense under the Merger Agreement or to the extent the Guaranteed Party has breached the terms of this Limited
Guarantee, but excluding defenses arising from bankruptcy or insolvency of Parent and other defenses waived in this Limited Guarantee) based upon or arising out of: (a) the failure or delay on the part of the Guaranteed Party to assert any
claim or demand or to enforce any right or remedy against Parent, Merger Sub or such Guarantor; (b) any change in the time,
2
place or manner of payment of any of the Guaranteed Obligations, or any waiver, compromise, consolidation or other amendment or modification of any of the terms or provisions of the Merger
Agreement made in accordance with the terms thereof or any agreement evidencing, securing or otherwise executed in connection with any of the Guaranteed Obligations; (c) any change in the legal existence, structure or ownership of Parent or
Merger Sub or any other Person now or hereafter liable with respect to the Guaranteed Obligations or otherwise interested in the transactions contemplated by the Merger Agreement (including any other Guarantor); (d) any insolvency, bankruptcy,
reorganization or other similar proceeding (or any consequences or effects thereof) instituted by or against Parent, Merger Sub or any other Person now or hereafter liable with respect to the Guaranteed Obligations; (e) the adequacy or
potential adequacy of any alternative means the Guaranteed Party may have of obtaining payment related to the Guaranteed Obligations; (f) the existence of any claim, set-off or other right which such
Guarantor may have at any time against Parent, Merger Sub or any of their respective Affiliates (or the existence of any claim, set-off or other right that Parent, Merger Sub or any of their respective
Affiliates may have at any time against any Guarantor), whether in connection with such Guarantors Obligation or otherwise; (g) the addition, substitution or release of any entity or other Person now or hereafter liable with respect to
the Guaranteed Obligations or otherwise interested in the transactions contemplated by the Merger Agreement (including any other Guarantor) or (h) any discharge of a Guarantor as a matter of applicable Law or equity (other than a discharge of a
Guarantor with respect to the Guaranteed Obligations as a result of indefeasible payment in full of the Guaranteed Obligations in accordance with their terms or as a result of defenses to the payment of the Guaranteed Obligations that would be
available to Parent or Merger Sub under the Merger Agreement or as a result of a breach by the Guaranteed Party of this Limited Guarantee, but excluding defenses arising from bankruptcy or insolvency of Parent and other defenses waived in this
Limited Guarantee). To the fullest extent permitted by applicable Law, each Guarantor waives (i) promptness, diligence, notice of the acceptance of this Limited Guarantee and of the Guaranteed Obligations; (ii) presentment, demand for
payment, notice of non-performance, default, dishonor and protest, notice of any Guaranteed Obligations incurred and all other notices of any kind (other than notices required to be delivered to Parent or
Merger Sub by the Guaranteed Party pursuant to the Merger Agreement); (iii) all defenses which may be available by virtue of any stay, moratorium or other similar Law now or hereafter in effect; or (iv) any right to require the marshaling of
assets of Parent or any other Person now or hereafter liable with respect to the Guaranteed Obligations. Each Guarantor acknowledges that it will receive substantial direct and indirect benefits from the transactions contemplated by the Merger
Agreement and that the waivers set forth in this Limited Guarantee are knowingly made in contemplation of such benefits.
Each Guarantor
hereby unconditionally and irrevocably waives any rights that it may now have or hereafter acquire against Parent or Merger Sub that arise from the existence, payment, performance or enforcement of such Guarantors obligations under or in
respect of this Limited Guarantee, including, without limitation, any right of subrogation, reimbursement, exoneration, contribution or indemnification and any right to participate in any claim or remedy of the Guaranteed Party against Parent or
Merger Sub, whether or not such claim, remedy or right arises in equity or under contract, statute or common law, including, without limitation, the right to take or receive from Parent or Merger Sub, directly or indirectly, in cash or other
property or by set-off or in any other manner, payment or security on account of such claim, remedy or right, and such Guarantor shall not exercise any such rights in each case unless and until the Guaranteed
Obligations (subject to such Guarantors Pro Rata Percentage of the Cap) shall have been
3
indefeasibly paid in full. If any amount shall be paid to such Guarantor in violation of the immediately preceding sentence at any time prior to the payment in full of such Guarantors Pro
Rata Percentage of the Guaranteed Obligations (subject to such Guarantors Pro Rata Percentage of the Cap), such amount shall be received and held in trust for the benefit of the Guaranteed Party, shall be segregated from other property and
funds of such Guarantor and shall forthwith be promptly paid or delivered to the Guaranteed Party in the same form as so received (with any necessary endorsement or assignment) to be credited and applied to payment of such Guarantors Pro Rata
Percentage of the Guaranteed Obligations until they are paid in full (subject to such Guarantors Pro Rata Percentage of the Cap).
Notwithstanding anything to the contrary contained in this Limited Guarantee or otherwise, the Guaranteed Party hereby agrees that, in
addition to any defenses of each Guarantor on the basis of a breach of this Limited Guarantee, each Guarantor shall have all defenses to the payment of its obligations under this Limited Guarantee (which in any event shall be subject to such
Guarantors Pro Rata Percentage of the Cap) that would be available to Parent, Merger Sub or any assignee in respect of the Merger Agreement with respect to the Guaranteed Obligations.
4. Representations and Warranties. Each Guarantor hereby represents and warrants that:
(a) it is a legal entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization;
(b) it has all requisite power and authority to execute, deliver and perform this Limited Guarantee and the execution, delivery and
performance of this Limited Guarantee has been duly and validly authorized and approved by all necessary action and do not contravene any provision of such Guarantors organizational documents or any Law, decree, order, judgment or contractual
restriction binding on such Guarantor or its assets;
(c) all consents, approvals, permits or authorizations of, and all filings
with and notifications to, any Governmental Authority necessary for the due execution, delivery and performance of this Limited Guarantee by such Guarantor have been obtained or made and all conditions thereof have been duly complied with, and no
other action by, and no notice to or filing with, any Governmental Authority or regulatory body is required in connection with the execution, delivery or performance of this Limited Guarantee by such Guarantor;
(d) assuming due execution and delivery of the Merger Agreement by the Company and of this Limited Guarantee by the Guaranteed Party,
this Limited Guarantee constitutes a legal, valid and binding obligation of such Guarantor enforceable against such Guarantor in accordance with its terms, subject to: (i) the effects of bankruptcy, insolvency, fraudulent conveyance,
reorganization, moratorium or other similar Laws affecting creditors rights generally and (ii) general equitable principles (whether considered in a proceeding in equity or at Law); and
(e) such Guarantor has the financial capacity to pay and perform its obligations under this Limited Guarantee, and it has uncalled
capital commitments or otherwise has available unrestricted funds necessary for such Guarantor to fulfill all of its obligations under this Limited Guarantee and such uncalled capital commitments or unrestricted funds shall be available to such
Guarantor for so long as this Limited Guarantee remains in effect in accordance with Section 7 hereof.
4
The Guaranteed Party hereby represents and warrants to the Guarantors that:
(a) it has all requisite power and authority to execute, deliver and perform this Limited Guarantee and the execution, delivery and
performance of this Limited Guarantee has been duly and validly authorized and approved by all necessary action and do not contravene any provision of the Guaranteed Partys organizational documents or any Law, decree, order, judgment or
contractual restriction applicable to or binding on the Guaranteed Party or its assets;
(b) all consents, approvals or
authorizations of, and all filings with and notifications, to any Governmental Authority necessary for the due execution, delivery and performance of this Limited Guarantee by the Guaranteed Party have been obtained or made and all conditions
thereof have been duly complied with by the Guaranteed Party, and no other action by, and no notice to or filing with, any Governmental Authority or regulatory body is required in connection with the execution, delivery or performance of this
Limited Guarantee by the Guaranteed Party; and
(c) assuming due execution and delivery of the Merger Agreement by all parties
thereto (other than the Guaranteed Party and any of its Affiliates party thereto) and of this Limited Guarantee by the Guarantors, this Limited Guarantee constitutes a legal, valid and binding obligation of the Guaranteed Party enforceable against
the Guaranteed Party in accordance with its terms, subject to: (i) the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other similar Laws affecting creditors rights generally and (ii) general
equitable principles (whether considered in a proceeding in equity or at Law).
5. No Assignment. Neither the
Guarantors nor the Guaranteed Party may assign, transfer or delegate its rights, interests or obligations under or in connection with this Limited Guarantee, in whole or in part, to any other Person without the prior written consent of the
Guaranteed Party (in the case of an assignment, transfer or delegation by any Guarantor) or the Guarantors (in the case of an assignment, transfer or delegation by the Guaranteed Party) and any purported assignment, transfer or delegation without
such consent shall be null and void ab initio; provided, however, that each Guarantor may assign, transfer or delegate all or part of its rights, interests and obligations hereunder without the prior written consent of the
Guaranteed Party to any other Person to which it has allocated all or a portion of its commitment under the Equity Commitment Letter in accordance with Section 1 of the Equity Commitment Letter; provided, further, that no such
assignment, transfer or delegation shall relieve such Guarantor of its obligations hereunder as a primary obligor.
6. Notices. Any notice, request, instruction or other communication to be given hereunder by any party hereto to the other
shall be in writing and delivered personally or sent by email or by overnight courier, delivery fees prepaid or by pdf delivered via email:
if to the Guarantors:
Bain
Capital Fund XIII, L.P.
Bain Capital Fund (Lux) XIII, SCSp
c/o Bain Capital Private Equity, LP
5
200 Clarendon Street
Boston, MA 02116
Attn.: David
Humphrey; Max de Groen Bryan Curran
Email: **********; **********; **********
with a copy (which shall not constitute notice) to:
Ropes & Gray LLP
Prudential Tower
800 Boylston
Street
Boston, MA 02199
Attn.: William Shields; Charles Boer; David Hutchins; Jessica Cooney;
Thomas Holden; Thomas Fraser
Email: **********; **********; **********; **********;
**********; **********
and if to the
Guaranteed Party, as provided in the Merger Agreement (or, in each case, to such other Persons or addresses as may be designated in writing by the party hereto to receive such notice as provided above). Any notice, request, instruction or other
communication delivered or required to be delivered or permitted to be provided hereunder shall be deemed given to the receiving party (a) upon actual receipt, if delivered personally, (b) on the next Business Day after deposit with an
overnight courier, if sent by an overnight courier, delivery fees prepaid, or (c) when sent by email (unless the sender receives a delivery failure notification, indicating that the email has not been delivered to the recipient).
7. Continuing Guarantee. Unless terminated pursuant to this
Section 7, this Limited Guarantee may not be revoked or terminated and shall remain in full force and effect as to a given Guarantor until such Guarantors Pro Rata Percentage of the Guaranteed Obligations have been
indefeasibly paid in full (subject to such Guarantors Pro Rata Percentage of the Cap). Notwithstanding the foregoing, or anything express or implied in this Limited Guarantee or otherwise, this Limited Guarantee shall terminate and no
Guarantor shall have any further obligations under or in connection with this Limited Guarantee as of the earliest to occur of (a) the consummation of the Closing, (b) any valid termination of the Merger Agreement pursuant to
Section 8.1(a) thereof or in circumstances where the Parent Termination Fee is not payable pursuant to the terms of Section 8.3(c) of the Merger Agreement, (c) the satisfaction of the Guarantors obligations in respect of the
Guaranteed Obligations (subject to the Cap) and (d) first (1st) anniversary of the date hereof (unless, in the case of clause (b) above and this clause (d), the Guaranteed Party shall
have commenced litigation against any Guarantor under and pursuant to this Limited Guarantee prior to such termination, in which case this Limited Guarantee shall terminate upon the final, non-appealable
resolution of such action and satisfaction by such Guarantor of any obligations finally determined by a court of competent jurisdiction or agreed in writing between the Guaranteed Party and such Guarantor, in each case to be owed by such Guarantor,
consistent with the terms hereof). Notwithstanding the foregoing, or anything express or implied in this Limited Guarantee or otherwise, in the event that the Guaranteed Party or any other Company Related Party (as defined in the Equity Commitment
Letter), asserts in any litigation or other proceeding in connection with this Limited Guarantee, the Merger Agreement, the equity commitment letter by and between the Guarantors and Parent, dated as of the date hereof
6
(the Equity Commitment Letter), or any of the transactions contemplated hereby or thereby, any of the following: (i) that the provisions of
Section 1 hereof limiting the Guarantors aggregate liability to the Cap or the provisions of this Section 7 or Section 8 hereof are illegal, invalid or unenforceable
in whole or in part, (ii) that any Guarantor is liable in the aggregate in respect of the Guaranteed Obligations in excess of, or to a greater extent than, such Guarantors Pro Rata Percentage of the Cap, or (iii) any theory of
liability (whether at law or in equity whether sounding in contract, tort, statute or otherwise) against any Non-Recourse Party (as defined in Section 8 hereof) with respect to this
Limited Guarantee, the Equity Commitment Letter, the Merger Agreement, any other agreement or instrument delivered in connection with this Limited Guarantee, the Equity Commitment Letter, the Merger Agreement or any of the transactions contemplated
hereby or thereby, in each case, other than Retained Claims (as defined in Section 8 hereof) asserted by the Guaranteed Party against the Non-Recourse Party(ies) against which such
Retained Claims may be asserted pursuant to Section 8 hereof, then: (x) the obligations of each Guarantor under or in connection with this Limited Guarantee shall terminate ab initio and be null and void;
(y) if any Guarantor has previously made any payments to the Guaranteed Party under or in connection with this Limited Guarantee, such Guarantor shall be entitled to recover and retain such payments; and (z) neither the Guarantors nor any
other Non-Recourse Parties shall have any liability whatsoever (whether at Law or in equity, whether sounding in contract, tort, statute or otherwise) to the Guaranteed Party or any other Person in any way
under, relating to or in connection with this Limited Guarantee, the Transaction Agreements (as defined below) or the transactions contemplated hereby or thereby.
8. No Recourse. The Guaranteed Party acknowledges the separate legal entity existence of Parent and Merger Sub apart from
each of the Guarantors. The Guaranteed Party acknowledges and agrees that the sole assets of Parent and Merger Sub are cash in a de minimis amount and their rights under the Merger Agreement and the Equity Commitment Letter and that no
additional funds are expected to be contributed to Parent or Merger Sub unless and until the Closing occurs pursuant to the Merger Agreement. Notwithstanding anything that may be expressed or implied in this Limited Guarantee, the Merger Agreement,
the Equity Commitment Letter, the Confidentiality Agreement or in any other agreement, certificate or instrument delivered under any of the foregoing or contemplated by any of the foregoing (collectively, the Transaction
Agreements) or statement made, information provided or action taken in connection with, or that otherwise in any manner relates to, the transactions contemplated by any of the Transaction Agreements or the negotiation, execution,
performance or breach of any Transaction Agreement (this Limited Guarantee, the other Transaction Agreements and such statements, information, actions, transactions, negotiations, executions, performances, breaches and other matters, collectively,
Transaction-Related Matters), and notwithstanding any equitable, common law or statutory right or claim that may be available to the Guaranteed Party or any of its Affiliates, and notwithstanding the fact that such
Guarantor may be a partnership, by its acceptance of the benefits of this Limited Guarantee, the Guaranteed Party covenants, acknowledges and agrees, on behalf of itself, its Affiliates and the other Company Related Parties, that:
(a) no Non-Recourse Party (as defined below) has or shall have any obligations (whether of an
equitable, contractual, tort, statutory or other nature) under, in connection with or in any manner related to any Transaction-Related Matter, other than with respect to (i) Parents and Merger Subs obligation to make a cash payment
to the Guaranteed Party under and pursuant to the terms of Section 8.3(c), Section 6.6(f) and Section 6.6(g) (with respect to any
7
Reimbursement Obligations that may be due pursuant to Section 6.6(f) or Section 6.6(g)) and Section 8.3(f) of the
Merger Agreement and, without duplication, each Guarantors obligation to guarantee such payment pursuant to the terms of this Limited Guarantee (subject to such Guarantors Pro Rata Percentage of the Cap) and to otherwise comply with the
terms of this Limited Guarantee, (ii) without duplication of the obligations referenced in clause (i) above, the other obligations of Parent and/or Merger Sub to perform their obligations under the Merger Agreement, on the terms and
subject to the conditions thereof, including any limitations of remedies under the Merger Agreement, (iii) each Guarantors obligation to Parent to specifically perform its agreement to make an equity contribution to Parent pursuant to the
Equity Commitment Letter on the terms and subject to the conditions thereof, and (iv) certain Non-Recourse Parties obligations under, and pursuant to the terms of, the Confidentiality Agreement (the
specific claims described in the foregoing clauses (i) through (iv), in each case against the Person or Persons specified in any such clause being referred to herein, collectively, as the Retained Claims);
(b) no recourse (whether under an equitable, contractual, tort, statutory or other claim or theory) under, in connection with or in any
manner related to any Transaction-Related Matter shall be sought or brought against (and, without limiting the generality of the foregoing, no liability shall attach to) any Non-Recourse Party, whether through
Parent, Merger Sub or any other Person interested in the transactions contemplated by any Transaction Agreement or otherwise, whether by or through theories of equity, agency, control, instrumentality, alter ego, domination, sham, single business
enterprise, piercing the veil, unfairness, undercapitalization, or any other attempt to avoid or disregard the entity form of any Non-Recourse Party, by or through a claim by or on behalf of the Guaranteed
Party or any of its Affiliates, any other Company Related Parties, Parent, Merger Sub or any other Person, against any Non-Recourse Party, by the enforcement of any assessment, by any legal or equitable
proceeding, by virtue of any applicable Law, or otherwise, except, in each case, for Retained Claims; and
(c) none of the
Guaranteed Party, any of its Affiliates nor any other Company Related Parties has relied on any statement, representation or warranty or assurance made by, or any action taken by, any Person in connection with or in any manner related to a
Transaction-Related Matter, other than those made by (i) each Guarantor in this Limited Guarantee and/or any Guarantor in its Equity Commitment Letter and (ii) Parent and Merger Sub in the Transaction Agreements.
The Retained Claims shall be the sole and exclusive remedy (whether at law or in equity, whether sounding in contract, tort, statute or
otherwise) of the Guaranteed Party and all of its Affiliates, the other Company Related Parties and any Person purporting to claim by or through any of them or for the benefit of any of them against any or all of the
Non-Recourse Parties, in respect of any claims, liabilities or obligations arising in any way under, in connection with or in any manner related to any Transaction-Related Matter. To the fullest extent
permitted by applicable Law, the Guaranteed Party, on behalf of itself and its Affiliates and the other Company Related Parties, hereby releases, remises and forever discharges all claims (other than Retained Claims) that the Guaranteed Party or any
of its Affiliates or the other Company Related Parties has had, now has or might in the future have against any Non-Recourse Party arising in any way under, in connection with or in any manner related to any
Transaction-Related Matter. The Guaranteed Party hereby covenants and agrees that, other than with respect to the Retained Claims, it shall not, and shall cause its Affiliates and the other Company Related Parties not to, institute any proceeding or
bring any claim in any way under, in connection with or in any manner related to any
8
Transaction-Related Matter (whether at law or in equity, whether sounding in contract, tort, statute or otherwise) against any Non-Recourse Party. Other
than the Non-Recourse Parties, no Person other than the Guarantors and the Guaranteed Party shall have any rights or remedies under, in connection with or in any manner related to this Limited Guarantee or the
transactions contemplated hereby.
As used herein, the term Non-Recourse
Parties means each Guarantor and any and all former, current or future direct or indirect holders of any equity, general or limited partnership or limited liability company interests, controlling persons, incorporators, directors,
officers, employees, co-investors, agents, attorneys, members, managers, management companies, portfolio companies, general or limited partners, stockholders, representatives, assignees or Affiliates of each
Guarantor (including Parent and Merger Sub) and any and all former, current or future direct or indirect holders of any equity, general or limited partnership or limited liability company interests, controlling persons, incorporators, directors,
officers, employees, co-investors, agents, attorneys, members, managers, management companies, portfolio companies, general or limited partners, stockholders, representatives, assignees or Affiliates of any of
the foregoing, and any and all former, current or future direct or indirect heirs, executors, administrators, trustees, representatives, successors, assigns or agents of any of the foregoing, and the Debt Financing Sources and any other providers of
the Debt Financing and any provider of the equity financing pursuant to the Equity Commitment Letter.
For the avoidance of doubt, nothing
herein is intended or shall be construed to affect the rights of Parent, Merger Sub or the Guarantors against any Debt Financing Source or any other providers of the Debt Financing or equity financing pursuant to the Equity Commitment Letter, or any
rights of Parent, Merger Sub or the Guarantors against any Persons that become or have committed to become holders of equity interests in Parent, Merger Sub or their respective Affiliates, with respect to such arrangements, or the liability of any
such parties to the Guarantors, Parent or Merger Sub with respect to such matters.
9. Governing Law; Jurisdiction; Venue;
Waiver of Jury Trial.
(a) This Limited Guarantee and all actions, proceedings, causes of action, claims or counterclaims
(whether based on contract, tort, statute or otherwise) based upon, arising out of or relating to this Limited Guarantee or the actions of the Guarantors or the Guaranteed Party in the negotiation, administration, performance and enforcement thereof
(including any claim or cause of action based upon, arising out of or related to any representation or warranty made in connection with this Limited Guarantee or as an inducement to enter into this Limited Guarantee), shall be governed by, and
construed in accordance with the Laws of the State of Delaware, including its statutes of limitations, without giving effect to any choice or conflict of laws provision or rule (whether of the State of Delaware or any other jurisdiction) that would
cause the application of the Laws, including any statutes of limitations, of any jurisdiction other than the State of Delaware.
(b) Each of the parties to this Limited Guarantee (a) irrevocably consents to the service of the summons and complaint and any
other process (whether inside or outside the territorial jurisdiction of the Chosen Courts) in any Legal Proceeding relating to the Merger or this Limited Guarantee, for and on behalf of itself or any of its properties or assets, in accordance with
Section 6 or in such other manner as may be permitted by applicable Law, and nothing in this Section 9 will
9
affect the right of any party hereto to serve legal process in any other manner permitted by applicable Law; (b) irrevocably and unconditionally consents and submits itself and its
properties and assets in any Legal Proceeding to the exclusive general jurisdiction of the Court of Chancery of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, if the Court of Chancery of the State of
Delaware declines to accept jurisdiction over a particular matter, any other state or federal court within the State of Delaware) (the Chosen Courts) in the event that any dispute or controversy arises out of this Limited
Guarantee or the transactions contemplated hereby; (c) agrees that it shall not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court; (d) agrees that any Legal Proceeding arising in
connection with this Limited Guarantee or the transactions contemplated hereby shall be brought, tried and determined only in the Chosen Courts; (e) waives any objection that it may now or hereafter have to the venue of any such Legal
Proceeding in the Chosen Courts or that such Legal Proceeding was brought in an inconvenient court and agrees not to plead or claim the same; and (f) agrees that it shall not bring any Legal Proceeding relating to this Limited Guarantee or the
transactions contemplated hereby in any court other than the Chosen Courts. Each of the parties to this Limited Guarantee agrees that a final judgment in any Legal Proceeding in the Chosen Courts will be conclusive and may be enforced in other
jurisdictions by suit on the judgment or in any other manner provided by applicable Law.
(c) EACH PARTY HERETO ACKNOWLEDGES AND
AGREES THAT ANY CONTROVERSY THAT MAY ARISE PURSUANT TO THIS LIMITED GUARANTEE IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT THAT SUCH PARTY MAY HAVE TO A TRIAL
BY JURY IN RESPECT OF ANY LEGAL PROCEEDING (WHETHER FOR BREACH OF CONTRACT, TORTIOUS CONDUCT OR OTHERWISE) DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS LIMITED GUARANTEE. EACH PARTY ACKNOWLEDGES AND AGREES THAT (i) NO
REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (ii) IT UNDERSTANDS AND HAS CONSIDERED THE
IMPLICATIONS OF THIS WAIVER; (iii) IT MAKES THIS WAIVER VOLUNTARILY; AND (iv) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9.
10. Counterparts. This Limited Guarantee shall not be effective until it has been executed and delivered by all parties
hereto. This Limited Guarantee may be executed by electronic transmission in .pdf format (including via DocuSign) and in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be
deemed to be an original but all of which taken together shall constitute one and the same agreement.
11. Third Party
Beneficiaries. This Limited Guarantee shall be binding upon, inure solely to the benefit of and be enforceable by the parties hereto and their respective successors and permitted assigns, and nothing express or implied in this Limited
Guarantee is intended to, or shall, confer upon any other Person any benefits, rights or remedies under or by reason of, or any rights to enforce or cause the Guaranteed Party to enforce, the obligations set forth herein; except that as a material
aspect of this Limited Guarantee the parties intend that all Non-Recourse Parties other
10
than the Guarantors shall be, and such Non-Recourse Parties are, intended third party beneficiaries of this Limited Guarantee who may rely on and enforce
the provisions of this Limited Guarantee that bar the liability, or otherwise protect the interests, of such Non-Recourse Parties.
12. Confidentiality. This Limited Guarantee shall be treated as confidential and is being provided to the Guaranteed Party
solely in connection with the transactions contemplated by the Merger Agreement. This Limited Guarantee may not be used, circulated, quoted or otherwise referred to in any document (other than the Merger Agreement and other Transaction Agreements),
except with the prior written consent of the Guarantors; provided, that no such written consent is required for any disclosure of the existence or content of this Limited Guarantee by the Guaranteed Party: (a) to its Affiliates and its
advisors and representatives that reasonably need to know such information (provided, that any such Affiliate, advisor or representative is advised of the confidential nature of such information and agrees to keep such information
confidential); (b) to the extent required by applicable Law (provided, that to the extent permissible by applicable Law, the disclosing party shall use its commercially reasonable efforts to give the
non-disclosing parties prior notice of such disclosure and, upon any such other partys request, use commercially reasonable efforts to obtain confidential treatment for the existence and terms of this
letter); or (c) to the extent required in connection with the enforcement of rights under this Limited Guarantee, the Equity Commitment Letter or the Merger Agreement. Notwithstanding the foregoing, this Limited Guarantee may be provided to
investment funds managed or controlled by Affiliates of Bain Capital Private Equity, LP, and the existence of this Limited Guarantee may be disclosed by them to (x) their respective Affiliates and representatives who are subject to
confidentiality obligations and (y) to the extent required by applicable Law.
13. Miscellaneous.
(a) This Limited Guarantee (together with the Equity Commitment Letter, the Merger Agreement and the Confidentiality Agreement) constitutes the entire agreement with respect to the subject matter hereof and supersedes any and all prior discussions, negotiations, proposals, undertakings, understandings and agreements,
whether written or oral, among the Guarantors or any of their Affiliates, on the one hand, and the Guaranteed Party, or any of its Affiliates, on the other hand with respect to the subject matter hereof. No amendment, supplementation, modification
or waiver of this Limited Guarantee or any provision hereof shall be enforceable unless approved by the Guaranteed Party and the Guarantors in writing.
(b) Any term or provision of this Limited Guarantee that is invalid or unenforceable in any jurisdiction shall be, as to such
jurisdiction, ineffective solely to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render
unenforceable such provision in any other jurisdiction; provided, however, that this Limited Guarantee may not be enforced without giving effect to the limitation of the aggregate amount payable by the Guarantors under
Section 1 hereof regarding the Cap and the amount payable by each Guarantor hereunder to such Guarantors Pro Rata Percentage of the Guaranteed Obligations (subject to such Guarantors Pro Rata Percentage of the
Cap), in each case provided in Section 1 hereof, and to the provisions of Sections 7 and 8 hereof. Each party hereto covenants and agrees that it shall not assert, and shall cause its
respective Affiliates and representatives not to assert, that this Limited Guarantee or any part hereof is invalid, illegal or unenforceable in accordance with its terms. Each of the Guarantors
11
covenants and agrees that it shall not assert, and shall cause its Affiliates and representatives not to assert, that this Limited Guarantee, any part hereof or the payment obligations pursuant
to the terms, and subject to the limitations, herein, in and of itself, diminishes or otherwise impairs any Guaranteed Partys rights to its specific performance pursuant to, and subject to the conditions of, Section 9.9(b) of the Merger
Agreement.
(c) The descriptive headings herein are inserted for convenience of reference only and are not intended to be part of or
to affect the meaning or interpretation of this Limited Guarantee.
(d) All parties acknowledge that each party and its counsel have
reviewed this Limited Guarantee and that any rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Limited Guarantee.
14. Pro Rata Percentage. Each party hereto acknowledges and agrees that (a) this Limited Guarantee is not intended
to, and does not, create any agency, partnership, fiduciary or joint venture relationship between or among any of the parties hereto and neither this Limited Guarantee nor any other document or agreement entered into by any party hereto relating to
the subject matter hereof shall be construed to suggest otherwise, (b) the obligations of each of the Guarantors under this Limited Guarantee are solely contractual in nature and (c) the determination of each Guarantor was independent of
each other. Notwithstanding anything to the contrary contained in this Limited Guarantee, the liability of each Guarantor hereunder shall be several, not joint or joint and several, based upon its respective Pro Rata Percentage, and no Guarantor
shall be liable for any amounts hereunder in excess of its Pro Rata Percentage of the Guaranteed Obligations (subject to the Cap). The Pro Rata Percentage of each Guarantor is as set forth below:
|
|
|
|
|
Bain Capital Fund XIII, L.P. |
|
|
87.069 |
% |
Bain Capital Fund (Lux) XIII, SCSp |
|
|
12.931 |
% |
[Remainder of page intentionally left blank]
12
IN WITNESS WHEREOF, each Guarantor and the Guaranteed Party has caused this Limited
Guarantee to be executed and delivered as of the date first written above by its officer or representative thereunto duly authorized.
|
|
|
BAIN CAPITAL FUND XIII, L.P. |
|
By: Bain Capital XIII General Partner, LLC |
Its: General Partner |
|
By: Bain Capital Investors, LLC |
Its: Manager |
|
|
By: |
|
/s/ Max de Groen |
Name: |
|
Max de Groen |
Title: |
|
Authorized Signatory |
|
BAIN CAPITAL FUND (LUX) XIII, SCSP |
|
By: Bain Capital Fund XIII (Lux) General |
Partner, S.à.r.l. |
Its: General Partner |
|
|
By: |
|
/s/ Alexis Hennebaut |
Name: |
|
Alexis Hennebaut |
Title: |
|
Manager |
|
|
By: |
|
/s/ Sean Kelly |
Name: |
|
Sean Kelly |
Title: |
|
Manager |
[Signature Page to Limited Guarantee]
|
|
|
POWERSCHOOL HOLDINGS, INC. |
|
|
By: |
|
/s/ Hardeep Gulati |
Name: |
|
Hardeep Gulati |
Title: |
|
Chief Executive Officer |
[Signature Page to Limited Guarantee]
Exhibit (b)(iii)
Execution Version
|
|
|
|
|
ARES CAPITAL
MANAGEMENT LLC 245 Park
Avenue, 44th Floor New York, New York 10029 |
|
BLACKSTONE
ALTERNATIVE CREDIT
ADVISORS LP 345 Park Avenue,
31st Floor New York, NY 10154 |
|
BLUE OWL CREDIT
ADVISORS LLC 399 Park
Avenue, 38th Floor New York, NY 10022 |
|
|
|
GOLUB CAPITAL LLC
200 Park Avenue New York, NY
10166 |
|
HPS INVESTMENT
PARTNERS, LLC 40 West 57th Street New York, NY 10019 |
|
SIXTH STREET
PARTNERS, LLC 2100 McKinney,
Suite 1500 Dallas, TX 75201 |
|
|
|
|
|
|
|
|
|
CONFIDENTIAL
June 6, 2024 |
BCPE Polymath Buyer, Inc.
c/o
Bain Capital Private Equity, LP
John Hancock Tower
200
Clarendon Street
Boston, MA 02116
Attention: Jonathan
Belitsos and Stephen Cameron
Project Picasso
Commitment Letter
Ladies and Gentlemen:
You have advised Ares Capital Management LLC (solely in its capacity as manager to one or more managed funds and accounts,
Ares), Blackstone Alternative Credit Advisors LP (on behalf of funds, accounts and clients managed, advised or sub-advised by it or its affiliates, Blackstone
Credit), Blue Owl Credit Advisors LLC (on behalf of its affiliated advisors and its and their managed funds and accounts, Blue Owl), Golub Capital LLC (together with its affiliates and its or their managed
funds, Golub), HPS Investment Partners LLC (together with its affiliates and any funds, entities, investors or accounts that it manages, sponsors, administers or advises, HPS), Sixth Street
Partners, LLC (acting as agent for and on behalf of certain of its affiliated funds, related funds and investment vehicles, Sixth Street, and together with Ares, Blackstone Credit, Blue Owl, Golub, HPS and any other
Commitment Parties as appointed as described below, collectively, the Commitment Parties, we or us) that BCPE Polymath Buyer, Inc., a Delaware corporation and newly formed
entity (Buyer or you) formed at the direction of Bain Capital Private Equity, LP (together with its affiliates and associated funds, the Sponsor), intends to acquire,
directly or indirectly, the Target Company (as defined in the Transaction Description), pursuant to the Acquisition Agreement (as defined in the Transaction Description). You have advised us that you desire to establish certain credit
facilities in order to consummate the Acquisition, the Closing Refinancing and the other Transactions as defined and described in the transaction description attached hereto as Exhibit A (the Transaction
Description). Capitalized terms used but not defined herein have the respective meanings assigned to them in the Transaction Description, the Summary of Terms and Conditions attached hereto as Exhibit B (the
Term Sheet) and the Conditions Precedent to Funding attached hereto as Exhibit C (together with this letter agreement, the Transaction Description and the Term Sheet, collectively, as amended, restated, supplemented
or otherwise modified from time to time, the Commitment Letter) and the fee letter of even date herewith addressed to you providing, among other things, for certain fees relating to the Facilities (as amended, restated,
supplemented or otherwise modified from time to time, the Fee Letter). In the case of any such capitalized term that is subject to multiple and differing definitions, the appropriate meaning thereof in this letter agreement
shall be determined by reference to the context in which it is used.
In connection with the Transactions, (a) (i) Ares hereby commits to provide the percentage set forth in Schedule 1 to this Commitment
Letter beside its name of the aggregate principal amount of the Initial Term Loan Facility, (ii) Blackstone Credit hereby commits to provide the percentage set forth in Schedule 1 to this Commitment Letter beside its name of the aggregate
principal amount of the Initial Term Loan Facility, (iii) Blue Owl hereby commits to provide the percentage set forth in Schedule 1 to this Commitment Letter beside its name of the aggregate principal amount of the Initial Term Loan Facility,
(iv) Golub hereby commits to provide the percentage set forth in Schedule 1 to this Commitment Letter beside its name of the aggregate principal amount of the Initial Term Loan Facility, (v) HPS hereby commits to provide the percentage set
forth in Schedule 1 to this Commitment Letter beside its name of the aggregate principal amount of the Initial Term Loan Facility and (vi) Sixth Street (acting as agent for and on behalf of certain of its affiliated funds, related funds and
investment vehicles) hereby commits to provide the percentage set forth in Schedule 1 to this Commitment Letter beside its name of the aggregate principal amount of the Initial Term Loan Facility (each of Ares, Blackstone Credit, Blue Owl, Golub,
HPS and Sixth Street, in such capacity, an Initial Term Loan Lender and, collectively, the Initial Term Loan Lenders), (b) (i) Ares hereby commits to provide the percentage set forth in
Schedule 1 to this Commitment Letter beside its name of the aggregate principal amount of the Revolving Credit Facility, (ii) Blackstone Credit hereby commits to provide the percentage set forth in Schedule 1 to this Commitment Letter beside
its name of the aggregate principal amount of the Revolving Credit Facility, (iii) Blue Owl hereby commits to provide the percentage set forth in Schedule 1 to this Commitment Letter beside its name of the aggregate principal amount of the
Revolving Credit Facility, (iv) Golub hereby commits to provide the percentage set forth in Schedule 1 to this Commitment Letter beside its name of the aggregate principal amount of the Revolving Credit Facility, (v) HPS hereby commits to
provide the percentage set forth in Schedule 1 to this Commitment Letter beside its name of the aggregate principal amount of the Revolving Credit Facility and (vi) Sixth Street (acting as agent for and on behalf of certain of its affiliated
funds, related funds and investment vehicles) hereby commits to provide the percentage set forth in Schedule 1 to this Commitment Letter beside its name of the aggregate principal amount of the Revolving Credit Facility (each of Ares, Blackstone
Credit, Blue Owl, Golub, HPS and Sixth Street, in such capacity, an Initial Revolving Lender and, collectively, the Initial Revolving Lenders) and (c) (i) Ares hereby commits to provide the
percentage set forth in Schedule 1 to this Commitment Letter beside its name of the aggregate principal amount of the Delayed Draw Term Loan Facility, (ii) Blackstone Credit hereby commits to provide the percentage set forth in Schedule 1 to
this Commitment Letter beside its name of the aggregate principal amount of the Delayed Draw Term Loan Facility, (iii) Blue Owl hereby commits to provide the percentage set forth in Schedule 1 to this Commitment Letter beside its name of the
aggregate principal amount of the Delayed Draw Term Loan Facility, (iv) Golub hereby commits to provide the percentage set forth in Schedule 1 to this Commitment Letter beside its name of the aggregate principal amount of the Delayed Draw Term
Loan Facility, (v) HPS hereby commits to provide the percentage set forth in Schedule 1 to this Commitment Letter beside its name of the aggregate principal amount of the Delayed Draw Term Loan Facility and (vi) Sixth Street (acting as
agent for and on behalf of certain of its affiliated funds, related funds and investment vehicles) hereby commits to provide the percentage set forth in Schedule 1 to this Commitment Letter beside its name of the aggregate principal amount of the
Delayed Draw Term Loan Facility (each of Ares, Blackstone Credit, Blue Owl, Golub, HPS and Sixth Street, in such capacity, an Initial DDTL Lender and, collectively, the Initial DDTL Lenders; the
Initial DDTL Lenders collectively with the Initial Term Loan Lenders and the Initial Revolving Lenders, the Initial Lenders; the banks, financial institutions or other entities becoming parties to the Facilities
Documentation, together with the Initial Lenders, the Lenders), in each case, upon the terms set forth in this letter agreement and in the Term Sheet and subject only to the satisfaction or waiver of the applicable
conditions expressly set forth in Exhibit C of this Commitment Letter.
You hereby appoint Ares, Blackstone Credit, Blue Owl, Golub, HPS and Sixth Street (or one or more of its affiliates) (each, in such capacity,
a Lead Arranger and collectively with any other Lead Arrangers appointed as described below, the Lead Arrangers) to act, and each Lead Arranger hereby agrees to act, as a lead arranger and
bookrunner, upon the terms set forth in this Commitment Letter. You hereby appoint HPS (in such capacity, a Joint Bookrunner and together with any other bookrunner appointed as described below, the Joint
Bookrunners) to act, and each Joint Bookrunner hereby agrees to act, as a bookrunner, upon the terms set forth in this Commitment Letter. It is agreed that Ares Capital Corporation will act as administrative agent in respect of the
Facilities (in such capacity, the Administrative Agent).
2
You and the Sponsor shall have the right to appoint, with up to 10.0% of the economics and
commitment amounts for each of the Facilities, additional banks, financial institutions or other entities as arrangers, bookrunners, managers, agents or co-agents (any such arranger, bookrunner, manager, agent
or co-agent, an Additional Arranger) within 20 business days after the date this Commitment Letter is executed by you; provided that (a) each such Additional Arrangers
several commitment shall be pro rata among the Facilities, (b) such Additional Arranger (or its affiliates) shall assume a proportion of the commitments with respect to the applicable Facilities that is equal to the proportion of the
economics allocated to such Additional Arranger (or its affiliates), (c) no Additional Arranger (together with its affiliates) shall receive greater compensatory economics with respect to any Facility than the economics allocated to the Initial
Lenders party to this Commitment Letter on the date hereof in respect of such Facility and (d) to the extent you appoint Additional Arrangers and/or confer additional titles in respect of the Facilities on the Additional Arrangers, the
economics allocated to, and the commitment amounts of, the Initial Lenders in respect of the Facilities will be proportionately reduced by the amount of the economics allocated to, and the commitment amount of, such Additional Arrangers (or their
respective affiliates), in each case upon the execution and delivery by such Additional Arrangers and you of customary joinder documentation or an amendment hereto, and, thereafter, each such Additional Arranger shall constitute a Commitment
Party, Initial Lender, and/or Lead Arranger, as applicable, under this Commitment Letter and under the Fee Letter, it being agreed and understood that Excluded Affiliates (as defined below) of such Additional Arrangers
shall be treated in the same manner as Excluded Affiliates of any Commitment Party hereunder.
It is further agreed that (a) Ares
shall appear on the left of all marketing and other materials in connection with the Facilities and will have the rights and responsibilities customarily associated with such name placement and (b) the Additional Arrangers will be
listed in the order determined by you in any marketing or other materials. Except as set forth above, no other arrangers, bookrunners, managers, agents or co-agents will be appointed and no compensation with
respect to any of the Facilities outside the terms contained herein and in the Fee Letter will be paid, in each case in order to obtain a commitment to participate in the Facilities, in each case, unless you and we so agree.
Except as provided herein with respect to Additional Arrangers, as applicable, upon the joinder of such Additional Arrangers pursuant to the
terms hereof, in respect of the amount allocated to such Additional Arrangers, (i) no Initial Lender shall be relieved, released or novated from its obligations hereunder (including its obligation to fund the Facilities on the Closing Date) in
connection with any assignment or participation of the Facilities, including its commitments hereunder in respect thereof, until after the initial funding of the Facilities and the occurrence of the Closing Date, (ii) no assignment or novation
by any Initial Lender shall become effective as between you and such Initial Lender with respect to all or any portion of such Initial Lenders commitments in respect of the Facilities until after the initial funding of the Facilities and the
occurrence of the Closing Date and (iii) unless you otherwise agree in writing, each Initial Lender shall retain exclusive control over all rights and obligations with respect to its commitments in respect of the Facilities, including all
rights with respect to consents, modifications, supplements, waivers and amendments, until the Closing Date has occurred. Notwithstanding anything set forth herein to the contrary, (a) no Initial Lender will assign or participate its
commitments hereunder (i) to those banks, financial institutions, institutional lenders or investors (including persons primarily engaged in private equity or venture capital) (or related funds of any such persons) identified in writing to the
Lead Arrangers by you, the Borrower or the Sponsor on or prior to the date hereof (or, (x) if after the date hereof and prior to the Closing Date, upon written notice to, and with the consent (not to be unreasonably withheld, conditioned or
delayed) of, the Lead Arrangers holding a majority of the aggregate commitments under the Facilities on the date hereof and (y) if on or after the Closing Date,
3
upon written notice to, and with the consent (not to be unreasonably withheld, conditioned or delayed) of, the Administrative Agent (without retroactive effect)) and, in the case of all of the
foregoing under this clause (i), their respective affiliates (to the extent reasonably identifiable on the basis of name or otherwise identified in writing by you to the Administrative Agent to be an affiliate), (ii) to any competitor of
(x) prior to the Closing Date, the Target Company and (y) from and after the Closing Date, Holdings and its affiliates (including the Target Company), and, in each case, any affiliate of such competitor, that is identified in writing to
the Lead Arrangers by you, the Borrower or any Sponsor (which list may be updated upon written notice to the Lead Arrangers (or if after the Closing Date, upon written notice to the Administrative Agent (without retroactive effect)) and, in the case
of all of the foregoing under this clause (ii), their respective affiliates (to the extent reasonably identifiable on the basis of name or otherwise identified by you to the Administrative Agent to be an affiliate) other than affiliates that
constitute bona fide diversified debt funds primarily investing in loans and (iii) to Excluded Affiliates (collectively, the Disqualified Institutions; provided that no fund or account operating as part of the
credit division of Blackstone Inc. shall constitute a Disqualified Institution), and no Disqualified Institutions may become Lenders or otherwise participate in the Facilities.
You hereby represent and warrant that, to your knowledge, insofar as it applies to information concerning the Target Company and its business,
(a) all written information concerning you, the Target Company and your and its respective subsidiaries and your and its respective businesses (other than any financial projections relating to you and the Target Company (such financial
projections of the Target Company (the Projections), estimates, forecasts and budgets and other forward-looking information and information of a general economic or industry nature) that has been or will be made available
by you (or on your behalf at your request) to any Commitment Party in connection with the Transactions and about the Target Company, its subsidiaries and their respective businesses (the Information) did not or will not
when furnished, taken as a whole, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements contained therein not materially misleading in light of the circumstances under which such
statements are made, in each case, as supplemented and updated from time to time, and (b) the Projections will be prepared in good faith based upon assumptions believed by you to be reasonable at the time of delivery thereof based on
information provided by you, the Target Company or your or their representatives; it being understood (i) that such Projections are subject to significant uncertainties and contingencies, many of which are beyond your control, (ii) that no
assurance can be given that any particular projections will be realized, that actual results may differ and that such differences may be material and (iii) that such Projections are not a guarantee of performance. If at any time prior to the
Closing Date, you become aware that any of the representations and warranties in the preceding sentence are incorrect in any material respect (to your knowledge insofar as it applies to the Information and Projections concerning the Target Company
and its business), you agree to (and to use your commercially reasonable efforts with respect to the Information and the Projections concerning the Target Company and its business) promptly supplement the Information and the Projections such that
the representations and warranties in the preceding sentence remain true in all material respects (to your knowledge insofar as it applies to the Information and Projections concerning the Target Company and its business), it being understood in
each case that such supplementation shall cure any breach of such representations and warranties. The accuracy of the foregoing representations and warranties, whether or not cured, shall not be a condition to the commitments and obligations of the
Initial Lenders hereunder or the funding of the Facilities on the Closing Date.
4
As consideration for the Initial Lenders commitments hereunder and the Lead Arrangers agreement to structure and arrange the
Facilities, you agree to pay (or to cause to be paid) the fees as set forth in the Fee Letter.
The Initial Lenders commitments hereunder to fund the Facilities on the Closing Date are subject solely to the applicable conditions
expressly set forth in Exhibit C hereto (and, solely with respect to the Delayed Draw Term Loan Facility (to the extent funded on the Closing Date) the condition set forth in clause (d) under the heading Conditions Precedent to
Borrowings under the Delayed Draw Term Loan Facility in Exhibit B hereto), and upon the satisfaction (or waiver by the Lead Arrangers) of such conditions, the initial funding of the Facilities shall occur. There are no conditions (implied or
otherwise) to the commitments hereunder, and there will be no conditions (implied or otherwise) under the Facilities Documentation to the funding of the Facilities on the Closing Date, including compliance with the terms of this Commitment Letter,
the Fee Letter and the Facilities Documentation or any other agreement, other than the waiver or satisfaction of the conditions that are expressly set forth in Exhibit C (and, solely with respect to the Delayed Draw Term Facility (to the
extent funded on the Closing Date), the condition set forth in clause (d) under the heading Conditions Precedent to Borrowings under the Delayed Draw Term Facility in Exhibit B).
Notwithstanding anything in this Commitment Letter, the Fee Letter, the Facilities Documentation or any other letter agreement or other
undertaking concerning the financing of the Transactions or otherwise to the contrary, (a) the only representations and warranties to be a condition to funding on the Closing Date, and that shall be made on the Closing Date, shall be
(i) such of the representations and warranties made by the Target Company with respect to the Target Company in the Acquisition Agreement as are material to the interests of the Lenders, but only to the extent that you (or any of your
affiliates) have the right (taking into account any applicable cure provisions) to terminate your (or its) obligations under the Acquisition Agreement or decline to consummate the Acquisition (in each case, in accordance with the terms of the
Acquisition Agreement) without incurring any liability as a result of a breach of such representations and warranties in the Acquisition Agreement (the Specified Acquisition Agreement Representations) and (ii) the
Specified Representations (as defined below) and (b) the terms of the Facilities Documentation shall be in a form such that they do not impair availability of the Facilities on the Closing Date if the conditions set forth in Exhibit C as
attached hereto are satisfied or waived by the Lead Arrangers (it being understood that to the extent any Collateral or any security interests therein (including the creation or perfection of any security interest therein) (other than (i) to
the extent that a lien on such Collateral may be perfected by the filing of a financing statement under the Uniform Commercial Code or (ii) by the delivery of stock or other equity certificates of the Borrower or any material domestic
wholly-owned restricted subsidiary of the Borrower (if any) that is part of the Collateral (solely, in the case of the subsidiaries of the Target, to the extent such stock or other equity certificates have been received from the Target Company after
your use of commercially reasonable efforts) is not or cannot be provided or perfected on the Closing Date after your use of commercially reasonable efforts to do so, or without undue burden or expense, the delivery of such Collateral or any
security interests (and creation or perfection of security interests therein), as applicable, shall not constitute a condition precedent to the availability of the Facilities on the Closing Date but shall instead be required to be delivered or
provided within 90 days after the Closing Date (or such later date as may be reasonably agreed by the Borrower and the Administrative Agent) pursuant to arrangements to be mutually agreed by the Borrower and the Administrative Agent). For purposes
hereof, Specified Representations means the representations and warranties made by the Loan Parties set forth in the Facilities Documentation relating to: organizational existence of the Loan Parties; organizational power
5
and authority of the Loan Parties, and due authorization, execution and delivery by the Loan Parties, in each case, as they relate to their entry into and performance of the Facilities
Documentation; enforceability of the Facilities Documentation against the Loan Parties; no conflicts with charter documents of the Loan Parties as it relates to their entry into and performance of the Facilities Documentation; solvency of the
Borrower and its restricted subsidiaries on a consolidated basis on the Closing Date after giving effect to the Transactions (with solvency being determined in a manner consistent with Annex I to Exhibit C attached hereto); subject to
the immediately preceding sentence and the limitations set forth in the Term Sheet, creation and perfection of security interests in the Collateral; Federal Reserve margin regulations; the use of proceeds of borrowings under the Facilities on the
Closing Date not violating the Patriot Act (as defined below), OFAC and FCPA; and the Investment Company Act. Notwithstanding anything to the contrary contained herein, to the extent any of the Specified Acquisition Agreement Representations or the
Specified Representations are qualified or subject to material adverse effect, the definition thereof shall be Company Material Adverse Effect as defined in the Acquisition Agreement (a Company Material Adverse
Effect) for purposes of any representations and warranties made or to be made on, or as of, the Closing Date. The provisions of this paragraph are referred to as the Certain Funds Provision.
6. |
Indemnity; Costs and Expenses. |
You agree to indemnify and hold harmless each Commitment Party, its affiliates (other than any Excluded Affiliate acting in its capacity as
such) and their respective officers, directors, employees, members, managed funds, managed accounts, agents, advisors, representatives and controlling persons involved in the Transactions and their respective successors and permitted assigns (each,
a Related Party), it being understood that in no event will this indemnity apply to any Commitment Party or its affiliates in their capacity as (a) financial advisors to you, the Sponsor, the Existing Investors, the
Target Company or your or its respective subsidiaries in connection with the Acquisition or any other potential acquisition of the Target Company or its subsidiaries, (b) a co-investor in the Transactions
or any potential acquisition of the Target Company or (c) a direct or indirect shareholder in the Target Company (collectively, the Indemnified Persons and each individually an Indemnified
Person), from and against any and all actual losses, claims, damages, liabilities and expenses, joint or several, actually incurred or suffered by any such Indemnified Person arising out of or in connection with any claim, litigation,
investigation or proceeding relating to this Commitment Letter, the Fee Letter or the Transactions (any of the foregoing, a Proceeding), regardless of whether any such Indemnified Person is a party thereto or whether a
Proceeding is brought by an Indemnified Party, a third party or by you or any of your affiliates, and whether or not any aspect of the Transactions is consummated and to reimburse each such Indemnified Person within 30 days after receipt of a
written request (together with reasonably detailed backup documentation supporting such reimbursement request) for the reasonable and documented out-of-pocket fees and
reasonable and documented out-of-pocket expenses of one primary counsel for all Indemnified Persons (taken as a whole) (and, solely in the case of an actual or perceived
conflict of interest, one additional counsel as necessary to the Indemnified Persons actually affected by such conflict, taken as a whole) and to the extent reasonably necessary, one local counsel for all Indemnified Persons (taken as a whole) in
each relevant material jurisdiction, but no other third-party advisors without your prior consent, and other reasonable and documented out-of-pocket expenses incurred in
connection with investigating, or defending any of the foregoing (in each case, excluding allocated costs of in-house counsel); provided that, the foregoing indemnity will not, as to any Indemnified
Person, apply to losses, claims, damages, liabilities or expenses to the extent (i) they resulted from (A) the willful misconduct, bad faith or gross negligence of such Indemnified Person or any of its affiliates or their respective
Related Parties (as determined in a final non-appealable judgment in a court of competent jurisdiction), (B) any material breach of the obligations of such Indemnified Person or any of its affiliates or their
respective Related Parties under this Commitment Letter or the Fee Letter (as determined in a final non-appealable judgment in a court of competent jurisdiction), or (C) any dispute
6
among Indemnified Persons (or their respective affiliates or Related Parties) that does not involve an act or omission by you or any of your subsidiaries (other than any claims against the
Administrative Agent or a Lead Arranger in its capacity as such but subject to clauses (i)(A) and (B) above) or (ii) they have resulted from any agreement governing any settlement referred to below by such Indemnified Person that is
effected without your prior written consent (which may include through electronic means) (which consent shall not be unreasonably withheld or delayed). Each Indemnified Person agrees (by accepting the benefits hereof), severally and not jointly, to
refund and return promptly any and all amounts paid by you (or on your behalf) under this Section 6 to such Indemnified Person to the extent such Indemnified Person is not entitled to payment of such amounts in accordance
with the terms hereof (as determined in a final non-appealable judgment of a court of competent jurisdiction).
In addition, if the Closing Date occurs, you hereby agree to reimburse the Lead Arrangers and Initial Lenders on the Closing Date (to the
extent you have been provided an invoice therefor at least three (3) business days prior to the Closing Date) for all reasonable and documented out-of-pocket
expenses (including, without limitation, reasonable and documented out-of-pocket expenses of the Lead Arrangers due diligence investigation, consultants fees
(to the extent any such consultant has been hired with your prior consent), travel expenses and reasonable and documented fees, disbursements and other charges of counsel, but in the case of legal fees and expenses of counsel, limited to the
reasonable and documented fees and reasonable and documented out-of-pocket expenses of Davis Polk & Wardwell LLP and, if reasonably necessary, one local counsel
in each relevant material jurisdiction) incurred in connection with the preparation of this Commitment Letter, the Fee Letter and the Facilities Documentation. You acknowledge that the Commitment Parties may receive a benefit, including, without
limitation, a discount, credit or other accommodation, from any such counsel based on the fees such counsel may receive on account of their relationship with us, including without limitation, fees paid pursuant hereto.
Notwithstanding any other provision of this Commitment Letter, no party hereto shall be liable for (i) any damages arising from the use
by others of information or other materials obtained through electronic, telecommunications or other information transmission systems, except to the extent such damages have resulted from the willful misconduct, bad faith, gross negligence or
material breach of such party or any of its affiliates or Related Parties of this Commitment Letter, the Fee Letter or the Facilities Documentation, as determined in a final, non-appealable judgment of a court
of competent jurisdiction, or (ii) any special, indirect, consequential or punitive damages arising out of or in connection with this Commitment Letter or the Fee Letter (provided that this clause (ii) shall not limit your indemnity
or reimbursement obligations to the extent set forth above in the second preceding paragraph in respect of any actual losses, claims, damages, liabilities and expenses, joint or several, actually incurred or suffered by an Indemnified Person to a
third party unaffiliated with the Commitment Parties that are otherwise required to be indemnified in accordance with this Section 6). You shall not be liable for any settlement of any Proceedings (or any expenses related
thereto) effected without your prior written consent (which may include through electronic means) (which consent shall not be unreasonably withheld or delayed), but if settled with your prior written consent or if there is a final non-appealable judgment against an Indemnified Person in any such Proceedings, you agree to indemnify and hold harmless each Indemnified Person from and against any and all actual losses, claims, damages,
liabilities and expenses incurred or suffered by reason of such settlement or judgment in accordance with the second preceding paragraph. You shall not, without the prior written consent of an Indemnified Person (which consent shall not be
unreasonably withheld, delayed, denied or conditioned, it being understood and agreed that the withholding of consent due to non-satisfaction of the conditions described in clauses (a) and (b) below shall
be deemed reasonable), effect any settlement of any pending or threatened Proceedings in respect of which indemnity could have been sought hereunder by such Indemnified Person unless (a) such settlement includes an unconditional release of such
Indemnified Person in form and substance reasonably satisfactory to such Indemnified Person from all liability on claims that are the subject matter of such Proceedings and (b) does not include any statement as to or any admission of fault,
culpability or a failure to act by or on behalf of such Indemnified Person.
7
In case any Proceeding is instituted involving any Indemnified Person for which
indemnification is to be sought hereunder by such Indemnified Person, then such Indemnified Person will promptly notify you of the commencement of any Proceeding; provided, however, that the failure to so notify you will not relieve
you from any liability that you may have to such Indemnified Person pursuant to this Section 6, except to the extent that you are materially prejudiced by such failure. Notwithstanding the above, following such
notification, you may elect in writing to assume the defense of such Proceeding, and, upon such election, you will not be liable for any legal costs subsequently incurred by such Indemnified Person (other than reasonable costs of investigation and
providing evidence) in connection therewith, unless (i) you have failed to provide counsel reasonably satisfactory to such Indemnified Person in a timely manner, (ii) counsel provided by you reasonably determines that its representation of
such Indemnified Person would present it with an actual conflict of interest, or (iii) the Indemnified Person reasonably determines that there are conflicts of interest between you and the Indemnified Person, including situations in which there
may be legal defenses available to it which are different from or in addition to those available to you. In connection with any one Proceeding, you will not be responsible for the fees and expenses of more than one separate law firm for all
Indemnified Persons plus additional conflicts and local counsel to the extent provided herein.
Each Indemnified Person shall, in
consultation with you, take all commercially reasonable steps to mitigate any losses, claims, damages, liabilities and expenses and shall use commercially reasonable efforts to give (subject to confidentiality or legal restrictions) such information
and assistance to you as you may reasonably request in connection with any Proceeding.
You acknowledge that the Lead Arrangers, the Initial Lenders and their respective affiliates may be providing debt financing, equity capital
or other services (including, without limitation, financial advisory services) to other companies in respect of which you or the Target Company may have conflicting interests. None of the Commitment Parties or their respective affiliates will use
information obtained from you, the Target Company, the Sponsor, the Existing Investors or any of your or their respective affiliates by virtue of the transactions contemplated by this Commitment Letter or any of their other respective relationships
with you, the Target Company, the Sponsor, the Existing Investors or any of your or their respective affiliates in connection with the performance by them and their respective affiliates of services for other persons or entities, and none of the
Commitment Parties or their respective affiliates will furnish any such information to such other persons or entities. You also acknowledge that none of the Commitment Parties or their respective affiliates has any obligation to use in connection
with the transactions contemplated by this Commitment Letter, or to furnish to you, the Sponsor, the Existing Investors, the Target Company or your or their respective subsidiaries, confidential information obtained by the Commitment Parties and
their respective affiliates from other persons or entities. This Commitment Letter and the Fee Letter are not intended to create a fiduciary relationship among the parties hereto or thereto.
You further acknowledge and agree that (a) no fiduciary, advisory or agency relationship between you and the Commitment Parties is
intended to be or has been created in respect of any of the debt transactions contemplated by this Commitment Letter, irrespective of whether the Commitment Parties have advised or are advising you on other matters, (b) the Commitment Parties,
on the one hand, and you, on the other hand, have an arms-length business relationship that does not directly or indirectly give rise to, nor do you rely on, any fiduciary duty on the part of the
Commitment Parties, (c) you are capable of and responsible for evaluating and understanding, and you understand and accept, the terms,
8
risks and conditions of the transactions contemplated by this Commitment Letter, (d) you have been advised that the Commitment Parties and their respective affiliates are engaged in a broad
range of transactions that may involve interests that differ from your interests and that the Commitment Parties and their respective affiliates have no obligation to disclose such interests and transactions to you by virtue of any fiduciary,
advisory or agency relationship and (e) the Commitment Parties and their affiliates have not provided any legal, accounting, regulatory or tax advice and you have consulted your own legal and financial advisors to the extent you deemed
appropriate.
You further acknowledge that certain of the Lead Arrangers (or an affiliate thereof) may be a full service securities firm
engaged in securities trading and brokerage activities as well as providing investment banking and other financial services. In the ordinary course of business, each such person may provide investment banking and other financial services to, and/or
acquire, hold or sell, for its own accounts and the accounts of customers, equity, debt and other securities and financial instruments (including bank loans and other obligations) of you and other companies with which you may have commercial or
other relationships. With respect to any securities and/or financial instruments so held by such person or any of its customers, all rights in respect of such securities and financial instruments, including any voting rights, will be exercised by
the holder of the rights, in its sole discretion in accordance with applicable law. To the fullest extent permitted by law, you hereby waive and release any claims that you may have against each such Lead Arranger with respect to any breach or
alleged breach of agency or fiduciary duty in connection with the financing transactions contemplated by this Commitment Letter.
You
agree that you will not disclose this Commitment Letter, the Fee Letter or the contents of any of the foregoing to any person without our prior written approval (which may include through electronic means) (not to be unreasonably withheld,
conditioned, delayed or denied), except that you may disclose (a) this Commitment Letter, the Fee Letter and the contents hereof and thereof (i) to the Sponsor, the Existing Investors, and to actual and potential co-investors (including, without limitation, to actual and potential purchasers of preferred equity) and to your, the Sponsors, the Existing Investors and such
co-investors respective officers, directors, agents, employees, affiliates, members, partners, stockholders, equityholders, controlling persons, agents, attorneys, accountants and advisors on a
confidential basis and (ii) as required by applicable law or compulsory legal process, pursuant to the order of any court or administrative agency or in any pending legal, judicial or administrative proceeding or to the extent required by
governmental and/or regulatory authorities (including, without limitation, any filing of this Commitment Letter with the U.S. Securities and Exchange Commission) (in which case you agree to use commercially reasonable efforts to inform us promptly
thereof to the extent lawfully permitted to do so), (b) this Commitment Letter, the Fee Letter and the contents hereof and thereof to the Target Company, any direct or indirect parent company of the Target Company and their respective officers,
directors, agents, employees, affiliates, members, partners, stockholders, equityholders, controlling persons, agents, attorneys, accountants and advisors, in each case in connection with the Transactions and on a confidential basis (provided
that any such disclosure of the Fee Letter shall be subject to redaction of the fees and the economic provisions contained therein in a customary manner (other than (i) after your countersigning of this Commitment Letter and the Fee Letter,
disclosures to the holders of the Rollover Equity and (ii) after the Closing Date, disclosures to the Target Company and its officers, directors, agents, employees, attorneys, accountants and advisors (but without disclosing the fees therein
specifically on a standalone basis))), (c) the existence and contents of the Term Sheet to any rating agency, (d) the existence and contents of this Commitment Letter and the Fee Letter to any actual or potential Additional Agent (and its respective
officers, directors, employees, attorneys, accountants, and advisors, in each case on a confidential basis) or, other than with respect to the Fee Letter, to a potential Lender (and its respective officers, directors, employees, attorneys,
accountants, and advisors, in each case on a confidential basis), (e) the existence and contents of this Commitment Letter (but not the Fee Letter or the contents thereof) to any actual or potential lender or other debt financing source (and its
9
respective officers, directors, employees, attorneys, accountants and advisors, in each case, on a confidential basis) in connection with the Transactions, (f) the aggregate fee amounts
contained in the Fee Letter as part of projections, pro forma information or a generic disclosure of aggregate sources and uses related to fee amounts related to the Transactions to the extent customary or required in offering and marketing
materials or in any public filing relating to the Transactions, (g) the existence and contents of this Commitment Letter in any proxy, public filing, prospectus, offering memorandum, offering circular, syndication materials or other marketing
materials in connection with the Acquisition or the financing thereof, (h) this Commitment Letter, the Fee Letter and the contents hereof and thereof in connection with protecting or enforcing any right under this Commitment Letter or the Fee
Letter or to defend any claim or exercise any remedies related to this Commitment Letter or the Fee Letter or (i) this Commitment Letter and the contents hereof to the extent it becomes publicly available other than as a result of a breach of
this Commitment Letter by you or breach of another confidentiality obligation owed to a Commitment Party by you, the Target Company or your or its respective affiliates; provided that, the foregoing restrictions shall cease to apply on the earlier
of (i) two years after the date hereof and (ii) the date the Facilities Documentation shall have been executed and delivered by the parties thereto (other than in respect of the Fee Letter and the contents thereof to the extent required
hereby).
Each Commitment Party agrees to keep confidential, and not to publish, disclose or otherwise divulge, information with respect
to the Transactions or obtained from or on behalf of you, the Target Company or your or its respective affiliates in the course of the transactions contemplated hereby, except that the Commitment Parties shall be permitted to disclose such
confidential information (a) to their respective directors, officers, agents, employees, attorneys, managed funds, managed accounts, limited partners, current or prospective investors and financing sources, accountants and advisors, and to
their respective affiliates involved in the Transactions (other than, in each case, Excluded Affiliates), on a need to know basis in connection with evaluating the financing transactions hereunder and who are made aware of and agree to
comply with the provisions of this paragraph, in each case on a confidential basis (with such Commitment Party responsible for such persons compliance with this Section 7), (b) on a confidential basis to any bona fide prospective Lender,
prospective participant or swap counterparty (in each case, other than a Disqualified Institution and other persons to whom you have affirmatively declined to consent to the assignment thereto prior to the disclosure of such confidential information
to such person) that agrees to keep such information confidential in accordance with (x) the provisions of this paragraph (or language substantially similar to this paragraph that is reasonably acceptable to the Sponsor and you) or
(y) other customary confidentiality language in a click-through arrangement) for the benefit of you, (c) as required by the order of any court or administrative agency or in any pending legal, judicial or administrative
proceeding, or otherwise as required by applicable law, regulation or compulsory legal process (in which case we agree to use commercially reasonable efforts to inform you promptly thereof to the extent lawfully permitted to do so (except with
respect to any audit or examination conducted by bank accountants or any self-regulatory authority or governmental or regulatory authority exercising examination or regulatory authority)), (d) to the extent requested by any federal, state or bank
regulatory or self-regulatory agencies or authority having jurisdiction over a Commitment Party (including in any audit, examination, inspection or other inquiry conducted by bank accountants or any self-regulatory authority or governmental or
regulatory authority exercising examination or regulatory authority), (e) to the extent such information: (i) becomes publicly available other than as a result of a breach of this Commitment Letter, the Fee Letter or other confidentiality or
fiduciary obligation owed by such Commitment Party to you, the Sponsor, the Existing Investors, the Target Company or your or their respective affiliates or (ii) becomes available to the Commitment Parties on a
non-confidential basis from a source other than you or on your behalf that, to such Commitment Partys knowledge (after due inquiry), is not in violation of any confidentiality or fiduciary obligation
owed to you, the Target Company, the Sponsor, the Existing Investors or your or their respective affiliates, (f) to the extent you shall have consented in advance to such disclosure in writing (which may include through electronic means), (g)
as is necessary in protecting and enforcing the Commitment
10
Parties rights with respect to this Commitment Letter or the Fee Letter or to defend any claim or exercise any remedies related to this Commitment Letter or the Fee Letter, (h) for
purposes of establishing any defense available under securities laws, including, without limitation, establishing a due diligence defense, (i) to the extent independently developed by such Commitment Party without reliance on
confidential information or (j) with respect to the existence and contents of the Term Sheet, in consultation with you, to any rating agency or to the CUSIP Service Bureau, Clearpar or Loanserv or any similar agency in connection with the
issuance and monitoring of CUSIP numbers, Private Placement Numbers or any other similar numbers with respect to the Facilities; provided that, no such disclosure shall be made to the members of such Commitment Partys or any of its
affiliates deal teams that are engaged as principals primarily in private equity or venture capital (a Private Equity Affiliate) or are engaged in the sale of the Target Company, including through the provision of
advisory services (a Sell Side Affiliate and, together with the Private Equity Affiliates, the Excluded Affiliates) other than a limited number of senior employees who are required, in accordance
with industry regulations or such Commitment Partys internal policies and procedures to act in a supervisory capacity and the Commitment Parties internal legal, compliance, risk management, credit or investment committee members, and who
are made aware of the provisions of this paragraph. The Commitment Parties and their respective affiliates, if any, obligations under this paragraph shall terminate automatically to the extent superseded by the confidentiality provision
in the Facilities Documentation upon the effectiveness thereof and, in any event, will terminate two years from the date hereof. It is understood and agreed that no Commitment Party may advertise or promote its role in arranging or providing any
portion of any Facility (including in any newspaper or other periodical, on any website or similar place for dissemination of information on the internet, as part of a case study incorporated into promotional materials, in the form of a
tombstone advertisement or otherwise) without the prior written consent of the Borrower (which consent may be withheld in the Borrowers sole and absolute discretion).
We hereby notify you that pursuant to the requirements of the USA PATRIOT Improvement and Reauthorization Act, Pub. L. 109-177 (signed into law March 9, 2006) (the Patriot Act)) and the requirements of 31 C.F.R. § 1010.230 (the Beneficial Ownership Regulation), each of us
and each of the Lenders may be required to obtain, verify and record information that identifies each Loan Party, which information may include its name and address and other information that will allow each of us and the Lenders to identify each
Loan Party in accordance with the Patriot Act or the Beneficial Ownership Regulation, as applicable. This notice is given in accordance with the requirements of the Patriot Act and the Beneficial Ownership Regulation and is effective for each of us
and the Lenders.
This Commitment Letter and the commitments hereunder and the Fee Letter shall not be assignable by any party hereto (except (a) by the
Commitment Parties as expressly set forth in Section 2 above (and subject to the limitations set forth therein), (b) by Ares, Blue Owl, Golub, HPS and Sixth Street to one or more of their respective affiliates, managed funds or managed accounts
without limitation, (c) notwithstanding anything to the contrary contained herein, each party hereto hereby agrees that Blackstone Credit, any of its affiliates, and shall include, without limitation, certain funds, accounts and clients
managed, advised or sub-advised by Blackstone Credit or any of their respective affiliates, as the context may require, and any warehouse entity (the Blackstone Entities) to (without
notice or consent of or payment of any fee to any person or entity) reallocate, sell, assign or otherwise transfer its commitment in respect of the Facilities and/or any closing payment to other Blackstone Entities; provided that no such re-allocation, sale, assignment or transfer shall reduce or release any such Blackstone Entity from its commitment in respect of the Facilities hereunder until the actual funding of the application
11
portion of the Facilities by the relevant transferee on the Closing Date and (d) by you to the Target Company or any newly-formed domestic entity that is or will be, directly or indirectly,
controlled by you or Closing Date Investors and which will, directly or indirectly, wholly own (or be wholly owned by) you after giving effect to the Transactions (including the Target Company)) without the prior written consent of each of the other
parties hereto, and any attempted assignment without such consent shall be void. This Commitment Letter may not be amended or any provision hereof waived or modified except by an instrument in writing signed by the Commitment Parties and you. This
Commitment Letter may be executed in any number of counterparts, each of which shall be deemed an original and all of which, when taken together, shall constitute one agreement. Delivery of an executed counterpart of a signature page of this
Commitment Letter by facsimile transmission or electronic transmission (e.g., pdf or tif) shall be effective as delivery of a manually executed counterpart of this Commitment Letter. Without limitation of the
foregoing, the words execution, executed, signed, signature and words of like import shall be deemed to include electronic signatures, each of which shall be of the same legal effect, validity or
enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in applicable law, including the Federal Electronic Signatures in Global and National Commerce
Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transaction Act.
This Commitment Letter and the Fee Letter (i) are the only agreements that have been entered into among the parties hereto with respect
to the Facilities and set forth the entire understanding of the parties hereto with respect thereto and (ii) supersede all prior understandings with respect to the matters referred to and contemplated therein and thereby. This Commitment Letter
is intended to be solely for the benefit of the parties hereto and is not intended to confer any benefits upon, or create any rights in favor of, any person other than the parties hereto, the Sponsor, the Indemnified Persons and, if any of this
Commitment Letter or any commitment hereunder is assigned in accordance with the first sentence of this Section 9 above, the applicable permitted assignee or assignees. Subject to the limitations set forth in Section 2 above, the
Commitment Parties may perform the duties and activities described hereunder through any of their respective affiliates (other than an Excluded Affiliate or other Disqualified Institution) and the provisions of Section 6 shall apply with equal
force and effect to any of such affiliates so performing any such duties or activities. This Commitment Letter and any claim, controversy or dispute arising under or related to this Commitment Letter shall be governed by, and construed in accordance
with, the laws of the State of New York; provided, however, that (a) the interpretation of the definition of Company Material Adverse Effect and whether a Company Material Adverse Effect has occurred, (b) the accuracy of any
Specified Acquisition Agreement Representations and whether you (or any of your affiliates) have the right (taking into account any applicable cure provisions) to terminate your (or your affiliates) obligations under the Acquisition Agreement
or decline to consummate the Acquisition (in each case, in accordance with the terms of the Acquisition Agreement) without incurring any liability as a result of a breach of such Specified Acquisition Agreement Representations and (c) whether
the Acquisition has been consummated in accordance with the terms of the Acquisition Agreement shall, in each case, be governed by and construed in accordance with the laws governing the Acquisition Agreement, regardless of the laws that might
otherwise govern under applicable principles of conflicts of laws thereof.
Each party hereto hereby irrevocably and unconditionally
submits to the exclusive jurisdiction of any state or Federal court sitting in the Borough of Manhattan in the City of New York, and, in each case, any appellate court thereof, over any suit, action or proceeding arising out of or relating to this
Commitment Letter or the Fee Letter or the transactions contemplated hereunder or thereunder, whether in contract, tort or otherwise, in equity or at law, and irrevocably and unconditionally agrees that it will not commence any such suit, action or
proceeding against any of the other parties hereto arising out of or in any way relating to this Commitment Letter or the Fee Letter or the transactions contemplated hereunder or thereunder in any forum other than such courts. Each party hereto
agrees that service of any
12
process, summons, notice or document by registered mail addressed to such party at its address above shall be effective service of process for any suit, action or proceeding brought in any such
court. Each party hereto hereby irrevocably and unconditionally waives (to the extent permitted by applicable law) any objection to the laying of venue of any such suit, action or proceeding brought in any such court and any claim that any such
suit, action or proceeding has been brought in any inconvenient forum and agrees that a final judgment in any such suit, action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other
matter provided by law. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES (TO THE EXTENT PERMITTED BY APPLICABLE LAW) TRIAL BY JURY IN ANY SUIT, ACTION, PROCEEDING, CLAIM OR COUNTERCLAIM (WHETHER IN CONTRACT, TORT OR OTHERWISE AND IN EQUITY OR AT LAW)
BROUGHT BY OR ON BEHALF OF ANY PARTY RELATED TO OR ARISING OUT OF THIS COMMITMENT LETTER OR THE FEE LETTER OR THE PERFORMANCE OF SERVICES HEREUNDER OR THEREUNDER OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.
Each of the parties hereto agrees that, if accepted by you, each of this Commitment Letter and the Fee Letter constitutes a binding and
enforceable agreement with respect to the subject matter herein and therein, including an agreement to negotiate in good faith the Facilities Documentation by the parties hereto in a manner consistent with this Commitment Letter; it being
acknowledged and agreed that (a) the initial funding of the Facilities is subject solely to the conditions specified in Exhibit C hereto, including the execution and delivery by the Loan Parties of the Facilities Documentation in a
manner consistent with this Commitment Letter (including the Documentation Principles) and (b) the commitments provided hereunder with respect to the Facilities are subject only to those conditions set forth in Exhibit C hereto.
Reasonably promptly after the execution by you of this Commitment Letter, the parties hereto shall proceed with the negotiation in good faith
of the Facilities Documentation in a manner consistent with this Commitment Letter (including the Documentation Principles) for the purpose of executing and delivering the Facilities Documentation substantially simultaneously with the closing of the
Acquisition.
The compensation (if applicable), expense reimbursement (if applicable), information, indemnification, jurisdiction, waiver
of jury trial, service of process, venue, governing law, absence of fiduciary duty, survival and confidentiality provisions contained herein and, if applicable, in the Fee Letter shall remain in full force and effect regardless of whether the
Facilities Documentation shall be executed and delivered and notwithstanding the termination of this Commitment Letter or the Initial Lenders commitments hereunder; provided that your obligations under this Commitment Letter, other than
your obligations relating to the confidentiality of the Fee Letter to the extent set forth herein, shall automatically terminate and be superseded by the provisions of the Facilities Documentation upon the execution and delivery thereof, and you
shall automatically be released from all liability in connection therewith at such time. You may terminate all or any portion of the Initial Lenders commitments (on a pro rata basis among the Initial Lenders in the applicable Facility)
hereunder at any time subject to the provisions of the preceding sentence.
Please indicate your acceptance of the terms hereof and of the
Fee Letter by signing in the appropriate space below and in the Fee Letter and returning to the Commitment Parties, the enclosed duplicate originals (or facsimiles or electronic copies) of this Commitment Letter and the Fee Letter, in each case not
later than 11:59 p.m., New York City time, on June 7, 2024, failing which the Initial Lenders commitments hereunder will expire at such time. In the event that (a) the initial borrowing in respect of the Term Loan Facility does not
occur on or before the date that is five business days after the Termination Date (as defined in the Acquisition Agreement as in effect on the date hereof), (b) the Acquisition closes with or without the use of the Facilities (in each
case, solely as to such Facility) or (c)
13
the Acquisition Agreement is validly terminated by you (or your affiliates) or with your (or your affiliates) written consent prior to the closing of the Acquisition, then this Commitment
Letter and the commitments hereunder shall automatically terminate unless we shall, in our sole discretion, agree to an extension. The termination of any commitment shall not prejudice your rights and remedies in respect of any breach of this
Commitment Letter or the Fee Letter.
[Signature Pages Follow]
14
We are pleased to have been given the opportunity to assist you in connection with the
financing for the Transactions.
|
|
|
Very truly yours, |
|
ARES CAPITAL MANAGEMENT LLC, as a Lead Arranger and as an Initial Lender, solely in its capacity as manager to certain funds and accounts |
|
|
By: |
|
/s/ Mark Affolter |
|
|
Name: Mark Affolter |
|
|
Title: Authorized Signatory |
[Signature Page to Commitment Letter]
We are pleased to have been given the opportunity to assist you in connection with the
financing for the Transactions.
|
|
|
Very truly yours, |
|
GOLUB CAPITAL LLC |
|
|
By: |
|
/s/ Robert G. Tuchscherer |
|
|
Name: Robert G. Tuchscherer |
|
|
Title: Senior Managing Director |
[Signature Page to Commitment Letter]
|
|
|
BLACKSTONE ALTERNATIVE CREDIT ADVISORS LP |
|
|
By: |
|
/s/ Marisa Beeney |
|
|
Name: Marisa Beeney |
|
|
Title: Authorized Signatory |
[Signature Page to Commitment Letter]
We are pleased to have been given the opportunity to assist you in connection with the
financing for the Transactions.
|
|
|
Very truly yours, |
|
BLUE OWL CREDIT ADVISORS LLC on behalf of its affiliated advisors and their managed funds and accounts |
|
|
By: |
|
/s/ Jon ten Oever |
|
|
Name: Jon ten Oever |
|
|
Title: Authorized Signatory |
[Signature Page to Commitment Letter]
We are pleased to have been given the opportunity to assist you in connection with the
financing for the Transactions.
|
|
|
Very truly yours, |
|
HPS INVESTMENT PARTNERS, LLC |
|
|
By: |
|
/s/ John Vitols |
|
|
Name: John Vitols |
|
|
Title: Managing Director |
[Signature Page to Commitment Letter]
|
|
|
SIXTH STREET PARTNERS, LLC, acting as agent for and on behalf of certain of its affiliated funds, related funds and investment vehicles |
|
|
By: |
|
/s/ Joshua Peck |
|
|
Name: Joshua Peck |
|
|
Title: Vice President |
[Signature Page to Commitment Letter]
|
|
|
Accepted and agreed to as of |
the date first written above: |
|
BCPE POLYMATH BUYER, INC. |
|
|
By: |
|
/s/ David Humphrey |
|
|
Name: David Humphrey |
|
|
Title: President |
[Signature Page to Commitment Letter]
Exhibit (c)(iii) Confidential Project Picasso – Board of Directors
Discussion Materials Goldman Sachs & Co. LLC March 5, 2024 Investment Banking
Confidential Disclaimer These materials have been prepared by Goldman
Sachs on a confidential basis for presentation solely to you in connection with an informational presentation which Goldman Sachs is making to senior management, at your invitation. These materials and Goldman Sachs’ presentation relating to
these materials (collectively, the “Presentation”) may not be disclosed to any third party or circulated or referred to publicly or used for or relied upon for any other purpose without the prior written consent of Goldman Sachs. The
Presentation was not prepared with a view to public disclosure or to conform to any disclosure standards under any state, federal or international securities laws or other laws, rules or regulations, and Goldman Sachs does not take any
responsibility for the use of the Presentation by persons other than those set forth above. Notwithstanding anything in this Presentation to the contrary, you may disclose to any person the US federal income and state income tax treatment and tax
structure of any transaction described herein and all materials of any kind (including tax opinions and other tax analyses) that are provided to you relating to such tax treatment and tax structure, without Goldman Sachs imposing any limitation of
any kind. The Presentation has been prepared by the Investment Banking Division of Goldman Sachs and is not a product of its research department. All information herein has been prepared specifically for you and is for discussion purposes only. The
terms and conditions set forth below are indicative only as of the date of this Presentation and are subject to change. This information is not an expressed nor an implied commitment by Goldman Sachs to act in any capacity in any such transaction,
to provide financing or to purchase or place any loans or securities, which commitment shall only be set forth in a separate agreement and such finalized terms and conditions are subject to further discussion and negotiation. Participation by
Goldman Sachs in any transaction contemplated herein is subject to, among other things, completion of mutually acceptable documents, satisfactory due diligence, internal review and approvals. Goldman Sachs does not provide accounting, tax,
regulatory or legal advice, such matters should be discussed with your advisors and/or counsel. Goldman Sachs and its affiliates are engaged in advisory, underwriting and financing, principal investing, sales and trading, research, investment
management and other financial and non-financial activities and services for various persons and entities. Goldman Sachs and its affiliates and employees, and funds or other entities they manage or in which they invest or have other economic
interest or with which they co-invest, may at any time purchase, sell, hold or vote long or short positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of you, any
other party to any transaction and any of their respective affiliates or any currency or commodity that may be involved in any transaction. The firm’s clients and counterparties may now or in the future include persons and entities that are
the subject of the Presentation and the firm may be, may have been or may become involved in other transactions and assignments with or involving these clients and counterparties and/or may have confidential information relating to these clients or
counterparties. The Presentation does not restrict Goldman Sachs from being engaged by, or otherwise acting with, any other party in any capacity. Nothing contained herein shall be deemed to create a fiduciary, advisory, agency or other relationship
between Goldman Sachs and you or your stockholders, directors, officers, employees or creditors, nor shall any of the foregoing persons rely on this document or the presentation thereof. The Presentation has been prepared based on historical
financial information, forecasts and other information obtained by Goldman Sachs from publicly available sources (other than information regarding you, which may have been obtained from your management). In preparing the Presentation, Goldman Sachs
has relied upon and assumed, without assuming any responsibility for independent verification, the accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by
us, and Goldman Sachs does not assume any liability for any such information. Goldman Sachs does not provide accounting, tax, legal or regulatory advice. Goldman Sachs has not made an independent evaluation or appraisal of the assets and liabilities
(including any contingent, derivative or off-balance sheet assets and liabilities) of you or any other party to any transaction or any of their respective affiliates and has no obligation to evaluate the solvency of you or any other party to any
transaction under any state or federal laws relating to bankruptcy, insolvency or similar matters. The analyses contained in the Presentation do not purport to be appraisals nor do they necessarily reflect the prices at which businesses or
securities actually may be sold or purchased. Any indications of value or synergies in the Presentation are based solely on public information, are for illustrative purposes only, and do not reflect actual values or synergies that may be achieved or
realized by you or any views of Goldman Sachs with respect to any such values or synergies. Investment Banking | 2
Confidential Executive Summary | GS Perspectives Goldman Sachs is
pleased to have the opportunity to present our perspectives on the current situation to the Picasso Board of Directors n Market backdrop in software is supportive and Picasso is operating from a position of strength — Software investors
are rewarding a balance of growth and margin, consistent with Picasso’s profile (12% revenue CAGR and 26% UFCF margin) — Tech M&A market has had an active start to the year with two large strategic transactions (HPE / Juniper for
~$14bn, Synopsys / Ansys for ~$35bn) as well as sponsor activity (e.g., Thoma / Everbridge for ~$2bn), all of which were priced at meaningful premiums (~32%, 29%, and 47% respectively) — Despite consistent operating performance, Picasso shares
have remained rangebound since the IPO (~$21/share today compared to $18/share IPO price) — Picasso has a number of strategic growth levers to continue to drive performance, ranging from AI to cross-sell to targeted acquisitions n Against
this backdrop, Picasso has received an unsolicited proposal to acquire the Company — Proposal is from a highly credible sponsor (Beta) and a premium to current ($25-27/share or 20-29% premium) — We believe that this proposal, or a
proposal from a competing party, could ultimately get to a valuation level that is compelling versus the standalone path, and therefore it makes sense to explore this option further at this time — Our recommendation is that Picasso use the
proposal from Beta to catalyze a targeted and efficient process over the next several weeks — We believe there are several other parties that could be interested in this situation. Process would be designed to receive indications of value from
these parties over the coming weeks such that the Board can make a more informed decision with respect to value versus standalone path Investment Banking | 3
Confidential Today’s Agenda 1 Review of the Software M&A
Environment 2 Review of Picasso’s Trading Performance 3 Positioning the Picasso Story 4 Perspectives on Process and Potential Buyers Investment Banking | 4
Review of the Software M&A Environment Investment Banking
Confidential Accelerating Software M&A Activity with Increasing
Sponsors Participation Sponsor % of Software M&A Volume (excl. Deals Over $20bn) 37 % 40 % 39 % 36 % 27% 22 % 38 % 50 % $ 450 Sponsors $ 29 Strategics $ 362 Deals Over $20bn $ 137 64 Strategic $ 235 $ 329 $ 214 Transactions $ 182 $ 71 $ 167 $ 69
$ 34 $ 130 $ 138 $ 28 $ 26 $ 91 $ 120 $ 69 $ 93 $ 59 61 Sponsor $ 66 $ 91 $ 86 Transactions $ 35 $ 70 $ 57 $ 52 $ 45 $ 38 $ 24 2016 2017 2018 2019 2020 2021 2022 2023 Number of Sponsor Take-Privates 8 2 10 6 6 10 16 18 12.73 2023 $1bn+ Software
Take-Privates Select 2023 Software Strategic M&A $10.5bn $4.6bn $1.3bn $3.6bn $28.1bn $2.3bn $1.1bn $1.4bn $11.7bn $1.5bn $4.5bn $2.6bn $6.1bn $1.4bn $1.7bn $4.0bn $4.4bn Jun-2023 Jun-2023 Jun-2023 Jul-2023 Sep-2023 Jan-2023 Jan-2023 Feb-2023
Mar-2023 Mar-2023 Mar-2023 Apr-2023 July-2023 Aug-2023 Aug-2023 Oct-2023 Dec-2023 Source: FactSet; market data as of 1-Jan-2024 Note: Analysis includes all software deals; public and private deals considered. Analysis excludes intra-China and
cancelled deals. Only transactions above $500mm or with undisclosed transaction sizes are included in both total volumes and total counts. Investment Banking | 6
Confidential Sponsors Remained Most Active Buyers Strategics ($>10bn)
Sponsors Strategics ($<10bn) Remain Active Through the Cycle 2022 Average: $55 2021 Average: $23 $ 95 $ 96 $ 44 2022 Average: $22 2021 Average: $17 2021 Average: $39 2023 Average: $17 $ 25 / $ 31 $ 60 $ 23 $ 28 $ 27 $ 25 2022 Average: $9 $ 50 $
23 2023 Average: $17 $ 14 $ 13 $ 33 2023 Average: $5 $ 14 $ 11 $ 14 $ 13 $ 26 $ 25 $ 12 $ 9 $ 24 $ 12 $ 22 $ 8 $ 7 $ 5 $ 5 $ 4 $ 8 $ 2 $ 2 $ 4 $ 2 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q
3Q 4Q 2021 2022 2023 2021 2022 2023 2021 2022 2023 Source: FactSet; market data as of 1-Jan-2024 Note: Analysis includes all software deals; public and private deals considered. Analysis excludes intra-China and cancelled deals. Only transactions
above $500mm or with undisclosed transaction sizes are included in both total volumes and total counts. Investment Banking | 7
10Y US Treasury Rate (%) Confidential Growth Remains Key Valuation
Driver but Investors Increasingly Focus on Profitability Again Correlation of Valuation vs. Growth and Rule of 40 Over Time After a period of outsized focus on profitability, growth is once again the main driver of valuation, though convergence is
reemerging 0.6 5% 0.56 4 % 4% 0.50 0.4 3% 2% 0.2 1% 0.0 0 % Sep-2021 Mar-2022 Aug-2022 Feb-2023 Jul-2023 Jan-2024 EV/NTM Sales: Revenue Growth EV/NTM Sales: Rule of 40 US 10Y Treasury Source: FactSet; market data as of 1-Jan-2024 Note: Analysis
includes 59 Cloud Companies. Valuation reflects EV/24E multiple. Growth reflects CY2024E growth. Rule of 40 calculated as sum of NTM 2024E growth and NTM 2024E FCF margin. Investment Banking | 8 Correlation (R2 )
Confidential Software Multiples Have Adjusted to a New Reality 70x 3Y
Avg. Pre- 1 2 COVID Current COVID Avg. Top 10 NTM Revenue 14.3 x 16.6 x 36.4 x 4 Multiple 60x 3 High Growth Software 9.3 8.9 30.4 (10y UST) 4.0 % All Software 6.3 5.7 9.8 4% 50x 40x 30x 2% 20x 16.6x 10x 8.9x 5.7x 0x 0% Jan-15 Jan-16 Jan-17 Jan-18
Jan-19 Jan-20 Jan-21 Jan-22 Jan-23 Jan-24 Source: FactSet; market data as of 1-Jan-2024 1 2 Note: Analysis includes 172 software companies. Average Pre-COVID represents average NTM Revenue Multiple from 1-Jan-2017 to 1-Jan-2020. COVID 3 Average
represents NTM Revenue Multiple from 20-Feb-2020 to 30-Oct-2021. Growth Software defined by companies which have a greater than 30% LFQ 4 YoY revenue growth rate. Top Software NTM revenue multiples index currently includes MicroStrategy
Incorporated, Snowflake, Fair Isaac Corporation, CrowdStrike, Cloudflare, Samsara, Cadence, Datadog, Zscaler and MongoDB. Investment Banking | 9 NTM Revenue Multiple
Review of Picasso’s Trading Performance Investment
Banking
Confidential Picasso Share Price Performance Since IPO Indexed Share
Price Performance | Since IPO Performance (%) Since IPO 2Y 1Y 210 % Picasso 15.2 % 37.8 % 3.8 % Instructure 20.3 6.0 (9.3) 190 % Tyler (11.0) 4.4 37.7 Vertical Software¹ 2.6 19.1 28.2 170 % 150 % 130 % 20.3 % 15.2 % 110 % 2.6 % 90 % (11.0)% 70
% 50 % Jul-2021 Nov-2021 Mar-2022 Jul-2022 Nov-2022 Mar-2023 Jul-2023 Nov-2023 Mar-2024 Picasso Instructure Tyler Vertical Software¹ Source: FactSet; market data as of 1-Mar-2024 Note: Reflects performance from 28-Jul-2021 to 1-Mar-2024.
Picasso indexed off initial IPO price of $18.00 per share. 1 Includes Appfolio, Autodesk, Aspen Tech, Descartes, Guidewire, Jamf, nCino, Procore, SPS Commerce, and Veeva. Investment Banking | 11
Confidential Picasso's Stock Price has Been Mostly Range Bound $40.0
VWAPs Current Share Price $ 20.73 VWAP Since IPO $ 20.57 vs. Current Share Price 0.8 % $30.0 2-Year VWAP $ 19.84 52-Week High: $ 25.02 vs. Current Share Price 4.5 % 1-Year VWAP $ 21.28 15.2% $20.73 vs. Current Share Price (2.6)% $20.0 6-Month VWAP $
22.53 52-Week Low: $ 16.49 vs. Current Share Price (8.0)% 1 Daily Average Trading Volume (k) YTD 6M 3M 3-Month VWAP $ 23.21 604 636 653 $10.0 vs. Current Share Price (10.7)% Jul-21 Nov-21 Mar-22 Jul-22 Nov-22 Mar-23 Jul-23 Nov-23 Mar-24 Source:
FactSet; market data as of 1-Mar-2024 Note: Reflects trading performance from 28-Jul-2021 to 1-Mar-2024. Picasso indexed off initial IPO price of $18.00 per share. 1 Current shares outstanding of 203mm. Investment Banking | 12
Confidential Recent Software Performance Reflects a Full Post-COVID
Market Correction NTM EV / Revenue Multiples Since Picasso IPO NTM EV / EBITDA Multiples Since Picasso IPO Average Since IPO 2Y 1Y Average Since IPO 2Y 1Y 18.0 x 60.0 x Picasso 7.0 x 6.8 x 6.8 x Picasso 22.6 x 21.5 x 20.5 x 1 1 Instructure 7.5 7.3
7.3 Instructure 20.1 19.0 18.5 Tyler 9.2 8.4 8.5 Tyler 35.7 32.9 33.6 2 2 Vertical Software 9.8 8.8 9.0 Vertical Software 30.8 29.0 31.1 15.0 x 50.0 x 12.0 x 40.0 x 35.2 x 10.5 x 9.1 x 9.0 x 30.0 x 28.0 x 6.5 x 6.0 x 6.5 x 20.0 x 19.1 x 16.0 x 3.0 x
10.0 x Jul-2021 Mar-2022 Nov-2022 Jul-2023 Mar-2024 Jul-2021 Mar-2022 Nov-2022 Jul-2023 Mar-2024 Source: FactSet median consensus estimates; market data as of 1-Mar-2024. Note: Reflects trading performance from 28-Jul-2021 to 1-Mar-2024. 1 Maximum
threshold for trading multiples set to 65.0x. Instructure EV PF for incremental debt and cash used for Parchment acquisition in Q1 2024. 2 Includes Appfolio, Autodesk, Aspen Tech, Descartes, Guidewire, Jamf, nCino, Procore, SPS Commerce, and Veeva.
Investment Banking | 13
Confidential Research Analyst: Picasso Views Current Research Analyst
Estimates FY24E Date Analyst Rating Target Price Revenue ($M) EBITDA ($M) EPS Methodology Mar-2024 Jefferies Buy $30.00 $789 $270 $0.23 21x FY25 EV/EBITDA Mar-2024 Restricted Buy 27.00 789 271 0.98 NA Median Feb-2024 Raymond James Overweight 26.00
787 268 1.06 NA Price Feb-2024 Needham Buy 26.00 789 270 1.02 7.5x FY24 EV/Revenue Target Feb-2024 Piper Sandler Buy 29.00 789 270 1.01 7.5x CY25 EV/Revenue implies Feb-2024 Restricted Overweight 26.00 789 NA 0.94 NA 30% upside to Feb-2024
Restricted Overweight 28.00 NA NA 1.00 NA current Feb-2024 Cantor Fitzgerald Buyer 30.00 $789 270 $0.93 NA stock Feb-2024 RBC Buyer 27.00 790 270 0.99 7.2x FY24 EV/Revenue price Jan-2024 Baptista Research Hold 26.70 789 265 (0.07) NA Median $27.00
$789 $270 $0.99 High 30.00 790 271 1.02 Low 26.00 787 265 (0.07) 1 % Variance 15% 0.4% 2% 110% 2 2 Current Research Analyst Estimates Current Research Analyst Estimates $30 $27.00 1 1 $25 1 1 1 1 1 2 2 2 2 1 1 $20.73 $20 14 14 13 13 13 13 13 12 12
12 12 12 12 $20.73 as of $15 Mar 1, 2024 $10 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Mar-2023 Jul-2023 Nov-2023 Mar-2024 Price Price Target Mean Buy Hold Sell 1 Source: Wall Street Research, FactSet, IBES Estimates as of 01-Mar-2024. % variance
is calculated as the delta between the high and low, divided by the 2 median. As of latest Mar-2024 earnings. Investment Banking | 14
Positioning the Picasso Story Investment Banking
Confidential Investment Highlights Key Value Drivers to Focus On
Vertical Software Market Leader in K-12 Unmatched System of Record and Breadth of Capabilities Best-in-Class Cloud Solutions Purpose-built for K-12 Enabling Software Uniquely Positioned to Highly Compelling Return on Investment Adoption in Unlock
the Power of AI International K-12 in Education Culture Built Around Intense Passion for Education Markets Unrivaled Data Asset, Analytics and Insight Platform Cutting-edge AI Capabilities Strong Track-Record of Early Innings in Meaningful
International Expansion Opportunity Cross-Sell Motion Consolidation Thesis, Supports Future Creating the Multiple Avenues for Continued Growth Margin Expansion Opportunity to Accelerate M&A Investment Banking | 16
Confidential Enabling Software Adoption in International K-12 Markets
Meaningful international expansion opportunity, with clear path to capturing market share Expansion in India International Leadership Appointed Stewart Monk to lead international strategy for all Picasso products Announced continued expansion of
Picasso’s Global PowerPartner Program Expansion in Africa “We’ve seen the innovative impact of OneConnect’s technology services and solutions and know they are the right partner to expand our support to the over n
September 2023 announced 240 million students enrolled in Sub-Saharan Africa acquisition of enterprise resource and beyond.” planning (ERP) software company -Hardeep Gulati, CEO Neverskip Expansion in Latin America n Picasso will
immediately expand its “We continued to expand our international reach in Q4 reach to over 900 schools and 1.2 by signing 4 additional channel partners, all of which million students in India are strong technology resellers and integrators
focused on the Latin America region, a strategic n Sets a foundation for growth to growth market for us, given our highly successful nationwide Schoology rollout in Uruguay during the support the larger Indian education pandemic.” market
-Hardeep Gulati, CEO Investment Banking | 17
Confidential Uniquely Positioned to Unlock the Power of AI in Education
Cutting-edge AI capabilities – and new PowerBuddy AI Assistant – keep Picasso at the vanguard of K-12 technology solutions Unique Position to Lead GenAI- Picasso AI in Products Today Powered Personalization Education Innovation Picasso's
AI assistant uniquely crafted for students, families, teachers, and administrators delivering personalized insights, fostering engagement, and creating a supportive environment to support all educational stakeholders Investment Banking |
18
Confidential Strong Track-Record of Cross-Sell Motion Supports Future
Margin Expansion Margin expansion led by best-in-class cross-sell capabilities, with significant room for existing customers to expand platform usage Q4 2023 107% 33% 1 1 Net Retention Rate Adj. EBITDA Margin 1 Figures as of Q4 2023. Investment
Banking | 19
Confidential Early Innings in Consolidation Thesis, Creating the
Opportunity to Accelerate M&A Payments Analytics International Communications Assessments UK Australia Enrollment & Marketing Engagement Pre-K Brazil India Learning Management Career System Readiness & Search Other Content Safety &
Other Well- being SIS & Talent Finance Investment Banking | 20
Perspectives on Process and Potential Buyers Investment
Banking
Confidential Situation Update th n February 29 received verbal
proposal from Beta n Range $25 - $27, representing a premium of 20 - 29% to the previous day’s close and 0 - 8% to the 52-week high n Key options for consideration: — Decline to engage, continue to execute as public company
— Use proposal as a catalyst to launch a process and drive potential value 1 — Exclusive process with only Beta 2 — Targeted process with outreach to limited investors 3 — Broad process with outreach to a wide group of
investors Investment Banking | 22
Confidential The Level And Quality Of Buyer Interest Will Impact The
Breadth Of The Sale Process GS Recommendation 1 2 3 Exclusive Process Targeted Process Broad Process n Engage in exclusive dialogue with Betan Approach a targeted list of well-informed potential n Invite a larger number of potentially
interested buyers buyers including both strategic and financial buyers n Only advisable after detailed discussions have Description taken place and buyer known to be aggressive on n May include both strategic and financial buyersn
Involves multiple stages with multiple buyers price included in process and then reduced at each stage + Maximum confidentiality + Increased confidentiality + Creates maximum competition and can result in higher price + Potentially quickest to
execute + Avoid perceptions of business being “shopped” if a decision is ultimately made to not sell + Limits buyers’ ability to assess negotiating position + Minimizes disruption to business of vendor + Effective
‘middle’ ground between options + Clear standout buyer with demonstrated strong Reasons For + Maximises likelihood that all viable buyers will be interest contacted + Increases likelihood of a “left field buyer” emerging
— Absence of competitive process reduces pressure — Risk that potentially interested buyers and high — Difficult to maintain confidentiality and an aborted on potential buyer to pay a premium valuation and value “left
field” buyers are excluded from process process could reflect negatively on business adhere to preferred timetable / terms Reasons Against — Time and resource intensive, general distraction for business and potentially costly —
Some buyers may be deterred by a broad process Confidentialityüüüüüü Speed of Processüüüüüü Value Contingent on buyer Maximisation üüüüü Potential Investment
Banking | 23
Confidential Landscape of Software Investors Financial Sponsor
Strategics Sponsor Select Current Investments Other Investors & Strategics Family Offices SWF / Pensions / Infra / Other Infrastructure Investment Banking | 24
Confidential Preliminary Proposed Partners Contact Fund Size (bn)
Contact Fund Size (bn) Dave Humphrey Bryan Taylor $25.0 (Fund X) Max de Groen $11.8 (Fund XIII) Lauren Young Valentin Fernandez Jason Wright $13.0 (Fund XI) Martin Brand $16.6 (Fund IX) Prakash Melwani Prashant Mehrotra $14.1 (Fund XII) Eli Nagler
Jason Glass Patrick McCarter $14.8 (Fund VIII) €26.0 (Fund IX) Alexandra Van Arkel Craig Greenseid Casey Manzella Tarim Wasim Deven Parekh $23.0 (Fund XI) $20.0 (Fund XII) Matt Eisen Anika Agarwal John Danhakl Richard Sarnoff $14.0 (Fund IX)
Usama Cortas Webster Chua $19.0 (Fund XIII) Saul Kopelowitz Aubrey Barth NA €9.0 (Fund XI) Greg Sheldon Tim Millikin Gautam Thakar $15.6 (Fund IX) NA John Rogers Denis Nikolaev Ramzi Musallam Jason Mironov $16.5 (Fund XV) $10.6 (Fund VIII) Dan
Sugar Holden Spaht $24.3 (Fund XV) Brian Jaffee Jamie Hutter Amy Aurora NA Arvindh Kumar €21.0 (Fund X) Kosmo Kalliarekos Mike Wetter NA Jesper Ridder Olsen NA Safra Catz NA Nick Yuan Dan Bitar NA Janet Glazer NA Kay Krafft NA Lynn Moore Jr
Brad Powell Brian Miller NA Geo Kane NA Jeff Puckett Steve McDermid Investment Banking | 25 Strategics Tier 1 Sponsor Likely Not Interested Tier 3 Sponsor Tier 2 Sponsor
Confidential Selected Public Software Transactions Transaction Premia |
Public Software Transactions Since 2022 Premium to Undisturbed (%) 94 % 77 % 63 % 62 % 59 % 57 % 53 % 53 % 52 % 52 % 47 % 46 % 46 % 44 % 44 % Median: 46 % 34 % 34 % 32 % 32 % 31 % 29 % 29 % 27 % 24 % 17 % Announcement Oct-2022 Dec-2022 Aug-2022
Mar-2023 Dec-2023 Feb-2023 Oct-2022 Mar-2022 Apr-2022 Jun-2022 Feb-2024 Jan-2023 Mar-2023 May-2022 Oct-2022 May-2023 Jun-2022 Aug-2023 Apr-2022 S ep-2023 Mar-2023 Jan-2024 Aug-2022 Jan-2022 Jul-2023 Absolute Avid Target UserTesting C oupa Ping
Identity Qualtrics Alteryx Sumo Logic ForgeRock Mandiant Datto Anaplan Everbridge Duck C reek Momentive VMware KnowBe4 Zendesk S ailPoint S plunk C vent Ansys Avalara C itrix New Relic S oftware Technology Silver Lake & S ymphony S ymphony
Francisco Francisco Acquiror Thoma Bravo Thoma Bravo Thoma Bravo C PP C learlake Thoma Bravo G oogle Kaseya Thoma Bravo Thoma Bravo Vista Technology Broadcom Vista C rosspoint Investor G roup Technology Thoma Bravo C isco Blackstone S ynopsys Vista
Vista & Elliott Partners & Partners Investments G roup G roup TPG Transaction $ 1.1 $ 8.1 $ 2.8 $ 11.7 $ 4.4 $ 1.4 $ 2.0 $ 5.4 $ 6.0 $ 10.1 $ 1.8 $ 2.3 $ 1.5 $ 69.2 $ 4.3 $ 0.9 $ 9.9 $ 1.4 $ 7.0 $ 29.8 $ 4.5 $ 34.6 $ 8.4 $ 16.4 $ 6.1 Value
($bn)¹ % C ash C onsideration 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 49 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 50 % 100 % 100 % 100 % Undisturbed as % 28 % 23 % 58 % 36 % 44 % 61 % 45 % 67 % 83 % 53 %
68 % 45 % 26 % 57 % 63 % 69 % 38 % 62 % 83 % 96 % 74 % 87 % 39 % 58 % 87 % of 52-Week High² Premium to (46)% (60)% (6)% (42)% (31)% (5)% (32)% 2 % 26 % (20)% (0)% (35)% (62)% (17)% (9)% (7)% (49)% (19)% 9 % 26 % (5)% 12 % (51)% (28)% 2 %
52-Week High² Source: Public Filings, FactSet | ¹ Transaction value includes convertible note breakage costs assuming takeout date per anticipated transaction close referenced in announcement press release. Convertible note breakage costs
exclude any impact from capped call unwind. ² Reflects 52-week high as of undisturbed date. Investment Banking | 26
Confidential Analysis at Various Prices Illustrative Share Price Metric
$ 20.73 $ 22.50 $ 25.00 $ 27.00 $ 30.00 $ 32.50 $ 35.00 Premium / Discount to C urrent $ 20.73 0% 9% 21% 30% 45% 57% 69% Software Median to Ansys: Juniper: Everbridge: 29% 32% Undisturbed 47% (2022 – Today): 44% Premium / Discount to 1M VWAP $
22.97 (10)% (2)% 9% 18% 31% 41% 52% Premium / Discount to IPO Price $ 18.00 15% 25% 39% 50% 67% 81% 94% Premium / Discount to 52 Week High $ 25.02 (17)% (10)% (0)% 8% 20% 30% 40% Software Median to 52-Week-High (2022 – Today): (19)% Fully
Diluted Equity Value 4,358 4,730 5,256 5,676 6,307 6,833 7,358 2023YE Net Debt 781 781 781 781 781 781 781 Enterprise Value $ 5,139 $ 5,511 $ 6,037 $ 6,457 $ 7,088 $ 7,613 $ 8,139 2024E EV / Adj. EBITDA $ 270 19.1 x 20.4 x 22.4 x 23.9 x 26.3 x 28.2
x 30.2 x Other Vertical Software: 16.0x 35.2x 28.0x 2024E EV / G rowth Adj. EBITDA 15% 1.3 x 1.4 x 1.5 x 1.6 x 1.7 x 1.9 x 2.0 x 2024E EV / uFC F $ 208 24.8 x 26.5 x 29.1 x 31.1 x 34.1 x 36.7 x 39.2 x Other Vertical Software: 19.8x 46.4x 36.3x
Source: Consensus broker projections Note: Current price as of 01-Mar-2024 closing. uFCF calculated as CFO – Capex - CapSW + Interest x (1 – tax rate). Investment Banking | 27
Confidential Framing Potential Process Timelines 2024 Mar Apr May 4 11
18 25 1 8 15 22 29 6 13 Milestones / Workstreams Marketing Document Preparation ~3 weeks Outbound Calls / NDAs Initial Buyer Management Meetings / Due Diligence 5 weeks First Round Bids Due Detailed / Confirmatory Diligence, Buyers Secure Financing
Contract Markup Due Final Bids / Negotiate & Sign Definitive Agreement Investment Banking | 28
Appendix A: GS Credentials Investment Banking
Confidential We Are the Software M&A Advisor of Choice + + + We
Deliver The Leading Unmatched Most Active in Superior Software M&A Industry the Market Outcomes Advisor Expertise #1 #1 23 230+ In client satisfaction Advisor across software Years of average Software transactions with 2x more votes M&A by
deal volume senior team since 2016 than the next firm and transaction count experience GS delivers better, measurable GS has advised on almost $1 Deep team with relationships With more than 350 M&A outcomes for our clients, trillion in
transaction value with the most important transactions since 2016, our having realized the highest since 2016 and 28% buyers, knowledge of their team is the most active in the sellside premiums and leadership over the #2 advisor priorities and the
industry M&A market with a strong achieving deal terms that trends that impact how to understanding of how buyers maximize deal certainty design a process to maximize operate and how successful value deals get done Differentiated Experience,
Advice, and Outcomes Investment Banking | 30
Confidential GS Involved in the Biggest, Most Recent Software Deals
2022 - 2023 Largest Sponsor Software Deals Largest Strategic Software Deals Transaction EV / NTM Announcemen Target Acquirer Transaction EV / NTM Announcemen Target Acquirer Target Acquirer Target Acquirer Value ($bn) Revenue t Date Advisor Advisor
Value ($bn) Revenue t Date Advisor Advisor Vista Equity Vista Equity Citrix Systems $16.4 5.0 x Jan-2022 Citrix Systems $69.2 5.3 x May-2022 Partners Partners Canada Pension Canada Pension Qualtrics Qualtrics Plan Investment Plan Investment
International, $11.7 7.1 x Mar-2023 International, $28.1 7.3 x Sep-2023 Board; Silver Board; Silver Inc. Inc. Lake Lake Anaplan, Inc. Thoma Bravo $10.1 12.8 x Mar-2022 Anaplan, Inc. Thoma Bravo $10.7 – Jun-2023 Hellman & Hellman & /
Zendesk, Inc. Friedman / $9.9 5.5 x Jun-2022 Zendesk, Inc. Friedman / $8.3 5.1 x Jan-2023 Permira Permira Vista Equity Vista Equity Avalara, Inc. $8.4 8.8 x Aug-2022 Avalara, Inc. $5.8 2.1 x Aug-2022 Partners Partners Coupa Software, Coupa Software,
Thoma Bravo $8.1 8.6 x Dec-2022 Thoma Bravo $4.6 – Jun-2023 Inc. Inc. SailPoint SailPoint Technologies Thoma Bravo $7.0 12.9 x Apr-2022 Technologies Thoma Bravo $4.3 10.8 x Jan-2022 Holdings, Inc. Holdings, Inc. TPG Capital; TPG Capital;
Francisco Francisco New Relic, Inc. $6.1 5.8 x Jul-2023 New Relic, Inc. $4.1 6.1 x Jul-2022 Partners Partners Management Management Cvent Holding Cvent Holding Blackstone $4.5 6.2 x Mar-2023 Blackstone $4.1 – Jan-2022 Corp. Corp. Engagesmart,
Vista Equity Engagesmart, Vista Equity $4.0 8.7 x Oct-2023 $3.6 – Jul-2023 Inc. Partners Inc. Partners Source: FactSet; market data as of 01-Jan-2024 Investment Banking | 31
Confidential Goldman Sachs Achieves Better Outcomes for Our Clients
Goldman Sachs is the Clear Leader in Software M&A, Having Advised on ~$880 Billion Deal Volume Since 2019 Software M&A League Tables 2019-2023 Software Deal Volume 2019-2023 Software Deal Count 2019 2020 2021 2022 2023 $ 878bn 1 179 above #2
above #2 46% 38% Morgan Morgan Morgan Morgan Morgan 130 2 $ 603bn 127 Stanley Stanley Stanley Stanley Stanley $ 431bn 85 82 3 JP Morgan JP Morgan JP Morgan Bank of America JP Morgan $ 310bn $ 285bn 4 Credit Suisse Bank of America Citi JP Morgan
Qatalyst 5 Barclays Credit Suisse Evercore Credit Suisse Citi Advising on the Largest Transformative M&A Source: FactSet; market data as of 1-Jan-2024 Note: public and private deals considered. Analysis excludes intra-China and cancelled deals.
Only transactions above $500mm or with undisclosed Investment Banking | 32 transaction sizes are included in both total volumes and total counts. League Table ranking based on deal volumes.
Confidential GS is the EdTech M&A Advisor of Choice Exclusive
Financial Advisor / Financial Advisor / Financial Advisor / Exclusive Exclusive Financial Advisor Lead Financial Advisor Lead Financial Advisor Committed Financing Provider Financing Provider Financial Advisor Financial Advisor Financing Provider
$1.7bn Sale of Equity $750mm $5.3bn $5.2bn Sale to Sale to Sale to Acquistion of Stake to Sale to Sale to Acquisition of January 2024 September 2023 April 2023 April 2022 January 2022 December 2021 December 2021 October 2021 / Exclusive Co-Lead
Exclusive Exclusive Exclusive Financial Advisor Financial Advisor Financial Advisor Financial Advisor Financial Advisor Financial Advisor Financial Advisor Financial Advisor $500mm $1.4bn $394mm Sale of $536mm Sale to $792mm Sale to Merger with
Acquisition of Merger with Acquisition of Equity Stake to Sale of Capita ESS to / / September 2021 September 2021 September 2021 July 2021 March 2021 February 2021 October 2020 January 2020 Financial Advisor, Financial Advisor & Financial
Advisor & Exclusive Financial Advisor Exclusive Financial Advisor Financial Advisor Financial Advisor Financial Advisor Lead Left Arranger Lead Left Arranger Lead Left Arranger Sale to Sale of minority in the in the in the $1.6bn $2.6bn Sale to
interest to Acquisition of Acquisition of Acquisition of Sale to Sale to And Undisclosed Undisclosed / November 2019 October 2019 May 2018 April 2018 September 2017 August 2017 August 2017 July 2017 Note: Includes transactions completed by GS team
members prior to joining GS. Investment Banking | 33
Appendix B: Selected Precedent Transactions Investment
Banking
Confidential Selected Public Software Transactions Transaction
Multiples | Public Software Transactions Since 2022 EV / NTM Revenue¹ 14.5 x 12.9 x 12.8 x 11.4 x 9.7 x 75th Percentile: 8.6 x Median: 6.8 x 8.8 x 8.6 x 25th Percentile: 5.0 x 8.4 x 8.0 x 7.7 x 7.1 x 7.1 x 6.8 x 6.2 x 5.8 x 5.5 x 5.1 x 5.0 x
5.0 x 4.3 x 4.1 x 4.0 x 3.4 x 3.0 x 3.0 x Announcement Jan-2024 Apr-2022 Jun-2022 Oct-2022 Mar-2022 Aug-2022 Dec-2022 Oct-2022 Apr-2022 Aug-2022 S ep-2023 Mar-2023 Jan-2023 Mar-2023 Jul-2023 Jun-2022 Oct-2022 May-2022 Jan-2022 Dec-2023 Feb-2023
Feb-2024 May-2023 Mar-2023 Aug-2023 Absolute Avid Target Ansys S ailPoint Anaplan KnowBe4 Mandiant Avalara C oupa ForgeRock Datto Ping Identity S plunk Qualtrics Duck C reek C vent New Relic Zendesk UserTesting VMware C itrix Alteryx Sumo Logic
Everbridge Momentive S oftware Technology Silver Lake & Francisco S ymphony S ymphony Francisco Acquiror S ynopsys Thoma Bravo Thoma Bravo Vista G oogle Vista Thoma Bravo Thoma Bravo Kaseya Thoma Bravo C isco C PP Vista Blackstone Partners &
Investor G roup Thoma Bravo Broadcom Vista & Elliott C learlake Thoma Bravo C rosspoint Technology Technology Partners Investments TPG G roup G roup Transaction $ 34.6 $ 7.0 $ 10.1 $ 4.3 $ 5.4 $ 8.4 $ 8.1 $ 2.0 $ 6.0 $ 2.8 $ 29.8 $ 11.7 $ 2.3 $
4.5 $ 6.1 $ 9.9 $ 1.1 $ 69.2 $ 16.4 $ 4.4 $ 1.4 $ 1.8 $ 0.9 $ 1.5 $ 1.4 Value ($bn)² % C ash C onsideration 50 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 49 % 100 % 100 % 100 % 100 % 100 %
100 % 100 % Premium to 29 % 32 % 52 % 44 % 53 % 27 % 77 % 53 % 52 % 63 % 31 % 62 % 46 % 29 % 17 % 34 % 94 % 44 % 24 % 59 % 57 % 47 % 34 % 46 % 32 % Undisturbed Acquiror EV / NTM - - - - - - - - - - - - - - - - - 7.8 x - - - - - - - Revenue Multiple
Target NTM 11 % 18 % 25 % 30 % 16 % 21 % 15 % 25 % 17 % 18 % 8 % 14 % 10 % 17 % 11 % 26 % 16 % 7 % 3 % 11 % 15 % 2 % 14 % 3 % 12 % Revenue Growth Target NTM Operating 42 % (4)% (3)% 12 % (14)% (0)% 8 % (10)% 19 % (4)% 21 % 10 % 8 % 18 % 16 % 8 %
(19)% 27 % 26 % 12 % (13)% 18 % 6 % 15 % 21 % Margin Source: Public Filings, FactSet ¹ Transaction multiple reflects metrics at announcement. NTM revenue reflects median consensus estimates for the next twelve-month period as of transaction
announcement date. ² Transaction value includes convertible note breakage costs assuming takeout date per anticipated transaction close referenced in announcement press release. Convertible note breakage costs exclude any impact from capped
call unwind. Investment Banking | 35
Exhibit (c)(iv) Project Picasso Tax Receivable Agreement
Disclaimer This presentation is intended to provide a discussion of the
transaction described herein. It should not be viewed as an opinion, nor should it be used in place of professional advice. This presentation does not address any issue not expressly identified herein, such as taxes not specifically identified;
jurisdictions not discussed (e.g., state, local and foreign taxing jurisdictions); and legal or non-tax issues such as corporate law or securities law matters. Our views are based on our understanding of the Internal Revenue Code
(“IRC”), regulations, court decisions, rulings and procedures issued by the IRS, and other authorities we deemed relevant, as of the date hereof. The applicable law and its interpretation are subject to change, potentially retroactive in
effect, and any such change could adversely affect this presentation. Should there be such a change, including a change having retroactive effect, our conclusions would need to be reevaluated. This document reflects our analysis of the applicable
authorities as of the date hereof, and we are not obligated to inform any person of a change, or otherwise update the conclusions herein, for changes subsequent to the date hereof. Accordingly, Ernst & Young LLP (“EY” or
“we”) accepts no responsibility for any action taken or not taken by anyone using this document. The information in this presentation is solely for your benefit and may not be relied upon by any other person or entity and we shall not
have any responsibility to anyone in respect of the information contained in this document. In preparing the analysis that follows, we have relied on information provided by client. The information has not been validated by EY at this time. All
references to Section(s) or § in this slide deck are to the IRC or to Treasury regulations, unless otherwise specified. Page 2 9 April 2024 Project Picasso – Tax Receivable Agreement
Overview of Picasso TRA • The Picasso TRA provides that Picasso
will pay to the pre-IPO shareholders 85% of cash tax savings from the use of covered tax attributes (listed below) at current effective tax rate • Tax attributes covered: • Amortizable tax basis at the time of the IPO and tax basis
step-ups created by subsequent exchanges and payments on the TRA • Net operating losses, capital losses, disallowed interest expense carryforwards and credit carryforwards of the Blockers that existed at the time of the IPO date •
Deductions attributable to the portion of TRA payments treated as imputed interest or guaranteed payments • As is customary with TRAs, upon a change in control of Picasso, Picasso becomes obligated to make an early termination payment to the
TRA holders (which is similar to a make-whole payment). The early termination payment is the present value, discounted at LIBOR plus 5.5%, of all the TRA payments required to be paid by Picasso, calculated based on certain “valuation
assumptions” (see below) • At a high level, the valuation assumptions include: • Picasso has taxable income sufficient to fully utilize the deductions arising from the covered tax attributes in the taxable years in which such
deductions would become available; • any covered loss, capital loss, disallowed interest expense, credit or similar carryovers as of the early termination will be utilized by Picasso in the earliest possible taxable year permitted by tax law;
• the US federal, state and local income tax rates in effect as of the early termination will hold constant (but taking into account any future changes in tax rates that have been enacted at the time of the early termination); • any
non-amortizable assets will be sold for cash at their fair market value in a fully taxable transaction on an assumed timeline; and • if, as of the change of control date, there are exchangeable units that have not been transferred in an
exchange, then all exchangeable units and (if applicable) shares of Class B Common Stock shall be deemed to be transferred in an exchange effective as of the change of control date Page 3 9 April 2024 Project Picasso – Tax Receivable
Agreement
Picasso Early Termination Payment Hypothetical exchange TRA attribute
Assumed share price Existing TRA attribute payment and iterative payment Total payment due at close $25.00 per share $335,611,626 $136,275,266 $471,886,892 $27.50 per share $335,611,626 $150,727,410 $486,339,036 $30.00 per share $335,611,626
$165,179,523 $500,791,149 $32.50 per share $335,611,626 $179,631,611 $515,243,237 $35.00 per share $335,611,626 $194,083,679 $529,695,305 $37.50 per share $335,611,626 $208,535,730 $544,147,356 $40.00 per share $335,611,626 $222,987,767 $558,599,393
$42.50 per share $335,611,626 $237,439,792 $573,051,417 Notes and assumptions [1] Assumes a discount rate of 5.50% computed as the minimum of (i) SOFR plus 100 bps taking into account a spread for the difference in LIBOR and SOFR; and (ii) 5.50% per
the Early Termination Rate” of the TRA. [2] Assumes a blended federal tax rate and state/local tax rate per clause (iii) of the definition of Valuation Assumptions in the TRA (based on 2023 apportionment factors). [3] Pubco has $41.6M of
accrued TRA payments through 12/31/2023 that have not been paid as the company is unable to make tax distributions pursuant to its credit agreement. [4] Hypothetical exchange TRA attribute and iterative payment represents additional step-up that is
generated by the existing TRA attribute payment itself. • Advisors’ recommended approach to first round of sales process: Bidders assume total TRA payment is $500M and treat as a debt-like item • Each incremental $1.00 per share
price represents approximately $5M in value Source: Calculated by EY based on Picasso data and the assumptions outlined above. Page 4 9 April 2024 Project Picasso – Tax Receivable Agreement
Picasso Tax Attributes Summary Projected Tax Basis Recovery Total
Existing §743(b) Step-Up [1] $555,033,999 $963,595,889 Existing Common Basis in Amortizable Assets and §743(b) Assets Hypothetical §743(b) Step-Up [2] $943,057,166 Total Recovery $2,461,687,054 Net Operating Losses (NOLs) Total
Pre-IPO NOLs not subject to Section 382 Limitation $340,333,519 Pre-IPO NOLs subject to Section 382 Limitation $18,768,596 Post-IPO NOLs generated by Pubco $36,042,800 $17,281,310 Post-IPO NOLs acquired [3] Total NOLs $412,426,225 Excess Business
Interest Expenses (EBIEs) Total Pre-IPO Blocker EBIEs $71,113,868 Post-IPO EBIEs $51,645,439 Total EBIEs $122,759,307 Notes and assumptions [1] Reflects §743(b) step-up from the a) Blocker mergers exchanged at IPO, and b) Severin Topco exchange
in March 2023. [2] Reflects §743(b) step-up from the hypothetical exchange upon transaction close. Assumes $30.00 share price. [3] Takes into account limitations under §382 for NOLs acquired as part of certain acquisitions. Source:
Calculated by EY based on Picasso data and the assumptions outlined above. Page 5 9 April 2024 Project Picasso – Tax Receivable Agreement
EY refers to the global organization, and may refer to one or more, of
the EY | Building a better working world member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Information about how EY collects and uses EY exists to build a better working world, helping to personal data and a description of the rights individuals have under data protection legislation are available via ey.com/privacy. EY member firms do
not create long-term value for clients, people and society practice law where prohibited by local laws. For more information about our and build trust in the capital markets. organization, please visit ey.com. © 2024 Ernst & Young LLP.
Enabled by data and technology, diverse EY teams in All Rights Reserved. over 150 countries provide trust through assurance and help clients grow, transform and operate. ey.com Working across assurance, consulting, law, strategy, tax and
transactions, EY teams ask better questions to find new answers for the complex issues facing our world today.
Exhibit (c)(v) CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL
REVISION [****] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and
Exchange Commission. Presentation to the Board of Directors Project Picasso Goldman Sachs & Co. LLC April 17, 2024 Goldman Sachs does not provide accounting, tax, or legal advice. Notwithstanding anything in this document to the contrary, and
except as required to enable compliance with applicable securities law, you (and each of your employees, representatives, and other agents) may disclose to any and all persons the US federal income and state tax treatment and tax structure of the
transaction and all materials of any kind (including tax opinions and other tax analyses) that are provided to you relating to such tax treatment and tax structure, without Goldman Sachs imposing any limitation of any kind.
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Disclaimer These materials have been prepared and are provided by Goldman Sachs on a confidential basis solely for the information and assistance of the Board of Directors (the “Board ) and senior management of Picasso (the Company ) in
connection with their consideration of the matters referred to herein. These materials and Goldman Sachs’ presentation relating to these materials (the “Confidential Information”) may not be disclosed to any third party or
circulated or referred to publicly or used for or relied upon for any other purpose without the prior written consent of Goldman Sachs. The Confidential Information was not prepared with a view to public disclosure or to conform to any disclosure
standards under any state, federal or international securities laws or other laws, rules or regulations, and Goldman Sachs does not take any responsibility for the use of the Confidential Information by persons other than those set forth above.
Notwithstanding anything in this Confidential Information to the contrary, the Company may disclose to any person the US federal income and state income tax treatment and tax structure of any transaction described herein and all materials of any
kind (including tax opinions and other tax analyses) that are provided to the Company relating to such tax treatment and tax structure, without Goldman Sachs imposing any limitation of any kind. The Confidential Information has been prepared by the
Investment Banking Division of Goldman Sachs and is not a product of its research department. Goldman Sachs and its affiliates are engaged in advisory, underwriting and financing, principal investing, sales and trading, research, investment
management and other financial and non-financial activities and services for various persons and entities. Goldman Sachs and its affiliates and employees, and funds or other entities they manage or in which they invest or have other economic
interests or with which they co-invest, may at any time purchase, sell, hold or vote long or short positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of the
Company, any other party to any transaction and any of their respective affiliates or any currency or commodity that may be involved in any transaction. Goldman Sachs’ investment banking division maintains regular, ordinary course client
service dialogues with clients and potential clients to review events, opportunities, and conditions in particular sectors and industries and, in that connection, Goldman Sachs may make reference to the Company, but Goldman Sachs will not disclose
any confidential information received from the Company. The Confidential Information has been prepared based on historical financial information, forecasts and other information obtained by Goldman Sachs from publicly available sources, the
management of the Company or other sources (approved for our use by the Company in the case of information from management and non-public information). In preparing the Confidential Information, Goldman Sachs has relied upon and assumed, without
assuming any responsibility for independent verification, the accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by us, and Goldman Sachs does not
assume any liability for any such information. Goldman Sachs does not provide accounting, tax, legal or regulatory advice. Goldman Sachs has not made an independent evaluation or appraisal of the assets and liabilities (including any contingent,
derivative or other off-balance sheet assets and liabilities) of the Company or any other party to any transaction or any of their respective affiliates and has no obligation to evaluate the solvency of the Company or any other party to any
transaction under any state or federal laws relating to bankruptcy, insolvency or similar matters. The analyses contained in the Confidential Information do not purport to be appraisals nor do they necessarily reflect the prices at which businesses
or securities actually may be sold or purchased. Goldman Sachs’ role in any due diligence review is limited solely to performing such a review as it shall deem necessary to support its own advice and analysis and shall not be on behalf of the
Company. Analyses based upon forecasts of future results are not necessarily indicative of actual future results, which may be significantly more or less favorable than suggested by these analyses, and Goldman Sachs does not assume responsibility if
future results are materially different from those forecast. The Confidential Information does not address the underlying business decision of the Company to engage in any transaction, or the relative merits of any transaction or strategic
alternative referred to herein as compared to any other transaction or alternative that may be available to the Company. The Confidential Information is necessarily based on economic, monetary, market and other conditions as in effect on, and the
information made available to Goldman Sachs as of, the date of such Confidential Information and Goldman Sachs assumes no responsibility for updating or revising the Confidential Information based on circumstances, developments or events occurring
after such date. The Confidential Information does not constitute any opinion, nor does the Confidential Information constitute a recommendation to the Board, any security holder of the Company or any other person as to how to vote or act with
respect to any transaction or any other matter. The Confidential Information, including this disclaimer, is subject to, and governed by, any written agreement between the Company, the Board and/or any committee thereof, on the one hand, and Goldman
Sachs, on the other hand. The Confidential Information does not address, nor does Goldman Sachs express any view as to, the potential effects of volatility in the credit, financial and stock markets on the Company, any other party to any transaction
or any transaction. 2
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Table
of Contents I. Process Update II. Overview of Management Plan III. Valuation Perspectives Appendix A: Supplementary Materials 3
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION I.
Process Update
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Summary of Party Engagement Sponsors (8) Strategics (5) [****] [****][****][****] [****] Initial Engagement (13)[****][****] [****][[ [****] [****][****] [****][ [****] [****] [****] [****] [****] Executed NDA, Management Presentations and/or Deep
Dive Meetings (8)[****] [****][* [****] [****] Indicated interest in Non-Binding partnering on a transaction [****] Verbal Indications Other of Interest Scheduled session for [****] Received diligence deep dive Process Update 5
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Summary of Investor Feedback to Date Diligence Follow Up MP Sessions Q&A Latest Developments ◼ Enthusiastic about the company and management and would like to get a transaction done by earnings ✓✓✓◼ While they
have received most of the information they need to this stage, they have requested additional time with management to walk through a product demo ◼ Spent time with EY and GS teams late last week to through the tax treatment and M&A
opportunity [****] ✓✓ ◼ Indicated a control transaction will be challenging and they would be willing to participate with another lead subject to valuation with flexibility to deploy capital from several pockets ◼
Complimentary of management and the process having spent time engaging through a management presentation, several diligence sessions, and multiple touch points with GS team [****] ✓✓✓ ◼ Through the process they validated
their initial assumptions, but were not able to get to an above market deal given conservatism around AI and international and a conservative M&A case ◼ Indicated this is a company with strong market leadership, strong organic and
inorganic growth with tailwinds from [****] AI ✓✓ ◼ Commented that it will be tough to provide a notable premium to market, especially when factoring in the TRA; however, they would be interested in opportunities to provide
liquidity through creative structures ◼ Indicated they have admiration for the company, but were having a hard time getting to a premium well above market [****] ✓✓ ◼ Expressed concerns over underwriting the combination of
forward growth + margin but indicated they would be interested in providing liquidity through a structured transaction that would require a premium to public investors ◼ Expressed uncertainty on reaching 3x MOIC within next ~3-4 years given
combination of organic investment ✓✓ [****] required coupled with delevering likely needed to go public again in that time frame ◼ More positive on the end market than the previous process; however, they do not have bandwidth to
take on given [****] integration in another complicated market (healthcare) [****]✓ ◼ However, they believe this is a company that aligns with senior leadership aspiration and would like to stay close depending on next steps ◼
Have requested additional diligence sessions to discuss growth / margin and investment trade-offs along with [****] ✓✓✓ additional detail for their diligence Initial Pass[****] [****][****][****] [****][****] Process Update 6
Strategics Tier 1 Sponsor
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Key
Themes from Investor Feedback ◼ Respect for Picasso’s market leadership and quality of the business built to date ◼ Respect for the management team, their vision and performance and appreciation for the time spent addressing
investor questions ◼ Investors and potential strategics had a tough time reaching above market prices for several reasons: — Combination of underwriting notable margin expansion coupled with plans to continue growing 10%+ through hold
period — In particular, there was a view that the business requires a strong second half to the year and investor models are highly sensitive to the net retention and organic growth required to meet 2024 budget and longer-term plan —
Certain products including Schoology, SchoolMessenger, and Naviance are facing headwinds which puts pressure on the remaining cloud solutions — Historical growth from LMS is slowing and Picasso saw the benefits of several larger than normal
contracts in the previous year — Conservatism in underwriting the full AI and International business plan – investors often haircut these aspects in their plan given the early stages in both — Ability to underwrite full M&A
plan available to Picasso as a private company — Capacity to take on control transaction given equity check likely required – several investors offered to think through structured solutions to provide some level of liquidity at a smaller
check size and lower premium — Most exit opportunities (e.g., sale to another sponsor) will prove challenging given scale and valuation the business will reach as a private company, especially in the current environment Process Update
7
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION II.
Overview of Management Plan
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Picasso Historical and Projected Financial Profile ($ in millions) Historical Picasso Management Plan CAGR 2021A 2022A 2023A 2024E 2025E 2026E 2027E 2028E 2029E 21-23A 24-29E Revenue $ 559 $ 631 $ 698 $ 788 $ 874 $ 975 $ 1,093 $ 1,231 $ 1,392 12 %
12 % YoY Growth 13 % 11 % 13 % 11 % 12 % 12 % 13 % 13 % Adjusted EBITDA $ 161 $ 196 $ 232 $ 277 $ 327 $ 378 $ 439 $ 513 $ 595 20 % 17 % YoY Growth 22 % 18 % 19 % 18 % 16 % 16 % 17 % 16 % % Margin 29 % 31 % 33 % 35 % 37 % 39 % 40 % 42 % 43 %
Unlevered Free Cash Flow $ 170 $ 146 $ 204 $ 206 $ 313 $ 365 $ 428 $ 475 $ 540 9 % 21 % YoY Growth (14)% 39 % 1 % 52 % 16 % 17 % 11 % 14 % % uFCF Conversion 106 % 74 % 88 % 75 % 96 % 96 % 97 % 93 % 91 % Source: Financial forecasts for Picasso
prepared by the Picasso Management and approved by Picasso for Goldman Sachs’ use (“Picasso Management Plan”). Overview of Management Plan 9
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Picasso Management vs Street Financial Profile ($ in millions) Unlevered Cash Flow Revenue Adjusted EBITDA Management expects 5% $ 378 higher margin in ‘25E $ 981 versus street estimates $ 313 $ 354 $ 327 $ 975 $ 873 $ 307 $ 272 $ 277 $ 874 $
225 $ 789 $ 270 $ 788 Management expects margin expansion $ 206 300bps greater than the street by 2026 Includes acquisition cash outflows of $42mm in ‘24E 2024E 2025E 2026E 2024E 2025E 2026E 2024E 2025E % YoY Growth % Margin % Margin 1 Street
13 % 11 % 12 % Street 34 % 35 % 36 % Street 29 % 31 % Mgmt. 13 % 11 % 12 % Mgmt. 35 % 37 % 39 % Mgmt. 26 % 36 % Source: Picasso Management Plan, Company filings, FactSet median consensus estimates; market data as of 16-Apr-2024. 1 Picasso (Street)
uFCF calculated as (CFO – CapEx – Cap. Software Costs + Interest Expense * (1- Tax Rate)). Assumes 1.2% illustrative pre-TRA payout tax rate, per Picasso Management. Overview of Management Plan 10
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Financial Profile Benchmarking CY 2024E – 2026E Revenue CAGR Median: 12 % 20 % 18 % 17 % 14 % 14 % 14 % 11 % 11 % 12 % 10 % 10 % 10 % 10 % 9 % Picasso Picasso Management Street CY 2024E EBITDA Margin ’24-’26 CAGR Median: 28 % 44 %
42 % 41 % 40 % 35 % 37 % 34 % 30 % 26 % 26 % 17 % 16 % 14 % 13 % 17 % 15 % 11 % 18 % 10 % 16 % 12 % 18 % 15 % 18 % 35 % 36 % 22 % 32 % Picasso Picasso Management Street 1 CY2024E uFCF Margin ’25 2 Growth 44 % Median: 21 % 36 % 35 % 32 % 31 %
29 % 24 % 23 % 20 % 19 % 15 % 14 % 13 % 11 % 26 % 21 % 5 % 6 % 19 % 16 % 39 % 13 % 16 % 26 % 78 % 35 % 46 % 37 % Picasso Picasso 3 Management Street 1 Source: Picasso Management Plan, Company filings, FactSet median consensus estimates; market data
as of 16-Apr-2024. uFCF margin is calculated as (CFO – CapEx – Cap. Software Costs + Interest Expense * (1- Tax Rate)) / 2 Revenue. Assumes 1.2% illustrative pre-TRA payout tax rate for Picasso, per Picasso Management. Software Costs
calculated as 2023 % of revenue multiplied by 2024 revenue if consensus estimates were unavailable. Reflects 3 2025 uFCF growth %. 2025 growth % used instead of 2024-2026 CAGR given 2026 consensus estimates unavailable. 2024E uFCF normalized to
exclude the $42mm of acquisition cash outflows. Overview of Management Plan 11
CONFIDENTIAL – PRELIMINARY DRAFT III. Valuation
Perspectives
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Picasso Stock Price History Since IPO $40.0 $30.0 52-Week High $ 25.16 $ 22.14 6-Month VWAP 9.6% 3-Month VWAP $ 22.06 1-Year VWAP $ 21.28 $ 20.58 VWAP Since IPO $20.0 2-Year VWAP $ 19.93 Current $19.73 $ 16.41 52-Week Low $10.0 Jul-21 Jan-22 Jun-22
Nov-22 May-23 Oct-23 Apr-24 Source: FactSet; market data as of 16-Apr-2024 Note: Reflects trading performance from 28-Jul-2021 to 16-Apr-2024. Valuation Perspectives 13 Share Price (USD)
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Valuation Multiples Over Times Since Picasso IPO NTM EV / EBITDA Multiples Since Picasso IPO NTM EV / UFCF Multiples Since Picasso IPO 70 x 70 x 1 1 1 1 60 x 60 x 2 2 2 2 50 x 50 x 40 x 41.2 x 40 x 37.8 x 30.8 x 30 x 30 x 28.9 x 23.5 x 20 x 20 x
19.9 x 16.0 x 13.8 x 10 x 10 x 0 x 0 x Jul-2021 Nov-2021 Mar-2022 Aug-2022 Dec-2022 Apr-2023 Aug-2023 Dec-2023 Apr-2024 Jul-2021 Nov-2021 Mar-2022 Aug-2022 Dec-2022 Apr-2023 Aug-2023 Dec-2023 Apr-2024 Source: FactSet median consensus estimates;
market data as of 16-Apr-2024. Note: Reflects trading performance from 28-Jul-2021 to 16-Apr-2024. Maximum threshold for trading multiples set to 100.0x. 1 Instructure EV PF for incremental debt and cash used for Parchment acquisition in Q1 2024. 2
Includes Appfolio, Autodesk, Aspen Tech, Descartes, Guidewire, Jamf, nCino, Procore, SPS Commerce, and Veeva. Valuation Perspectives 14
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Current Wall Street Perspectives Street Projections | Target Price & Analyst Sentiment | $ in Millions Evolution of Analyst Sentiment Evolution of Picasso Revenue Estimates $ 1,100 12 12 12 14 14 14 14 13 14 $ 1,000 7 % 7 % 8 % 8 % 8 % $ 981 14
% 14 % 21 % $ 900 33 % $ 873 25 % 25 % $ 800 $ 789 $ 700 $ 600 93 % 93 % 92 % 86 % 86 % Apr-2022 Oct-2022 Apr-2023 Oct-2023 Apr-2024 79 % 67 % 67 % 67 % FY2024E FY2025E FY2026E Evolution of Picasso EBITDA Estimates $ 400 Apr-2022 Jul-2022 Oct-2022
Jan-2023 Apr-2023 Jul-2023 Oct-2023 Jan-2024 Apr-2024 $ 354 $ 350 Buy Hold Sell $ 307 $ 300 Broker Valuation Methodologies $ 270 $ 250 12-Month PV of Price 1 Broker Date Price Target Target Valuation Methodology $ 200 Apr-2022 Oct-2022 Apr-2023
Oct-2023 Apr-2024 Piper Sandler 5-Mar-2024 $29.00 $26.00 7.5x 2025E Revenue FY2024E FY2025E FY2026E Jefferies 4-Mar-2024 $30.00 $27.00 DCF IBES Median Target Price Macquarie 27-Feb-2024 $26.00 $23.50 7.5x 2024E Revenue $40 Barclays 27-Feb-2024
$28.00 $25.00 21.0x 2025E EBITDA $30 $ 27.00 $ $ 19.73 20.58 BofA 26-Feb-2024 $30.00 $27.00 25.4x 2024E EBITDA $20 $10 UBS 26-Feb-2024 $25.00 $22.50 26.3x 2025E FCF $0 RBC 26-Feb-2024 $27.00 8.0x 2024E Revenue $24.50 Apr-2022 Oct-2022 Apr-2023
Oct-2023 Apr-2024 Share Price Target Price Median $28.00 $25.00 Source: FactSet Market data as of 16-Apr-2024 Note: Anonymous brokers are excluded from the Current Broker Recommendation table but included in median. 1 12-month price target
discounted back at 10.1% WACC and rounded to the nearest $0.50. Valuation Perspectives 15 Share Price (USD) Yearly EBITDA Yearly Revenue Estimate (USD) Estimate (USD)
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Picasso Shareholder Evolution Top 25 Institutions Historical Positions Q2 '24 (Shares in mm) Position Cost Unrealized AUM Last Report Shares 1 2 3 Institution Fund Country Refinitiv Style ($bn) Entry Date Date Basis Gain % BSO (mm) Q1 '24 Q4 '23 Q3
'23 Q2 '23 Q1 '23 Q4 '22 Q3 '22 Q2 '22 Vanguard United States Index 5,862.4 Q3 '21 31-Dec-2023 18.18 16.5 4.7 9.5 9.5 9.5 6.9 9.0 5.4 7.1 6.6 6.6 Wellington United States Value 652.4 Q3 '21 31-Dec-2023 18.89 12.1 2.3 4.7 4.7 4.7 7.1 6.5 4.5 3.8 3.1
2.3 BlackRock Institutional Trust Co. United States Index 3,464.6 Q3 '21 31-Dec-2023 23.34 (9.3) 2.0 4.1 4.1 4.1 3.7 3.4 3.0 2.7 2.4 2.6 Wasatch Global Investors Inc United States GARP 21.8 Q3 '23 31-Dec-2023 21.95 (3.6) 1.7 3.5 3.5 3.5 3.1 William
Blair & Company, L.L.C. (Research) United States Broker Dealer 31.7 Q4 '21 31-Dec-2023 19.53 8.4 1.6 3.3 3.3 3.3 3.3 3.1 3.0 1.5 1.2 0.1 TimesSquare Capital Management, LLC United States Growth 7.7 Q3 '21 31-Dec-2023 19.81 6.9 1.0 1.9 1.9 1.9
2.4 2.9 3.0 2.7 2.5 2.5 Mackenzie Financial Corporation Canada Growth 99.0 Q3 '21 31-Dec-2023 19.03 11.3 0.9 1.8 1.8 1.8 1.8 1.8 0.0 0.0 0.0 0.0 Dimensional Fund Advisors United States Quantitative 541.2 Q3 '22 31-Dec-2023 20.00 5.8 0.8 1.7 1.7 1.7
1.4 1.0 0.8 0.6 0.3 Riverbridge Partners, LLC United States Growth 8.5 Q3 '23 31-Dec-2023 21.95 (3.5) 0.8 1.6 1.6 1.6 1.5 State Street Global Advisors (US) United States Index 2,297.3 Q3 '21 31-Dec-2023 23.67 (10.6) 0.6 1.3 1.3 1.3 1.2 1.1 1.0 0.9
0.9 0.9 Geode Capital Management, L.L.C. United States Index 1,213.1 Q3 '21 31-Dec-2023 23.87 (11.3) 0.6 1.2 1.2 1.2 1.1 0.9 0.8 0.7 0.7 0.7 Calvert Research and Management United States Value 15.5 Q3 '23 31-Dec-2023 21.99 (3.7) 0.6 1.2 1.2 1.2 0.8
T. Rowe Price United States GARP 808.9 Q3 '21 31-Dec-2023 20.00 5.8 0.6 1.1 1.1 1.1 1.2 1.1 1.1 0.7 0.0 0.0 Goldman Sachs Asset Management, L.P. United States Growth 316.1 Q4 '21 31-Dec-2023 19.23 10.1 0.5 1.1 1.1 1.1 1.0 1.1 0.0 0.1 0.1 0.0 JP
Morgan Asset Management United States GARP 645.0 Q4 '21 31-Dec-2023 21.89 (3.3) 0.5 1.1 1.1 1.1 1.1 0.1 0.1 0.0 0.0 0.0 Morgan Stanley & Co. LLC United States Broker Dealer 208.4 Q3 '21 31-Dec-2023 20.86 1.5 0.5 1.0 1.0 1.0 0.9 0.4 0.1 0.0 0.0
0.1 NewEdge Wealth, LLC United States Other 4.2 Q1 '22 31-Dec-2023 15.62 35.5 0.5 1.0 1.0 1.0 1.0 1.0 0.9 0.9 0.9 0.9 Pictet Asset Management Ltd. England Growth 142.4 Q4 '21 31-Dec-2023 19.23 10.1 0.5 0.9 0.9 0.9 0.8 0.8 0.0 0.0 0.0 0.0 Nuveen LLC
United States Pension 423.9 Q3 '21 31-Dec-2023 17.76 19.2 0.4 0.9 0.9 0.9 1.1 1.2 1.2 1.1 0.9 0.2 Loomis, Sayles & Co. United States GARP 74.4 Q3 '23 31-Dec-2023 21.96 (3.6) 0.4 0.9 0.9 0.9 0.8 Fort Washington Investment Advisors, Inc. United
States GARP 15.7 Q3 '23 31-Dec-2023 21.96 (3.6) 0.4 0.8 0.8 0.8 0.7 Gulati (Hardeep) United States Strategic 0.0 Q1 '23 05-Apr-2024 21.28 (0.5) 0.3 0.7 0.8 0.9 1.0 1.1 1.2 1.0 1.0 Total 22.2 % 45.3 45.4 45.6 43.9 36.5 26.2 22.9 20.6 17.9 Median $
20.43 3.7 % Weighted Average⁴ $ 20.18 5.9 % Source: Refinitiv; market data as of 16-Apr-2024. 1 Note: BSO of 204.1mm and includes Class A and Class B shares. Calculated as the weighted average cost of current shares held based on quarterly
VWAPs and all share purchases 2021-present. 2 3 Calculated as the average cost of all historical share purchases 2021-present based on quarterly VWAPs. Position at latest filing. Valuation Perspectives 16
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Picasso Illustrative Standalone Valuation Summary Methodology Illustrative Share Price Commentary ◼ 9.0% - 10.5% Discount Rate Discounted Cash◼ 2.0% - 4.0% Perpetuity Growth Rate $ 18.10 $ 31.80 ◼ 10.75 Year DCF Flow ◼ Based
on preliminary Company tax model ◼ Picasso Management: $343 - $456mm (2025E – 2027E EBITDA) Present Value of Future Share ◼ High: 20.0x EV / NTM EBITDA Price $ 19.00 $ 28.70 ◼ Low: 16.0x EV / NTM EBITDA (EBITDA) ◼ Cost
of Equity: 11.0% ◼ Picasso Management: $313 - $428mm (2025E – 2027E UFCF) Present Value of Future Share ◼ High: 23.5x EV / NTM UFCF Price $ 21.70 $ 31.80 ◼ Low: 19.5x EV / NTM UFCF (uFCF) ◼ Cost of Equity: 11.0% ◼
Picasso share price of $19.73 (as of 16-Apr-2024) Precedent Premia th ◼ High: 75 Percentile of 52% $ 23.90 $ 29.97 th (2019 to Present) ◼ Low: 25 Percentile of 21% ◼ Picasso Management: NTM EBITDA of $304mm Precedent Transactions $
13.60 $ 37.40 ◼ High: 29.3x EV/NTM EBITDA (2019 to Present) ◼ Low: 12.6x EV/NTM EBITDA ◼ 52 Week Intra High: $25.16 (09-Feb-2024) $ 16.41 $ 25.16 Historical Trading ◼ 52 Week Intra Low: $16.41 (05-May-2023) ◼ High PV of
Price Target: $27.00 – BofA: 26-Feb-2024 $ 22.50 $ 27.00 Analyst Target Price ◼ Low PV of Price Target: $22.50 – UBS: 26-Feb-2024 Median: $25.00 Current Price: $ 19.73 Source: Picasso Management Plan; Market data as of 16-Apr-2024
Note: Illustrative share price includes the impact of TRA at ~$419M Book Value as of most recent public filings. Guided buyers to ~$500M based on assumed $30 share price. Valuation Perspectives 17 For Reference
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Picasso Illustrative Analysis at Various Prices ($ in millions, except per share data) Current Illustrative Share Price $ 19.73 $ 22.00 $ 24.00 $ 26.00 $ 28.00 $ 30.00 % Premium to Current $ 19.73 0 % 12 % 22 % 32 % 42 % 52 % to 52 Week High 25.16
(22) (13) (5) 3 11 19 to 52 Week Low 16.41 20 34 46 58 71 83 to 1 Month VWAP 20.91 (6) 5 15 24 34 43 to 3 Month VWAP 22.06 (11) (0) 9 18 27 36 to 6 month VWAP 22.14 (11) (1) 8 17 26 36 Implied Equity Value $ 4,211 $ 4,696 $ 5,122 $ 5,549 $ 5,976 $
6,403 (+) Debt 961 961 961 961 961 961 (+) TRA Book Value 419 419 419 419 419 419 (-) Cash (17) (17) (17) (17) (17) (17) Implied Enterprise Value $ 5,574 $ 6,058 $ 6,485 $ 6,912 $ 7,339 $ 7,766 Other Instructure Tyler Vertical EV / EBITDA
(Management ) Metric CY2024E $ 277 20.1 x 21.9 x 23.4 x 25.0 x 26.5 x 28.1 x 14.2 x 31.8 x 27.7 x CY2025E 327 17.1 x 18.5 x 19.8 x 21.1 x 22.5 x 23.8 x 12.8 x 28.3 x 26.0 x Other Metric Instructure Tyler Vertical EV / uFCF (Management ) 1 CY2024E $
248 22.5 x 24.4 x 26.1 x 27.9 x 29.6 x 31.3 x 16.3 x 42.9 x 35.1 x CY2025E 313 17.8 x 19.4 x 20.7 x 22.1 x 23.4 x 24.8 x 15.3 x 37.1 x 29.7 x Source: Picasso Management Plan; Company filings; market data as of 16-Apr-2024 1 2024E uFCF normalized to
exclude the $42mm of acquisition cash outflows. Valuation Perspectives 18
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Appendix A: Supplementary Materials
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Illustrative Sources and Uses Assumes Illustrative Acquisition Premium of 22% or $24.00 per share ($ in millions, except per share data) LTM June EBITDA Source of Capital Amount % of Total First Lien Term Loan 1,530 23% 5.5 x 2nd Lien Term Loan 417
6% 1.5 x Preferred Equity 556 8% 2.0 x Cash on Balance Sheet 17 0% 0.1 x Sponsor Check 4,213 63% 15.1 x Total $ 6,733 Uses of Capital Amount % of Total LTM June EBITDA Purchase of Equity $ 5,122 76% 18.4 x Debt Takeout 961 14% 3.5 x Cash to Balance
Sheet 50 1% 0.2 x Illustrative Trxn and Financing Fees 100 1% 0.4 x TRA 500 7% 1.8 x Total $ 6,733 Source: Picasso Management Note: Assumes an acquisition price of $24.00 which is calculated based on 22% premium to the $19.73 closing price as of
16-Apr-2024. Supplementary Materials 20
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Picasso Valuation Benchmarking EV / CY 2024E EBITDA CY 2024 Growth Median: 27.7 x 2 Adj. EBITDA Multiple 39.5 x 39.1 x 32.2 x 31.8 x 27.9 x 27.4 x 27.2 x 25.9 x 22.4 x 20.7 x 20.1 x 14.2 x NM NM 1 Picasso Picasso Street Management 1.42 x 1.19 x 2.25
x 1.11 x 1.81 x 2.10 x 2.43 x 0.75 x 1.68 x 1.42 x 1.91 x 1.48 x NM NM 3 EV / 2024E uFCF CY 2024 Growth Median: 35.1 x 4 Adj. uFCF Multiple 52.5 x 51.6 x 42.9 x 41.2 x 35.2 x 35.0 x 33.2 x 28.0 x 24.7 x 24.6 x 22.5 x 16.3 x NM NM Picasso Picasso 1 5
Street Management 1.19 x 0.86 x 2.01 x 1.12 x 2.71 x 3.08 x 1.89 x 0.89 x 2.10 x 0.36 x 4.61 x 2.58 x NM NM 1 Source: Company filings, FactSet median consensus estimates; market data as of 16-Apr-2024. Note: Max. threshold for trading multiples of
55.0x. Instructure EV PF for incremental debt and cash from Parchment acquisition in Q1 2 3 2024. Growth Adj. EBITDA multiple shown as EV / 2024 EBITDA divided by 2024 – 2026 CAGR. uFCF shown as (CFO – CapEx – Cap. Software Costs +
Interest Expense * (1- Tax Rate)). Assumes 1.2% illustrative pre-TRA 4 payout tax rate for Picasso, per Picasso Management. Software Costs shown as 2023 % of revenue multiplied by 2024 revenue if estimates were unavailable. Growth Adj. uFCF multiple
shown as EV / 2024 EBITDA divided by 5 2025 uFCF growth %. 2025 growth % used instead of 2024-2026 CAGR given 2026 estimates unavailable. 2024E uFCF normalized to exclude the $42mm of acquisition cash outflows. Supplementary Materials 21
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Select Precedent Transactions EBITDA Multiples | Software Transactions >$1 Billion with <15% Revenue Growth Since 2019 1 EV / NTM EBITDA 29.3 x 28.7 x 27.6 x 75th Percentile: 19.5 x Median: 16.6 x 25th Percentile: 14.3 x 19.7 x 19.3 x 18.4 x
17.5 x 16.6 x 15.7 x 14.2 x 14.5 x 14.4 x 14.1 x 14.0 x 12.6 x Announcement Dec-2020 Dec-2023 Jul-2023 Jun-2021 Aug-2022 Jan-2024 Feb-2024 Mar-2023 Nov-2021 Apr-2023 Dec-2021 May-2022 Jan-2022 Aug-2023 Aug-2023 Avid Target RealPage Alteryx New Relic
Cloudera Procare Procare Everbridge Momentive McAfee Software AG Cerner VMware Citrix SUSE Technology Symphony Symphony Francisco Acquiror Thoma Bravo Clearlake CD&R & KKR Frontline Roper Thoma Bravo Technology Investor Group Silver Lake
Oracle Broadcom Vista & Elliott EQT Technology Partners & TPG Group Group Transaction $ 10.3 $ 4.4 $ 6.1 $ 4.9 $ 3.7 $ 1.9 $ 1.8 $ 1.5 $ 14.1 $ 2.6 $ 29.4 $ 69.2 $ 16.4 $ 3.5 $ 1.4 Value ($bn)² % Cash 100 % 100 % 100 % 100 % 100 % 100 %
100 % 100 % 100 % 100 % 100 % 49 % 100 % 100 % 100 % Consideration Premium to 31 % 59 % 17 % 24 % - - 47 % 46 % 23 % 63 % 20 % 44 % 24 % 67 % 32 % Undisturbed Acquiror EV / - - - - - - - - - - - 12.4 x - - - NTM EBITDA Multiple Target NTM 13 % 11 %
11 % 7 % 0 % 0 % 3 % 3 % 10 % 7 % 6 % 7 % 3 % 5 % 12 % Revenue Growth Target NTM Operating 25 % 12 % 16 % 16 % - - 18 % 15 % 42 % 16 % 22 % 27 % 26 % - 21 % Margin Source: Public Filings, FactSet ¹ Transaction multiple reflects metrics at
announcement. NTM EBITDA reflects median consensus estimates for the next twelve-month period as of transaction announcement date. ² Transaction value includes convertible note breakage costs assuming takeout date per anticipated transaction
close referenced in announcement press release. Convertible note breakage costs exclude any impact from capped call unwind. Supplementary Materials 22
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Precedent M&A Transaction Premia 2019 – 2024 YTD | All Cash TMT Deals Median Premia to Undisturbed Price th 25 percentile: 21% th 75 percentile: 52% Median: 32 % 33 % 32 % 32 % 31 % 26 % 25 % 2018 2019 2020 2021 2023 2024 YTD Source:
FactSet as of 16-Apr-2024 Note: Includes all-cash U.S. TMT M&A transactions since 01-Jan-2019 with an enterprise value greater than $200mm. N = 171. Supplementary Materials 23
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Common Stock Comparison ($ in millions, except per share data) EV / Revenue EV / EBITDA EV / uFCF EV / uFCF Revenue Growth EBITDA Margin uFCF Margin % of 52-Week Fully Diluted Enterprise Closing Price Company Name High Equity Value Value CY2024
CY2025 CY2024 CY2025 CY2024 CY2025 LFQ '23 - '25 CY2024 CY2025 CY2024 CY2025 Picasso (Management) $ 19.73 79 % $ 4.2 $ 5.6 7.1 x 6.4 x 20.1 x 17.1 x 22.5 x 17.8 x 13 % 11 % 35 % 37 % 31 % 36 % Picasso (Street) $ 19.73 79 % $ 4.2 $ 5.6 7.1 x 6.4 x
20.7 x 18.2 x 24.7 x 20.5 x 13 % 12 % 34 % 35 % 29 % 31 % Vertical Software Peers Appfolio $ 214.58 86 % $ 8.0 $ 7.7 10.1 x 8.5 x 39.5 x 30.6 x 52.5 x 41.6 x 39 % 18 % 26 % 28 % 19 % 20 % AspenTech 200.45 85 12.9 12.7 10.8 9.8 25.9 21.9 33.2 28.7 6
9 42 45 32 34 Autodesk 228.24 86 50.1 50.2 8.4 7.6 22.4 20.0 35.0 25.1 11 10 37 38 24 30 Dassault 90.91 99 7.9 7.6 12.4 11.2 27.9 24.8 35.2 29.7 17 10 44 45 35 38 Guidewire 109.31 90 9.1 8.7 8.6 7.6 NM 42.8 NM 43.9 4 11 14 18 14 17 1 Instructure
19.53 69 2.8 3.8 5.8 5.3 14.2 12.8 16.3 15.3 9 10 41 41 36 34 JAMF 18.14 81 2.5 2.7 4.3 3.8 27.4 17.2 28.0 15.8 16 14 16 22 15 24 Ncino 29.94 80 3.6 3.6 6.6 5.7 39.1 29.5 51.6 35.3 13 17 17 19 13 16 Paycor 72.99 89 11.4 10.7 9.4 7.8 NM 50.3 NM NM 29
20 13 16 11 12 SPS Commerce 163.35 77 6.2 5.9 9.6 8.4 32.2 27.2 41.2 36.4 19 14 30 31 23 23 Tyler Technologies 399.22 90 17.3 17.8 8.4 7.7 31.8 28.3 42.9 37.1 6 10 26 27 20 21 Veeva 200.37 85 33.1 29.0 10.7 9.4 27.2 23.5 24.6 23.4 12 14 40 40 44 40
Peer Mean 8.8 x 7.7 x 28.8 x 27.4 x 36.0 x 30.2 x 15 % 13 % 29 % 31 % 24 % 26 % Peer Median 9.0 x 7.8 x 27.7 x 26.0 x 35.1 x 29.7 x 13 % 12 % 28 % 29 % 21 % 24 % 1 Source: Picasso Management Plan; Company filings, FactSet median consensus estimates;
market data as of 16-Apr-2024. Note: Maximum threshold for trading multiples set to 55.0x. Instructure EV PF for incremental debt and cash used for Parchment acquisition in Q1 2024. Supplementary Materials 24
Exhibit (c)(vi) – CONFIDENTIAL PRELIMINARY DRAFT SUBJECT TO
MATERIAL REVISION [****] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the
Securities and Exchange Commission. Presentation to the Board of Directors Project Picasso Goldman Sachs & Co. LLC April 24, 2024 Goldman Sachs does not provide accounting, tax, or legal advice. Notwithstanding anything in this document to the
contrary, and except as required to enable compliance with applicable securities law, you (and each of your employees, representatives, and other agents) may disclose to any and all persons the US federal income and state tax treatment and tax
structure of the transaction and all materials of any kind (including tax opinions and other tax analyses) that are provided to you relating to such tax treatment and tax structure, without Goldman Sachs imposing any limitation of any
kind.
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Disclaimer These materials have been prepared and are provided by Goldman Sachs on a confidential basis solely for the information and assistance of the Board of Directors (the “Board ) and senior management of Picasso (the Company ) in
connection with their consideration of the matters referred to herein. These materials and Goldman Sachs’ presentation relating to these materials (the “Confidential Information”) may not be disclosed to any third party or
circulated or referred to publicly or used for or relied upon for any other purpose without the prior written consent of Goldman Sachs. The Confidential Information was not prepared with a view to public disclosure or to conform to any disclosure
standards under any state, federal or international securities laws or other laws, rules or regulations, and Goldman Sachs does not take any responsibility for the use of the Confidential Information by persons other than those set forth above.
Notwithstanding anything in this Confidential Information to the contrary, the Company may disclose to any person the US federal income and state income tax treatment and tax structure of any transaction described herein and all materials of any
kind (including tax opinions and other tax analyses) that are provided to the Company relating to such tax treatment and tax structure, without Goldman Sachs imposing any limitation of any kind. The Confidential Information has been prepared by the
Investment Banking Division of Goldman Sachs and is not a product of its research department. Goldman Sachs and its affiliates are engaged in advisory, underwriting and financing, principal investing, sales and trading, research, investment
management and other financial and non-financial activities and services for various persons and entities. Goldman Sachs and its affiliates and employees, and funds or other entities they manage or in which they invest or have other economic
interests or with which they co-invest, may at any time purchase, sell, hold or vote long or short positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of the
Company, any other party to any transaction and any of their respective affiliates or any currency or commodity that may be involved in any transaction. Goldman Sachs’ investment banking division maintains regular, ordinary course client
service dialogues with clients and potential clients to review events, opportunities, and conditions in particular sectors and industries and, in that connection, Goldman Sachs may make reference to the Company, but Goldman Sachs will not disclose
any confidential information received from the Company. The Confidential Information has been prepared based on historical financial information, forecasts and other information obtained by Goldman Sachs from publicly available sources, the
management of the Company or other sources (approved for our use by the Company in the case of information from management and non-public information). In preparing the Confidential Information, Goldman Sachs has relied upon and assumed, without
assuming any responsibility for independent verification, the accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by us, and Goldman Sachs does not
assume any liability for any such information. Goldman Sachs does not provide accounting, tax, legal or regulatory advice. Goldman Sachs has not made an independent evaluation or appraisal of the assets and liabilities (including any contingent,
derivative or other off-balance sheet assets and liabilities) of the Company or any other party to any transaction or any of their respective affiliates and has no obligation to evaluate the solvency of the Company or any other party to any
transaction under any state or federal laws relating to bankruptcy, insolvency or similar matters. The analyses contained in the Confidential Information do not purport to be appraisals nor do they necessarily reflect the prices at which businesses
or securities actually may be sold or purchased. Goldman Sachs’ role in any due diligence review is limited solely to performing such a review as it shall deem necessary to support its own advice and analysis and shall not be on behalf of the
Company. Analyses based upon forecasts of future results are not necessarily indicative of actual future results, which may be significantly more or less favorable than suggested by these analyses, and Goldman Sachs does not assume responsibility if
future results are materially different from those forecast. The Confidential Information does not address the underlying business decision of the Company to engage in any transaction, or the relative merits of any transaction or strategic
alternative referred to herein as compared to any other transaction or alternative that may be available to the Company. The Confidential Information is necessarily based on economic, monetary, market and other conditions as in effect on, and the
information made available to Goldman Sachs as of, the date of such Confidential Information and Goldman Sachs assumes no responsibility for updating or revising the Confidential Information based on circumstances, developments or events occurring
after such date. The Confidential Information does not constitute any opinion, nor does the Confidential Information constitute a recommendation to the Board, any security holder of the Company or any other person as to how to vote or act with
respect to any transaction or any other matter. The Confidential Information, including this disclaimer, is subject to, and governed by, any written agreement between the Company, the Board and/or any committee thereof, on the one hand, and Goldman
Sachs, on the other hand. The Confidential Information does not address, nor does Goldman Sachs express any view as to, the potential effects of volatility in the credit, financial and stock markets on the Company, any other party to any transaction
or any transaction. 2
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Table
of Contents I. Process Update II. Valuation Perspectives Appendix A: Supplementary Materials 3
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION I.
Process Update
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Summary of Party Engagement Sponsors (9) Strategics (5) [****] [****][****] [****][****] Initial Engagement (14) [****] [****] [****] [****] [****] [****] [****][****] [****] [****] [****] Executed NDA, Management Presentations and/or Deep Dive
Meetings (8) [****] [****][****] [****] Conducted extensive Non-Binding financial diligence as well as follow up sessions on [****] Written Proposals Other product development, tech Received stack and R&D spend Process Update 5
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Summary of Potential Bidders Feedback to Date Diligence Follow Up MP Sessions Q&A Latest Developments ◼ Enthusiastic about the company and management and would like to get a transaction done by earnings ◼ While they have received
most of the information they need to this stage, they have requested additional time with ✓✓✓ management to walk through a product demo ◼ Current perspective on value based on assessment of market, retention, and product /
growth initiatives ◼ Indicated a control transaction will be challenging and they would be willing to participate with another lead subject [****] ✓✓ to valuation with flexibility to deploy capital from several pockets ◼
Complimentary of management and the process having spent time engaging through a management presentation, several diligence sessions, and multiple touch points with GS team [****] ✓✓✓ ◼ Through the process they validated
their initial assumptions, but were not able to get to an above market deal given conservatism around AI and international and a conservative M&A case ◼ Indicated this is a company with strong market leadership, strong organic and
inorganic growth with tailwinds from AI [****] ✓✓ ◼ Commented that it will be tough to provide a notable premium to market, especially when factoring in the TRA; however, they would be interested in opportunities to provide
liquidity through creative structures ◼ Indicated they have admiration for the company, but were having a hard time getting to a premium above market [****]✓✓ ✓ ◼ Expressed concerns over underwriting the combination
of forward growth + margin but indicated they would be interested in providing liquidity through a structured transaction ◼ Expressed uncertainty on reaching 3x MOIC within next ~3-4 years given combination of organic investment
✓✓✓ [****] required coupled with delevering likely needed to go public again in that time frame ◼ More positive on the end market than other times where they have discussed the sector historically; however, they do not
have bandwidth to take on given [****] integration in another complicated market (healthcare) ✓ [****] ◼ However, they believe this is a company that aligns with senior leadership aspiration and would like to stay close over the longer
term (e.g., if there would be another opportunity to consider in 4-5 years) ◼ Conducted extensive financial diligence as well as follow up sessions on product development, tech stack and [****] R&D spend ✓✓✓ ◼
Continue to address diligence follow-up questions pertaining to financial profile [****] [****] [****] [****] [****] [****] Initial Pass Process Update 6 Strategics Tier 1 Sponsor
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Key
Themes from Potential Bidder Feedback ◼ Respect for Picasso’s market leadership and quality of the business built to date ◼ Recent trends in net retention (potentially from ESSR funding roll off) could make longer term sustainable
growth more challenging ◼ If funding headwinds are present, this could make the second half of the year more challenging ◼ Sponsors and strategics conveyed various challenges to submitting a proposal exceeding market prices for several
reasons: — Combination of underwriting notable margin expansion coupled with plans to continue growing 10%+ through hold period — In particular, there was a view that the business requires a strong second half to the year and potential
bidders models are highly sensitive to the net retention and organic growth required to meet 2024 budget and longer-term plan — Certain products including Schoology, SchoolMessenger, and Naviance are facing headwinds which puts pressure on the
remaining cloud solutions — Historical growth from LMS is slowing and Picasso saw the benefits of several larger than normal contracts in the previous year — Conservatism in underwriting the full AI and International business plan
– potential bidders often haircut these aspects in their plan given the early stages in both — Ability to underwrite full M&A plan available to Picasso as a private company — Most exit opportunities (e.g., sale to another
sponsor) will prove challenging given anticipated scale of the business, especially in the current environment — Higher cost of capital at current rates makes returns more difficult and any M&A case more expensive — Limited IPO
market over the past 2 years calls into question viability of clean exit — Capacity to take on control transaction given equity check likely required – some investors offered to think through structured solutions that would provide
investment for funding M&A or potential secondary liquidity, but not a control transaction Note: Bold indicates Bain feedback. Process Update 7
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Summary of Bain Capital Proposal Date◼ April 24, 2024 ◼ $22.17 per share ($5.97B enterprise value) Headline Offer ◼ 25% premium to prior day’s closing share price Price ◼ 24x 2024E Unlevered Free Cash Flow of $248
Million ◼ Assumes $706M of net debt on Picasso’s balance sheet at close ◼ Assumes $500M liability associated with tax receivable agreement Offer Price Consideration ◼ Conversion of incentive units that vest at the transaction
price into deferred cash awards to be paid out at the transaction price on the existing time-based vesting schedule ◼ Transaction will be funded through combination of equity funds from Bain Capital, third party equity co-investors, and
third-party debt financing ◼ Request consent to include the following financing sources: Ares, Golub, Blackstone Credit, Financing HPS, Owl Rock, Sixth Street, Barclays, RBC, UBS, Jefferies and CalPERS. ◼ Require rollover from existing
shareholders subject to Bain controlling a majority of the Pro Forma equity ◼ Completing diligence and signing definitive documentation by May 7, 2024 Timing ◼ Require any transaction in which the Sponsors [Vista and Onex] roll or in
which there is a payment made under the Tax Receivable Agreement to be conditioned upon the approval of a fully-empowered special committee of the board comprised exclusively of directors Other independent from the Sponsors and approval of a
majority of stockholders unaffiliated with the Sponsors Source: Bain Capital non-binding proposal dated April 24, 2024 . Process Update 8
CONFIDENTIAL – PRELIMINARY DRAFT II. Valuation
Perspectives
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Picasso Stock Price History Since IPO $40.0 17-Apr-2024 Short-seller Spruce Point Management releases critical report Share Price Performance Since $30.0 Announcement: (11)% 52-Week High $ 25.16 $ 21.75 6-Month VWAP (2.9)% 3-Month VWAP $ 21.26 $
21.14 1-Year VWAP $ 20.53 VWAP Since IPO $20.0 2-Year VWAP $ 19.90 Current $17.48 $ 16.41 52-Week Low $10.0 Jul-21 Jan-22 Jun-22 Nov-22 May-23 Oct-23 Apr-24 Source: FactSet; market data as of 22-Apr-2024 Note: Reflects trading performance from
28-Jul-2021 to 22-Apr-2024. Valuation Perspectives 10 Share Price (USD)
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Picasso Illustrative Analysis at Various Prices ($ in millions, except per share data) Current Final Bain Bid Illustrative Enterprise Value $ 4,463 $ 5,865 $ 5,951 $ 5,972 (-) Net Debt as of 30-Sep-2024 (706) (706) (706) (706) Implied Equity Value
(excl. TRA) $ 3,757 $ 5,158 $ 5,244 $ 5,266 Fully Diluted Shares Outstanding as of 30-Jun-2024 214.94 214.94 214.94 214.94 Implied Share Price (excl. TRA) $ 17.48 $ 24.00 $ 24.40 $ 24.50 (-) TRA Guided Value (500) (500) (500) (500) Implied Equity
Value (incl. TRA) $ 3,257 $ 4,658 $ 4,744 $ 4,766 Based on 9/30 balance sheet and Implied Share Price (incl. TRA) $ 15.15 $ 21.67 $ 22.07 $ 22.17 $500mm TRA change of control % Premium to Share Price Incl. TRA Current value, per Picasso Management
to Current $ 17.48 (13)% 24 % 26 % 27 % to 52 Week High 25.16 (40) (14) (12) (12) to 52 Week Low 16.41 (8) 32 35 35 to 1 Month VWAP 19.64 (23) 10 12 13 to 3 Month VWAP 21.26 (29) 2 4 4 to 6 month VWAP 21.75 (30) (0) 1 2 to 1 Year VWAP 21.14 (28) 3 4
5 to 2 Year VWAP 19.90 (24) 9 11 11 Implied Equity Value $ 3,257 $ 4,658 $ 4,744 $ 4,766 % Premium to Share Price Exl. TRA Current to Current $ 17.48 0 % 37 % 40 % 40 % to 52 Week High 25.16 (31) (5) (3) (3) to 52 Week Low 16.41 7 46 49 49 to 1
Month VWAP 19.64 (11) 22 24 25 to 3 Month VWAP 21.26 (18) 13 15 15 to 6 month VWAP 21.75 (20) 10 12 13 to 1 Year VWAP 21.14 (17) 14 15 16 to 2 Year VWAP 19.90 (12) 21 23 23 Implied Equity Value $ 3,757 $ 5,158 $ 5,244 $ 5,266 Source: Picasso
Management Plan; Company filings; market data as of 22-Apr-2024 Valuation Perspectives 11
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Picasso Illustrative Analysis at Various Prices (Cont’d) ($ in millions) Current Final Bain Bid Illustrative Enterprise Value $ 4,463 $ 5,865 $ 5,951 $ 5,972 Other Vertical EV / EBITDA (Management ) Metric Instructure Tyler Software CY2024E $
277 16.1 x 21.2 x 21.5 x 21.6 x 14.0 x 32.8 x 28.4 x CY2025E 327 13.7 x 17.9 x 18.2 x 18.3 x 12.6 x 29.1 x 26.4 x Other Vertical EV / uFCF (Management ) Metric Instructure Tyler Software 1 CY2024E $ 248 18.0 x 23.6 x 24.0 x 24.1 x 16.0 x 44.2 x 34.4
x CY2025E 313 14.3 x 18.7 x 19.0 x 19.1 x 15.1 x 38.2 x 29.4 x Other Vertical EV / EBITDA (Street) Metric Instructure Tyler Software CY2024E $ 270 16.6 x 21.7 x 22.1 x 22.1 x 14.0 x 32.8 x 28.4 x CY2025E 307 14.5 x 19.1 x 19.4 x 19.5 x 12.6 x 29.1 x
26.4 x Other Vertical EV / uFCF (Street) Metric Instructure Tyler Software CY2024E $ 225 19.8 x 26.0 x 26.4 x 26.5 x 16.0 x 44.2 x 34.4 x CY2025E 278 16.1 x 21.1 x 21.4 x 21.5 x 15.1 x 38.2 x 29.4 x Source: Picasso Management Plan; Company filings;
market data as of 22-Apr-2024 1 2024E uFCF normalized to exclude the $42mm of acquisition cash outflows. Valuation Perspectives 12
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Picasso Illustrative Standalone Valuation Summary Methodology Illustrative Share Price Commentary ◼ 9.0% - 10.5% Discount Rate Discounted Cash◼ 2.0% - 4.0% Perpetuity Growth Rate $ 18.00 $ 31.60 ◼ 10.75 Year DCF Flow ◼ Based
on Picasso Management tax model ◼ Picasso Management Plan: $327 - $439mm (2025E – 2027E EBITDA) Present Value of ◼ High: 20.0x EV / NTM EBITDA Future Share Price $ 17.80 $ 27.40 ◼ Low: 16.0x EV / NTM EBITDA (EBITDA) ◼
Cost of Equity: 11.0% ◼ Picasso Management Plan: $313 - $428mm (2025E – 2027E UFCF) Present Value of ◼ High: 23.5x EV / NTM UFCF Future Share Price $ 21.60 $ 31.60 ◼ Low: 19.5x EV / NTM UFCF (uFCF) ◼ Cost of Equity:
11.0% ◼ Picasso share price of $17.48 (as of 22-Apr-2024) Precedent Premia th ◼ High: 75 Percentile of 51.9% $ 21.10 $ 26.60 th (2019 to Present) ◼ Low: 25 Percentile of 20.9% ◼ Picasso Management Plan: NTM EBITDA of $289mm
Precedent Transactions ◼ High: 29.3x EV/NTM EBITDA $ 12.60 $ 35.10 (2019 to Present) ◼ Low: 12.6x EV/NTM EBITDA ◼ 52 Week Intra High: $25.16 (06-Feb-2024) Historical Trading $ 16.41 $ 25.16 ◼ 52 Week Intra Low: $16.41
(05-May-2023) ◼ High PV of Price Target: $27.00 – BofA: 26-Feb-2024 $ 22.50 $ 27.00 Analyst Target Price ◼ Low PV of Price Target: $22.50 – UBS: 26-Feb-2024 Median: $25.00 Current Price: $ 17.48 Bain Bid excl. TRA $[24.50]
Source: Picasso Management Plan; Market data as of 22-Apr-2024 Bain Bid incl. TRA $22.17 Note: Illustrative share price includes the impact of TRA at ~$418M Book Value as of most recent public filings. Picasso guided potential bidders to ~$500M
based on assumed $30 share price. Valuation Perspectives 13 For Reference
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Appendix A: Supplementary Materials
CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION
Common Stock Comparison ($ in millions, except per share data) EV / Revenue EV / EBITDA EV / uFCF EV / uFCF Revenue Growth EBITDA Margin uFCF Margin % of 52-Week Fully Diluted Enterprise Closing Price Company Name High Equity Value Value CY2024
CY2025 CY2024 CY2025 CY2024 CY2025 LFQ '23 - '25 CY2024 CY2025 CY2024 CY2025 Picasso (Management) $ 17.48 70 % $ 3.8 $ 5.1 6.5 x 5.9 x 18.5 x 15.7 x 20.6 x 16.4 x 13 % 11 % 35 % 37 % 31 % 36 % Picasso (Street) $ 17.48 70 % $ 3.8 $ 5.1 6.5 x 5.9 x
19.0 x 16.7 x 22.7 x 18.4 x 13 % 12 % 34 % 35 % 29 % 32 % Vertical Software Peers Appfolio $ 214.79 86 % $ 8.0 $ 7.8 10.1 x 8.5 x 39.2 x 29.9 x 52.2 x 41.6 x 39 % 18 % 26 % 28 % 19 % 20 % AspenTech 197.08 85 12.7 12.5 10.6 9.6 25.5 21.6 32.7 28.2 6
9 42 45 32 34 Autodesk 217.13 81 47.7 47.7 8.0 7.2 21.3 19.0 33.3 23.9 11 10 37 38 24 30 Descartes 91.47 99 8.0 7.7 12.3 11.1 27.9 24.8 35.6 29.4 17 10 44 45 35 38 Guidewire 109.79 91 9.2 8.8 8.6 7.6 NM 43.0 NM 44.1 4 11 14 18 14 17 1 Instructure
19.18 68 2.8 3.8 5.7 5.2 14.0 12.6 16.0 15.1 9 10 41 41 36 34 JAMF 19.15 86 2.7 2.8 4.6 4.0 28.9 18.1 29.5 16.6 16 14 16 22 15 24 Ncino 29.64 79 3.6 3.5 6.6 5.6 38.7 29.2 51.1 34.9 13 17 17 19 13 16 Paycor 70.58 86 11.0 10.4 9.1 7.6 NM 48.5 NM NM 29
20 13 16 11 12 SPS Commerce 168.64 80 6.4 6.1 9.9 8.6 33.3 28.1 42.5 36.9 19 14 30 31 23 23 Tyler Technologies 411.41 93 17.9 18.4 8.7 7.9 32.8 29.1 44.2 38.2 6 10 26 27 20 21 Veeva 199.06 85 32.8 28.8 10.7 9.4 27.0 23.3 24.4 23.2 12 14 40 40 44 40
Peer Mean 8.7 x 7.7 x 28.8 x 27.3 x 36.1 x 30.2 x 15 % 13 % 29 % 31 % 24 % 26 % Peer Median 8.9 x 7.8 x 28.4 x 26.4 x 34.4 x 29.4 x 13 % 12 % 28 % 30 % 21 % 24 % 1 Source: Picasso Management Plan; Company filings, FactSet median consensus estimates;
market data as of 22-Apr-2024. Note: Maximum threshold for trading multiples set to 55.0x. Instructure EV PF for incremental debt and cash used for Parchment acquisition in Q1 2024. Supplementary Materials 15
Exhibit (C)(vii)
*** For Discussion Purposes Only *** Project Picasso Tax Receivable Agreement Discussion May 1, 2024
*** For Discussion Purposes Only *** Overview of TRAs ◾ A Tax Receivable Agreement (TRA) is a contractual
agreement between a public company and the companys pre-IPO owners that requires payments from the former to the latter related to tax attributes held by the company ◾ These tax attributes are most
often found in IPOs, in which selling pre-IPO shareholders recognize a taxable gain that also triggers a valuable tax basis step-up at the newly public company In
essence, the TRA forces the company to compensate these parties for the step-up as a distinct asset Additionally, TRAs can be found in a wide range of other settings and cover other tax attributes, such
as NOLs ◾ As the relevant tax attributes are used by the company, a TRA obligates the company to make periodic cash payments to the pre-IPO owners party to the TRA for a portion of the achieved savings
TRAs often require that 85% of the cash tax benefit realized by the company be paid to pre-IPO owners ◾ TRAs were introduced in the 1990s and have recently become much more common in IPOs (both
traditional and de-SPAC transactions); they have a number of practical implications in financial analyses and M&A transactions Relatedly, an Up-C is a
corporate structure that is often encountered in conjunction with a TRA and will require additional consideration as compared to a typical C-corp structure (the most common public company form) 1 Source: Company materials, academic research and
other public sources.
*** For Discussion Purposes On ly *** Tax Attributes Potentially Subject to TRAs ◾ Tax basis held by the
company before the IPO; assets will continue to be depreciated or Pre-IPO amortized for tax accounting purposes following the IPO Basis◾ This may be basis that was created when the pre-IPO owners initially acquired the company (e.g., in a corporate carveout or under a 338(h)(10) election) Related to Companys ◾ NOLs held by the company pre-IPO
continue to remain available for use by the company NOLs Pre-IPO Tax once it is publicly traded Attributes ◾ Other tax attributes may include Alternative Minimum Tax credits, foreign tax credits and
Other items related to stock-based compensation ◾ In an Up-C structure, there can be a step-up in the tax basis of the companys assets and Basis Step-
liabilities that is triggered by the IPO Created In Up at IPO◾ Tax attributes are created when operating partnership (OP) units are exchanged or sold Connection to the public company C-corporation at the
time of IPO With IPO (e.g., Up-C ◾ In an Up-C structure, the pre-IPO owners party to a TRA generally retain some of their
Structure) Subsequent OP units post-IPO; future exchanges of units create additional basis step-ups Basis Step- Ups◾ Additionally, TRA payments themselves create
additional basis step-ups in a circular manner, as these payments are considered additional purchase price
*** For Discussion Purposes Only *** General Structure Overview: Up-C
IPO With a TRA Umbrella Partnership C-Corporation Overview Structure Summary ◾ A company planning to go public that has its assets and operations in an operating partnership or who will contribute them
to one (OP, a pass-through entity for tax Public Pre-IPO Own ers purposes) can pursue a Up-C IPO Shareholders Initially the OP is 100% owned by pre-IPO owners 100% of Class B 100% of Class A 0% Economic ◾ A C-corporation (taxable entity) is formed and carries out 100% Economic 100X% Voting an
IPO, selling shares to public investors and receiving cash X% Voting TRA the OP units, thereby Payments◾ The C-corp uses the cash to purchase Publicly Traded becoming a partner in the OP alongside the
pre-IPO owners C-Corp ◾ Pre-IPO owners retain whatever OP units were not sold and have the right to swap OP units one-for-one in Sole Managing exchange for shares of the public corporation post IPO Member 100X% of OP Units X% of OP Units Under this structure, pre-IPO owners also receive a separate class of shares in the public corporation with supervoting rights but no additional economics OP ◾ Under U.S. tax law, this structure allows the public C-Corp to receive a step-up in the basis of its pro rata share of the OPs assets, which provides a future cash tax benefit to the corporation All assets and operations
◾ A TRA can be used to pay pre-IPO owners a portion of the tax savings created by the incremental amortization expense if and when those tax benefits are realized by the
C-Corp Source: Company materials, academic research and other public sources.
*** For Discussion Purposes Only *** Current Picasso Structure Canada Management Pension Plan Company Public
Coinvestors Vista Onex Investment D&Os Stockholders and Others Board 34,205,680 71,118,123 10,111,111 1,208,949 Class 48,583,080 2% interest 98% Class A Class A Class A A Common Class A in Topco interest in Common Stock
Common Stock Common Stock Stock Common Stock Topco ~20.7% of Class A ~43.0% of Class A ~6.1% of Class A ~0.7% of Class A ~29.4% of Class A Severin Topco LLC 165,226,943 Class A Common Stock (Topco)
37,654,059 Class B Common Stock ~81.4% of the voting power the Company ~18.6% of the voting power the Company(voting rights only) PowerSchool Holdings, Inc. 37,654,059 LLC units (the Company) ~18.6% of the outstanding LLC
units(economic rights only) 165,226,943 LLC units(1) ~81.4% of the outstanding LLC units PowerSchool Holdings LLC (the LLC) Operating Entities Note: The figures and structure chart are approximate and for illustrative purposes only, and
have been derived from the Companys prospectus dated July 27, 2021, 4 the Companys Schedule 14A, dated as of April 4, 2024 and the organizational chart provided in the virtual data room of the Company. (1) Numerous blocker
entities sit between the Company and the LLC.
*** For Discussion Purpose s Only *** TRAs In M&A ◾ Should a public company that is party to a TRA
undergo a change-of-control, the TRA generally calls for an acceleration of the estimated future payments Calculation of the liability involves an NPV
calculation, oftentimes using a discount rate based on a spread to LIBOR or SOFR, and takes into account variables including the companys taxable income and tax rate Calculation includes both currently existing tax attributes (i.e.,
those picked up in the balance sheet carrying value of the TRA liability) as well as those that are deemed to come into existence from a basis step-up triggered by the exchange of pre-IPO owners retained OP units In a change-of-control, the value of the TRA increases with the price paid, as the OP
units deemed to be exchanged are worth more at a higher price, increasing the amount of the associated basis step-up ◾ Treatment of the TRA liability is one part of an M&A negotiation and is impacted
by the deal circumstances ◾ A review of precedents suggests three general approaches are used: TRA eliminated with no payment TRA settled at a discounted payment or paid installments TRA remains in place *
** For Discussion Purposes Only *** TRA Precedents M&A Context Primary TRA Holder TEV Total TRA CoC
Pymt Terminated Payment to Term. Date Acquirer Target (Pre-IPO Owner) % Own. ($bn) $mm % Deal Size w/o Payment? $mm % Total Liab. Mar-23 Solenis Diversey Bain Capital
73% $4.6 $77 2% (2)ï Dec-22 BDT Weber BDT Capital Partners 67% 3.7 9 (1) 0%ï >50% Sep-22 CVS Signify Health New Mountain 60% 8.0 59 1%ï May-22 Chicken Soup for the Soul Redbox Apollo Global Management 74% 0.4 165 44%ï Nov-21 Advent, Permira & Others McAfee TPG, Intel, Thoma Bravo, GIC 94% 14.0
392 3%ï Sep-21 Goldman Sachs GreenSky CEO, director, TPG 79% 2.2 446 20%ï Aug-21 Chesapeake Energy Vine Energy Blackstone 71% 2.2 7 0%ï Ownership Aug-21 DraftKings Golden Nugget Online Tilman Fertitta 80% 1.4 322 23%ï Nov-20 American Securities Foundation Bldg. Mats. Lone Star Funds 52% 1.4 <85 6% 75 88% Mar-19 Brookfield Oaktree Senior execs. and others 54% 7.9 188 2% TRA amended in merger to fixed payment schedule Holder Aug-17 United Rentals Neff Corporation Wayzata Funds
63% 1.3 30 2%ï May-17 Surgery Partners NSH HIG Capital 54% 0.8 120 16% TRA amended in merger to fixed payment schedule TRA Apr-17 Century Communities UCP PICO
Holdings 57% 0.4 ï Oct-13 Sumitomo Edgen Jefferies Capital Partners 56% 1.1 2 0%ï Dec-23 Stone Point, Gen. Atlantic HireRight General Atlantic 48% $1.7
$184 (1) 11% Acceleration provision waived; TRA to remain outstanding Sep-23 Smuckers Hostess C. Dean Metropoulos NA 5.6 85 2% 86 102% Jul-23 Rithm Capital Sculptor
Capital Och-Ziff Capital 13% 0.7 173 (1) 24% Accel. provisio n does not exist; Agreed to TRA guaranty Feb-23 CD&R Focus Financial Partners Stone Point Capital 20% 7.0 225 3% 300 133% <50% Jan-23 Nuvei Paya GTCR 34% 1.3 20 2% 20 100% Aug-22 Global Payments EVO Payments Founder Rafik Sidhom, MDP ~20% 4.0 322 8% 225 70%
May-22 Digital Bridge Switch Founder and affiliates 24% 10.3 1,196 12% 75 6% Mar-21 Expro Group Franks International Mosing Family NA 2.1 18 15 83% Jan-21 Optum (UnitedHealth) Change Healthcare Blackstone, H&F 20% 12.8 178 (1) 1% <178 100% Ownership Dec-20 Vista, Partners Group Pluralsight Insight Partners 4% 3.5
417 12%ï Oct-20 Pioneer Parsley Energy Founders and affiliates 15% 7.6 164 2% 164 100% Jul-20 MDP Benefytt Founder Michael Kosloske 9% 0.6 35 (1) 5% 40 116% Holder Jan-20 Yum Brands Habit Restaurant KarpReilly 11% 0.4 63 17% 50 79% Sep-18 Univar Nexeo TPG 35% 2.0 71 4% 60 84% TRA May-17 Avantor VWR
Corporation Varietal 35% 6.5 58 1% 56 97% Apr-17 Tyson Foods AdvancePierre Foods Oaktree 42% 4.2 254 6% 224 88% Feb-17 SoftBank Fortress Founding principals 45% 3.3 154
5% 154(4) 100% Sep-14 Encana Athlon Energy Athlon management 17% 5.9 (5) 0% 25 Median 20% $159 5% $68 99% Mean 24% 201 7% 107 90% Memo: Picasso 64% $6.0(6) $465 - $500 7.8% - 8.3% Source: Company
filings and FactSet as of April 29, 2024. (1) Reflects stated TRA liability at date of last filing. (2) BDT was owner of previous TRA; existing liability near completion at time of merger. (3) Terminated each TRA by making the respective early
termination payments specified, pursuant to the applicable discount rate and methodology set forth. (4) TRA amended in merger agreement to fixed payment schedule equal to required change of control payment. 6 (5) Athlon filings stated was not
expecting to be in a federal income tax paying position for the foreseeable future, and so did not recognize a TRA liability. (6) Reflects illustrative transaction value.
*** For Discussion Purposes Only *** Assumes headline share price of $24.50 and fully diluted share count of
~214.9m Analysis at Various Scenarios of TRA Payout Headline Share Price Metric $24.50 $24.50 $24.50 $24.50 $24.50 $24.50 Illus. TRA Payment $500 $400 $300 $200 $100 $0 Illus. TRA Payment Per Share Impact $2.33 $1.86 $1.40 $0.93 $0.47 $0.00 Illus.
Price Per Share ex TRA $22.17 $22.64 $23.10 $23.57 $24.03 $24.50 Premia at Various Share Prices Current $17.32 28.0% 30.7% 33.4% 36.1% 38.8% 41.5% 52W High $25.16 (11.9%) (10.0%) (8.2%) (6.3%) (4.5%) (2.6%) 52W Low $16.41 35.1% 38.0% 40.8% 43.6%
46.5% 49.3% 30 Day VWAP $19.28 15.0% 17.4% 19.8% 22.2% 24.6% 27.1% 90 Day VWAP $21.31 4.0% 6.2% 8.4% 10.6% 12.8% 14.9% Note: Units in millions, except per share amounts. Source: Company financials and FactSet as of 04/30/24.
Appendix *** For Discussion Purposes Only ***
Picasso Early Termination Payment As per E&Y Existing TRA Attribute Hypothetical Exchange TRA
Assumed Share Price Payment Attribute and Iterative Payment Total Payment Due At Close $25.00 per share $335,611,626 $136,275,266 $471,886,892 $27.50 per share $335,611,626 $150,727,410 $486,339,036 $30.00 per share $335,611,626 $165,179,523
$500,791,149 $32.50 per share $335,611,626 $179,631,611 $515,243,237 $35.00 per share $335,611,626 $194,083,679 $529,695,305 $37.50 per share $335,611,626 $208,535,730 $544,147,356 $40.00 per share $335,611,626 $222,987,767 $558,599,393 $42.50 per
share $335,611,626 $237,439,792 $573,051,417 Notes and assumptions: 1) Assumes a discount rate of 5.50% computed as the minimum of (i) SOFR plus 100 bps taking into account a spread for the difference in LIBOR and SOFR; and (ii) 5.50% per the
Early Termination Rate of the TRA 2) Assumes a blended federal tax rate and state/local tax rate per clause (iii) of the definition of Valuation Assumptions in the TRA (based on 2023 apportionment factors) 3) Pubco has
$41.6M of accrued TRA payments through 12/31/2023 that have not been paid as the company is unable to make tax distributions pursuant to its credit agreement ◾ Advisors recommended approach to first round of sales process: Bidders assume
total TRA payment is $500M and treat as a debt like item◾ Each incremental $1.00 per share price represents approximately $5M in value 9 Source: Calculated by EY based on Picasso data and the assumptions outlined above.
*** For Discussion Purposes Only ** * Disclaimer This presentation has been prepared by Centerview Partners LLC
(Centerview) for use solely by the Special Committee of the Board of Directors of Picasso in connection with its evaluation of a proposed sale of Picasso and for no other purpose. The information contained herein is based upon
information supplied by or on behalf of Picasso and publicly available information, and portions of the information contained herein may be based upon statements, estimates and forecasts provided by Picasso. Centerview has relied upon the accuracy
and completeness of the foregoing information, and has not assumed any responsibility for any independent verification of such information or for any independent evaluation or appraisal of any of the assets or liabilities (contingent or otherwise)
of Picasso or any other entity, or concerning the solvency or fair value of Picasso or any other entity. With respect to financial forecasts, Centerview has assumed that such forecasts have been reasonably prepared on bases reflecting the best
currently available estimates and judgments of the management of Picasso as to the future financial performance of Picasso, and at your direction Centerview has relied upon such forecasts, as provided by Picassos management, with respect to
Picasso. Centerview assumes no responsibility for and expresses no view as to such forecasts or the assumptions on which they are based. The information set forth herein is based upon economic, monetary, market and other conditions as in effect on,
and the information made available to us as of, the date hereof, unless indicated otherwise and Centerview assumes no obligation to update or otherwise revise these materials. The financial analysis in this presentation is complex and is not
necessarily susceptible to a partial analysis or summary description. In performingthis financial analysis, Centerview has considered the results of its analysis as a whole and did not necessarily attribute a particular weight to any particular
portion of the analysis considered. Furthermore, selecting any portion of Centerviews analysis, without considering the analysis as a whole, would create an incomplete view of the process underlying its financial analysis. Centerview may have
deemed various assumptions more or less probable than other assumptions, so the reference ranges resulting from any particular portion of the analysis described above should not be taken to be Centerviews view of the actual value of Picasso.
These materials and the information contained herein are confidential, were not prepared with a view toward public disclosure, and may not be disclosed publicly or made available to third parties without the prior written consent of Centerview.
These materials and any other advice, written or oral, rendered by Centerview are intended solely for the benefit and use of the Special Committee of the Board of Directors of Picasso (in its capacity as such) in its consideration of the proposed
transaction, and are not for the benefit of, and do not convey any rights or remedies for any holder of securities of Picasso or any other person. Centerview will not be responsible for and has not provided any tax, accounting, actuarial, legal or
other specialist advice. These materials are not intended to provide the sole basis for evaluating the proposed transaction, and this presentation does not represent a fairness opinion, recommendation, valuation or opinion of any kind, and is
necessarily incomplete and should be viewed solely in conjunction with the oral presentation provided by Centerview. 10
Exhibit (c)(viii) – Preliminary Working Draft – –
Highly Confidential – Center view Pv Project Picasso Confidential Discussion Materials for the Special Committee May 3, 2024
Organic – Preliminary Working Draft – – Highly
Confidential – Management Plan Summary Historical Projected CAGR / Change 2021 2022 2023 2024 2025 2026 2027 2028 2029 '21-'23 '23-'29 ARR $539 $598 $701 $778 $864 $968 $1,091 $1,237 $1,405 +9.7% +12.1% 477 543 600 695 774 867 977 1,106 1,257
12.1% 13.1% Subscriptions and Support 62 70 73 78 85 92 99 107 116 8.2% 8.2% Service L&O 19 17 25 15 16 16 17 18 19 13.5% (4.4%) Revenue $559 $631 $698 $788 $874 $975 $1,093 $1,231 $1,392 11.8% 12.2% Adjusted Gross Profit $376 $429 $491 $559
$623 $701 $793 $900 $1,020 14.3% 13.0% 67.3% 68.1% 70.4% 70.9% 71.3% 71.9% 72.5% 73.1% 73.3% % of Revenue +3.1pp +2.9pp 86 91 87 98 106 116 126 138 152 R&D +0.9% +9.7% % of Revenue 15.4% 14.3% 12.5% 12.4% 12.1% 11.8% 11.5% 11.2% 10.9% (2.8pp)
(1.6pp) 75 80 109 122 132 143 157 174 192 S&M +20.9% +9.9% % of Revenue 13.4% 12.8% 15.7% 15.4% 15.0% 14.6% 14.4% 14.1% 13.8% +2.3pp (1.9pp) 55 63 62 62 59 64 70 75 81 G&A +6.5% +4.5% 9.8% 10.0% 8.9% 7.9% 6.7% 6.6% 6.4% 6.1% 5.8% % of
Revenue (0.9pp) (3.1pp) Other 11 (0) ––– ––– Adj. EBITDA $161 $195 $232 $277 $327 $378 $439 $513 $595 39 12 33 40 53 59 68 81 93 ∆ in Deferred Revenue 10 (18) (21) (18) (17) (20) (24) (28) (32) ∆ in
NWC Purchase of PP&E (4) (4) (2) (5) (5) (6) (7) (7) (8) ––– (5) – – ––– India Office Expansion (36) (41) (39) (41) (44) (46) (49) (52) (59) Capitalized Product Dev. Costs Unlevered FCF $170 $146
$204 $248 $313 $365 $428 $507 $588 % of Adj. EBITDA 105.8% 74.4% 87.8% 89.7% 95.8% 96.4% 97.4% 98.8% 98.8% 1 Source: Picasso management. Note: Dollars in millions.
– Preliminary Working Draft – – Highly Confidential
– Management Plan Summary (Cont’d) Historical / Projections ($mm) YoY Growth % / Margin % ‘21-’23 ‘23-’29E YoY Growth % CAGR: 12% CAGR: 12% $1,392 $1,231 $1,093 $975 $874 $788 $698 12.9% 12.9% 13.1% $631 12.1%
12.6% 10.9% 11.6% $559 10.6% Revenue nm '21A '22A '23A '24E '25E '26E '27E '28E '29E '21A '22A '23A '24E '25E '26E '27E '28E '29E Margin % ‘21-’23 ‘23-’29E CAGR: 14% CAGR: 13% $1,020 73.3% 73.1% $900 72.5% 71.9% $793 71.3%
$701 70.9% 70.4% $623 $559 $491 $429 Gross Profit 68.1% $376 67.3% '21A '22A '23A '24E '25E '26E '27E '28E '29E '21A '22A '23A '24E '25E '26E '27E '28E '29E ‘21-’23 ‘23-’29E Margin % CAGR: 20% CAGR: 17% $595 41.7% 42.8% $513
40.1% 38.8% $439 37.4% $378 Adjusted 35.1% $327 $277 33.3% $232 30.9% $195 $161 28.7% EBITDA '21A '22A '23A '24E '25E '26E '27E '28E '29E '21A '22A '23A '24E '25E '26E '27E '28E '29E ‘21-’23 ‘23-’29E % of Adj. EBITDA CAGR: 9%
CAGR: 19% $588 105.8% $507 98.8% 98.8% 97.4% 95.8% 96.4% $428 89.7% $365 87.8% $313 $248 uFCF 74.4% $204 $170 $146 '21A '22A '23A '24E '25E '26E '27E '28E '29E '21A '22A '23A '24E '25E '26E '27E '28E '29E Historical Management Plan 2 Source: Picasso
management. Note: Dollars in millions.
– Preliminary Working Draft – – Highly Confidential
– ARR Growth – Historical Deconstruction § Organic ARR CAGR approximated +9.7% over 2021 to 2023 period, driven largely by Up-sell / X-sell and ability to increase price Historical ARR Deconstruction – 2021 to 2023 ($mm) % of
Organic $ Change 16.0% 42.3% 31.8% 4.1% 5.7% 0.0% 1 $53 $701 $1 13 $6 $5 $46 $18 $539 ($78) Y Organic CAGR = +9.7% Organic $ Change = +$110 ■& & 5^ & o* -f' T c< e^'1 V' n> -( s°^ o° 09s (je.< t5^ G'^ Memo: ARR
CAGR Contribution 2021-2023 +1.5% +10.0% (6.9%) +4.1% +0.4% +0.5% 0.0% +4.4% +14.1% 3 Source: Picasso management.
– Preliminary Working Draft – – Highly Confidential
– ARR Growth – Projection Deconstruction § Projections imply acceleration in organic growth, driven by growth in International and AI initiatives ARR Deconstruction – 2023 to 2029 ($mm) % of Organic $ Change 8.0% 24.9% 33.2%
0.9% 12.5% 20.5% % of Organic $ Change (excluding International and Personalized) 12.0% 37.1% 49.6%1.3% 1 1 $ 1,405 $142 $7 $514 $87 $6 $231 ($341) $56 $701 Y Organic $ Change = +$696 Organic CAGR = +12.1% vs. +9.7% historically & & %r o**
c< <£■ o'*1 '<?> n> fs- (V° 0> or ^0 t> t> Memo: ARR CAGR Contribution +1.0% +9.2% (6.2%) +4.1% +0.1% +1.5% +2.3% +0.2% +12.3% 2023-2029 4 Source: Picasso management.
– Preliminary Working Draft – – Highly Confidential
– Projected Change In Business Mix % of ARR Over Time 2023 2029 Other International Other 9% Personalized 2% 12% Student International Education AI Information 7% 0% Student o Cloud Information ERP Cloud 31% Cloud 6% Personalized 36% Education
AI Analytics & 10% Insights / Data o 7% ERP Cloud 6% CCLR Cloud 11% Personalized Learning Cloud Analytics & w 9% Personalized Insights / Data Talent Cloud Talent Cloud 12% Learning Cloud CCLR Cloud 11% 10% 15% 6% 5 Source: Picasso
management.
– Preliminary Working Draft – – Highly Confidential
– ARR Growth – Deconstruction by Cloud % of ARR ARR ($mm) CAGR Product 2023 2029E 2023 2029E ’21-’23 ’23-’29E Student Information $251 $429 +10.0% +9.3% Cloud 36% 31% ~50% of ARR today driving ~28% of growth
Personalized $108 $130 +3.7% +3.1% Learning Cloud 15% 9% $79 $147 +11.2% +11.0% Talent Cloud 11% 10% Analytics & $46 $165 +64.7% +23.6% Insights / Data 7% 12% ~10% of ARR today driving ~50% of growth Personalized $0 $142 na +168.1% Education AI
0% 10% International $15 $102 +32.6% +38.3% 2% 7% Other $203 $290 +19.6% +6.1% 6 29% 21% Source: Picasso management.
– Preliminary Working Draft – – Highly Confidential
– ARR Growth – Deconstruction by Product % of ARR ARR ($mm) CAGR Product 2023 2029E 2023 2029E ’21-’23 ’23-’29E Commentary § Forward growth driven by balance of pricing and new adds (greenfield) +9.0% SIS 26%
22% $181 $303 +8.5% § Leadership position Picasso to benefit from upgrade cycle § Growth driven by teacher shortage Talent and need for more sophisticated 11% 10% $79 $147 +11.2% +11.0% Management talent management solutions at schools and
districts § Historical success with enterprise customers Insights 7% 12% $46 $165 +64.7% +23.6% § Potential to increase penetration of midsized customers § Growing to ~9mm students by 2029 Personalized (15% of U.S. student count) 0%
10% $0 $142 na +168.1% Education AI § Positive early traction: e.g., 0.5mm already booked, strong beta use § Assumes increased penetration in International 2% 7% $15 $102 +32.6% +38.3% India, Middle East, LatAm and Southeast Asia 7 Source:
Picasso management.
– Preliminary Working Draft – – Highly Confidential
– ARR Growth – Deconstruction by Product (Cont’d) % of ARR ARR ($mm) CAGR ’23- Product 2023 2029E 2023 2029E ’21-’23 ’29E CCLR 11% 6% $75 $87 +0.0% +2.5% Learning 8% 5% $59 $70 +1.1% +2.7% ►
Registration 8% 7% $57 $100 +14.7% +9.8% ► Communica- 7% 6% $49 $85 na +9.7% tions ► ERP 6% 6% $44 $81 +4.1% +10.8% ► Other 14% 9% $97 $122 +10.4% +3.9% ► 8 Source: Picasso management.
– Preliminary Working Draft – – Highly Confidential
– Management Plan Expense And Spending Profile Over Time Spend ($mm) % of Revenue 15.4% 14.3% $152 $138 $126 $116 12.5% 12.4% $106 $98 12.1% $91 $86 $87 11.8% 11.5% Adjusted R&D 11.2% 10.9% '21A '22A '23A '24E '25E '26E '27E '28E '29E '21A
'22A '23A '24E '25E '26E '27E '28E '29E 6.6% 6.4% 5.5% Capitalized 5.2% 5.0% 4.8% Product Dev. 4.5% $59 $52 $46 $49 $41 $44 4.3% 4.3% $39 $41 $36 Costs '21A '22A '23A '24E '25E '26E '27E '28E '29E '21A '22A '23A '24E '25E '26E '27E '28E '29E 15.7%
15.4% 15.0% $174 $192 14.6% $157 14.4% $143 14.1% $132 $122 13.8% $109 13.4% Adjusted S&M $80 $75 12.8% '21A '22A '23A '24E '25E '26E '27E '28E '29E '21A '22A '23A '24E '25E '26E '27E '28E '29E 10.0% 9.8% 8.9% 7.9% 6.7% Adjusted G&A 6.6% $81
$75 6.4% $70 $64 $63 $62 $62 6.1% $55 $59 5.8% '21A '22A '23A '24E '25E '26E '27E '28E '29E '21A '22A '23A '24E '25E '26E '27E '28E '29E 9 Source: Picasso management. Historical Management Plan Note: Dollars in millions.
– Preliminary Working Draft – – Highly Confidential
– Management Plan Working Capital Items Over Time Cash Flow Cash Flow as % of ∆ in Revenue $93 57% $81 $68 $59 $53 33% $40 $39 $33 Deferred Revenue $12 '21A '22A '23A '24E '25E '26E '27E '28E '29E '21-'23 '23-'29 Memo: % of Revenue 7.0%
2.0% 4.7% 5.1% 6.0% 6.0% 6.2% 6.7% 6.6% $10 Historical Management Plan (Increase) / ($17) ($18) ($18) Decrease in ($20) ($21) ($24) NWC (20.0%) ($28) ($32) (27.7%) '21A '22A '23A '24E '25E '26E '27E '28E '29E '21-'23 '23-'29 Memo: % of Revenue 1.8%
(2.8%) (3.0%) (2.3%) (2.0%) (2.1%) (2.2%) (2.3%) (2.2%) 10 Source: Picasso management. Note: Dollars in millions.
– Preliminary Working Draft – – Highly Confidential
– Projections vs. Consensus: Key Items (1) 2024E 2025E 2026E # of Est = 13 # of Est = 12 # of Est = 3 (0.1%) +0.1% (0.2%) $947 $974 $975 $994 $893 $874 $875 $864 $787 $788 $789 $791 Revenue (1) Low Mgt. Consensus High Low Mgt. Consensus High
Low Consensus Mgt. High # of Est = 6 # of Est = 5 # of Est = 3 +0.2% +1.3% +2.5% $700 $701 $710 $682 $622 $623 $608 $583 $559 $559 Adjusted $552 $527 Gross Profit Low Consensus Mgt. High Low Consensus High Mgt. Low Consensus Mgt. High # of Est = 12
# of Est = 11 # of Est = 3 +8.0% +6.9% +2.8% $378 $357 $350 $343 $327 $314 $306 $298 $277 $269 $271 $265 Adjusted EBITDA Low Consensus High Mgt. Low Consensus High Mgt. Low Consensus High Mgt. Source: Picasso management and FactSet. 11 Note: Dollars
in millions. (1) Reflects average of Goldman Sachs, UBS and Barclays 2026 estimates.
– Preliminary Working Draft – – Highly Confidential
– Projections vs. Consensus: Key Ratios (1) 2024E 2025E 2026E (0.2pp) +0.3pp +0.1pp 13.1% 13.3% 12.9% 12.9% 12.8% 11.6% 11.3% 11.4% 10.8% 10.9% 9.7% 9.6% Revenue Growth (1) Low Mgt. Consensus High Low Consensus Mgt. High Low High Consensus
Mgt. - +1.0pp +1.8pp 71.9% 72.0% 70.9% 71.3% 71.4% 71.9% 69.9% 70.7% 69.7% 69.5% 67.5% 67.0% Adjusted Gross Profit Margin Low Consensus High Mgt. Low Consensus High Mgt. High Consensus Mgt. Low +1.0pp +6.9% +2.4pp 37.4% 38.8% 36.0% 36.2% 35.9% 35.1%
35.0% 35.2% 34.1% 34.2% 34.5% 33.7% Adjusted EBITDA Margin Low Consensus High Mgt. Low Consensus High Mgt. High Consensus Low Mgt. Source: Picasso management and FactSet. 12 Note: Dollars in millions. (1) Reflects average of Goldman Sachs, UBS and
Barclays 2026 estimates.
– Preliminary Working Draft – – Highly Confidential
– Picasso Quarterly Performance vs. Street Consensus (Since IPO) Beat Miss $ Revenue $145 $149 $146 $150 $158 $162 $161 $159 $174 $182 $182 +5% Revenue – +3% % Beat / +2% +2% (Miss) vs. +1% +1% +1% Consensus +0% (1%) (1%) (1%) 2Q21 3Q21
4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 $ Adj. EBITDA $50 $40 $33 $43 $49 $52 $53 $49 $61 $62 $59 +11% +10% +10% +9% Adj. +7% +6% EBITDA – +6% % Beat / +4% +3% +3% +2% (Miss) vs. Consensus 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23
4Q23 Adj. EBITDA % Margin 34.5% 26.9% 22.8% 28.5% 30.9% 32.2% 32.8% 31.0% 35.2% 34.0% 32.6% 13 Source: Public company filings and FactSet. Note: Dollars in millions.
– Preliminary Working Draft – – Highly Confidential
– Management Plan vs. Public As Presented On Investor Day (September 2023) (1) Mgt. Plan Consensus $975mm $974mm > 71.9% 71.9% ≈ 16.6% n.a. ≈ 21.2% n.a. > 38.8% 36.0% < 28% n.a. < 11% n.a. ≈ 14 Source: Company
filings and Picasso management. (1) Reflects average of Goldman Sachs, UBS and Barclays 2026 estimates. Our Midterm Financial Targets 2022 2023' 2026 Target •r Revenue $691M $631M $1B+ Adj. Gross Margin 68% 71% - 72% Adj. R&.D (incl Cap
R&D) 21% 15% -18% % of revenue Adj. SG&.A 23% 23% - 25% % of revenue Adj. EBITDA margin 31% 33% 36%+ Free cash flow 16% 20-25% % of revenue r Stock-based compensation 8% 9-10% 10% - 12% % of revenue
– Preliminary Working Draft – – Highly Confidential
– Disclaimer This presentation has been prepared by Centerview Partners LLC (“Centerview”) for use solely by the Special Committee of the Board of Directors of Picasso in connection with its evaluation of a proposed sale of Picasso
and for no other purpose. The information contained herein is based upon information supplied by or on behalf of Picasso and publicly available information, and portions of the information contained herein may be based upon statements, estimates and
forecasts provided by Picasso. Centerview has relied upon the accuracy and completeness of the foregoing information, and has not assumed any responsibility for any independent verification of such information or for any independent evaluation or
appraisal of any of the assets or liabilities (contingent or otherwise) of Picasso or any other entity, or concerning the solvency or fair value of Picasso or any other entity. With respect to financial forecasts, Centerview has assumed that such
forecasts have been reasonably prepared on bases reflecting the best currently available estimates and judgments of the management of Picasso as to the future financial performance of Picasso, and at your direction Centerview has relied upon such
forecasts, as provided by Picasso’s management, with respect to Picasso. Centerview assumes no responsibility for and expresses no view as to such forecasts or the assumptions on which they are based. The information set forth herein is based
upon economic, monetary, market and other conditions as in effect on, and the information made available to us as of, the date hereof, unless indicated otherwise and Centerview assumes no obligation to update or otherwise revise these materials. The
financial analysis in this presentation is complex and is not necessarily susceptible to a partial analysis or summary description. In performingthis financial analysis, Centerview has considered the results of its analysis as a whole and did not
necessarily attribute a particular weight to any particular portion of the analysis considered. Furthermore, selecting any portion of Centerview’s analysis, without considering the analysis as a whole, would create an incomplete view of the
process underlying its financial analysis. Centerview may have deemed various assumptions more or less probable than other assumptions, so the reference ranges resulting from any particular portion of the analysis described above should not be taken
to be Centerview’s view of the actual value of Picasso. These materials and the information contained herein are confidential, were not prepared with a view toward public disclosure, and may not be disclosed publicly or made available to third
parties without the prior written consent of Centerview. These materials and any other advice, written or oral, rendered by Centerview are intended solely for the benefit and use of the Special Committee of the Board of Directors of Picasso (in its
capacity as such) in its consideration of the proposed transaction, and are not for the benefit of, and do not convey any rights or remedies for any holder of securities of Picasso or any other person. Centerview will not be responsible for and has
not provided any tax, accounting, actuarial, legal or other specialist advice. These materials are not intended to provide the sole basis for evaluating the proposed transaction, and this presentation does not represent a fairness opinion,
recommendation, valuation or opinion of any kind, and is necessarily incomplete and should be viewed solely in conjunction with the oral presentation provided by Centerview. 15
Exhibit (C)(ix)
Project Picasso Confidential Discussion Materials Prepared for the Special Committee of the Board of Directors
May 6, 2024
Disclaimer This presentation has been prepared by Centerview Partners LLC (Centerview) for use
solely by the Special Committee of the Board of Directors of Picasso in connection with its evaluation of a proposed sale of Picasso and for no other purpose. The information contained herein is based upon information supplied by or on behalf of
Picasso and publicly available information, and portions of the information contained herein may be based upon statements, estimates and forecasts provided by Picasso. Centerview has relied upon the accuracy and completeness of the foregoing
information, and has not assumed any responsibility for any independent verification of such information or for any independent evaluation or appraisal of any of the assets or liabilities (contingent or otherwise) of Picasso or any other entity, or
concerning the solvency or fair value of Picasso or any other entity. With respect to financial forecasts, Centerview has assumed that such forecasts have been reasonably prepared on bases reflecting the best currently available estimates and
judgments of the management of Picasso as to the future financial performance of Picasso, and at your direction Centerview has relied upon such forecasts, as provided by Picassos management, with respect to Picasso. Centerview assumes no
responsibility for and expresses no view as to such forecasts or the assumptions on which they are based. The information set forth herein is based upon economic, monetary, market and other conditions as in effect on, and the information made
available to us as of, the date hereof, unless indicated otherwise and Centerview assumes no obligation to update or otherwise revise these materials. The financial analysis in this presentation is complex and is not necessarily susceptible to a
partial analysis or summary description. In performing this financial analysis, Centerview has considered the results of its analysis as a whole and did not necessarily attribute a particular weight to any particular portion of the analysis
considered. Furthermore, selecting any portion of Centerviews analysis, without considering the analysis as a whole, would create an incomplete view of the process underlying its financial analysis. Centerview may have deemed various
assumptions more or less probable than other assumptions, so the reference ranges resulting from any particular portion of the analysis described above should not be taken to be Centerviews view of the actual value of Picasso. These materials
and the information contained herein are confidential, were not prepared with a view toward public disclosure, and may not be disclosed publicly or made available to third parties without the prior written consent of Centerview. These materials and
any other advice, written or oral, rendered by Centerview are intended solely for the benefit and use of the Special Committee of the Board of Directors of Picasso (in its capacity as such) in its consideration of theproposed transaction, and are
not for the benefit of, and do not convey any rights or remedies for any holder of securities of Picasso or any other person. Centerview will not be responsible for and has not provided any tax, accounting, actuarial, legal or other specialist
advice. These materials are not intended to provide the sole basis for evaluating the proposed transaction, and this presentation does not represent a fairness opinion, recommendation, valuation or opinion of any kind, and is necessarily incomplete
and should be viewed solely in conjunction with the oral presentation provided by Centerview. 1
Bain Proposal Summary Bain Proposal (4/24/24) Share Price $22.17 * DSO 214.7 Implied Equity Value $4,759 Plus:
Net Debt (est. as of Q324E) $706 Plus: Assumed TRA Payment 500 Implied Enterprise Value $5,966 Implied Premium Metric Premium Current $16.89 +31.3% 52-week High $25.16 (11.9%) 52-week Low $16.41 +35.1% 30-Day VWAP $18.90 +17.3% 60-Day VWAP $20.18 +9.9% 90-Day VWAP $21.00
+5.6% Implied Enterprise Value Multiples EV / Adjusted EBITDA (Management)(1) CY 2024E $277 21.5x NTM 309 19.3x CY 2025E 327 18.3x EV / Adjusted EBITDA (Consensus)(1) CY 2024E $270 22.1x NTM 288 20.7x CY 2025E 307 19.4x 2 Source: Picasso management
and FactSet. (1) Unburdened by stock-based compensation expense. NTM EBITDA as of 6/30/24.
Illustrative Tax Receivable Payment Impact on Share Price Assumes headline enterprise value of $5,966mm and
fully diluted share count of 214.7m Analysis at Various Scenarios of TRA Payout Illust. TRA Payment $500 $400 $300 $200 $100 Offer Enterprise Value $5,966 $5,966 $5,966 $5,966 $5,966 $5,966 (Less): Net Debt (est. as of Q324E) (706)
(706) (706) (706) (706) (706) (Less): TRA Payment (500) (400) (300) (200) (100) Implied Equity Value $4,759 $4,859 $4,959 $5,059 $5,159 $5,259 / Diluted Shares Outstanding 214.7 214.7 214.7 214.7 214.7 214.7 Implied Price per Share $22.17
$22.64 $23.10 $23.57 $24.03 $24.50 Implied Premia at Various Share Prices Metric Current $16.89 +31.3% +34.0% +36.8% +39.5% +42.3% +45.1% 52-week High $25.16 (11.9%) (10.0%) (8.2%) (6.3%) (4.5%) (2.6%) 52-week Low $16.41 +35.1% +38.0% +40.8% +43.7% +46.5% +49.3% 30-Day VWAP $18.90 +17.3% +19.8% +22.2% +24.7% +27.2% +29.6% 60-Day VWAP
$20.18 +9.9% +12.2% +14.5% +16.8% +19.1% +21.4% 90-Day VWAP $21.00 +5.6% +7.8% +10.0% +12.2% +14.5% +16.7% 3 Source: Picasso management and FactSet. Note: Units in millions, except per share amounts.
Bain Proposal Sources & Uses Proposal SummarySources & Uses Uses Transaction
Price $ 22.17 Common Shares 204.8 RSUs 7.2 MSUs 0.9 PSUs 0.5 Diluted Shares Outstanding 213.5 Equity Value $ 4,732 Plus: Net Debt (est. as of Q324E) 708 Plus: Assumed TRA Payment 500 Total Enterprise Value $ 5,940 Est. Fees & Expenses
180 Est. Cash to BS 50 Total Uses $ 6,170 Sources Est. Debt $2,175 Est. Deferred Cash Awards 192 Existing Shareholders $1,864 Bain + LPs 1,940 Equity $3,804 Total Sources $6,170 Source: Picasso management. Note: Units in millions, except per share
amounts. As per sources and uses received 5/3/24. Diluted share count assumes MIUs extinguished in connection with proposed transaction. 4
Picasso Equity Performance Review
Source: Picasso filings and FactSet as of May 3, 2024. Note: Shows stock performance as of July 28,
2021. 6
Decomposition of Share Price Performance Since IPO to Current: Pre/Post COVID Perspective Picassos
organic and inorganic growth have been more than offset by valuation pressure PWSC Price Peak Share â^ in Fwd â^ in EV / Capital Price at â^ in Fwd â^ in EV / Capital Current at IPO Price 9/03/21
Growth Est. EBITDA Structure 1/01/2023 Growth Est. EBITDA Structure 5/3/2024 NTM EBITDA $161 +$58 $219 +$63 $282 EV / NTM EBITDA 50.1x (25.4x) 24.7x (9.5x) 15.2x EV 8,055 5,414 4,285 Net Debt 805 629 799 Equity Value 7,234 4,786 3,486 Source:
Picasso filings and FactSet as of May 3, 2024. 7
Wall Street Analyst Positioning Has Been Varied Peers utilized by Wall Street Analysts at IPO and in subsequent
research coverage Source: Wall Street research. 8
Trading Performance Across Various Verticals Source: FactSet as of May 3, 2024. (1) Vertical Software
includes Ncino, Appfolio, Aspen Technology, Guidewire, Q2, Tyler Technologies and Veeva. (2) EdTech / B2C Content includes Chegg, Coursera, Udemy. (3) Other Non-Vertical Software comprised of Intuit,
SPS, Vertex and Descartes. (4) Exclude outlier multiples above >75x. 9
Picasso & Instructure Valuations Over Time 30.0x 1-Yr Avg:
16.5x 2-Yr Avg: 17.7x EBITDA 20.0x 17.2x 14.1x NTM 10.0x / EV 0.0x May-22 Nov-22 May-23 Nov-23 May-24 Wall Street Consensus $724 $661 $475 $530 Performance 2022 2023 2024 2025 Revenue Rev Growth 17.2% 11.6% 4.5%(1) 9.5% EBITDA $180 $214 $269 $298 EBITDA (%) 38%
40% 41% 41% NRR 106% 103% Picasso 30.0x 1-Yr Avg: 18.0x 2-Yr Avg: 19.0x 20.0x 19.0x 15.2x 10.0x 0.0x May-22 Nov-22 May-23 Nov-23 May-24 Wall Street Consensus $873 $789 $698 $631 2022 2023 2024 2025 12.9%
10.6% 13.1% 10.6% $196 $232 $270 $307 31% 33% 34% 35% 109% 107% Source: FactSet as of May 3, 2024. Note: Dollars in millions. (1) Instructure 2024 growth figure is pro forma for Parchment acquisition. 10
Valuation Perspectives
Overview of Valuation Methodologies Methodology Description 52-Week
Range of closing share prices for Picasso stock over the 52 weeks ending 5/3/2024 Trading Range For Analyst Price targets for Picasso per recent Wall Street analyst research reports Reference Price Targets
1-day price premiums of announced or closed transactions with $1-10bn in implied Equity Value Premia Paid involving U.S. targets(1) Trading EV / NTM EBITDA unburdened by
stock-based compensation expense Multiples Adj. EBITDA Multiples applied to Picasso Management Plan NTM EBITDA Precedent EV / NTM EBITDA unburdened by stock-based compensation expense Transactions Adj. EBITDA Multiples applied to Picasso Management
Plan NTM EBITDA Discounted Cash Picasso Management Plan; includes value of TRA tax benefits retained by shareholders Flow Analysis Assumes terminal EBITDA multiples of 16.0x 20.0x (Including Value of TRA Benefits) Weighted Average Cost of
Capital of 12.5% 15.5% Source: Picasso management, Wall Street research and FactSet. (1) Per S&P Capital IQ. Excludes transactions in the Energy, Materials, Financials, Utilities and Real Estate industries, and transactions with
negative premium. 12
Picasso Valuation Analysis Methodology Relevant Metrics Implied Share Price Range 52-Week Low (5/5/2023) / Trading Range High (2/9/2024) $16.49 $25.02 For Analyst Low / Reference Price Targets High $25.00 $30.00 Premia Paid 15.0%50.0% Premium $19.05 $24.85 Trading EV / NTM 18.0x
22.0x NTM Adj. $22.45 $28.15 Multiples Adj. EBITDA EBITDA of $309mm Precedent EV / NTM 19.0x 23.0x NTM Adj. $23.90 $29.55 Transactions Adj. EBITDA EBITDA of $309mm Discounted Cash WACC: 12.5% 15.5% Flow Analysis Terminal NTM EBITDA
$21.15 $32.80 (Including Value of TRA Benefits) Multiple: 16.0x 20.0x $21.05 $32.65 Excl. TRA Excl. TRA Current: $16.58 Source: Picasso management, public filings, CapitalIQ, FactSet and Bloomberg. Note: Dollars in millions except per share
amounts. Balance sheet as of 9/30/2024. Fully diluted share count per Picasso materials as of 6/30/24, inclusive of MIUs. EBITDA figures unburdened by stock-based compensation expense. Share prices rounded to nearest $0.05, except for 52-week trading range. NTM metrics reflect NTM as of 6/30/24. 13 May-22 Sep-22 Feb-23 Jul-23 Dec-23 May-24
Share Price Performance Over Time L2Y Share Price Performance Source: FactSet as of May 3, 2024. Note:
Prices indexed to Picasso as of May 3, 2022. 14
Research Analyst Price Targets Source: Wall Street research. (1) Indicates whether analyst explicitly
treats TRA as debt. Prem. to Disc.TRA Valuation Methodology Curr. SP as Debt (1) 80.9% 22.0x EV / FY25E EBITDA supported by DCF 80.9% 27.0x EV / FCF on Q5Q8 estimates 80.9% 25.0x EV / CY24E EBITDA 80.9% 25.4x EV / CY24E
EBITDA 74.9% 7.5x EV / CY25E Revenue 68.9% 21.0x EV / CY25E EBITDA 62.8% 8.0x EV / CY24E Revenue 62.8% DCF (11.3% WACC, 3.5% TGR) 56.8% EV / EBITDA and EV / Sales 56.8% 7.5x EV / FY25E Revenue 50.8% 26.3x EV/ CY25E FCF
68.9% Hold 15
10 Year Management Plan Summary Actual Management Projections 2023A 2024E 2025E 2026E 2027E 2028E 2029E 2030E
2031E 2032E 2033E 2034E Revenue $698 $788 $874 $975 $1,093 $1,231 $1,392 $1,531 $1,654 $1,769 $1,876 $1,969 % growth 10.6% 12.9% 10.9% 11.6% 12.1% 12.6% 13.1% 10.0% 8.0% 7.0% 6.0% 5.0% Adjusted Gross Profit $491 $559 $623 $701 $793 $900 $1,020
$1,125 $1,219 $1,306 $1,386 $1,457 R&D 87 98 106 116 126 138 152 165 174 177 183 187 S&M 109 122 132 143 157 174 192 207 219 225 230 236 G&A 62 62 59 64 70 75 81 86 90 93 96 98 Adj. EBITDA $232 $277 $327 $378 $439 $513 $595 $668 $736
$811 $878 $935 % margin 33.3% 35.1% 37.4% 38.8% 40.1% 41.7% 42.8% 43.7% 44.5% 45.9% 46.8% 47.5% Cash Flow Items â^ in Deferred Revenue 33 40 53 59 68 81 93 102 110 118 125 131 â^ in NWC (21) (18) (17) (20) (24) (28) (32)
(35) (38) (41) (43) (46) Purchase of PP&E (2) (5) (5) (6) (7) (7) (8) (9) (10) (11) (11) (12) India Office Expansion (5) Product Dev. Costs (39) (41) (44) (46) (49)
(52) (59) (62) (64) (65) (65) (64) 16 Source: Picasso management. Note: Dollars in millions.
Selected Public Comparables CY23A-25E CAGR EBITDA Mgn. EV /
EBITDA Company Name Enterprise Value ($bn) Revenue EBITDA CY24E NTM Picasso (Mgmt.) $4.3 11.9% 18.7% 35.1% 14.6x Picasso (Consensus) $4.3 11.8% 15.0% 34.2% 15.2x Veeva $29.5 14.5% 20.2% 39.6% 26.1x Tyler Technologies 20.9 9.3% 14.5% 26.7%
35.4x AspenTech 12.9 9.4% 5.7% 40.7% 25.7x Guidewire 9.4 11.4% 80.3% 13.5% 58.5x Appfolio 8.7 21.8% 60.9% 26.0% 39.4x CCC 7.9 9.1% 10.9% 41.4% 19.3x Q2 4.1 10.7% 38.7% 16.3% 32.7x Instructure(1) 3.9 7.0% 11.7% 40.7% 14.1x NCINO 3.6 15.0% 37.0% 17.0%
35.6x Docebo 1.3 22.3% 74.0% 15.0% 34.6x Peer Median 11.0% 28.6% 26.3% 33.6x % DiscountPicasso Cons. EV / NTM EBITDA vs. Peer Median (55%) Source: Picasso management, public filings and FactSet. Note: All figures in USD. Picasso balance sheet
and share count figures reflect latest publicly available data. EBITDA figures unburdened by stock-based compensation expense. Debt figures reflect face value. Convertible notes treated on an as-converted
basis. TRA liabilities not included as debt-like item. Excludes operating leases. CCC warrants treated as an equity instrument. NTM metrics reflect NTM as of 5/3/24. (1) Instructure enterprise value and growth figures are pro forma for Parchment
acquisition. 17
Overview Of Various Vertical Addressable Markets Picasso Vertical / Use Case Focus K-12 K-12 + Real Estate Auto Financial Financial Life Sciences Public P&C Learning Industrial Higher Ed. Insurance Institutions Services Sector(1) Insurance Mgt.
Automation Stated TAM $10.5bn $8bn $5bn$9bn(2) $10bn+ $17bn $18.7bn $20bn+ $21bn ~$25bn $25bn ~$60bn(2) U.S. / Canada Global LMS + Residential units Digitizing Regional & Americas Commercial, 88k+ local pure-play N. Am
$9.1bn Industrial $6bn Global and community Claims $6bn Community $10.3bn clinical, quality, govt. TAM for Automation Non-Trad. LMS association units Financial EMEA regulatory & insurance EMEA $8.4bn Institutions $6.1bn safety industry(2)
+Int.l $15bn + +$38bn (e.g., banks & APAC RoW $7.5bn Personal Ed. expansion + credit unions) $2.3bn $75bn Parchment Customer Profile 17,000 8,085 19,737 35,000 1,400+ 1,800 1,432 40k client 580 SMB,
Mid- 3,000 customers customers customers customers customers customers customers installations customers Market, Large customers Enterprises Individual Higher Ed., 300 insurance, Regional & 13k client
Insurance O&G, chemicals, schools, school continuing Ed., 29.5k collision community FIs locations companies E&C, Utilities, districts and K-12 districts repair, 5k part with ~22mm across size
Metals & Mining, states(3) suppliers accounts spectrum Pharma Annual Revenue Per Customer ~$41k ~$65k ~$31k ~$25k ~$445k ~$265k ~$1,650k n/a ~$1,560k n/a ~$350k Source: Public filings, Wall Street research. (1) Includes: Public
Administration, Courts & Public Safety, Schools, Data & Payments, Health & Human Services. (2) Per Wall Street research. (3) Representing over 80% of all K-12 students in
the U.S. and Canada. 18
Multiple Evolution Over Time EV / NTM EBITDA Since Picasso IPO(1) Average EV / NTM EBITDA Name 2-Yr 1-Yr YTD Picasso 19.0x 18.0x 17.5x Peer Median 28.5x 29.7x 31.2x Mult. Discount (9.5x) (11.8x) (13.7x) % Discount (33%) (40%) (44%) Source: FactSet as of May 3, 2024
Note: Peer median includes Veeva, Tyler Technologies, AspenTech, Guidewire, Appfolio, CCC, Q2, Instructure, NCINO and Docebo. (1) Reflects period starting August 19, 2021 (date of first available estimate). 19
Selected Precedent Transactions Annc. TEV EV / NTM NTM EBITDA 2-Yr Fwd.
Date Acquirer Target ($bn) Sales EBITDA Margin Sales CAGR 1/25/24 (1) Roper Technologies Procare $1.9 7.2x 19.6x 36.5% Mid-Teens 4/27/23 Deutsche Boerse SimCorp 3.9 6.4 26.4 24.1% 8.2% 8/30/22 (2)
Roper Technologies Frontline 3.7 10.1 21.3 47.3% High Single Digits 4/7/22 Brookfield CDK Global 8.3 4.4 11.7 37.9% 5.9% 8/5/21 Clearlake Capital Group Cornerstone On Demand 5.2 5.9 15.9 37.2% 9.0% 2/10/21 Tyler Technologies NIC 2.3 4.7
18.5 25.2% 1.3% 2/4/21 Insight / Stone Point CoreLogic 6.0 4.6 12.7 36.4% 0.7% 12/21/20 Thoma Bravo RealPage 10.2 8.2 28.7 28.4% 10.9% 8/13/20 Roper Technologies Vertafore 5.4 9.1 18.4 49.2% n.a. 2/14/20(3) Thoma Bravo Instructure 2.0 6.2 na na
17.4% Mean 6.7x 19.2x 35.8% 7.6% Median 6.3 18.5 36.5% 8.2% Source: Public filings and materials, FactSet. (1) TEV and financial metrics per acquiror investor materials. TEV excludes $110mm of estimated tax benefits. NTM multiples based on
figures for 12 month period ending 3/31/25. Including tax benefits, EV / NTM Sales would be 6.7x and EV / NTM EBITDA multiple would be 18.4x. Forward growth guidance per management commentary on 4/26/24. (2) TEV and financial metrics per acquiror
investor materials. TEV excludes $350mm of estimated tax benefits. NTM multiples based on 2023E figures. Including the tax benefits, the EV / Sales multiple would be 9.1x and the EV / EBITDA multiple would be 19.3x. Growth outlook based on Wall
Street analyst commentary. (3) TEV and financial metrics per acquiror investor materials. NTM multiples based on figures for 2021E. 20
Picasso Discounted Cash Flow Analysis Unlevered Free Cash Flow Detail Fiscal Year Ending December 31
Terminal FY24(1) FY25 FY26 FY27 FY28 FY29 FY30 FY31 FY32 FY33 FY34 Year (NTM) Revenue $788 $874 $975 $1,093 $1,231 $1,392 $1,531 $1,654 $1,769 $1,876 $1,969 $2,068 % Growth 12.9%
10.9% 11.6% 12.1% 12.6% 13.1% 10.0% 8.0% 7.0% 6.0% 5.0% 5.0% Adj. EBITDA (Unburd. SBC) $277 $327 $378 $439 $513 $595 $668 $736 $811 $878 $935 $982 % Margin 35.1% 37.4% 38.8% 40.1% 41.7% 42.8% 43.7% 44.5% 45.9% 46.8% 47.5% 47.5% (-): Stock-Based
Compensation (87) (96) (107) (120) (135) (153) (168) (182) (195) (206) (217) (-): Cash Taxes (excl. TRA) (28) (36) (46) (57) (72) (88) (102) (116) (133) (147) (160) +/(-): Change in NWC 22 35 39 44 54 61 67 72 77 82 86 (-): CapEx &
Capitalized R&D (46) (49) (52) (56) (60) (68) (71) (74) (75) (76) (76) (-): Other (5) Unlevered Free Cash Flow $133 $181 $212 $250 $300 $347 $393 $436 $486 $530 $569
Enterprise Value ($bn) Share Price Exit Multiple Exit Multiple Discounted Cash 16.0x 18.0x 20.0x 16.0x 18.0x 20.0x Flow Sensitivities 12.5% $6.6 $7.2 $7.8 12.5% $27.25 $29.95 $32.65 (Excludes impact of TRA) WACC 14.0% 5.9 6.4 6.9 WACC 14.0% $23.95
$26.30 $28.65 15.5% 5.2 5.7 6.1 15.5% $21.05 $23.10 $25.15 Source: Picasso management. Note: Figures in $mm unless otherwise noted, except for per share figures. Picasso Balance sheet as of 9/30; share count as of 6/30/2024. EBITDA figures
unburdened 21 by stock-based compensation expense. Assumes mid-year discounting. Excludes impact of TRA. Share prices rounded to nearest $0.05. (1) Assumes valuation date of 9/30/2024; discounted cash flows
only Q4 cash flows from 2024. Q424 UFCF of $30mm.
Appendix
Picasso WACC Analysis Peer Unlevered Beta Market Debt / Beta(1) Company Debt Cap. Equity Levered Unlevered Q2
$495 $3,907 13% 1.98 1.81 NCINO 54 3,647 1% 1.80 1.78 Docebo 1,409 0% 1.59 1.59 Appfolio 8,937 0% 1.36 1.36 Tyler Technologies 600 20,508 3% 1.37 1.34 Veeva 33,541 0% 1.33 1.33 Guidewire 400 9,897 4% 1.24 1.20 Instructure (5)
1,326 2,947 18% 0.77 0.68 CCC 782 7,264 11% 0.71 0.66 AspenTech 12,982 0% 0.64 0.64 Peer Median 2% 1.34 1.34 Memo: Picasso $838 $3,486 24% 1.14 0.97 WACC Sensitivity Debt / Unlevered Beta Sensitivity Equity 1.00 1.09 1.18 1.26 1.35 %
12.9% 13.5% 14.1% 14.8% 15.4% 10% 12.7% 13.3% 13.9% 14.5% 15.2% 20% 12.6% 13.2% 13.8% 14.4% 15.0% 30% 12.5% 13.1% 13.6% 14.2% 14.8% WACC Calculation Cost of Equity 20Y U.S. Treasury Yield 4.8% Unlevered Beta 1.34 Target Debt / Equity 2% Levered Beta
1.36 LT U.S. Historical Risk Premium(2) 7.2% Size Premium(2) 1.0% Cost of Equity 15.4% Cost of Debt Pre-Tax Cost of Debt(3) 7.7% Tax Rate 25.0% After-Tax Cost of Debt
5.7% Memo: Debt / Capital 2% WACC(4) 15.2% Source: Picasso management, KPMG, public filings, FactSet and Bloomberg. Note: Figures in $mm unless otherwise noted, except for per share figures. Picasso Balance sheet and share count as of 6/30/2024;
does not include TRA liability. (1) Represents two-year unadjusted weekly average beta. Unlevered betas assume 25% tax rate for each company, except for Docebo which assumes 26.5%. (2) Duff &
Phelps, 2023. Size premium reflects companies with market capitalization between $3.0bn and $4.6bn. (3) Reflects BofA B corporate index effective yield. (4) WACC equals ((debt / capitalization * (cost of debt * (1 tax rate))) +
(equity / capitalization * levered cost of equity)). (5) Current Instructure debt pro forma for Parchment acquisition; debt to equity metric (and corresponding unlevered beta calculation) reflects average debt to equity over prior 8 quarters. 23
TRA Benefit Discounted Cash Flow Analysis Reflects tax benefits of asset
step-up during IPO captured through Picassos modified Up-C structure; Class A Shareholders retain 15% of TRA tax benefits Cash Flow Benefit of Tax Receivable
Agreement (TRA) Fiscal Year Ending December 31 FY24 (1) FY25 FY26 FY27 FY28 FY29 FY30 FY31 FY32 FY33-44 Total TRA Benefit $20 $22 $33 $42
$46 $33 $28 $20 $14 $99 x 15% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% TRA Benefit to Shareholders $3 $3 $5 $6 $7 $5 $4 $3 $2 $15 TRA Benefit to ShareholdersSensitivities Present Value (2) Value Per Share ($mm) 12.5%
$27 $0.13 WACC 14.0% 26 $0.13 15.5% 24 $0.12 Source: Picasso Tax Asset Projection. Note: Dollars in millions. Illustrative valuation date of 9/30/2024. Assumes mid-year discounting. 24 (1) Assumes valuation
date of 9/30/2024; TRA benefit calculation only includes Q4 cash flows from 2024. Assumes FY24 TRA benefit evenly prorated across the year. (2) Assumes value per share based on Picasso basic shares outstanding as of 6/30/24.
1-Day Premiums Over Time Reflects announced or closed transactions
involving U.S. targets since 2014 Includes only transactions where implied equity between is between $1bn and $10bnExcludes transactions in Energy, Materials, Financials, Utilities and Real Estate industries
1-Day Premium(1) N = 398 Source: S&P Capital IQ as of May 3, 2024. Note: Screening criteria includes all cash announced and closed transactions involving U.S. targets, where the implied equity
value is between $1bn and $10bn. Sample set excludes transactions in the Energy, Materials, Financials, Utilities and Real Estate industries. Also excludes transactions where premium was negative. 25
Quarterly Cash Flow and Balance Sheet Trends Source: Picasso filings, Picasso management. (1) $300mm acq. of
SchoolMessenger closed in Q423. 26
Projections vs. Consensus: Key Items Source: Picasso management and FactSet as of May 3, 2024. Note:
Dollars in millions. (1) Reflects average of Goldman Sachs, UBS and Barclays 2026 estimates. 27
Picasso Quarterly Performance vs. Street Consensus (Since IPO) 28
Source: Picasso filings and FactSet. Note: Dollars in millions. Picasso Capitalization Summary Picasso
Capitalization Summary (Share Count as of 6/30/24; Balance Sheet as of 9/30/24) Price Per Share (Current) $22.17 Basic Shares Outstanding (mm) 204.1 Restricted Stock Units 7.9 Issue / Participation Performance Stock Units Amount Payout Factor 0.5
Threshold Market-Share UnitsTranche 1 0.5 $ 19.48 1.14x 0.5 Market-Share UnitsTranche 2 0.4 $ 20.90 1.06x 0.4 Management Incentive Units 2.7 $ 12.11 n.m. 1.2 Fully Diluted Shares Outstanding 214.7 Equity Value ($mm) $4,759 29
Source: Picasso management. Note: Figures in $mm unless otherwise noted, except for per share figures. Current
Picasso Structure Note: The figures and structure chart are approximate and for illustrative purposes only, and have been derived from Picassos prospectus dated July 27, 2021, Picassos 30 Schedule 14A, dated as of April 4, 2024
and the organizational chart provided in Picassos virtual data room. (1) Numerous blocker entities sit between the Company and the LLC.
Exhibit (c)(x) Project Picasso Confidential Discussion Materials Prepared
for the Special Committee of the Board of Directors June 2024
– Draft for Discussion Purposes – Disclaimer This presentation
has been prepared by Centerview Partners LLC (“Centerview”) for use solely by the Special Committee of the Board of Directors of Picasso in connection with its evaluation of a proposed sale of Picasso and for no other purpose. The
information contained herein is based upon information supplied by or on behalf of Picasso and publicly available information, and portions of the information contained herein may be based upon statements, estimates and forecasts provided by
Picasso. Centerview has relied upon the accuracy and completeness of the foregoing information, and has not assumed any responsibility for any independent verification of such information or for any independent evaluation or appraisal of any of the
assets or liabilities (contingent or otherwise) of Picasso or any other entity, or concerning the solvency or fair value of Picasso or any other entity. With respect to financial forecasts, Centerview has assumed that such forecasts have been
reasonably prepared on bases reflecting the best currently available estimates and judgments of the management of Picasso as to the future financial performance of Picasso, and at your direction Centerview has relied upon such forecasts, as provided
by Picasso’s management, with respect to Picasso. Centerview assumes no responsibility for and expresses no view as to such forecasts or the assumptions on which they are based. The information set forth herein is based upon economic,
monetary, market and other conditions as in effect on, and the information made available to us as of, the date hereof, unless indicated otherwise and Centerview assumes no obligation to update or otherwise revise these materials. The financial
analysis in this presentation is complex and is not necessarily susceptible to a partial analysis or summary description. In performing this financial analysis, Centerview has considered the results of its analysis as a whole and did not necessarily
attribute a particular weight to any particular portion of the analysis considered. Furthermore, selecting any portion of Centerview’s analysis, without considering the analysis as a whole, would create an incomplete view of the process
underlying its financial analysis. Centerview may have deemed various assumptions more or less probable than other assumptions, so the reference ranges resulting from any particular portion of the analysis described above should not be taken to be
Centerview’s view of the actual value of Picasso. These materials and the information contained herein are confidential, were not prepared with a view toward public disclosure, and may not be disclosed publicly or made available to third
parties without the prior written consent of Centerview. These materials and any other advice, written or oral, rendered by Centerview are intended solely for the benefit and use of the Special Committee of the Board of Directors of Picasso (in its
capacity as such) in its consideration of theproposed transaction, and are not for the benefit of, and do not convey any rights or remedies for any holder of securities of Picasso or any other person. Centerview will not be responsible for and has
not provided any tax, accounting, actuarial, legal or other specialist advice. These materials are not intended to provide the sole basis for evaluating the proposed transaction, and this presentation does not represent a fairness opinion,
recommendation, valuation or opinion of any kind, and is necessarily incomplete and should be viewed solely in conjunction with the oral presentation provided by Centerview. 1
– Draft for Discussion Purposes – Overview of Bain Proposal
Submitted 6/2/2024 Offer Share Price $22.80 * DSO 214.8 Implied Equity Value $4,897 Plus: Net Debt (Q3'24E) $708 Implied Enterprise Value $5,605 Implied Premium / (Discount) Metric Premium Unaffected Price (5/7/24) $16.64 +37.0% 52-week High
(Unaffected) $25.02 (8.9%) 52-week Low (Unaffected) $16.58 +37.5% 10-Day VWAP (Unaffected) $17.01 +34.0% 30-Day VWAP (Unaffected) $18.58 +22.7% 60-Day VWAP (Unaffected) $19.91 +14.5% 90-Day VWAP (Unaffected) $20.74 +10.0% Memo: Current Price $22.22
+2.6% Implied Enterprise Value Multiples (1) EV / Adjusted EBITDA (Consensus) CY 2024E $270 20.8x NTM (as of 6/30/24) 288 19.4x CY 2025E 307 18.3x (1) EV / Adjusted EBITDA (Management) CY 2024E $277 20.2x NTM (as of 6/30/24) 309 18.2x CY 2025E 327
17.1x Memo: No TRA Liability to be Paid 2 Source: Picasso management, Bloomberg and FactSet as of June 4, 2024. Note: Picasso DSO as of 6/4/24 and balance sheet as of 9/30/24 per Picasso management estimate (balance sheet conforms to proposal
letter). (1) Unburdened by stock-based compensation expense. NTM EBITDA as of 6/30/24.
– Draft for Discussion Purposes – Summary of Party Engagement
Sponsors Strategics Initial Engagement 10 5 (15) Executed NDA, Management Presentation 81 and/or Deep Dive Meetings (9) Conducted extensive Non-Binding financial diligence as Proposals well as follow up Other 2 1 (Written & sessions on product
Verbal) development, tech stack and R&D spend 3
– Draft for Discussion Purposes – Overview of Valuation
Methodologies Methodology Description 52-Week § Range of closing share prices for Picasso stock over the 52 weeks ending 5/7/2024 (unaffected date) Trading Range For Analyst § Price targets for Picasso per recent Wall Street analyst
research reports as of latest available date Reference Price Targets § 1-day price premiums of announced or closed transactions with $1-10bn in implied Equity Value Premia Paid (1) involving U.S. targets § EBITDA unburdened by stock-based
compensation expense Trading EV / NTM Multiples Adj. EBITDA § Multiples applied to Picasso Management Plan NTM EBITDA § EBITDA unburdened by stock-based compensation expense Precedent EV / NTM Transactions Adj. EBITDA § Multiples
applied to Picasso Management Plan NTM EBITDA § Picasso Management Plan; includes value of TRA tax benefits retained by shareholders Discounted Cash Flow Analysis § Assumes terminal EBITDA multiples of 15.0x – 19.0x (Including Value
of TRA Benefits) § Weighted Average Cost of Capital of 12.25% – 15.25% 4 Source: Picasso management, Wall Street research, FactSet and Bloomberg. (1) Per S&P Capital IQ. Excludes transactions in the Energy, Materials, Financials,
Utilities and Real Estate industries, and transactions with negative premium.
– Draft for Discussion Purposes – Picasso Valuation Analysis
Methodology Relevant Metrics Implied Share Price Range Low (5/3/2024) / 52-Week High (2/9/2024) $16.58 $25.02 Trading Range (Unaffected Date) For Analyst Low / High $20.00 $31.00 Reference Price Targets (Latest Available Reports) 15.0% - 50.0%
Premium Premia Paid $19.15 $24.95 (to Unaffected Price) Trading EV / NTM 17.0x – 21.0x NTM Adj. $21.15 $26.85 Multiples Adj. EBITDA EBITDA of $309mm Precedent EV / NTM 18.0x – 22.0x NTM Adj. $22.60 $28.25 Transactions Adj. EBITDA EBITDA
of $309mm Discounted Cash WACC: 12.25% – 15.25% Flow Analysis Terminal NTM EBITDA $21.65 $33.80 (Including Value of TRA Benefits) Multiple: 15.0x – 19.0x Bain Proposal 6/2/2024 $22.80 Source: Picasso management, public filings,
CapitalIQ, FactSet and Bloomberg. 5 Note: Dollars in millions except per share amounts. Balance sheet as of 9/30/2024 per Picasso management estimate. Fully diluted share count as of 6/4/24 inclusive of MIUs. EBITDA figures unburdened by stock-based
compensation expense. Share prices rounded to nearest $0.05, except for 52-week trading range. NTM metrics reflect NTM as of 6/30/24.
– Draft for Discussion Purposes – Share Price Performance Over
Time Indexed Share Price Performance –Two Years Prior to Unaffected Date $32 $30 $28 Picasso 52-Week High (2/9/24): $25.02 $26 Current (Memo): $24 $22.22 +66% $22 $20 +45% $18 +33% $16.64 $16 Picasso 52- +24% Week Low $14 Picasso (5/3/24):
$13.42 unaffected $16.58 $12 price $10 $8 $6 $4 Picasso S&P 500 NASDAQ $2 $0 May-22 Oct-22 Mar-23 Aug-23 Jan-24 Jun-24 6 Source: FactSet as of June 4, 2024. Note: Prices indexed to Picasso as of May 9, 2022. Unaffected date as of May 7,
2024.
– Draft for Discussion Purposes – Research Analyst Price
Targets As of 5/7/24 Prem. to Pre Earnings Broker Price Target Valuation Methodology Unaff. SP Price Targets $31.00 86.3% 23.5x EV / CY'25E EBITDA $30.00 $30.00 80.3% 22.0x EV / FY'25E EBITDA supported by DCF $30.00 $27.00 62.3% DCF (11.7% WACC,
3.5% TGR) $27.00 24.0x EV / FCF on Q5 - Q8 estimates $26.00 56.3% $30.00 Lowered from 27x based on lower peer multiples 56.3% 7.5x EV / FY'24E Revenue $26.00 $26.00 $25.00 50.2% EV / CY'24E EBITDA $30.00 6.5x EV / CY'25E Revenue 44.2% $29.00 $24.00
Downward revision given peer group multiple compression 18.0x EV / CY'25E EBITDA 38.2% $28.00 $23.00 Reduced multiple from 21x CY’25E EBITDA 7.0x EV / CY'24E Revenue 32.2% $27.00 $22.00 Lowered from 8x based on peer group multiple contraction
32.2% 18x EV / '25E EBITDA and 27x EV / '25E FCF $26.00 $22.00 21.6x EV/ CY'25E FCF 20.2% $25.00 $20.00 Multiple based on regression of peers Median $25.00 50.2% $28.00 Buy Hold 7 Source: Wall Street research, Bloomberg and FactSet.
– Draft for Discussion Purposes – 10 Year Management Plan
Summary Management Plan Summary Fiscal Year Ending December 31 FY'23A FY'24 FY'25 FY'26 FY'27 FY'28 FY'29 FY'30 FY'31 FY'32 FY'33 FY'34 Revenue $698 $788 $874 $975 $1,093 $1,231 $1,392 $1,552 $1,707 $1,852 $1,977 $2,076 % Growth 10.6% 12.9% 10.9%
11.6% 12.1% 12.6% 13.1% 11.5% 10.0% 8.5% 6.7% 5.0% Adjusted Gross Profit $491 $559 $623 $701 $793 $900 $1,020 $1,141 $1,258 $1,367 $1,461 $1,536 % Margin 70.4% 70.9% 71.3% 71.9% 72.5% 73.1% 73.3% 73.5% 73.7% 73.8% 73.9% 74.0% R&D $87 $98 $106
$116 $126 $138 $152 $167 $179 $185 $193 $197 S&M 109 122 132 143 157 174 192 210 226 235 242 249 G&A 626259 6470758187 9397 101 104 Adj. EBITDA (Unburd. SBC) $232 $277 $327 $378 $439 $513 $595 $677 $760 $849 $925 $986 % Margin 33.2% 35.1%
37.4% 38.8% 40.1% 41.7% 42.8% 43.7% 44.5% 45.9% 46.8% 47.5% Stock-Based Compensation 63 87 96 107 120 135 153 171 188 204 218 228 D&A 130 146 156 154 155 155 165 155 152 150 147 144 Δ Deferred Revenue 33 40 53 59 68 81 93 103 114 123 132
138 Δ NWC (21) (18) (17) (20) (24) (28) (32) (36) (39) (43) (46) (48) Capital Expenditures 2 5 5 6 7 7 8 9 10 11 12 12 Capitalized R&D 394144 4649525963 666868 67 (1) – 10– –– –––
––– – Other Source: Picasso management. 8 Note: Dollars in millions. Reflects management forecast received by Centerview on 5/6/24. (1) Includes India office expansion and incremental Q4’24 $5mm payment related to
SchoolMessenger acquisition.
– Draft for Discussion Purposes – Selected Public Comparables
CY'23A-'25E CAGR EBITDA Mgn. EV / EBITDA Company Name Enterprise Value ($bn) Revenue EBITDA CY'24E NTM Picasso (Mgmt., Unaffected) $4.3 11.9% 18.7% 35.1% 14.6x Picasso (Consensus, Unaffected) $4.3 11.9% 15.1% 34.2% 15.2x Veeva $24.6 13.5% 19.9%
40.0% 21.5x Tyler Technologies 21.4 9.3% 14.5% 26.6% 35.7x AspenTech 13.0 8.5% 5.3% 40.3% 26.1x Guidewire 8.9 11.5% 82.1% 13.5% 53.6x CCC 8.3 9.1% 10.9% 41.4% 20.2x Appfolio 8.2 22.1% 63.1% 26.2% 35.9x (1) Instructure (Unaffected) 4.2 7.1% 12.7%
41.2% 14.6x Q2 4.0 10.8% 38.9% 16.3% 31.7x NCINO 3.6 14.6% 38.5% 17.3% 34.4x Docebo 1.0 18.3% 68.1% 15.2% 27.0x Peer Median 11.2% 29.2% 26.4% 29.3x % Discount - Picasso Cons. EV / NTM EBITDA vs. Peer Median (48%) Source: Picasso management, public
filings and FactSet as of June 4, 2024. Note: All figures in USD. Picasso balance sheet and share count figures as of 10-K filing on 3/1/24; share price and estimates as of 5/7/24. EBITDA figures unburdened 9 by stock-based compensation expense.
Debt figures reflect face value. Convertible notes treated on an as-converted basis. TRA liabilities not included as debt- like item. Excludes operating leases. Peer NTM metrics reflect NTM as of 6/4/24, except for Instructure which reflects NTM as
of unaffected date (5/17/24). (1) Instructure growth figures are pro forma for Parchment acquisition. All metrics as of unaffected date (5/17/24); current affected multiple is 15.5x.
– Draft for Discussion Purposes – Multiple Evolution Over
Time EV / NTM EBITDA – Two Years to Unaffected Date 60x Avg. EV / NTM EBITDA (to Unaffected) Picasso Peer Median Instructure L2Y L1Y YTD Picasso 20.6x 20.0x 19.1x Peer Median 29.2x 30.7x 31.0x 50x Mult. Discount (8.6x) (10.7x) (12.0x) %
Discount (30%) (35%) (39%) Memo: Instructure 18.0x 17.0x 15.1x Memo: % Prem. +15% +18% +26% 40x Peer current multiple 29.3x 30x 29.8x Picasso unaffected 20x mult. (5/7/24) 18.5x 16.1x 15.2x 14.6x INST unaffected 10x mult. (5/17/24) 0.0x May-22
Oct-22 Mar-23 Aug-23 Jan-24 Jun-24 Source: FactSet as of June 4, 2024 10 Note: Peer median includes Veeva, Tyler Technologies, AspenTech, Guidewire, Appfolio, CCC, Q2, Instructure, NCINO and Docebo. Unaffected date as of May 7, 2024. Excludes peer
multiples that are negative or higher than 125x. Instructure multiple held constant after 5/17/24 (unaffected date). Instructure multiple includes impact of Parchment acquisition from the first day that consensus includes Parchment in EBITDA
estimates (2/21/24).
– Draft for Discussion Purposes – Selected Precedent
Transactions Annc. TEV EV / NTM NTM EBITDA 2-Yr Fwd. Date Acquirer Target ($bn) Sales EBITDA Margin Sales CAGR (1) (1) 1/25/24 Roper Technologies Procare $1.8 6.7x 18.4x 36.5% Mid-Teens 4/27/23 Deutsche Boerse SimCorp 3.9 6.4 26.4 24.1% 8.2% (2) (2)
8/30/22 Roper Technologies Frontline 3.4 9.1 19.3 47.3% High Single Digits 4/7/22 Brookfield CDK Global 8.3 4.4 11.7 37.9% 5.9% 8/5/21 Clearlake Capital Group Cornerstone On Demand 5.2 5.9 15.9 37.2% 9.0% 2/10/21 Tyler Technologies NIC 2.3 4.7 18.5
25.2% 1.3% 2/4/21 Insight / Stone Point CoreLogic 6.0 4.6 12.7 36.4% 0.7% 12/21/20 Thoma Bravo RealPage 10.2 8.2 28.7 28.4% 10.9% 8/13/20 Roper Technologies Vertafore 5.4 9.1 18.4 49.2% n.a. (3) 2/14/20 Thoma Bravo Instructure 2.0 6.2 n.a. n.a.
17.4% Mean 6.5x 18.9x 35.8% 7.6% Median 6.3 18.4 36.5% 8.2% Source: Public filings and materials, FactSet. (1) TEV and financial metrics per acquiror investor materials. TEV includes $110mm of estimated tax benefits. NTM multiples based on figures
for 12 month period ending 3/31/25. Excluding tax benefits, EV / NTM Sales would be 7.2x and EV / NTM EBITDA multiple would be 19.6x. Forward growth guidance per management commentary on 4/26/24. (2) TEV and financial metrics per acquiror investor
materials. TEV includes $350mm of estimated tax benefits. NTM multiples based on 2023E figures. Excluding the 11 tax benefits, the EV / Sales multiple would be 10.1x and the EV / EBITDA multiple would be 21.3x. Growth outlook based on Wall Street
analyst commentary. (3) TEV and financial metrics per acquiror investor materials. NTM multiples based on figures for 2021E.
– Draft for Discussion Purposes – Picasso Discounted Cash
Flow Analysis Unlevered Free Cash Flow Detail Fiscal Year Ending December 31 Terminal (1) FY'24 FY'25 FY'26 FY'27 FY'28 FY'29 FY'30 FY'31 FY'32 FY'33 FY'34 Year (NTM) Revenue $788 $874 $975 $1,093 $1,231 $1,392 $1,552 $1,707 $1,852 $1,977 $2,076
$2,180 % Growth 12.9% 10.9% 11.6% 12.1% 12.6% 13.1% 11.5% 10.0% 8.5% 6.7% 5.0% 5.0% Adj. EBITDA (Unburd. SBC) $277 $327 $378 $439 $513 $595 $677 $760 $849 $925 $986 $1,036 % Margin 35.1% 37.4% 38.8% 40.1% 41.7% 42.8% 43.7% 44.5% 45.9% 46.8% 47.5%
47.5% (-): Stock-Based Compensation (87) (96) (107) (120) (135) (153) (171) (188) (204) (218) (228) (-): Cash Taxes (excl. TRA) (28) (36) (46) (57) (72) (88) (104) (121) (141) (157) (170) +/(-): Change in NWC 2235394454616874818690 (-): CapEx &
Capitalized R&D (46) (49) (52) (56) (60) (68) (72) (76) (79) (80) (80) (2) (-): Other (10) –––– ––– ––– Unlevered Free Cash Flow $128 $181 $212 $250 $300 $347 $398 $449 $507 $557 $598
(3) Enterprise Value ($bn) Share Price Implied Perpetuity Growth Rate NTM Exit Multiple NTM Exit Multiple NTM Exit Multiple Discounted 15.0x 17.0x 19.0x 15.0x 17.0x 19.0x 15.0x 17.0x 19.0x Cash Flow Sensitivities 12.25% $6.7 $7.3 $8.0 12.25% $27.85
$30.80 $33.70 12.25% 7.8% 8.3% 8.7% (Excludes impact 13.75% 6.0 6.5 7.1 13.75% $24.50 $27.00 $29.55 13.75% 9.3% 9.8% 10.2% of TRA) 15.25% 5.3 5.8 6.3 15.25% $21.55 $23.75 $26.00 15.25% 10.7% 11.2% 11.6% Source: Picasso management. Note: Figures in
$mm unless otherwise noted, except for per share figures. Picasso balance sheet as of 9/30/24 per Picasso management estimate and share count as of 6/4/24. EBITDA figures unburdened by stock-based compensation expense. Assumes mid-year discounting.
Excludes impact of TRA. Share prices rounded to nearest $0.05. 12 (1) Assumes valuation date of 9/30/2024; discounted cash flows only include Q4 cash flows from 2024. Q4’24 UFCF of $26mm. (2) Includes India office expansion and incremental
Q4’24 $5mm payment related to SchoolMessenger acquisition. (3) Implied perpetuity growth rate calculated based on FY’34E unlevered free cash flow. WACC WACC WACC
Appendix
– Draft for Discussion Purposes – Overview Of Various
Vertical Addressable Markets Picasso Vertical / Use Case Focus K-12 K-12 + Real Estate Auto Financial Financial Life Sciences Public P&C Learning Industrial (1) Higher Ed. Insurance Institutions Services Sector Insurance Mgt. Automation Stated
TAM (2) (2) $10.5bn $8bn $5bn - $9bn $10bn+ $17bn $18.7bn $20bn+ $21bn ~$25bn $25bn ~$60bn U.S. / Canada Global LMS + Residential units Digitizing Regional & Americas Commercial, 88k+ local “pure-play” N. Am $9.1bn Industrial $6bn
Global and community Claims $6bn Community $10.3bn clinical, quality, govt. TAM for Automation Non-Trad. LMS association units Financial regulatory & insurance EMEA $8.4bn EMEA (2) Institutions safety industry $6.1bn +Int.’l $15bn + (e.g.,
banks & RoW $7.5bn +$38bn APAC Personal Ed. credit unions) expansion + $2.3bn $75bn Parchment Customer Profile 17,000 8,085 19,737 35,000 1,400+ 1,800 1,432 40k client 580 SMB, Mid- 3,000 customers customers customers customers customers
customers customers installations customers Market, Large customers Enterprises Individual Higher Ed., 300 insurance, Regional & 13k client Insurance O&G, chemicals, schools, school continuing Ed., 29.5k collision community FIs locations
companies E&C, Utilities, districts and K-12 districts repair, 5k part with ~22mm across size Metals & Mining, (3) states suppliers accounts spectrum Pharma Annual Revenue Per Customer ~$41k ~$65k ~$31k ~$25k ~$445k ~$265k ~$1,650k n/a
~$1,560k n/a ~$350k Source: Public filings, Wall Street research. (1) Includes: Public Administration, Courts & Public Safety, Schools, Data & Payments, Health & Human Services. 14 (2) Per Wall Street research. (3) Representing over 80%
of all K-12 students in the U.S. and Canada.
– Draft for Discussion Purposes – Picasso WACC Analysis Peer
Unlevered Beta WACC Calculation (1) Market Debt / Beta Company Debt Cap. Equity Levered Unlevered Cost of Equity Q2 $495 $3,893 13% 2.20 2.01 20Y U.S. Treasury Yield 4.6% NCINO 54 3,708 1% 1.86 1.84 Unlevered Beta 1.35 Docebo – 1,111 0% 1.45
1.45 Target Debt / Equity 2% Veeva – 29,379 0% 1.43 1.43 Levered Beta 1.38 (2) Tyler Technologies 600 20,955 3% 1.41 1.38 7.2% LT U.S. Historical Risk Premium (2) Appfolio – 8,482 0% 1.33 1.33 1.0% Size Premium Guidewire 400 9,436 4%
1.30 1.26 Cost of Equity 15.4% CCC 782 7,702 10% 0.75 0.69 AspenTech – 13,139 0% 0.69 0.69 Cost of Debt (5) (3) Instructure (Unaffect.) 1,173 3,072 18% 0.75 0.67 7.4% Pre-Tax Cost of Debt Peer Median 2% 1.37 1.35 Tax Rate 25.0% $838 $3,499 24%
1.14 0.97 After-Tax Cost of Debt 5.5% Picasso (Unaffected) Memo: Debt / Capital 2% (4) WACC Sensitivity 15.2% WACC Debt / Unlevered Beta Sensitivity Equity 1.00 1.09 1.18 1.27 1.35 –% 12.7% 13.3% 13.9% 14.6% 15.2% 10% 12.5% 13.1% 13.8% 14.4%
15.0% 20% 12.4% 13.0% 13.6% 14.2% 14.8% 30% 12.3% 12.9% 13.5% 14.1% 14.7% Source: Picasso management, KPMG, public filings, Bloomberg and FactSet as of June 4, 2024. Note: Figures in $mm unless otherwise noted, except for per share figures. Picasso
balance sheet and share count figures as of 10-K filing on 3/1/24; Picasso beta as of unaffected date (5/7/2024). (1) Represents two-year unadjusted weekly average beta. Unlevered betas assume 25% tax rate for each company, except for Docebo which
assumes 26.5%. (2) Duff & Phelps, 2023. Size premium reflects companies with market capitalization between $3.0bn and $4.6bn. (3) Reflects BofA B 15 corporate index effective yield. (4) WACC equals ((debt / capitalization * (cost of debt * (1
– tax rate))) + (equity / capitalization * levered cost of equity)). (5) Instructure debt to equity metric (and corresponding unlevered beta calculation) reflects average debt to equity over prior 8 quarters. INST beta as of INST unaffected
date (5/17/2024).
– Draft for Discussion Purposes – Treasury Yields Over Time
US 20-Year Treasury Yield – Last 1 Year 6.0% 20-Year US Treasury Yield Min. Avg. Max. Last 1 Month 4.6% 4.7% 4.8% Last 3 Months 4.4% 4.7% 4.9% 5.5% Last 6 Months 4.1% 4.5% 4.9% Last 1 Year High: 5.3% Last 9 Months 4.1% 4.6% 5.3% Last 1 Year
4.0% 4.5% 5.3% 5.0% 4.6% 4.5% 4.0% 4.0% Last 1 Year Low: 4.0% 3.5% 3.0% Jun-23 Jul-23 Sep-23 Nov-23 Dec-23 Feb-24 Apr-24 Jun-24 16 Source: Federal Reserve as of June 4, 2024.
– Draft for Discussion Purposes – TRA Benefit Discounted Cash
Flow Analysis Reflects tax benefits of asset step-up during IPO captured through Picasso’s modified Up-C structure; Class A Shareholders retain 15% of TRA tax benefits Cash Flow Benefit of Tax Receivable Agreement (TRA) Fiscal Year Ending
December 31 (1) FY'24 FY'25 FY'26 FY'27 FY'28 FY'29 FY'30 FY'31 FY'32 FY'33-'44 Total TRA Benefit $20 $22 $33 $42 $46 $33 $28 $20 $14 $99 x 15% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% TRA Benefit to Shareholders $3 $3 $5 $6 $7 $5
$4 $3 $2 $15 TRA Benefit to Shareholders - Sensitivities Present Value (2) Value Per Share ($mm) 12.25% $28 $0.14 13.75% 26 $0.13 15.25% 25 $0.12 Source: Picasso Tax Asset Projection. Note: Dollars in millions. Illustrative valuation date of
9/30/2024. Assumes mid-year discounting. 17 (1) Assumes valuation date of 9/30/2024; TRA benefit calculation only includes Q4 cash flows from 2024. Assumes FY’24 TRA benefit evenly prorated across the year. (2) Assumes value per share based on
Picasso basic shares outstanding as of 6/4/24. WACC
– Draft for Discussion Purposes – 1-Day Premiums §
Reflects announced or closed transactions involving U.S. targets since 2014 § Includes only transactions where implied equity between is between $1bn and $10bn § Excludes transactions in Energy, Materials, Financials, Utilities and Real
Estate industries (1) 1-Day Premium – N = 405 48% 24% 13% 25th Percentile Median 75th Percentile Source: S&P Capital IQ as of June 4, 2024. 18 Note: Screening criteria includes all cash announced and closed transactions involving U.S.
targets, where the implied equity value is between $1bn and $10bn. Sample set excludes transactions in the Energy, Materials, Financials, Utilities and Real Estate industries. Also excludes transactions where premium was negative.
– Draft for Discussion Purposes – Quarterly Cash Flow and
Balance Sheet Trends $277 $220 $187 $174 Cash Flow $52 $42 $43 $20 ($16) ($26) ($33) from ($60) ($65) ($90) Operating Activities Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1A Q2 Q3 Q4 2021A 2022A 2023A 2024E $165 $125 $70 $30 Revolver $10 $10 Q3 Q4 Q1 Q2 Q3 Q4
Q1 Q2 Q3 Q4 Q1A Q2 Q3 Q4 2021A 2022A 2023A 2024E $838 $838 $836 $834 $832 $830 $754 $752 $750 $748 $746 $744 $742 $740 Term Loan Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1A Q2 Q3 Q4 2021A 2022A 2023A 2024E (1) $988 $943 $802 $799 $756 $722 $708 $678 $677 $663
$665 $637 $607 $525 Net Debt Δ = ($165) Δ = ($197) Δ = ($280) Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1A Q2 Q3 Q4 2021A 2022A 2023A 2024E 19 Source: Picasso filings, Picasso management. (1) $300mm acq. of SchoolMessenger closed in
Q4’23.
– Draft for Discussion Purposes – Picasso Capitalization
Summary Picasso Capitalization Summary Price Per Share (Offer) $22.80 Basic Shares Outstanding (mm) 203.7 Restricted Stock Units 8.3 Issue / Participation Performance Stock Units Amount Payout Factor 0.5 Threshold Market-Share Units - Tranche 1 0.5
$19.48 1.17x 0.6 Market-Share Units - Tranche 2 0.4 $20.90 1.09x 0.4 Management Incentive Units 2.7 $12.11 n.m. 1.3 Fully Diluted Shares Outstanding 214.8 Equity Value ($mm) $4,897 20 Source: Picasso management. Note: Figures in $mm unless otherwise
noted, except for per share figures. Share count as of 6/4/24.
– Draft for Discussion Purposes – Projections vs. Consensus:
Key Items (Unaffected Date) (1) 2024E 2025E 2026E # of Est = 13 # of Est = 12 # of Est = 3 +0.1% +0.1% (0.2%) $947 $974 $975 $994 $893 $874 $864 $873 $787 $788 $789 $791 Revenue Low Mgt. Consensus High Low Consensus Mgt. High Low Consensus Mgt. High
# of Est = 6 # of Est = 5 # of Est = 3 +0.2% +0.1% +1.3% $700 $701 $710 $682 $615 $622 $623 $605 Adjusted $550 $558 $559 $559 Gross Profit Low Consensus Mgt. High Low Consensus High Mgt. Low Consensus Mgt. High # of Est = 12 # of Est = 11 # of Est =
3 +8.0% +6.4% +2.6% $378 $357 $350 $343 $327 $314 $307 $298 $277 $268 $270 $271 Adjusted EBITDA Low Consensus High Mgt. Low Consensus High Mgt. Low Consensus High Mgt. Source: Picasso management and FactSet. 21 Note: Dollars in millions. Estimates
as of 5/7/2024 (unaffected date). (1) Reflects average of Goldman Sachs, UBS and Barclays 2026 estimates.
Exhibit (C)(xi)
Project Picasso Confidential Discussion Materials Prepared for the Special Committee of the Board of Directors
June 2024
Disclaimer This presentation has been prepared by Centerview Partners LLC (Centerview) for use
solely by the Special Committee of the Board of Directors of Picasso in connection with its evaluation of a proposed sale of Picasso and for no other purpose. The information contained herein is based upon information supplied by or on behalf of
Picasso and publicly available information, and portions of the information contained herein may be based upon statements, estimates and forecasts provided by Picasso. Centerview has relied upon the accuracy and completeness of the foregoing
information, and has not assumed any responsibility for any independent verification of such information or for any independent evaluation or appraisal of any of the assets or liabilities (contingent or otherwise) of Picasso or any other entity, or
concerning the solvency or fair value of Picasso or any other entity. With respect to financial forecasts, Centerview has assumed that such forecasts have been reasonably prepared on bases reflecting the best currently available estimates and
judgments of the management of Picasso as to the future financial performance of Picasso, and at your direction Centerview has relied upon such forecasts, as provided by Picassos management, with respect to Picasso. Centerview assumes no
responsibility for and expresses no view as to such forecasts or the assumptions on which they are based. The information set forth herein is based upon economic, monetary, market and other conditions as in effect on, and the information made
available to us as of, the date hereof, unless indicated otherwise and Centerview assumes no obligation to update or otherwise revise these materials. The financial analysis in this presentation is complex and is not necessarily susceptible to a
partial analysis or summary description. In performing this financial analysis, Centerview has considered the results of its analysis as a whole and did not necessarily attribute a particular weight to any particular portion of the analysis
considered. Furthermore, selecting any portion of Centerviews analysis, without considering the analysis as a whole, would create an incomplete view of the process underlying its financial analysis. Centerview may have deemed various
assumptions more or less probable than other assumptions, so the reference ranges resulting from any particular portion of the analysis described above should not be taken to be Centerviews view of the actual value of Picasso. These materials
and the information contained herein are confidential, were not prepared with a view toward public disclosure, and may not be disclosed publicly or made available to third parties without the prior written consent of Centerview. These materials and
any other advice, written or oral, rendered by Centerview are intended solely for the benefit and use of the Special Committee of the Board of Directors of Picasso (in its capacity as such) in its consideration of the proposed transaction, and are
not for the benefit of, and do not convey any rights or remedies for any holder of securities of Picasso or any other person. Centerview will not be responsible for and has not provided any tax, accounting, actuarial, legal or other specialist
advice. These materials are not intended to provide the sole basis for evaluating the proposed transaction, and this presentation does not represent a fairness opinion, recommendation, valuation or opinion of any kind, and is necessarily incomplete
and should be viewed solely in conjunction with the oral presentation provided by Centerview. 1
Overview of Bain Proposal Submitted 6/2/2024 Share Price $22.80 * DSO 214.8 Implied Equity Value $4,897 Plus:
Net Debt (Q324E) $708 Implied Enterprise Value $5,605 Metric Premium Unaffected Price (5/7/24) $16.64 +37.0% 52-week High (Unaffected) $25.02 (8.9%) 52-week Low (Unaffected) $16.58 +37.5% 10-Day VWAP (Unaffected) $17.01 +34.0% 30-Day VWAP
(Unaffected) $18.58 +22.7% 60-Day VWAP (Unaffected) $19.91 +14.5% 90-Day VWAP (Unaffected) $20.74 +10.0% Memo: Current Price $22.24 +2.5% EV / Adjusted EBITDA (Consensus)(1) CY 2024E $270 20.8x NTM (as of 6/30/24) 288 19.4x CY 2025E 307 18.3x EV /
Adjusted EBITDA (Management)(1) CY 2024E $277 20.2x NTM (as of 6/30/24) 309 18.2x CY 2025E 327 17.1x Memo: No TRA Liability to be Paid Source: Picasso management, Bloomberg and FactSet as of June 5, 2024. 2 Note: Picasso DSO as of 6/4/24 and
balance sheet as of 9/30/24 per Picasso management estimate (balance sheet conforms to proposal letter). (1) Unburdened by stock-based compensation expense. NTM EBITDA as of 6/30/24.
Overview of Valuation Methodologies Methodology Description 52-Week ? Range of closing share prices for Picasso
stock over the 52 weeks ending 5/7/2024 (unaffected date) Trading Range Analyst ? Price targets for Picasso per recent Wall Street analyst research reports as of latest available date Price Targets ? 1-day price premiums of announced or closed
transactions with $1-10bn in implied Equity Value Premia Paid involving U.S. targets(1) EV / NTM ? EBITDA unburdened by stock-based compensation expense Adj. EBITDA ? Multiples applied to Picasso Management Plan NTM EBITDA EV / NTM ? EBITDA
unburdened by stock-based compensation expense Adj. EBITDA ? Multiples applied to Picasso Management Plan NTM EBITDA ? Picasso Management Plan; includes value of TRA tax benefits retained by shareholders ? Assumes terminal EBITDA multiples of 15.0x
19.0x ? Weighted Average Cost of Capital of 12.25% 15.25% 3 Source: Picasso management, Wall Street research, FactSet and Bloomberg. (1) Per S&P Capital IQ. Excludes transactions in the Energy, Materials, Financials, Utilities and
Real Estate industries, and transactions with negative premium.
Picasso Valuation Analysis Methodology Relevant Metrics Implied Share Price Range Low (5/3/2024) / 52-Week High
(2/9/2024) $16.58 $25.02 Trading Range (Unaffected Date) Analyst Low / High $20.00 $31.00 Price Targets (Latest Available Reports) 15.0%50.0% Premium Premia Paid $19.15 $24.95 (to Unaffected Price) EV / NTM 17.0x 21.0x NTM Adj. $21.15
$26.85 Adj. EBITDA EBITDA of $309mm EV / NTM 18.0x 22.0x NTM Adj. $22.60 $28.25 Adj. EBITDA EBITDA of $309mm WACC: 12.25% 15.25% Terminal NTM EBITDA $21.65 $33.80 Multiple: 15.0x 19.0x Bain Proposal 6/2/2024 $22.80 Source:
Picasso management, public filings, CapitalIQ, FactSet and Bloomberg. Note: Dollars in millions except per share amounts. Balance sheet as of 9/30/2024 per Picasso management estimate. Fully diluted share count as of 6/4/24 inclusive of 4 MIUs.
EBITDA figures unburdened by stock-based compensation expense. Share prices rounded to nearest $0.05, except for 52-week trading range. NTM metrics reflect NTM as of 6/30/24.
Share Price Performance Over Time Indexed Share Price Performance Two Years Prior to Unaffected Date $32
$30 $28 $26 Picasso 52-Week High (2/9/24): $25.02 Current (Memo): $24 $22.24 $22 +66% $20 +48% $18 +34% $16.64 $16 Picasso 52- +24% $14 Week Low $13.42 (5/3/24): Picasso $12 $16.58 unaffected price $10 $8 $6 $4 $2 Picasso S&P 500 NASDAQ $0 May-22 Oct-22 Mar-23 Aug-23 Jan-24 Jun-24 5 Source: FactSet as of June 5, 2024. Note: Prices indexed to Picasso as of May 9, 2022. Unaffected date as of May 7, 2024.
Research Analyst Price Targets As of 5/7/24 Prem. to Pre Earnings Broker Price Target Valuation Methodology
Unaff. SP Price Targets $31.00 86.3% 23.5x EV / CY25E EBITDA $30.00 $30.00 80.3% 22.0x EV / FY25E EBITDA supported by DCF $30.00 $27.00 62.3% DCF (11.7% WACC, 3.5% TGR) $27.00 24.0x EV / FCF on Q5Q8 estimates $26.00 56.3% $30.00
Lowered from 27x based on lower peer multiples $26.00 56.3% 7.5x EV / FY24E Revenue $26.00 $25.00 50.2% EV / CY24E EBITDA $30.00 6.5x EV / CY25E Revenue $24.00 44.2% $29.00 Downward revision given peer group multiple compression
18.0x EV / CY25E EBITDA $23.00 38.2% $28.00 Reduced multiple from 21x CY25E EBITDA 7.0x EV / CY24E Revenue $22.00 32.2% $27.00 Lowered from 8x based on peer group multiple contraction $22.00 32.2% 18x EV / 25E EBITDA and 27x
EV / 25E FCF $26.00 21.6x EV/ CY25E FCF $20.00 20.2% $25.00 Multiple based on regression of peers Median $25.00 50.2% Buy Hold 6 Source: Wall Street research, Bloomberg and FactSet.
10 Year Management Plan Summary FY23A FY24 FY25 FY26 FY27 FY28 FY29
FY30 FY31 FY32 FY33 FY34 Revenue $698 $788 $874 $975 $1,093 $1,231 $1,392 $1,552 $1,707 $1,852 $1,977 $2,076 % Growth 10.6% 12.9% 10.9% 11.6% 12.1% 12.6% 13.1% 11.5% 10.0% 8.5% 6.7% 5.0% Adjusted Gross Profit $491 $559
$623 $701 $793 $900 $1,020 $1,141 $1,258 $1,367 $1,461 $1,536 % Margin 70.4% 70.9% 71.3% 71.9% 72.5% 73.1% 73.3% 73.5% 73.7% 73.8% 73.9% 74.0% R&D $87 $98 $106 $116 $126 $138 $152 $167 $179 $185 $193 $197 S&M 109 122 132 143 157 174 192 210
226 235 242 249 G&A 62 62 59 64 70 75 81 87 93 97 101 104 Adj. EBITDA (Unburd. SBC) $232 $277 $327 $378 $439 $513 $595 $677 $760 $849 $925 $986 % Margin 33.2% 35.1% 37.4% 38.8% 40.1% 41.7% 42.8% 43.7% 44.5% 45.9% 46.8% 47.5% Stock-Based
Compensation 63 87 96 107 120 135 153 171 188 204 218 228 D&A 130 146 156 154 155 155 165 155 152 150 147 144 Î Deferred Revenue 33 40 53 59 68 81 93 103 114 123 132 138 Î NWC (21) (18) (17) (20) (24) (28) (32) (36) (39)
(43) (46) (48) Capital Expenditures 2 5 5 6 7 7 8 9 10 11 12 12 Capitalized R&D 39 41 44 46 49 52 59 63 66 68 68 67 Other(1) 10 Source: Picasso management. 7 Note:
Dollars in millions. Reflects management forecast received by Centerview on 5/6/24. (1) Includes India office expansion and incremental Q424 $5mm payment related to SchoolMessenger acquisition.
Selected Public Comparables Company Name Enterprise Value ($bn) Revenue EBITDA CY24E NTM Picasso (Mgmt.,
Unaffected) $4.3 11.9% 18.7% 35.1% 14.6x Picasso (Consensus, Unaffected) $4.3 11.9% 15.1% 34.2% 15.2x Veeva $25.1 13.4% 19.9% 40.0% 22.0x Tyler Technologies 21.6 9.3% 14.5% 26.6% 36.1x AspenTech 13.3 8.5% 5.3% 40.3% 26.8x Guidewire 10.5 11.5% 76.5%
13.9% 62.5x Appfolio 8.4 22.1% 63.1% 26.2% 36.6x CCC 8.3 9.1% 10.9% 41.4% 20.3x Instructure (Unaffected)(1) 4.2 7.1% 12.7% 41.2% 14.6x Q2 4.1 10.8% 38.9% 16.3% 32.1x NCINO 3.6 14.6% 38.5% 17.3% 33.7x Docebo 1.1 18.3% 68.1% 15.2% 28.1x Peer Median
11.2% 29.2% 26.4% 30.1x % DiscountPicasso Cons. EV / NTM EBITDA vs. Peer Median (50%) Source: Picasso management, public filings and FactSet as of June 5, 2024. Note: All figures in USD. Picasso balance sheet and share count figures as of
10-K filing on 3/1/24; share price and estimates as of 5/7/24. EBITDA figures unburdened by stock-based compensation expense. Debt figures reflect face value. Convertible notes treated as equity if current
stock price is above conversion price and as debt if below. TRA liabilities not included as debt-like item. Excludes operating leases. Peer NTM metrics reflect NTM as of 6/5/24, except for Instructure 8 which reflects NTM as of unaffected date
(5/17/24). (1) Instructure growth figures are pro forma for Parchment acquisition. All metrics as of unaffected date (5/17/24); current affected multiple is 15.7x.
Multiple Evolution Over Time EV / NTM EBITDA Two Years to Unaffected Date 60x Picasso Peer Median
Instructure L2Y L1Y YTD Picasso 20.6x 20.0x 19.1x Peer Median 29.2x 30.7x 31.0x 50x Mult. Discount (8.6x) (10.7x) (12.0x) % Discount (30%) (35%) (39%) Memo: Instructure 18.0x 17.0x 15.1x 40x Memo: % Prem. +15% +18% +26% Peer current multiple 30x
30.1x 29.8x Picasso unaffected 20x mult. (5/7/24) 18.5x 16.1x 15.2x 14.6x INST unaffected 10x mult. (5/17/24) 0.0x May-22 Oct-22
Mar-23 Aug-23 Jan-24 Jun-24 Source: FactSet as of June 5, 2024 Note: Peer median
includes Veeva, Tyler Technologies, AspenTech, Guidewire, Appfolio, CCC, Q2, Instructure, NCINO and Docebo. Unaffected date as of May 7, 9 2024. Excludes peer multiples that are negative or higher than 125x. Instructure multiple held constant
after 5/17/24 (unaffected date). Instructure multiple includes impact of Parchment acquisition from the first day that consensus includes Parchment in EBITDA estimates (2/21/24).
Selected Precedent Transactions Annc. TEV NTM EBITDA 2-Yr Fwd. Date
Acquirer Target ($bn) Sales EBITDA Margin Sales CAGR (1) (1) 1/25/24 Roper Technologies Procare $1.8 6.7x 18.4x 36.5% Mid-Teens 4/27/23 Deutsche Boerse SimCorp 4.3 6.4 26.4 24.1% 8.2% 8/30/22 Roper
Technologies Frontline 3.4 9.1(2) 19.3(2) 47.3% High Single Digits 4/7/22 Brookfield CDK Global 8.2 4.4 11.7 37.9% 5.9% 8/5/21 Clearlake Capital Group Cornerstone On Demand 5.3 5.9 15.9 37.2% 9.0% 2/10/21 Tyler Technologies NIC 2.1 4.7
18.5 25.2% 1.3% 2/4/21 Insight / Stone Point CoreLogic 7.7 4.6 12.7 36.4% 0.7% 12/21/20 Thoma Bravo RealPage 10.4 8.2 28.7 28.4% 10.9% (3) 8/13/20 Roper Technologies Vertafore 5.4 9.1 18.4 49.2% n.a. 2/14/20 Thoma Bravo Instructure 1.9 6.1 n.a. n.a.
17.4% Mean 6.5x 18.9x 35.8% 7.6% Median 6.3 18.4 36.5% 8.2% Source: Public filings and materials, FactSet. (1) TEV and financial metrics per acquiror investor materials. TEV includes $110mm of estimated tax benefits. NTM multiples based on figures
for 12 month period ending 3/31/25. Excluding tax benefits, EV / NTM Sales would be 7.2x and EV / NTM EBITDA multiple would be 19.6x. Forward growth guidance per management commentary on 4/26/24. (2) TEV and financial metrics per acquiror investor
materials. TEV includes $350mm of estimated tax benefits. NTM multiples based on 2023E figures. Excluding the 10 tax benefits, the EV / Sales multiple would be 10.1x and the EV / EBITDA multiple would be 21.3x. Growth outlook based on Wall Street
analyst commentary. (3) TEV and financial metrics per acquiror investor materials. NTM multiples based on figures for 2021E.
Picasso Discounted Cash Flow Analysis FY24(1) FY25 FY26 FY27 FY28 FY29
FY30 FY31 FY32 FY33 FY34 NTM Revenue $788 $874 $975 $1,093 $1,231 $1,392 $1,552 $1,707 $1,852 $1,977 $2,076 $2,180 % Growth 12.9% 10.9% 11.6% 12.1% 12.6% 13.1% 11.5% 10.0% 8.5% 6.7% 5.0% 5.0% Adj. EBITDA (Unburd. SBC)
$277 $327 $378 $439 $513 $595 $677 $760 $849 $925 $986 $1,036 % Margin 35.1% 37.4% 38.8% 40.1% 41.7% 42.8% 43.7% 44.5% 45.9% 46.8% 47.5% 47.5% (-): Stock-Based Compensation (87) (96) (107) (120) (135) (153) (171) (188) (204) (218) (228) (-): Cash
Taxes (excl. TRA) (28) (36) (46) (57) (72) (88) (104) (121) (141) (157) (170) +/(-): Change in NWC 22 35 39 44 54 61 68 74 81 86 90 (-): CapEx & Capitalized R&D (46) (49) (52) (56) (60) (68) (72) (76) (79) (80) (80) (-): Other(2) (10)
Unlevered Free Cash Flow $128 $181 $212 $250 $300 $347 $398 $449 $507 $557 $598 Discounted 15.0x 17.0x 19.0x 15.0x 17.0x 19.0x 15.0x 17.0x 19.0x Cash Flow Sensitivities 12.25% $6.7 $7.3
$8.0 12.25% $27.85 $30.80 $33.70 12.25% 7.8% 8.3% 8.7% (Excludes impact of TRA) 13.75% 6.0 6.5 7.1 13.75% $24.50 $27.00 $29.55 13.75% 9.3% 9.8% 10.2% 15.25% 5.3 5.8 6.3 15.25% $21.55 $23.75 $26.00 15.25% 10.7% 11.2% 11.6% Source: Picasso management.
Note: Figures in $mm unless otherwise noted, except for per share figures. Picasso balance sheet as of 9/30/24 per Picasso management estimate and share count as of 6/4/24. EBITDA figures unburdened by stock-based compensation expense. Assumes mid-year discounting. Excludes impact of TRA. Share prices rounded to nearest $0.05. (1) Assumes valuation date of 9/30/2024; discounted cash flows only include Q4 cash flows from 2024. Q424 UFCF of $26mm. 11
(2) Includes India office expansion and incremental Q424 $5mm payment related to SchoolMessenger acquisition. (3) Implied perpetuity growth rate calculated based on FY34E unlevered free cash flow.
Appendix
Picasso WACC Analysis Market Debt / Beta(1) Company Debt Cap. Equity Levered Unlevered Cost of Equity Q2 $495
$3,953 13% 2.07 1.89 20Y U.S. Treasury Yield 4.5% NCINO 54 3,641 1% 1.88 1.86 Unlevered Beta 1.35 Veeva 29,867 0% 1.48 1.48 Target Debt / Equity 1% Docebo 1,155 0% 1.44 1.44 Levered Beta 1.36 Tyler Technologies 600 21,165 3% 1.43 1.40
LT U.S. Historical Risk Premium(2) 7.2% Appfolio 8,650 0% 1.31 1.31 Size Premium(2) 1.0% Guidewire 11,450 0% 1.31 1.31 Cost of Equity 15.2% AspenTech 13,463 0% 0.70 0.70 Instructure (Unaffect.) (5) 1,173 3,072 18% 0.75 0.67 Cost
of Debt CCC 782 7,744 10% 0.70 0.65 Pre-Tax Cost of Debt(3) 7.4% Peer Median 1% 1.37 1.35 Tax Rate 25.0% Picasso (Unaffected) $838 $3,499 24% 1.14 0.97 After-Tax Cost of Debt 5.5% Memo: Debt / Capital 1%
WACC(4) 15.2% Debt / Unlevered Beta Sensitivity Equity 1.00 1.09 1.18 1.26 1.35 % 12.6% 13.3% 13.9% 14.5% 15.2% 10% 12.5% 13.1% 13.7% 14.3% 15.0% 20% 12.4% 13.0% 13.6% 14.2% 14.8% 30% 12.2% 12.8% 13.4% 14.0% 14.6% Source: Picasso management,
KPMG, public filings, Bloomberg and FactSet as of June 5, 2024. Note: Figures in $mm unless otherwise noted, except for per share figures. Picasso balance sheet and share count figures as of 10-K filing
on 3/1/24; Picasso beta as of unaffected date (5/7/2024). (1) Represents two-year unadjusted weekly average beta. Unlevered betas assume 25% tax rate for each company, except for Docebo which assumes 26.5%.
(2) Duff & Phelps, 2023. Size premium reflects companies with market capitalization between $3.0bn and $4.6bn. (3) Reflects BofA B corporate index effective yield. (4) WACC equals ((debt / capitalization * (cost of debt * (1
tax rate))) + (equity / capitalization * levered cost of equity)). (5) 13 Instructure debt to equity metric (and corresponding unlevered beta calculation) reflects average debt to equity over prior 8 quarters. INST beta as of INST unaffected
date (5/17/2024).
TRA Benefit Discounted Cash Flow Analysis Reflects tax benefits of asset
step-up during IPO captured through Picassos modified Up-C structure; Class A Shareholders retain 15% of TRA tax benefits (1) FY24 FY25 FY26
FY27 FY28 FY29 FY30 FY31 FY32 FY33-44 Total TRA Benefit $20 $22 $33 $42 $46 $33 $28 $20 $14 $99 x 15% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% 15.0% TRA Benefit to Shareholders $3 $3 $5 $6
$7 $5 $4 $3 $2 $15 Present Value (2) Value Per Share ($mm) 12.25% $28 $0.14 13.75% 26 $0.13 15.25% 25 $0.12 Source: Picasso Tax Asset Projection. Note: Dollars in millions. Illustrative valuation date of 9/30/2024. Assumes mid-year discounting. 14 (1) Assumes valuation date of 9/30/2024; TRA benefit calculation only includes Q4 cash flows from 2024. Assumes FY24 TRA benefit evenly prorated across the year. (2) Assumes value per
share based on Picasso basic shares outstanding as of 6/4/24.
1-Day Premiums ? Reflects announced or closed transactions involving U.S. targets since 2014 ? Includes only
transactions where implied equity between is between $1bn and $10bn ? Excludes transactions in Energy, Materials, Financials, Utilities and Real Estate industries 1-Day Premium(1) N = 405 48% 24% 13% 25th Percentile Median 75th Percentile
Source: S&P Capital IQ as of June 5, 2024. 15 Note: Screening criteria includes all cash announced and closed transactions involving U.S. targets, where the implied equity value is between $1bn and $10bn. Sample set excludes transactions in
the Energy, Materials, Financials, Utilities and Real Estate industries. Also excludes transactions where premium was negative.
Quarterly Cash Flow and Balance Sheet Trends $220 $277 $174 $187 Cash Flow $42 $43 $52 $20 from ($16) ($33)
($26) ($65) ($60) ($90) Operating Activities Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1A Q2 Q3 Q4 2021A 2022A 2023A 2024E $165 $125 $70 Revolver $30 $10 $10 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1A Q2 Q3 Q4 2021A 2022A 2023A 2024E $838 $838 $836 $834 $832 $830 $754
$752 $750 $748 $746 $744 $742 $740 Term Loan Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1A Q2 Q3 Q4 2021A 2022A 2023A 2024E $802 $799 $943 $988 $663 $665 $756 $678 $722 $708 $677 $637 $607 $525 Net Debt Î = ($165) Î = ($197)
Î = ($280) Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1A Q2 Q3 Q4 2021A 2022A 2023A 2024E 16 Source: Picasso filings, Picasso management.
Picasso Capitalization Summary Price Per Share (Offer) $22.80 Basic Shares Outstanding (mm) 203.7 Restricted
Stock Units 8.3 Issue / Participation Performance Stock Units Amount Payout Factor 0.5 Threshold Market-Share UnitsTranche 1 0.5 $19.48 1.17x 0.6 Market-Share UnitsTranche 2 0.4 $20.90 1.09x 0.4 Management Incentive Units 2.7 $12.11 n.m.
1.3 Fully Diluted Shares Outstanding 214.8 Equity Value ($mm) $4,897 17 Source: Picasso management. Note: Figures in $mm unless otherwise noted, except for per share figures. Share count as of 6/4/24.
Exhibit (c)(xii) [****] indicates information has been omitted on the
basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. Presentation to the Board of Directors
Project Picasso Goldman Sachs & Co. LLC th June 6 , 2024 Goldman Sachs does not provide accounting, tax, or legal advice. Notwithstanding anything in this document to the contrary, and except as required to enable compliance with applicable
securities law, you (and each of your employees, representatives, and other agents) may disclose to any and all persons the US federal income and state tax treatment and tax structure of the transaction and all materials of any kind (including tax
opinions and other tax analyses) that are provided to you relating to such tax treatment and tax structure, without Goldman Sachs imposing any limitation of any kind.
Disclaimer These materials have been prepared and are provided by
Goldman Sachs on a confidential basis solely for the information and assistance of the Board of Directors (the “Board ) and senior management of Picasso (the Company ) in connection with their consideration of the matters referred to herein.
These materials and Goldman Sachs’ presentation relating to these materials (the “Confidential Information”) may not be disclosed to any third party or circulated or referred to publicly or used for or relied upon for any other
purpose without the prior written consent of Goldman Sachs. The Confidential Information was not prepared with a view to public disclosure or to conform to any disclosure standards under any state, federal or international securities laws or other
laws, rules or regulations, and Goldman Sachs does not take any responsibility for the use of the Confidential Information by persons other than those set forth above. Notwithstanding anything in this Confidential Information to the contrary, the
Company may disclose to any person the US federal income and state income tax treatment and tax structure of any transaction described herein and all materials of any kind (including tax opinions and other tax analyses) that are provided to the
Company relating to such tax treatment and tax structure, without Goldman Sachs imposing any limitation of any kind. The Confidential Information has been prepared by the Investment Banking Division of Goldman Sachs and is not a product of its
research department. Goldman Sachs and its affiliates are engaged in advisory, underwriting and financing, principal investing, sales and trading, research, investment management and other financial and non-financial activities and services for
various persons and entities. Goldman Sachs and its affiliates and employees, and funds or other entities they manage or in which they invest or have other economic interests or with which they co-invest, may at any time purchase, sell, hold or vote
long or short positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of the Company, any other party to any transaction and any of their respective affiliates or any
currency or commodity that may be involved in any transaction. Goldman Sachs’ investment banking division maintains regular, ordinary course client service dialogues with clients and potential clients to review events, opportunities, and
conditions in particular sectors and industries and, in that connection, Goldman Sachs may make reference to the Company, but Goldman Sachs will not disclose any confidential information received from the Company. The Confidential Information has
been prepared based on historical financial information, forecasts and other information obtained by Goldman Sachs from publicly available sources, the management of the Company or other sources (approved for our use by the Company in the case of
information from management and non-public information). In preparing the Confidential Information, Goldman Sachs has relied upon and assumed, without assuming any responsibility for independent verification, the accuracy and completeness of all of
the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by us, and Goldman Sachs does not assume any liability for any such information. Goldman Sachs does not provide accounting, tax, legal or
regulatory advice. Goldman Sachs has not made an independent evaluation or appraisal of the assets and liabilities (including any contingent, derivative or other off-balance sheet assets and liabilities) of the Company or any other party to any
transaction or any of their respective affiliates and has no obligation to evaluate the solvency of the Company or any other party to any transaction under any state or federal laws relating to bankruptcy, insolvency or similar matters. The analyses
contained in the Confidential Information do not purport to be appraisals nor do they necessarily reflect the prices at which businesses or securities actually may be sold or purchased. Goldman Sachs’ role in any due diligence review is
limited solely to performing such a review as it shall deem necessary to support its own advice and analysis and shall not be on behalf of the Company. Analyses based upon forecasts of future results are not necessarily indicative of actual future
results, which may be significantly more or less favorable than suggested by these analyses, and Goldman Sachs does not assume responsibility if future results are materially different from those forecast. The Confidential Information does not
address the underlying business decision of the Company to engage in any transaction, or the relative merits of any transaction or strategic alternative referred to herein as compared to any other transaction or alternative that may be available to
the Company. The Confidential Information is necessarily based on economic, monetary, market and other conditions as in effect on, and the information made available to Goldman Sachs as of, the date of such Confidential Information and Goldman Sachs
assumes no responsibility for updating or revising the Confidential Information based on circumstances, developments or events occurring after such date. The Confidential Information does not constitute any opinion, nor does the Confidential
Information constitute a recommendation to the Board, any security holder of the Company or any other person as to how to vote or act with respect to any transaction or any other matter. The Confidential Information, including this disclaimer, is
subject to, and governed by, any written agreement between the Company, the Board and/or any committee thereof, on the one hand, and Goldman Sachs, on the other hand. The Confidential Information does not address, nor does Goldman Sachs express any
view as to, the potential effects of volatility in the credit, financial and stock markets on the Company, any other party to any transaction or any transaction. 2
Table of Contents I. Process and Transaction Overview II. Public Market
Valuation Perspectives III. Overview of Management Plan IV. Financial Analysis Appendix A: Supplementary Materials 3
I. Process and Transaction Overview
Summary of Party Engagement Sponsors Outbound (9) Sponsor Inbound
Strategics (5) (1) [****] [****] [****] [****] Initial [****] [****] [****] Engagement (15) [****] [****] [****] [****] [****] [****] [****] [****] [****] [****] Executed NDA, Management Presentations and/or Deep Dive [****] [****] [****] [****]
[****] Meetings (9) [****] Non-Binding Proposals “Best and Final” written offer Verbal offer Received $22.80 $20-21 Process and Transaction Overview 5
Picasso Illustrative Analysis at Various Prices ($ in millions, except
per share data) 1 Undisturbed Deal Price Share Price $ 16.64 $ 22.80 Fully Diluted Shares Outstanding 213.99 214.78 Implied Equity Value $ 3,561 $ 4,897 (+) Net Debt as of 31-Mar-2024 943 943 2 (+) TRA 419 0 Illustrative Enterprise Value $ 4,922 $
5,840 3 Undisturbed % Premium to Share Price Undisturbed Share Price (07-May-2024) $ 16.64 37 % 1 Month VWAP 18.15 26 3 Month VWAP 20.01 14 6 Month VWAP 21.27 7 52 Week High 25.16 (9) 52 Week Low 16.15 41 Metric EV / EBITDA (Management ) CY2024E $
277 17.8 x 21.1 x CY2025E $ 327 15.1 x 17.9 x Metric EV / uFCF (Management ) 4 CY2024E $ 248 19.8 x 23.5 x CY2025E $ 313 15.7 x 18.7 x Metric EV / EBITDA (Street) CY2024E $ 271 18.2 x 21.6 x CY2025E $ 307 16.0 x 19.0 x Metric EV / uFCF (Street)
CY2024E $ 230 21.4 x 25.4 x CY2025E $ 280 17.6 x 20.9 x Source: Financial forecasts for Picasso prepared by the Picasso Management and approved by Picasso for Goldman Sachs’ use (“Picasso Management Plan”). Note: Fully diluted
shares outstanding represents deal price of $22.80 according to the 04-Jun-2024 equity capitalization, calculated using treasury stock method consisting of common shares of 203,742,206, performance MIUs of 2,704,549 with a weighted average
participation threshold of $12.11, restricted share units (“RSU”) of 8,207,817, market share units (“MSU”) of 555,775 issued on 25- Mar-2023 with a strike price of $19.48, MSUs of 404,784 issued on 01-Apr-2024 with a strike
price of $20.90, performance share units (“PSU”) of 537,799 issued on 01-Apr-2024, net debt of $1,362M as of 31-Mar-2024, comprised of gross debt of $961M, tax receivable agreement (“TRA”) of $419M, and cash and cash
equivalents of $17M, all, as provided by Picasso Management or obtained from 1 2 Picasso most recent public filings, and approved by Picasso for Goldman Sachs’ use collectively defined as “Picasso Capitalization”. Reflects closing
price as of 07-May-2024. Book Value as of most 3 4 recent public filings. 52-week high / low and VWAPs shown as of 07-May-2024 to reflect the date of the undisturbed price. 2024 uFCF excludes $42M cash paid for acquisitions. Process and Transaction
Overview 6
II. Public Market Valuation Perspectives
Picasso Stock Price Performance Since Picasso IPO $30.0 52-Week High $
25.16 $ 22.24 Current $ 21.27 6-Month VWAP $20.0 $ 20.01 3-Month VWAP 23.6% $ 18.15 1-Month VWAP Undisturbed Price $ 16.64 07-May-2024 52-Week Low $ 16.15 08-May-2024 WSJ reports Bain Capital interest in Picasso Share price rises from $16.64 to
$19.15 – 15% $10.0 Jul-21 Jan-22 Jul-22 Jan-23 Jun-23 Dec-23 Jun-24 Source: FactSet; market data as of 05-Jun-2024 Note: Reflects trading performance from 28-Jul-2021 to 05-Jun-2024. 52-week high / low and VWAPs shown as of 07-May-2024 to
reflect the date of the undisturbed price. Public Market Valuation Perspectives 8 Share Price (USD)
Picasso Indexed Stock Price Performance Since Picasso IPO 225 % Since
IPO Performance (%) 1Y 6M YTD 3M 1M Picasso 24 % 18 % (4)% (6)% 10 % 34 % 200 % Instructure 18 (8) (16) (17) 5 14 Tyler (2) 21 18 16 16 3 Performance since IPO up to 1 Vertical Software 13 26 8 5 2 (0) undisturbed date (07-May-2024) 175 % (8) % 150
% 125 % 24 % 18 % 13 % 100 % (2)% 75 % 50 % 25 % 0 % Jul-2021 Nov-2021 Feb-2022 Jun-2022 Sep-2022 Jan-2023 Apr-2023 Aug-2023 Nov-2023 Feb-2024 Jun-2024 Source: FactSet, market data as 05-Jun-2024 Note: Since Picasso IPO as 28-Jul-2021. Picasso share
price performance indexed to $18.00 per share. 1 Includes Appfolio, Autodesk, Aspen Tech, Descartes, Guidewire, Jamf, nCino, Procore, SPS Commerce, and Veeva. Public Market Valuation Perspectives 9 Indexed Share Price Performance
Valuation Multiples Over Times Since Picasso IPO NTM EV / EBITDA
Multiples Since Picasso IPO NTM EV / UFCF Multiples Since Picasso IPO 70 x 70 x 60 x 60 x 50 x 50 x 49.1 x 40 x 40 x 39.7 x 36.2 x 30 x 30 x 30.9 x 24.6 x 21.5 x 20 x 20 x 18.3 x 15.2 x 10 x 10 x Undisturbed NTM EV / EBITDA Undisturbed NTM EV / UFCF
Multiple: 17.4 x Multiple: 19.9 x 0 x 0 x Jul-2021 Jan-2022 Jul-2022 Jan-2023 Jun-2023 Dec-2023 Jun-2024 Jul-2021 Jan-2022 Jul-2022 Jan-2023 Jun-2023 Dec-2023 Jun-2024 1 Instructure Vertical Software Picasso Tyler Source: FactSet median consensus
estimates; market data as of 05-Jun-2024 Note: Reflects trading performance from 28-Jul-2021 to 04-Jun-2024. Maximum threshold for trading multiples set to 70.0x. 1 Includes Appfolio, Autodesk, Aspen Tech, Descartes, Guidewire, Jamf, nCino, Procore,
SPS Commerce, and Veeva. Public Market Valuation Perspectives 10
Current Wall Street Perspectives Street Projections | Target Price
& Analyst Sentiment | $ in Millions Evolution of Analyst Sentiment Evolution of Picasso Revenue Estimates $ 1,100 $ 1,000 $ 981 7 % 7 % 7 % 7 % 7 % 7 % 8 % 8 % 8 % 8 % $ 900 14 % 14 % 14 % $ 874 $ 800 $ 789 $ 700 $ 600 93 % 93 % 93 % 93 % 93 %
93 % 92 % 92 % 92 % 92 % Jun-2023 Dec-2023 Jun-2024 86 % 86 % 86 % FY2024E FY2025E FY2026E Evolution of Picasso EBITDA Estimates $ 400 Jun-2023 Jul-2023 Aug-2023 Sep-2023 Oct-2023 Nov-2023 Dec-2023 Jan-2024 Feb-2024 Mar-2024 Apr-2024 May-2024
Jun-2024 Buy Hold $ 355 $ 350 Broker Valuation Methodologies $ 307 $ 300 $ 271 12-Month PV of Price $ 250 1 Broker Date Price Target Target Valuation Methodology $ 200 Piper Sandler 10-May-24 $24.00 $21.00 6.5x 2025E Revenue Jun-2023 Dec-2023
Jun-2024 Jefferies 8-May-24 $30.00 $26.50 DCF FY2024E FY2025E FY2026E IBES Median Target Price Macquarie 8-May-24 $27.00 $23.50 DCF Barclays 8-May-24 $23.00 $20.00 18.0x 2025E EBITDA $40 BofA 8-May-24 $31.00 $27.00 $30 23.5x 2025E EBITDA $ 26.00 $20
$ 22.24 UBS 8-May-24 $20.00 $17.50 21.6x 2025E FCF $10 Needham 13-May-24 $26.00 $23.00 7.5x 2024E Revenue $0 Jun-2023 Dec-2023 Jun-2024 RBC 8-May-24 $22.00 $19.50 7.0x 2024E Revenue Share Price Target Price 2 $25.00 $22.00 Median Source: FactSet;
market data as of 05-Jun-2024 Note: Anonymous brokers are excluded from the Current Broker Recommendation table but included in median. 1 2 12-month price target discounted back at 11.4% Ke as of 07-May-2024 and rounded to the nearest $0.50.
Represents median of the select brokers listed in the table and not necessarily reconcile to the IBES median target price. Public Market Valuation Perspectives 11 Yearly Revenue Share Price (USD) Yearly EBITDA Estimate (USD) Estimate
(USD)
III. Overview of Management Plan
Picasso Historical and Projected Financial Profile ($ in millions)
Historical Picasso Management Plan CAGR 2021A 2022A 2023A 2024E 2025E 2026E 2027E 2028E 2029E 21-23A 24-29E Revenue $ 559 $ 631 $ 698 $ 788 $ 874 $ 975 $ 1,093 $ 1,231 $ 1,392 12 % 12 % YoY Growth 13 % 11 % 13 % 11 % 12 % 12 % 13 % 13 % Adjusted
EBITDA $ 161 $ 196 $ 232 $ 277 $ 327 $ 378 $ 439 $ 513 $ 595 20 % 17 % YoY Growth 22 % 18 % 19 % 18 % 16 % 16 % 17 % 16 % % Margin 29 % 31 % 33 % 35 % 37 % 39 % 40 % 42 % 43 % Unlevered Free Cash Flow $ 170 $ 146 $ 204 $ 206 $ 313 $ 365 $ 428 $ 475
$ 540 9 % 21 % YoY Growth (14)% 39 % 1 % 52 % 16 % 17 % 11 % 14 % % uFCF Conversion 106 % 74 % 88 % 75 % 96 % 96 % 97 % 93 % 91 % Source: Picasso Management Plan Overview of Management Plan 13
Picasso Management vs Street Financial Profile ($ in millions)
Unlevered Cash Flow Revenue Adjusted EBITDA Management expects 4% $ 378 higher margin in ‘25E $ 363 $ 981 versus street estimates $ 355 $ 355 $ 327 $ 975 $ 313 $ 874 $ 307 $ 277 $ 874 $ 280 $ 248 $ 789 $ 271 $ 788 Management expects margin
expansion $ 230 300bps greater than the street by 2026 Excludes acquisition cash outflows of $42mm in ‘24E 2024E 2025E 2026E 2024E 2025E 2026E 2024E 2025E 2026E % YoY Growth % Margin % Margin 1 Street 13 % 11 % 12 % Street 34 % 35 % 36 %
Street 29 % 32 % 36 % Mgmt. 13 % 11 % 12 % Mgmt. 35 % 37 % 39 % Mgmt. 31 % 36 % 37 % 1 Source: Picasso Management Plan, Company filings, FactSet median consensus estimates; market data as of 05-Jun-2024. Picasso (Street) uFCF calculated as (CFO
– CapEx – Cap. Software Development Costs + Interest Expense * (1- Tax Rate)). Assumes 1.2% illustrative pre-TRA payout tax rate, per Picasso Management. Overview of Management Plan 14
Financial Profile Benchmarking CY 2024E – 2026E Revenue CAGR
Median: 12 % 20 % 19 % 17 % 15 % 14 % 13 % 12 % 11 % 11 % 11 % 11 % 9 % 9 % 9 % Picasso Picasso Street Management CY 2024E EBITDA Margin ’24-’26 CAGR Median: 28 % 44 % 41 % 40 % 40 % 35 % 37 % 34 % 30 % 27 % 26 % 17 % 15 % 16 % 14 % 17 %
14 % 12 % 11 % 13 % 15 % 10 % 18 % 14 % 23 % 35 % 35 % 37 % 20 % Picasso Picasso Management Street 1 CY2024E uFCF Margin ’25 2 Growth 42 % Median: 23 % 35 % 34 % 31 % 31 % 29 % 24 % 21 % 24 % 20 % 15 % 14 % 12 % 13 % 26 % 22 % 15 % 21 % 15 %
13 % 40 % 20 % 25 % 15 % 37 % 48 % 105 % 38 % Picasso Picasso 3 Management Street 1 Source: Picasso Management Plan, Company filings, FactSet median consensus estimates; market data as of 05-Jun-2024. uFCF margin is calculated as (CFO – CapEx
– Cap. Software Development Costs + Interest Expense * (1- Tax Rate)) / Revenue. Assumes 1.2% illustrative pre-TRA payout tax rate for Picasso, per Picasso Management. 2024 Cap. Software Development Costs calculated as 2023 % of revenue
multiplied by 2024 revenue if 2 3 consensus estimates were unavailable. Reflects 2025 uFCF growth %. 2025 growth % used instead of 2024-2026 CAGR given 2026 consensus estimates unavailable. 2024E uFCF normalized to exclude the $42mm of acquisition
cash outflows. Overview of Management Plan 15
IV. Financial Analysis
Picasso Financial Analysis Summary Methodology Implied Equity Value Per
Share Commentary n 9.0% - 10.5% Discount Rate Discounted Cash n 2.0% - 4.0% Perpetuity Growth Rate $ 18.00 $ 31.50 Flow n 10.75 Year DCF n Picasso Management: $327 - $439mm (2025E – 2027E EBITDA) Present Value of Future
Share n High: 20.0x EV / NTM EBITDA $ 17.75 $ 27.10 Price n Low: 16.0x EV / NTM EBITDA 1 (EBITDA) n Cost of Equity : 11.4% n Picasso Management: $313 - $428mm (2025E – 2027E UFCF) Present Value of Future Share n High:
23.5x EV / NTM UFCF $ 21.55 $ 31.30 Price n Low: 19.5x EV / NTM UFCF 1 (uFCF) n Cost of Equity : 11.4% n Picasso undisturbed share price of $16.64 (as of 07-May-2024) th $ 20.70 $ 25.40 n High: 75 Percentile of 52.7% Precedent
Premia th n Low: 25 Percentile of 24.5% n Picasso 52 Week Intra High Share Price of $25.16 (as of 06-Feb-2024) Precedent Premia to 52 Week th $ 19.10 $ 27.95 n High: 75 Percentile of 11.1% th High n Low: 25 Percentile of (24.1)%
n Picasso Management: NTM EBITDA of $289mm th $ 13.00 $ 20.00 n High: 75 Percentile 19.5x EV/NTM EBITDA Precedent Transactions th n Low: 25 Percentile 14.3x EV/NTM EBITDA n 52 Week Intra High: $25.16 (06-Feb-2024) $ 16.15 $ 25.16
Historical Trading n 52 Week Intra Low: $16.15 (07-May-2024) n High PV of Price Target: $27.00 – BofA: 08-May-2024 $ 17.50 $ 27.00 Analyst Target Price n Low PV of Price Target: $17.50 – UBS: 08-May-2024 Median: $22.00 1
Undisturbed Price : $ 16.64 Deal Price: $22.80 Source: Picasso Management Plan; Picasso Capitalization as of 04-Jun-2024; Company filings; Market data as of 05-Jun-2024 1 Note: Implied Equity Value per Share includes the impact of TRA at ~$419M Book
Value as of most recent public filings. As of 07-May-2024. Financial Analysis 17 For Reference
Picasso Illustrative Analysis at Various Prices ($ in millions, except
per share data) 1 Undisturbed Deal Price Share Price $ 16.64 $ 22.80 Fully Diluted Shares Outstanding 213.99 214.78 Implied Equity Value $ 3,561 $ 4,897 (+) Net Debt as of 31-Mar-2024 943 943 2 (+) TRA 419 0 Illustrative Enterprise Value $ 4,922 $
5,840 3 Undisturbed % Premium to Share Price Undisturbed Share Price (07-May-2024) $ 16.64 37 % 1 Month VWAP 18.15 26 3 Month VWAP 20.01 14 6 Month VWAP 21.27 7 52 Week High 25.16 (9) 52 Week Low 16.15 41 Metric EV / EBITDA (Management ) CY2024E $
277 17.8 x 21.1 x CY2025E $ 327 15.1 x 17.9 x Metric EV / uFCF (Management ) 4 CY2024E $ 248 19.8 x 23.5 x CY2025E $ 313 15.7 x 18.7 x Metric EV / EBITDA (Street) CY2024E $ 271 18.2 x 21.6 x CY2025E $ 307 16.0 x 19.0 x Metric EV / uFCF (Street)
CY2024E $ 230 21.4 x 25.4 x CY2025E $ 280 17.6 x 20.9 x Source: Picasso Management Plan; Picasso Capitalization. 1 2 3 4 Note: Reflects closing price as of 07-May-2024. Book Value as of most recent public filings. 52-week high / low and VWAPs shown
as of 07-May-2024 to reflect the date of the undisturbed price. 2024 uFCF excludes $42M cash paid for acquisitions. Financial Analysis 18
Illustrative Picasso Discounted Cash Flow Analysis 10.75 Year DCF
Discounted to 31-Mar-2024 Implied Equity Value per Share Implied Terminal Value / Terminal Year uFCF Multiple Perpetuity Growth Rate Perpetuity Growth Rate 18.0 x 2.0 % 3.0 % 4.0 % 8.8 x 2.0 % 3.0 % 4.0 % 9.00 % $ 23.90 $ 27.10 $ 31.50 9.00 % 10.7 x
12.7 x 15.3 x 9.75 % 20.65 23.05 26.25 9.75 % 9.7 11.2 13.3 10.50 % 18.00 19.85 22.25 10.50 % 8.8 10.1 11.8 Implied Growth Adjusted Terminal Value / Terminal Year uFCF Multiple Perpetuity Growth Rate 1.3 x 2.0 % 3.0 % 4.0 % 9.00 % 1.55 x 1.83 x 2.22
x 9.75 % 1.40 x 1.63 x 1.93 x 10.50 % 1.28 x 1.46 x 1.71 x Source: Picasso Capitalization as of 04-Jun-2024 and Picasso Management Plan Note: Future cash flow discounted to 31-Mar-2024 using mid-year convention for cash flows. Terminal value
calculated using terminal year projected financials. Implied share price calculated by subtracting net debt and book value of TRA (per most recent public filings) from the enterprise value, and dividing by fully diluted shares outstanding, per
Picasso Capitalization. Financial Analysis 19 WACC WACC WACC
Illustrative Picasso Present Value of Future Share Price – EBITDA
Multiple Method (All Other Figures in US$ millions) 1,2 1,2 Illustrative Future Share Price Illustrative PV of Future Share Price $ 36.50 $ 30.50 $ 32.55 $ 27.10 $ 25.35 $ 25.25 $ 28.65 $ 23.35 $ 24.20 $ 27.05 $ 22.40 $ 20.55 $ 23.65 $ 22.30 $ 16.64
$ 21.30 $ 16.64 $ 19.55 $ 17.75 $ 19.25 Undisturbed 31-Dec-24B 31-Dec-25E 31-Dec-26E Undisturbed 31-Dec-24B 31-Dec-25E 31-Dec-26E Share Price: Share Price: 07-May-2024 07-May-2024 NTM EBITDA Multiple @ 16.0x NTM EBITDA Multiple @ 18.0x NTM EBITDA
Multiple @ 20.0x 1 Illustrative Future Share Price Metrics 2024YE 2025YE 2026YE NTM EBITDA $ 327 $ 378 $ 439 Debt 830 821 813 160 425 749 Cash 3 Fully Diluted Shares Outstanding (M) 215 220 225 Source: Picasso Management Plan, Picasso
Capitalization, FactSet, market data as of 05-Jun-2024 1 2 Note: Share prices rounded to nearest 5 cents for illustrative purposes and include impact of TRA with book value as of most recent public filings. Present value of future share prices
calculated by discounting 3 future shares prices to 31-Mar-2024 at an illustrative cost of equity of 11.4%. Future share count reflects diluted count (including RSUs, Performance MIUs, MSUs, and PSUs) and forecast share-based compensation issued at
future share prices, per Picasso management. Debt and cash balance reflects Picasso Management Plan. Financial Analysis 20
Illustrative Picasso Present Value of Future Share Price –
Unlevered Free Cash Flow Multiple Method (All Other Figures in US$ millions) 1,2 1,2 Illustrative Future Share Price Illustrative PV of Future Share Price $ 42.15 $ 38.35 $ 35.10 $ 34.50 $ 31.30 $ 31.80 $ 29.05 $ 26.90 $ 29.20 $ 28.45 $ 28.45 $
26.25 $ 26.30 $ 24.20 $ 23.35 $ 25.65 $ 16.64 $ 23.55 $ 16.64 $ 21.55 Undisturbed 31-Dec-24B 31-Dec-25E 31-Dec-26E Undisturbed 31-Dec-24B 31-Dec-25E 31-Dec-26E Share Price: Share Price: 07-May-2024 07-May-2024 1 Illustrative Future Share Price
Metrics 2024YE 2025YE 2026YE NTM Unlevered Free Cash Flow $ 313 $ 365 $ 428 Debt 830 821 813 160 425 749 Cash 3 Fully Diluted Shares Outstanding (M) 215 220 225 Source: Picasso Management Plan, Picasso Capitalization, FactSet, market data as of
05-Jun-2024 1 2 Note: Share prices rounded to nearest 5 cents for illustrative purposes and include impact of TRA with book value as of most recent public filings. Present value of future share prices calculated by discounting 3 future shares prices
to 31-Mar-2024 at an illustrative cost of equity of 11.4%. Future share count reflects diluted count (including RSUs, Performance MIUs, MSUs, and PSUs) and forecast share-based compensation issued at future share prices, per Picasso management. Debt
and cash balance reflects Picasso Management Plan. Financial Analysis 21
Select Precedent Transactions EBITDA Multiples | Software Transactions
>$1 Billion with <15% Revenue Growth Since 2019 1 EV / NTM EBITDA 29.3 x 28.7 x 27.6 x 75th Percentile: 19.5 x Median: 16.6 x 25th Percentile: 14.3 x 19.7 x 19.3 x 18.4 x 17.5 x 16.6 x 15.7 x 14.2 x 14.5 x 14.4 x 14.1 x 14.0 x 12.6 x Dec-2020
Dec-2023 Jul-2023 Jun-2021 Aug-2022 Jan-2024 Feb-2024 Mar-2023 Nov-2021 Apr-2023 Dec-2021 May-2022 Jan-2022 Aug-2023 Aug-2023 Announcement Avid Target RealPage Alteryx New Relic Cloudera Frontline Procare Everbridge Momentive McAfee Software AG
Cerner VMware Citrix SUSE Technology Francisco Symphony Symphony Thoma Investor Clearlake Partners & CD&R & KKR Roper Roper Thoma Bravo Technology Silver Lake Oracle Broadcom Vista & Elliott EQT Technology Acquiror Bravo Group TPG
Group Group Transaction $ 10.3 $ 4.4 $ 6.1 $ 4.9 $ 3.7 $ 1.9 $ 1.8 $ 1.5 $ 14.1 $ 2.6 $ 29.4 $ 69.2 $ 16.4 $ 3.5 $ 1.4 Value ($bn)² % Cash 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 100 % 49 % 100 % 100 % 100 % Consideration
Premium to 31 % 59 % 17 % 24 % - - 47 % 46 % 23 % 63 % 20 % 44 % 24 % 67 % 32 % Undisturbed Acquiror EV / - - - - - - - - - - - 12.4 x - - - NTM EBITDA Multiple Target NTM 13 % 11 % 11 % 7 % 0 % 0 % 3 % 3 % 10 % 7 % 6 % 7 % 3 % 5 % 12 % Revenue
Growth Target NTM Operating 25 % 12 % 16 % 16 % - - 18 % 15 % 42 % 16 % 22 % 27 % 26 % - 21 % Margin Source: Public Filings, FactSet ¹ Transaction multiple reflects metrics at announcement. NTM EBITDA reflects median consensus estimates for the
next twelve-month period as of transaction announcement date. ² Transaction value includes convertible note breakage costs assuming takeout date per anticipated transaction close referenced in announcement press release. Convertible note
breakage costs exclude any impact from capped call unwind. Financial Analysis 22
Precedent M&A Transaction Premia 2019 – 2024 YTD | All Cash
TMT Deals Median Premia to Undisturbed Price Median Premia to 52-Week High th th 75 percentile: 53% 75 percentile: 11% th th 25 percentile: 25% 25 percentile: (24)% Median: (2)% Median: 34 % 10 % 44 % 5 % 32 % 32 % 33 % 31 % 2 % 26 % (2)% (6)% 2019
2020 2021 2022 2023 2024 YTD 2020 2021 2022 2023 2024 YTD Source: FactSet as of 05-Jun-2024 Note: Includes all-cash U.S. TMT M&A transactions since 01-Jan-2019 with an enterprise value greater than $200mm. N = 173. Financial Analysis
23
Appendix A: Supplementary Materials
Common Stock Comparison ($ in millions, except per share data) EV /
Revenue EV / EBITDA EV / uFCF Revenue Growth EBITDA Margin uFCF Margin % of 52-Week Fully Diluted Enterprise Closing Price Company Name High Equity Value Value CY2024 CY2025 CY2024 CY2025 CY2024 CY2025 LFQ '23 - '25 CY2024 CY2025 CY2024 CY2025
Picasso (Management) $ 22.24 89 % $ 4.8 $ 6.1 7.8 x 7.0 x 22.2 x 18.8 x 24.7 x 19.6 x 16 % 11 % 35 % 37 % 31 % 36 % Picasso (Street) $ 22.24 89 % $ 4.8 $ 6.1 7.8 x 7.0 x 22.7 x 20.0 x 26.7 x 21.9 x 16 % 11 % 34 % 35 % 29 % 32 % Vertical Software
Peers Appfolio $ 231.43 93 % $ 8.6 $ 8.4 10.9 x 9.1 x 41.4 x 31.6 x 46.2 x 38.5 x 38 % 20 % 26 % 29 % 24 % 24 % AspenTech 210.54 95 13.5 13.3 11.4 10.5 28.4 25.1 36.8 32.5 21 9 40 42 31 32 Autodesk 216.28 81 47.9 47.9 8.0 7.2 21.4 19.1 33.4 23.9 12
11 37 38 24 30 Descartes 92.57 93 8.1 7.9 12.5 11.2 28.1 24.9 36.0 29.7 12 11 44 45 35 38 Guidewire 127.46 100 10.6 10.3 10.0 8.8 71.8 49.6 67.6 49.4 16 12 14 18 15 18 Instructure 22.46 79 3.3 4.3 6.6 6.0 15.9 14.3 19.4 16.9 21 9 41 42 34 35 JAMF
15.55 70 2.2 2.4 3.8 3.4 23.8 15.8 29.9 14.6 15 14 16 21 13 23 Ncino 29.62 79 3.7 3.6 6.8 5.9 39.2 29.5 48.8 33.0 13 17 17 20 14 18 Procore 66.28 80 10.5 9.8 8.5 7.1 56.2 40.7 68.7 49.9 26 19 15 18 12 14 SPS Commerce 190.26 90 7.2 6.9 11.1 9.7 37.3
31.5 51.8 41.4 19 15 30 31 21 23 Tyler Technologies 483.83 97 21.2 21.6 10.1 9.2 38.1 33.7 52.0 45.1 9 9 27 27 20 20 Veeva 181.69 77 29.9 25.1 9.4 8.3 23.4 20.4 22.4 19.5 24 13 40 41 42 43 Peer Mean 9.1 x 8.0 x 35.4 x 28.0 x 42.7 x 32.9 x 19 % 13 %
29 % 31 % 24 % 27 % Peer Median 9.7 x 8.6 x 32.8 x 27.3 x 41.5 x 32.8 x 17 % 12 % 28 % 30 % 23 % 23 % Source: Picasso Management Plan, Company filings, FactSet median consensus estimates; market data as of 05-Jun-2024. Note: Maximum threshold for
trading multiples set to 55.0x. Supplementary Materials 25
Projected Unlevered Free Cash Flow 10.75 Year DCF at 31-Mar-2024 | (US$
in millions) Terminal Q2-Q4'24B 2025E 2026E 2027E 2028E 2029E 2030E 2031E 2032E 2033E 2034E Year Total Revenue $ 604 $ 874 $ 975 $ 1,093 $ 1,231 $ 1,392 $ 1,552 $ 1,707 $ 1,852 $ 1,977 $ 2,076 $ 2,076 % YoY Growth 11 % 12 % 12 % 13 % 13 % 12 % 10 %
9 % 7 % 5 % Adj. EBITDA (Unburdened by SBC) $ 218 $ 327 $ 378 $ 439 $ 513 $ 595 $ 677 $ 760 $ 849 $ 925 $ 986 $ 986 % Margin 36 % 37 % 39 % 40 % 42 % 43 % 44 % 45 % 46 % 47 % 48 % 48 % % YoY Growth 18 % 16 % 16 % 17 % 16 % 14 % 12 % 12 % 9 % 92 %
(65) (96) (107) (120) (135) (153) (171) (188) (204) (218) (228) (228) (-) Stock Based Compensation 11 % 11 % 11 % 11 % 11 % 11 % 11 % 11 % 11 % 11 % 11 % 11 % % of Revenue Adjusted EBITDA (Burdened by SBC) $ 153 $ 231 $ 271 $ 319 $ 378 $ 442 $ 507 $
572 $ 646 $ 708 $ 758 $ 758 25 % 26 % 28 % 29 % 31 % 32 % 33 % 34 % 35 % 36 % 37 % 37 % % Margin (109) (156) (154) (155) (155) (165) (155) (152) (150) (147) (144) (144) (-) Depreciation and Amortization 18 % 18 % 16 % 14 % 13 % 12 % 10 % 9 % 8 % 7 %
7 % 7 % % of Revenue Adjusted EBIT (Burdened by SBC) $ 44 $ 75 $ 117 $ 164 $ 223 $ 277 $ 352 $ 420 $ 496 $ 561 $ 614 $ 614 7 % 9 % 12 % 15 % 18 % 20 % 23 % 25 % 27 % 28 % 30 % 30 % % Margin Adjusted EBIT (Burdened by SBC) $ 44 $ 75 $ 117 $ 164 $ 223
$ 277 $ 352 $ 420 $ 496 $ 561 $ 614 $ 614 1 0 0 0 0 (32) (48) (64) (81) (101) (117) (130) (153) (-) Cash Taxes % of Adjusted EBIT (Burdened by SBC) 0 % 0 % 0 % 0 % 14 % 17 % 18 % 19 % 20 % 21 % 21 % 25 % (+) Depreciation and Amortization 109 156 154
155 155 165 155 152 150 147 144 144 18 % 18 % 16 % 14 % 13 % 12 % 10 % 9 % 8 % 7 % 7 % 7 % % of Revenue (-/+) Inc / Dec in Deferred Revenue 130 53 59 68 81 93 103 114 123 132 138 138 0 % 61 % 58 % 58 % 59 % 58 % 65 % 73 % 85 % 105 % 140 % 140 % % of
Revenue (-/+) (Inc) / Dec in Net Working Capital (2) (17) (20) (24) (28) (32) (36) (39) (43) (46) (48) (48) (0)% (2)% (2)% (2)% (2)% (2)% (2)% (2)% (2)% (2)% (2)% (2)% % of Revenue (-) Purchase of PP&E (3) (5) (6) (7) (7) (8) (9) (10) (11) (12)
(12) (12) (1)% (1)% (1)% (1)% (1)% (1)% (1)% (1)% (1)% (1)% (1)% (1)% % of Revenue (-) India Office Expansion 0 0 0 0 0 0 0 0 0 0 0 0 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % % of Revenue (-) Capitalized Product Dev. Costs (31) (44) (46) (49)
(52) (59) (63) (66) (68) (68) (67) (43) (5)% (5)% (5)% (5)% (4)% (4)% (4)% (4)% (4)% (3)% (3)% (2)% % of Revenue (-) Cash Paid for Acquisitions (32) 0 0 0 0 0 0 0 0 0 0 0 Unlevered Free Cash Flow $ 216 $ 217 $ 258 $ 307 $ 340 $ 387 $ 438 $ 489 $ 547
$ 597 $ 638 $ 640 % Margin 36 % 25 % 26 % 28 % 28 % 28 % 28 % 29 % 30 % 30 % 31 % 31 % % YoY Growth 81 % 19 % 19 % 10 % 14 % 13 % 12 % 12 % 9 % 7 % Source: Picasso Management Plan Note: Based on valuation date of 31-Mar-2024, projection period of
10.75 years, to year-end 2034 (final year of Picasso Management Plan). 1 Excludes impact of TRA and assumes 25% corporate tax rate for the terminal year, per company management. Supplementary Materials 26
Exhibit 107
CALCULATION OF FILING FEE TABLES
SC 13E3
(Form Type)
PowerSchool Holdings, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Transaction Value
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposed
Maximum Aggregate Value
of Transaction |
|
Fee
rate |
|
Amount of
Filing Fee |
|
|
|
|
Fees to Be
Paid |
|
$4,006,932,670.80 (1) |
|
0.00014760 |
|
$591,423.27 (2) |
|
|
|
|
Fees Previously
Paid |
|
|
|
|
|
$0.00 |
|
|
|
|
Total Transaction
Valuation |
|
$4,006,932,670.80 |
|
|
|
|
|
|
|
|
Total Fees Due for
Filing |
|
|
|
|
|
$591,423.27 |
|
|
|
|
Total Fees
Previously Paid |
|
|
|
|
|
$0.00 |
|
|
|
|
Total Fee
Offsets |
|
|
|
|
|
$591,423.27 (3) |
|
|
|
|
Net Fee Due |
|
|
|
|
|
$0.00 |
(1) |
Aggregate number of securities to which transaction applies: As of June 6, 2024, the maximum number of
shares of Class A Common Stock, par value $0.0001 per share (the Class A Common Stock) to which this transaction applies is estimated to be 175,742,661, which consists of (1) 166,088,147 shares of Class A Common Stock
entitled to receive the per share merger consideration of $22.80; (2) 8,270,817 shares of Class A Common Stock underlying the outstanding restricted stock units, which may be entitled to receive the per share merger consideration of $22.80; (3)
845,898 shares of Class A Common Stock underlying the outstanding market share units, which may be entitled to receive the per share merger consideration of $22.80; and (4) 537,799 shares of Class A Common Stock underlying the outstanding
performance share units, which may be entitled to receive the per share merger consideration of $22.80. |
(2) |
Estimated solely for the purpose of calculating the filing fee, the aggregate value of the transaction was
calculated by adding (a) 166,088,147 shares of Class A Common Stock, par value $0.0001 per share (the Class A Common Stock) were issued and outstanding entitled to receive the per share merger consideration, multiplied by the
per share merger consideration of $22.80, plus (b) the product of 8,270,817 shares of Class A Common Stock underlying the outstanding restricted stock units and the per share merger consideration of $22.80; plus (c) the product of
845,898 shares of Class A Common Stock underlying the outstanding market share units and the per share merger consideration of $22.80; and plus (d) the product of 537,799 shares of Class A Common Stock underlying the outstanding
performance share units and the per share merger consideration of $22.80. In accordance with Rule 0-11 of the Exchange Act, as amended, the filing fee was determined by multiplying the sum calculated
in the preceding sentence by .00014760. |
(3) |
PowerSchool Holdings, Inc. previously paid $591,423.27 upon the filing of its Preliminary Information Statement
on Schedule 14C on July 23, 2024, in connection with the transaction reported hereby. |
Table 2: Fee Offset Claims and Sources
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registrant or
Filer Name |
|
Form or
Filing Type |
|
File
Number |
|
Initial
Filing Date |
|
Filing
Date |
|
Fee Offset
Claimed |
|
Fee Paid
with Fee Offset
Source |
|
|
|
|
|
|
|
|
Fee Offset
Claims |
|
PowerSchool Holdings, Inc. |
|
PREM14C |
|
001-40684 |
|
July 23, 2024 |
|
|
|
$591,423.27 |
|
|
|
|
|
|
|
|
|
|
Fee Offset Sources |
|
PowerSchool Holdings, Inc. |
|
PREM14C |
|
001-40684 |
|
|
|
July 23, 2024 |
|
|
|
$591,423.27 (3) |
2
Grafico Azioni PowerSchool (NYSE:PWSC)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni PowerSchool (NYSE:PWSC)
Storico
Da Feb 2024 a Feb 2025